sulfadoxine has been researched along with Plasmodium falciparum Malaria in 948 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (0.21) | 18.7374 |
| 1990's | 138 (14.56) | 18.2507 |
| 2000's | 455 (48.00) | 29.6817 |
| 2010's | 278 (29.32) | 24.3611 |
| 2020's | 75 (7.91) | 2.80 |
| Authors | Studies |
|---|---|
| Fidock, DA; Flannery, EL; Winzeler, EA | 1 |
| Diarra, A; Drakeley, C; Lindsay, SW; Nébié, I; Ouedraogo, A; Ouedraogo, ZA; Sirima, SB; Sombié, S; Tiono, AB; Wilson, AL; Yaro, JB | 1 |
| Bojang, K; Cairns, M; Ceesay, SJ; Diallo, A; Dicko, A; Eloike, T; Gamougam, K; Kessely, H; Merle, C; Milligan, P; Moroso, D; Ndiaye, JL; Ogboi, JS; Ouedraogo, JB; Sagara, I; Scott, S; Snell, P; Van Hulle, S; Zongo, I | 1 |
| Cao, JP; Feng, J; Feng, XY; Huang, F; Kong, XL; Lin, KM; Xia, ZG; Yan, H; Yin, JH; Zhang, T; Zhou, SS | 1 |
| Chen, N; Chu, X; Feng, L; Li, M; Liu, Y; Wang, Q; Wang, S; Yan, P; Yang, K; Zhang, N; Zhang, Z | 1 |
| Counihan, H; de Cola, MA; Diar, MSI; Moukenet, A; Rassi, C; Richardson, S; Roca-Feltrer, A | 1 |
| Enato, IG; Ibadin, OM; Odunvbun, ME; Sadoh, AE | 1 |
| Ahuka, S; Arima, H; Chitama, BA; Culleton, R; Kaneko, O; Mita, T; Muyembe, JJ; Nundu, SS; Simpson, SV; Yamamoto, T | 1 |
| Agboraw, E; Churcher, TS; Diarra, A; Lambert, B; Lankouande, M; Lindsay, SW; Ouedraogo, A; Ouedraogo, ZA; Ranson, H; Sagnon, N; Sanou, A; Soulama, I; Tiono, AB; Traore, A; Wilson, AL; Worrall, E; Yaro, JB | 1 |
| Attaher, O; Barry, A; Dembele, AB; Diarra, BN; Dicko, A; Djimde, A; Duffy, PE; Freedman, B; Fried, M; Issiaka, D; Kanoute, MB; Levitt, B; Mahamar, A; Sagara, I; Sumner, KM; Taylor, SM; Traore, A | 1 |
| Akinyi, M; Bejon, P; de Laurent, Z; Gichuki, P; Kandie, R; Kepha, S; Kimenyi, KM; Mwandawiro, C; Ndwiga, L; Ochola-Oyier, LI; Okoyo, C; Osoti, V; Snow, RW; Wamae, K | 1 |
| Adu, B; Ahiabor, C; Anang, AK; Ariey, F; Courtin, D; Deloron, P; Frempong, NA; Houzé, S; Kusi, KA; Mama, A; Ndam, NT; Ofori, MF; Tornyigah, B | 1 |
| Kalawong, L; Khumchum, N; Kuesap, J; Suphakhonchuwong, N | 1 |
| Amone, J; Dall'Oglio, G; De Vita, E; Di Gennaro, F; Fantoni, M; Iacobelli, V; Ictho, J; L'Episcopia, M; Lochoro, P; Marotta, C; Murri, R; Ngole, B; Ogwang, J; Okori, S; Olal, L; Onapa, E; Putoto, G; Saracino, A; Segala, FV; Severini, C | 1 |
| Asante, KP; Bailey, JA; Chandramohan, D; Dosoo, DK; Greenwood, B; Niaré, K; Opoku-Mensah, J; Oppong, FB; Owusu-Agyei, S | 1 |
| Barnes, KI; Dahlström Otienoburu, S; Flegg, JA; Guerin, PJ; Hopkins Sibley, C; Humphreys, GS; Jacome-Meza, ZJ; Montanez, B; Raman, J; Strickland, T | 1 |
| Bhullar, S; Mishra, N | 1 |
| Bamadio, A; Chico, RM; Cohee, LM; Coumare, S; Dara, A; Diarra, M; Djimde, AA; Doumbo, OK; Kodio, A; Maiga, H; Opondo, C; Sagara, I; Sidibe, B; Tekete, M; Traore, OB; Traore, ZI | 1 |
| Achidi, EA; Amambua-Ngwa, A; Anchang-Kimbi, JK; Apinjoh, TO; Chi, HF; Dionne-Odom, J; Kwi, PN; Mayaba, JM; Moyeh, MN; Ntui, VN; Tangi, LN; Tita, ATN; Titanji, VPK; Toussi, CT | 1 |
| Barazorda, K; Braga, G; Delgado-Ratto, C; Gamboa, D; Joya, CA; Lizewski, SE; Lucas, C; Nolasco, O; Ricopa, L; Salas, CJ; Sanchez, JF; Valdivia, HO; Villena, FE | 1 |
| Clapp, S; Freedman, B; Green, CL; Kirui, JK; Korwa, S; Njuguna, FM; O'Meara, WP; Taylor, SM; Wu, A | 1 |
| Chenet, SM; Cortés, LJ; Guerra, AP; Lucchi, NW; Macedo de Oliveira, A; Olivera, MJ | 1 |
| Bazie, T; Beshir, KB; Bojang, K; Cairns, M; Ceesay, S; Diallo, A; Dicko, A; Doumagoum, D; Eloike, T; Gamougam, K; Kessely, H; Kolie, F; Lamine, MM; Laminou, IM; Loua, K; Maiga, H; Mansukhani, R; Merle, CS; Milligan, P; Moroso, D; Muwanguzi, J; Nader, J; NDiaye, JL; Ogboi, SJ; Ouedraogo, JB; Razafindralambo, L; Sagara, I; Scott, S; Snell, P; Sutherland, CJ; Traore, A; Zongo, I | 1 |
| Callery, JJ; Day, NPJ; Dondorp, AM; Dysoley, L; Hongvanthong, B; Imwong, M; Kouhathong, J; Madmanee, W; Mayxay, M; Newton, PN; Peto, TJ; Pongvongsa, T; Srisutham, S; Sutawong, K; Tripura, R; van der Pluijm, RW; White, NJ | 1 |
| Bal, M; Das, A; Khan, N; Pati, S; Rana, R; Ranjit, M; Sandeepta, S | 1 |
| Das, A; Das, S; Hati, AK; Nag, A; Roy, S; Sharma, MK; Tripathy, S | 1 |
| Enato, IG; Ibadin, OM; Odunvbun, ME; Osaigbovo, II; Sadoh, AE | 1 |
| Berry, A; Bidzogo Lebobo, M; Cohen, O; Eboumbou, C; Guemas, E; Iriart, X; Menard, S; Ondobo Ekae, C; Talom Ngassa, C; Tiyou Kenmeni, C; Tsague Kenfack, M | 1 |
| Ajibaye, O; Beshir, KB; Ekholuenetale, M; Maxwell, K; Olukosi, AY; Oluwagbemiga, AO; Omoniwa, O; Oresanya, O; Sutherland, CJ; Tibenderana, JK; Ujuju, C | 1 |
| Cândido, ALM; Dimbu, PR; Ferreira, CM; Fortes, F; Horth, R; Kelley, J; Labuda, S; Martins, JF; Morais, JFM; Nieto Andrade, B; Oh, JM; Pluciński, MM; Rosillo, SR; Talundzic, E | 1 |
| Achonduh-Atijegbe, O; Ali, IM; Alifrangis, M; Bigoga, JD; Chedjou, JPK; Cui, L; Evehe, MB; Fomboh, CT; Hansson, H; Hocke, EF; Jørgensen, MHM; Mbacham, WF; Niba, PTN; Nji, AM; Stresman, G | 1 |
| Bernieri, F; Cavallari, S; Doderer-Lang, C; Guidetti, C; L'Episcopia, M; Menard, D; Perrotti, E; Priuli, GB; Severini, C | 1 |
| Campino, S; Chan, C; Clark, TG; Gitaka, J; Kagaya, W; Kaneko, A; Kita, K; Kongere, J; Ngara, M; Osborne, A; Phelan, JE | 1 |
| Bantango, W; Débé, S; Ganou, A; Gansané, A; Guelbéogo, MW; Hien, EY; Ilboudo, S; Kinda, R; Ménard, D; Nonkani, WG; Sagnon, A; Sagnon, N; Siribié, M; Soré, H; Tarama, CW; Tiendrebeogo, F; Traoré, Y; Yira, K | 1 |
| Abram, A; Alruwaili, M; Eckert, E; Gutman, JR; Mbituyumuremyi, A; Munguti, K; Murindahabi, M; Piercefield, E; Sethi, R; Sullivan, DJ; Umulisa, N; Uwimana, A | 1 |
| Duah-Quashie, NO; Tandoh, KZ | 1 |
| Arikpo, I; Bissombolo, D; Doderer-Lang, C; Figueroa-Romero, A; González, R; Lemba, E; Llach, M; Ma, L; Maly, C; Mayor, A; Menard, D; Menéndez, C; Meremikwu, M; Nhama, A; Pagnoni, F; Pons-Duran, C; Rakotosaona, R; Ratsimbasoa, A; Roman, E; Sacoor, C; Sanz, S | 1 |
| Benjamin, JM; Davis, TME; Kasian, B; Kong, C; Laman, M; Moore, BR; Mueller, I; Ome-Kaius, M; Robinson, LJ; Rogerson, S; Tobe, R; Yadi, G | 1 |
| Jally, S; Kattenberg, E; Mueller, I; Ome-Kaius, M; Pomat, W; Robinson, LJ; Rogerson, SJ; Rosanas-Urgell, A; Umbers, AJ; Unger, HW | 1 |
| Feng, L; Qi-Cheng, Z | 1 |
| Attaher, O; Barry, A; Cisse, KB; Coulibaly, B; Dembele, A; Diarra, BS; Diarra, K; Dicko, A; Duffy, PE; Fried, M; Issiaka, D; Kanoute, MB; Keita, S; Kwan, JL; Mahamar, A; Samassekou, MB; Sissoko, S; Traore, T; Zaidi, I | 1 |
| Aydemir, O; Bailey, JA; Bhatt, S; Brazeau, NF; Carrel, M; Deutsch-Feldman, M; Juliano, JJ; Kashamuka, M; Meshnick, SR; Taylor, SM; Tshefu, AK; Verity, R | 1 |
| Aponte, JJ; Cisteró, P; Cot, M; Desai, M; González, R; Gupta, H; Huijben, S; Kariuki, S; Macete, E; Massougbodji, A; Mayor, A; Menéndez, C; Mombo-Ngoma, G; Mwangoka, G; Ndam, NT; Ramharter, M; Shi, YP; Uberegui, E | 1 |
| Chen, X; Huang, Y; Li, C; Lu, Y; Pi, L; Qin, P; Qin, Y; Rosenthal, BM; Si, Y; Wang, S; Xiang, Z; Yang, G; Yang, Z; Zeng, W; Zhang, Y; Zhao, L | 1 |
| Abuaku, B; Anto, F; Aydemir, O; Bailey, J; Ghansah, A; Hathaway, NJ; Marsh, PW; Mensah, BA; Myers-Hansen, JL; Opoku, M | 1 |
| Day, NPJ; Dondorp, AM; Imwong, M; Kunasol, C; Mathema, VB; Prempree, P; Sudathip, P; Sugaram, R; Suwannasin, K | 1 |
| Freedman, B; Kalilani-Phiri, L; Khairallah, C; Levitt, B; Madanitsa, M; Meshnick, SR; Mwapasa, V; Taylor, SM; Ter Kuile, FO; Thwai, KL | 1 |
| Boncy, J; Chang, MA; Druetz, T; Eisele, TP; Elismé, T; Existe, A; Hamre, KES; Herman, C; Huber, CS; Lemoine, JF; Mace, KE; Mondélus, G; Pierre, B; Présumé, J; Rogier, E; Romilus, I; Udhayakumar, V | 1 |
| Aydemir, O; Bailey, JA; Brazeau, NF; Conrad, M; Denton, M; Fulton, T; Ghani, AC; Ghansah, A; Gutman, J; Hathaway, NJ; Ishengoma, DS; Juliano, JJ; Marsh, PW; Mensah, BA; Meshnick, SR; Morgan, AP; Moss, WJ; Mulenga, M; Mwandagalirwa, MK; Myers-Hansen, JL; Ngondi, J; Norris, DE; Parr, JB; Rosenthal, PJ; Thwai, K; Tshefu, AK; Tumwebaze, PK; Verity, R; Watson, OJ | 1 |
| Agola, EL; Gikunju, SW; Kimani, F; King, C; Kinyua, J; LaBeaud, AD; Malhotra, I; Mutuku, F; Ondondo, RO; Thiong'o, K | 1 |
| Anvikar, AR; Ashley, EA; Chandramohan, D; Cohee, LM; D'Alessandro, U; Genton, B; Gilder, ME; Guérin, PJ; Juma, E; Kalilani-Phiri, L; Kennon, K; Kuepfer, I; Laufer, MK; Lwin, KM; Mansoor, R; McGready, R; Meshnick, SR; Mosha, D; Mwapasa, V; Mwebaza, N; Nambozi, M; Ndiaye, JA; Nosten, F; Nyunt, M; Ogutu, B; Parikh, S; Paw, MK; Phyo, AP; Pimanpanarak, M; Piola, P; Rijken, MJ; Saito, M; Sriprawat, K; Stepniewska, K; Tagbor, HK; Tarning, J; Tinto, H; Valéa, I; Valecha, N; White, NJ; Wiladphaingern, J | 1 |
| Bwire, GM; Kilonzi, M; Mikomangwa, WP | 1 |
| Bojang, K; Cairns, M; Coulibaly, SO; Desai, M; Ghani, ACH; Griffin, JT; Gutman, J; Hill, J; Kalilani-Phiri, L; Kariuki, S; Kayentao, K; Khairallah, C; Madanitsa, M; Meshnick, SR; Mwapasa, V; Slater, H; Tagbor, H; Taylor, S; Ter Kuile, FO; Walker, PGT; Williams, JE | 1 |
| Diwan, V; Gawariker, S; Mårtensson, A; Pathak, A; Purohit, M; Sharma, A; Ursing, J | 1 |
| Djontu, JC; Leke, RGF; Lloyd, YM; Megnekou, R; Salanti, A; Seumko'o, RMN; Taylor, DW | 1 |
| Adebusuyi, SA; Adedokun, SA; Amoo, AOJ; Fagbemi, KA; Nderu, D; Ojurongbe, O; Pallerla, SR; Thomas, BN; Velavan, TP | 1 |
| Accrombessi, M; Briand, V; Cot, M; Cottrell, G; Fievet, N; Hounkonnou, CPA; Mama, A; Massougbodji, A; Ndam, NT; Sossou, D; Vianou, B; Yovo, E | 1 |
| Boncy, J; Chang, MA; Hamre, KES; Lemoine, JF; Mace, K; Namuyinga, R; Pierre, B; Rogier, EW; Udhayakumar, V | 1 |
| Bridges, DJ; Chipeta, J; Chizema-Kawesha, E; Daniels, RF; Eisele, TP; Hamainza, B; Hawela, MB; Lindtjorn, B; Miller, JM; Mudenda-Chilufya, M; Mwenda, MC; Nerland, AH; Sitali, L | 1 |
| Abdelbagi, H; Ahmed, A; Ahmed, AE; Ali, MS; Ali, Y; Edris, YB; Elsadig, AR; Mohamed, NS; Mohammed, AA; Mustafa, M; Omer, RA; Osman, EY; Osman, HA; Osman, MM; Sibley, CH; Siddig, EE; Yousif, AM | 1 |
| Bazié, DLC; Coulibaly-Traoré, M; Kirakoya-Samadoulougou, F; Natama, HM; Samadoulougou, S; Tinto, H; Toussaint, R | 1 |
| Amimo, F; Hashizume, M; Lambert, B; Magit, A; Sacarlal, J; Shibuya, K | 1 |
| Cheng, W; Jiang, T; Li, J; Tan, H; Wu, K; Yao, Y | 1 |
| Abdulhaq, AA; Al-Mekhlafi, HM; Anwar, AA; Atroosh, WM; Eisa, ZM; Ghailan, KY; Ghzwani, AH; Madkhali, AM; Zain, KA | 1 |
| Ategeka, J; Chandramohan, D; Clark, TD; Dorsey, G; Havlir, DV; Jagannathan, P; Kajubi, R; Kakuru, A; Kamya, MR; Nakalembe, M; Ochieng, T; Ochokoru, H; Roh, ME; Ruel, T; Staedke, SG | 1 |
| Abuaku, B; Ahorlu, C; Awandare, G; Ghansah, A; Koram, KA; Mensah, BA; Myers-Hansen, JL; Ngwa, AA; Oyebola, MK; Wilson, MD | 1 |
| Cheng, W; Dong, H; Fu, X; Huang, Y; Jiang, T; Li, J; Shen, C; Sun, Y; Wei, W; Wu, K | 1 |
| Abdoulaye Louis Padounou, M; Adamou, R; Courtin, D; Diallo, A; Ibrahim, ML; Mahaman Moustapha, L; Ndiaye, JLA; Testa, J | 1 |
| Afutu, LL; Boampong, JN; Quashie, NB | 1 |
| Ajogbasile, FV; Akano, K; Eromon, PJ; Folarin, OA; Happi, CT; Kayode, AT; Oluniyi, PE; Sowunmi, A; Uwanibe, JN; Wirth, DF | 1 |
| Bruce, J; Chandramoha, D; Chaponda, EB; Matthew Chico, R; Mharakurwa, S; Michelo, C | 1 |
| Adeothy, A; Dagnon, F; Halsey, ES; Houngbo, E; Kpemasse, A; Lucchi, NW; Patton, ME; Saliou, R; Sianou, A; Svigel, SS; Tchevoede, A; Udhayakumar, V | 1 |
| Ambrose, T; Mbotwa, CH; Moshi, FV; Mushi, V; Zacharia, A | 1 |
| Alifrangis, M; Bygbjerg, IC; Hansson, H; Jensen, RW; Lusingu, JPA; Minja, DTR; Moeller, SL; Msemo, OA; Nag, S; Schmiegelow, C; Theander, TG; Yde, AM | 1 |
| Agongo, G; Amenga-Etego, LN; Asoala, V; Awandare, GA; Goncalves, S; Jacob, C; Kwiatkowski, D; Rockett, KA | 1 |
| Andemel, N; Attaher, O; Barry, A; Dembele, AB; Diarra, BS; Dicko, A; Duffy, PE; Fried, M; Gaoussou, S; Keita, S; Mahamar, A; Sidibe, Y; Swihart, B; Traore, M | 1 |
| Agyeman, YN; Annor, RB; Newton, S; Owusu-Dabo, E | 1 |
| Das, S; Hati, AK; Kar, A; Mandal, S; Manna, S; Saha, B | 1 |
| DeMol, P; Devleesschauwer, B; Hayette, MP; Kabututu, PZ; Kayiba, NK; Lusamba, PD; Mukomena, ES; Mvumbi, DM; Mvumbi, GL; Rosas-Aguirre, A; Speybroeck, N; Tchakounang, VRK; Yobi, DM | 1 |
| Belem, AMG; Chandramohan, D; Cohuet, A; Compaoré, YD; Greenwood, B; Lefèvre, T; Nikièma, F; Ouattara, SB; Ouédraogo, JB; Tinto, H; Yaméogo, KB; Yao, FA; Yerbanga, RS; Zongo, I | 1 |
| Corral, MG; Leroux, J; Mylne, JS; Stubbs, KA | 1 |
| Abdel Hamid, MM; Adam, MA; Elkando, NS; Elnour, FAA; Malik, EM; Mohamed, AO; Mohamed, OS; Suliman, A | 1 |
| d'Alessandro, U; de Jong, MD; Derra, K; Geskus, RB; Lompo, P; Mens, PF; Ruizendaal, E; Schallig, HDFH; Scott, S; Tahita, MC; Tinto, H; Traore-Coulibaly, M; Versteeg, I | 1 |
| Achidi, EA; Anchang-Kimbi, JK; Mendimi, JN; Nkegoum, B; Sverremark-Ekström, E; Troye-Blomberg, M | 1 |
| Chatterjee, M; Ganguly, S; Guha, SK; Maji, AK; Saha, P | 1 |
| Ali, NA; Bharti, PK; Dhariwal, AC; Kashyotia, SS; Kumar, A; Mishra, S; Shukla, MM; Singh, N | 1 |
| Bailey, JA; Doctor, SM; Gutman, J; Hathaway, NJ; Ishengoma, DS; Juliano, JJ; Kaspar, N; Keeler, C; Kitojo, C; Lalji, S; Meshnick, SR; Mkude, S; Munishi, OM; Ngondi, JM; Paxton, LA; Thwai, KL; Willilo, RA | 1 |
| Clark, RL | 1 |
| Amambua-Ngwa, A; Awolola, TS; Idowu, ET; Olukosi, YA; Oyebola, KM | 1 |
| Baiwog, F; Davis, TME; Ilett, KF; Karunajeewa, HA; Kose, K; Mueller, I; Page-Sharp, M; Rogerson, SJ; Salman, S; Siba, PM | 1 |
| Bhagavathula, AS; Gebreyohannes, EA; Seid, MA; Tegegn, HG | 1 |
| Bhadhuria, S; Bhatta, RS; Bhosale, VV; Chandasana, H; Chhonker, YS; Choudhary, SC; Gaur, SPS; Jain, GK; Kumar, D; Sharma, S; Singh, RK; Sonkar, SK; Vaish, AK; Vaish, S | 1 |
| Griffin, JT; Okell, LC; Roper, C | 1 |
| Mens, PF; Ruizendaal, E; Schallig, HDFH; Tahita, MC; Tinto, H; Traoré-Coulibaly, M | 1 |
| Boudová, S; Divala, T; Laufer, MK; Mawindo, P; Mungwira, R; Tomoka, T | 1 |
| Aweeka, F; Conrad, MD; Dorsey, G; Foster, M; Havlir, DV; Huang, L; Jagannathan, P; Kakuru, A; Kamya, MR; Legac, J; Mota, D; Nayebare, P; Rosenthal, PJ; Tukwasibwe, S; Tumwebaze, P; Wallender, E; Whalen, M | 1 |
| Bansal, D; Bharti, PK; Bhattacharyya, DR; Mahanta, J; Mohapatra, PK; Parida, P; Sarma, K; Sarmah, NP; Sehgal, R; Singh, N; Sultan, AA | 1 |
| Bateko, JP; Imir, T; Ruh, E; Taylan-Ozkan, A | 1 |
| Falade, CO; Fayemiwo, SA; Meyer, CG; Nguetse, CN; Ojurongbe, O; Ojurongbe, TA; Thomas, BN; Velavan, TP | 1 |
| Berens-Riha, N; Esu, E; Gai, P; Loescher, T; Meremikwu, M; Pritsch, M; Tacoli, C | 1 |
| Choi, L; Garner, P; Gelband, H; Graves, PM | 1 |
| Bousema, T; Bradley, J; Brown, JM; Chen, I; Diarra, K; Diawara, H; Dicko, A; Drakeley, C; Gosling, R; Hwang, J; Issiaka, D; Keita, S; Kone, DT; Lanke, K; Mahamar, A; McCulloch, C; Müller, O; Roh, ME; Sanogo, K; Soumare, HM; Srinivasan, V; Stone, WJR; Traore, SF | 1 |
| Allen, EN; Barnes, KI; Bell, DJ; de Kock, M; Denti, P; Djimde, AA; Tarning, J; Tekete, MM; Ward, SA; Workman, L | 1 |
| Amambua-Ngwa, A; Bouriema, SH; D'Alessandro, U; Fandeur, T; Grais, RF; Guérin, PJ; Laminou, IM; Langendorf, C; Makarimi, R; Sibley, CH; Woi-Messe, L | 1 |
| Adibe, MO; Aguwa, NC; Igboeli, NU; Ukwe, CV | 1 |
| Abdelbagi, H; Basheir, HM; Boshara, SA; Chen, I; Elobied, ME; Elsafi, HMH; Gosling, R; Gumaa, SA; Hamid, MMA; Hamid, T; Ley, B; Mahgoub, NS; Marfurt, J; Price, RN; Thriemer, K | 1 |
| Alifrangis, M; Magnussen, P; Osarfo, J; Tagbor, H | 1 |
| Kestens, L; Mens, PF; Natama, HM; Rosanas-Urgell, A; Rovira-Vallbona, E; Sawadogo, O; Schallig, HDFH; Scott, S; Somé, MA; Sorgho, H; Tinto, H; Traoré-Coulibaly, M; Valéa, I; Zango, SH; Zongo, SC | 1 |
| Awantang, GN; Babalola, SO; Fox, KA; Koenker, H; Lewicky, N; Toso, M | 1 |
| Aydemir, O; Bailey, JA; Emch, M; Ghani, AC; Ghansah, A; Greenhouse, BR; Hathaway, NJ; Janko, M; Juliano, JJ; Marsh, PW; Meshnick, SR; Mwandagalirwa, MK; Reimonn, T; Tessema, SK; Tran, A; Tshefu, AK; Verity, R | 1 |
| Anvikar, A; Goomber, S; Mishra, N; Valecha, N; Yadav, CP | 1 |
| Anvikar, AR; Arya, T; Bruce, J; Chandramohan, D; Greenwood, B; Kuepfer, I; Mishra, DR; Mishra, N; Mishra, V; Mohanty, R; Mohanty, S; Sharma, S; Srivastava, B; Valecha, N | 1 |
| Berens-Riha, N; Esu, E; Loescher, T; Meremikwu, M; Nwachuku, N; Pritsch, M | 1 |
| Aweeka, F; Beeson, J; Charlebois, ED; Clark, TD; Dorsey, G; Drakeley, C; Feeney, ME; Greenhouse, B; Havlir, DV; Jagannathan, P; Kakuru, A; Kamya, MR; Muhindo, MK; Nakalembe, M; Nankya, F; Natureeba, P; Okiring, J; Olwoch, P; Opira, B; Prahl, M; Reiling, L; Rodriguez-Barraquer, I; Ssewanyana, I; Tetteh, K; Wallender, E | 1 |
| Bi Shamamba, SK; Latour, C; Losimba Likwela, J; Matendo Kakina, L; Moke Mbongi, D; Muepu Tshilolo, L; Ngoyi Mumba, D; Nkoli Mandoko, P; Parzy, D; Rouvier, F; Sinou, V; Tamfum Muyembe, JJ | 1 |
| Al-Harthi, SA | 1 |
| Deloron, P; Dhiab, J; Jafari-Guemouri, S; Massougbodji, A; Tuikue, NN | 1 |
| Aguilar, R; Alonso, PL; Aponte, JJ; Barbosa, A; Bassat, Q; Berthoud, T; Dobaño, C; Doolan, DL; Groves, PL; Guinovart, C; Jiménez, A; Manaca, MN; Nhabomba, AJ; Quintó, L; Rodríguez, MH; Santano, R | 1 |
| Feng, Z; Gurski, K; Manore, CA; Peace, A; Prosper, O; Teboh-Ewungkem, MI | 1 |
| Baliga, S; Boloor, A; Devi, R; Gai, P; Gai, PP; Jain, A; Kulkarni, SS; Mahabala, C; Mockenhaupt, FP; Rasalkar, R; Shenoy, D; Siegert, K; Tacoli, C; Wedam, J | 1 |
| Kilonzi, M; Marealle, AI; Mbwambo, DP; Mikomangwa, WP; Mlyuka, HJ; Mutagonda, RF | 1 |
| Boxberger, M; Gaillard, T; Madamet, M; Pradines, B | 1 |
| Djimde, AA; Djimde, M; Doumbo, OK; Fofana, B; Jacobs, J; Mgina, EJ; Niangaly, H; Sagara, I; Samouda, H; Sombie, SB; Tekete, M; Vaillant, M | 1 |
| Amimo, F; Lambert, B; Magit, A; Moon, TD; Nomura, S; Sacarlal, J | 1 |
| John-Stewart, G; Juma, DW; Kamau, E; Muiruri, P; Ottichilo, R; Polyak, C; Singa, B; Waitumbi, J; Yuhas, K | 1 |
| Ategeka, J; Clark, TD; Dorsey, G; Havlir, DV; Jagannathan, P; Kajubi, R; Kakuru, A; Kamya, MR; Nakalembe, M; Nayebare, P; Ochieng, T; Ochokoru, H; Opira, B; Ruel, T | 1 |
| Chen, J; Du, W; Eyi, JUM; Fu, H; Jiang, T; Li, J; Lin, M; Matesa, RA; Obono, MMO; Tan, H; Wu, K; Yao, Y | 1 |
| Desai, M; Gutman, J; Hopkins Sibley, C; Kayentao, K; Khairallah, C; Koshy, G; Larsen, DA; Meshnick, SR; Okell, LC; Rogerson, SJ; Roper, C; Slaughter, DEC; Taylor, SM; Ter Kuile, FO; van Eijk, AM | 1 |
| Abdallah, WME; Abdel Hamid, MM; Ahmed, ME; Hussien, M; Malik, EM; Mohamed, AO; Mohammed, NM | 1 |
| Buffet, C; Karahalios, A; Khairallah, C; Kuile, FOT; Madanitsa, M; Mwapasa, V; Narum, DL; Phiri, LK; Randall, LM; Rogerson, SJ; Teo, A | 1 |
| Baker, DA; Benavente, ED; Campino, S; Clark, TG; Ravenhall, M; Sutherland, CJ | 1 |
| Abdel-Muhsin, AA; Abdelraheem, MH; Al Dhuhli, A; Al Hosni, A; Al Rubkhi, M; Al-Hamidhi, S; Babiker, HA; Bakhiet, AMA; Gadalla, A; Gismelseed, L; Kheir, A; Mukhtar, M; Naiem, A; Omer, S; Sultan, AA | 1 |
| Biswas, A; Das, S; Ganguly, S; Guha, SK; Kundu, PK; Maji, AK; Saha, P | 1 |
| Ashorn, P; Cheung, YB; Kulmala, T; Luntamo, M; Maleta, K | 1 |
| Kleinschmidt, I; Tsoka-Gwegweni, JM | 1 |
| Awab, GR; Day, NP; Dondorp, AM; Imwong, M; Jamornthanyawat, N; Pukrittayakamee, S; White, NJ; Woodrow, CJ; Yamin, F | 1 |
| Benito, A; Berzosa, P; Charle, P; de Lucio, A; Nseng Nchama, G; Raso, J | 1 |
| Anglewicz, PA; Bennett, A; Eisele, TP; Keating, J; Larsen, DA; Steketee, RW; Yukich, J | 1 |
| Aponte, JJ; Bardají, A; Eckert, E; Gutman, J; Mangiaterra, V; Menéndez, C; Nahlen, B; Slutsker, L | 1 |
| Anvikar, A; Juliano, JJ; MacDonald, PD; Meshnick, SR; Mishra, N; Poole, C; Schapira, A; Shah, NK; Srivastava, B; Valecha, N | 1 |
| Abiola, A; Alifrangis, M; Dieng, Y; Faye, B; Gaye, O; Hallett, R; Lo, AC; Ndiaye, D; Ndiaye, JL; Ndiaye, M; Sylla, K; Tine, R | 1 |
| Abiola, A; Ba, el-H; Cairns, M; Cisse, B; Dieng, Y; Faye, B; Faye, O; Gaye, O; Gomis, JF; Hallett, R; Lo, AC; Milligan, P; Ndiaye, D; Ndiaye, JL; Ndiaye, M; Ndir, O; Sokhna, C; Sutherland, C; Tine, R | 1 |
| Azagnandji, C; Bello, M; Chippaux, JP; d'Almeida, S; Kinde Gazard, D; Koussihoude, L; Massougbodji, A; Ndam, NT; Ogouyèmi-Hounto, A; Ollo, E | 1 |
| Bonaparte, F; Hobday, K; Kelly, PM; Martins, JS; Zwi, AB | 1 |
| Rogerson, SJ | 1 |
| Barrera, SM; Cucunubá, ZM; Guerra, AP; Hernández, DC; Nicholls, RS | 1 |
| Alifrangis, M; De Tove, YS; Deloron, P; Doritchamou, J; Luty, AJ; Massougbodji, A; Moussiliou, A; Ndam, NT | 1 |
| Anchang-Kimbi, JK; Bissemou, ZB; Kimbi, HK; Lehman, LG; Nyabeyeu, HN; Tonga, C | 1 |
| Ali, D; Gutman, J; Mathanga, DP; Mwandama, D; Skarbinski, J; Wiegand, RE | 1 |
| Anvikar, AR; Das, MK; Mishra, N; Ratha, J; Shah, NK; Sharma, SK; Srivastava, B; Srivastava, P; Valecha, N | 1 |
| Abdallah, TM; Adam, I; Atwal, S; Gadalla, NB; Sutherland, CJ | 1 |
| Dara, A; Djimdé, A; Doumbo, OK; Doumbo, S; Doumtabé, D; Kayentao, K; Ongoiba, OA; Ouologuem, TD; Traoré, B | 1 |
| Marma, AS; Mita, T; Nakamura, M; Ohashi, J; Plowe, CV; Tanabe, K; Venkatesan, M | 1 |
| Bata, GG; Boulay, A; Gondje, S; Kazanji, M; Le-Fouler, L; Manirakiza, A; Moussa, S; Moyen, JM; Sakanga, O; Sepou, A; Serdouma, E; Vray, M | 1 |
| Alifrangis, M; Plowe, CV; Roper, C; Venkatesan, M | 1 |
| Dondorp, AM; Faiz, MA; Hien, TT; Mokuolu, OA; Pukrittayakamee, S; White, NJ | 1 |
| Flegg, JA; Gharbi, M; Guerin, PJ; Hopkins Sibley, C; Metcalf, CJE; Shewchuk, T; Venkatesan, M | 1 |
| Naidoo, I; Roper, C | 2 |
| Hailemeskel, E; Kassa, M; Kebede, A; Mohammed, H; Petros, B; Sleshi, M; Taddesse, G; Tasew, G; Woyessa, A | 1 |
| Chandramohan, D; Chico, RM; Hack, BB; Newport, MJ; Ngulube, E | 1 |
| Azagnandji, C; Bello, M; Chippaux, JP; Fadégnon, G; Kinde Gazard, D; Massougbodji, A; Moussiliou, A; Ndam, NT; Ogouyèmi-Hounto, A | 1 |
| Akouete, F; Akpaloo, Y; Caumes, E; D'Almeida, S; Kendjo, E; Klement, E; Patassi, A; Pitché, P; Prince-Agbodjan, S; Singo, A; Tossa, K | 1 |
| Abdul-Ghani, R; Allam, AF; Farag, HF; Shawky, SM | 1 |
| Aguilar, R; Alonso, PL; Arese, P; Barbosa, A; Dobaño, C; Guinovart, C; Manaca, MN; Marrocco, T; Nhabomba, A; Quintó, L; Schwarzer, E; Skorokhod, OA | 1 |
| Bouyou-Akotet, MK; Kombila, M; Mawili-Mboumba, DP | 1 |
| D'Alessandro, U; Drabo, MK; Guiguemde, RT; Henry, MC; Huybregts, L; Kolsteren, P; Roberfroid, D; Tinto, H; Valea, I | 1 |
| Macedo De Oliveira, A; Rodriguez, B; Soto, AM; Sridaran, S; Udhayakumar, V | 1 |
| Awad, AI; Elamin, SB; Matar, KM | 1 |
| Aguilar, R; Alonso, PL; Aponte, JJ; Barbosa, A; Bassat, Q; Chitnis, CE; Cisteró, P; Dobaño, C; Guinovart, C; Jiménez, A; Manaca, MN; Mayor, A; Nhabomba, AJ; Quintó, L; Rodríguez, MH | 1 |
| Kalinga, A; Kauki, JS; Kavishe, AA; Kavishe, RA; Matondo, SI; Reyburn, H; Temba, GS; van Zwetselaar, M | 1 |
| Dent, AE; Goldenberg, RL; Hudgens, M; King, CL; Lazebnik, N; McClure, EM; Meshnick, SR; Mungai, P; Siega-Riz, AM | 1 |
| Arinaitwe, E; Baliraine, FN; Conrad, MD; Dorsey, G; Greenhouse, B; Kamya, M; Mbogo, GW; Nankoberanyi, S; Nsobya, SL; Rosenthal, PJ; Staedke, SG; Tappero, J; Tukwasibwe, S | 1 |
| Chase, RP; Gutman, J; Hendler, N; Khamis, AR; Kitojo, C; McElroy, PD; Msellem, MI; Plotkin, M; Roman, E; Said, K; Schwartz, AC | 1 |
| Chalwe, V; Craig, AS; Filler, SJ; Kamuliwo, M; Katalenich, BL; Mace, KE; Meshnick, SR; Nambozi, M; Tan, KR; Taylor, SM; Wiegand, RE | 1 |
| Antonia, AL; Chaluluka, E; Duffy, PE; Fried, M; Goheen, MM; Harrington, WE; Kabyemela, E; Kalilani-Phiri, L; Khairallah, C; Madanitsa, M; Meshnick, SR; Mwapasa, V; Rogerson, SJ; Taylor, SM; Ter Kuile, FO; Tshefu, AK | 1 |
| Chilongola, J; Genton, B; Mosha, D; Mwingira, F; Ndeserua, R | 1 |
| Garner, P; Gelband, H; Graves, PM | 3 |
| Borkowsky, W; Chakravarty, S; Chen, J; Conteh, S; Donnelly, L; Duffy, PE; Healy, S; Hinderer, J; Hobbs, CV; Hoffman, SL; Lambert, L; Marsh, K; Neal, J; Orr-Gonzalez, S; Penzak, SR | 1 |
| Anvikar, AR; Bharti, RS; Dev, V; Dhariwal, AC; Kaitholia, K; Mishra, N; Narayan, JP; Phookan, S; Rana, R; Shah, NK; Sonal, GS; Srivastava, B; Valecha, N | 1 |
| Ahmed, MA; Bhattacharyya, DR; Bora, K; Goswami, BK; Mahanta, J; Mohapatra, PK; Prakash, A; Sarma, B; Sarma, DK | 1 |
| Basuki, S; Dachlan, YP; Riyanto, S; Uemura, H | 1 |
| Akindeh-Nji, M; Ali, IM; Atogho-Tiedeu, B; Baldip, K; Diakite, M; Domkam, IK; Evehe, MS; Lamb, T; Mbacham, WF; Mimche, PN; Netongo, PM; Ngora, H; Ranford-Cartwright, L | 1 |
| Bamba, S; Bayane, D; Cisse, M; Guiguemde, RT; Lougue, G; Sangare, I | 1 |
| Ako, BA; Bassinka, I; Beourou, S; Bokossa, EM; Coulibaly, B; Coulibaly, MA; Esmel, B; Gba, B; Gbessi, EA; Koffi, D; Kone, PL; N' Guessan, LT; Nogbou, M; Soumahoro, A; Swa, T; Toure, OA | 1 |
| Ali, D; Chaluluka, E; Dzinjalamala, F; Gutman, J; Kalilani, L; Khairallah, C; Madanitsa, M; Mathanga, DP; Meshnick, S; Mwandama, D; Shi, YP; Skarbinski, J; Taylor, S; ter Kuile, FO; Thwai, KL; Wiegand, RE; Zhou, Z | 1 |
| Amran, JG; Arale, AM; Barrette, A; Elmi, HH; Hassan, AM; Jibril, AM; Mohammady, HE; Muse, A; Nada, RA; Omar, AS; Warsame, M; Yusuf, FE | 1 |
| Djadid, ND; Pirahmadi, S; Raeisi, A; Rouhani, M; Zakeri, S | 1 |
| Artimovich, E; Dzinjalamala, FK; Escalante, AA; Kublin, JG; Laufer, MK; Plowe, CV; Schneider, K; Takala-Harrison, S; Taylor, TE | 1 |
| Dondorp, A; von Seidlein, L | 1 |
| Beavogui, AH; Dama, S; Dara, A; Dembele, D; Diallo, N; Djimde, AA; Doumbo, OK; Maiga, H; N'Dong, C; Niangaly, H; Sagara, I; Sangare, CP; Tekete, M; Toure, O; Traore, OB; Traore, ZI | 1 |
| Chalwe, V; Craig, AS; Filler, SJ; Kamuliwo, M; Katalenich, BL; Mace, KE; Mubikayi, L; Mulele, CK; Nambozi, M; Tan, KR; Wiegand, RE | 1 |
| Barnwell, JW; Goldman, IF; Kariuki, S; Komino, F; Ljolje, D; Lucchi, NW; Okoth, SA; Onyona, P; Shi, YP; Udhayakumar, V | 1 |
| Bakoua, D; Fesser, A; Koukouikila-Koussounda, F; Nkombo, M; Ntoumi, F; Vouvoungui, C | 1 |
| Chipeta, J; Mharakurwa, S; Michelo, C; Siame, MN; Thuma, P | 1 |
| Abdallah, J; Gutman, J; Iriemenam, NC; Mathanga, DP; Mwandama, D; Shi, YP; Skarbinski, J; Wiegand, RE | 1 |
| Batty, KT; Benjamin, JM; Davis, TM; Lorry, L; Moore, BR; Mueller, I; Page-Sharp, M; Robinson, LJ; Salman, S; Siba, PM; Tawat, S; Yadi, G | 1 |
| Kamchonwongpaisan, S; Sirawaraporn, W; Talawanich, Y; Yuthavong, Y | 1 |
| Brown, GV; Hasang, W; Mueller, I; Randall, LM; Rogerson, SJ; Siba, PM; Teo, A; Unger, HW | 1 |
| Abate, L; Awono-Ambéné, PH; Berry, A; Chauvin, P; Iriart, X; Menard, S; Morlais, I; Nsango, SE; Tchioffo, MT | 1 |
| Cot, M; Denoeud-Ndam, L; Ezinmegnon, S; Girard, PM; Ibitokou, SA; Ladékpo, R; Luty, AJ; Massougbodji, A; Ndam, NT; Zannou, DM | 1 |
| Bejon, P; Gitonga, CW; Karuri, SW; Kibuchi, E; Mwandawiro, C; Noor, AM; Sang, G; Snow, RW | 1 |
| Anvikar, AR; Gupta, R; Kumar, A; Mishra, N; Rana, R; Srivastava, B; Tyagi, PK; Valecha, N | 1 |
| Alifrangis, M; Birungi, J; Magnussen, P; Malamba, S; Mbonye, AK; Shokoples, S; Yanow, SK | 1 |
| Bardají, A; Ferenchick, E; Mangiaterra, V; Menéndez, C; Roman, E | 1 |
| Bahamontes-Rosa, N; Bouyou-Akotet, MK; Kombila, M; Mawili-Mboumba, DP; Nzong, J; Tshibola, ML; Tsoumbou-Bakana, G | 1 |
| Duffy, PE; Fried, M; Harrington, WE | 1 |
| Gutman, J; Meshnick, SR; Taylor, S; Ter Kuile, FO | 1 |
| Anvikar, A; Chandra, J; Gahlawat, SK; Gupta, P; Kumar, A; Moirangthem, R; Singh, V; Valecha, N | 1 |
| Ariti, C; Cano, J; Chandramohan, D; Chico, RM; Collier, TJ; Greenwood, B; Roper, C | 1 |
| D'Alessandro, U; Erhart, A; Fitzhenry, R; Guiguemde, RT; Kazienga, A; Ouedraogo, JB; Rosanas-Urgell, A; Tahita, MC; Tinto, H; Van Geertruyden, JP; VanOvermeir, C | 1 |
| Adak, T; Dang, AS; Dykes, CL; Lather, M; Sharma, D; Singh, OP | 1 |
| Guma, GT; Kassa, M; Kebede, A; Leta, GT; Mohammed, H; Petros, B; Tessema, SK; Woyessa, A | 1 |
| Anna, F; Christevy, VJ; Damien, B; Felix, KK; Francine, N; Michael, K | 1 |
| Adeel, AA; AlDarsi, M; Aljasari, A; AlMahdi, A; Almohager, AM; Atta, H; Barrette, A; Galab, MH; Mahammed, MH; Mohammady, HE; Nada, RA; Saeed, NA; Salaeah, YA; Warsame, M; Zamani, G | 1 |
| Basu, A; Guha, SK; Saha, S | 1 |
| Auma, A; Bigira, V; Bowen, K; Boyle, MJ; Dorsey, G; Farrington, LA; Feeney, ME; Jagannathan, P; Kamya, MR; Kapisi, J; McIntyre, TI; Nalubega, M; Naluwu, K; Nankya, F; Sikyomu, E; Vance, HM; Wamala, S | 1 |
| Bamaga, OA; Lim, YA; Mahdy, MA | 1 |
| Babakhanyan, A; Bobbili, N; Fogako, J; Leke, RG; Leke, RJ; Salanti, A; Taylor, DW; Tutterrow, YL; Wey, A | 1 |
| Benoit-Vical, F; Berry, A; Cissé, NH; Coulibaly, CO; Dara, A; Djimdé, AA; Doumbo, OK; Guindo, CO; Niaré, K; Ringwald, P; Sagara, I; Sissoko, MS | 1 |
| Alim, F; Awab, GR; Day, NP; Dondorp, AM; Hanpithakpong, W; Imwong, M; Pukrittayakamee, S; Tarning, J; White, NJ; Woodrow, CJ | 1 |
| Tarning, J | 1 |
| Carlton, JM; Chauhan, K; Das, A; Kar, NP; Kumar, A; Nanda, N | 1 |
| Kalilani, L; Khairallah, C; Meshnick, SR; Mwapasa, V; Patel, JC; Taylor, SM; Ter Kuile, FO; Thwai, KL | 1 |
| Bass, JK; Bigira, V; Boivin, MJ; Dorsey, G; Familiar-Lopez, I; Kamya, M; Kapisi, J; Muhindo, M; Nakasujja, N; Opoka, RO; Ruiseñor-Escudero, H; Sikorskii, A | 1 |
| Caillet, C; Guerin, PJ; Newton, PN | 1 |
| Abd-Elmajid, MB; Adam, MA; Adeel, AA; Ali, MS; Atta, H; Barrette, A; Elhelo, MM; Elmardi, KA; Elnour, FA; Mohammady, HE; Nada, RA; Warsame, M; Zamani, G | 1 |
| Al-Jasari, A; Al-Mekhlafi, HM; Atroosh, WM; Lau, YL; Nasr, NA; Sady, H; Snounou, G; Surin, J | 1 |
| de Jager, C; Hongoro, C; Longwe, H; Mutero, CM; Mwendera, C; Phiri, K | 1 |
| Almeida-de-Oliveira, NK; Daniel-Ribeiro, CT; Ferreira-da-Cruz, Mde F; Fortes, F; Gama, BE; Gomes, LR; Kaingona-Daniel, EP; Ménard, D | 1 |
| Ambounda, N; Bouyou-Akotet, MK; Kendjo, E; Kombila, M; Mawili-Mboumba, DP; Moutandou Chiesa, S; Tshibola Mbuyi, ML; Tsoumbou-Bakana, G; Zong, J | 1 |
| Ayoub, A; Duparc, S; Kamiza, S; Kimani, J; Orrico, R; Phiri, K; Robbins, J; Rojo, R; Vandenbroucke, P | 1 |
| Moshiro, C; Protas, J; Tarimo, D | 1 |
| Alifrangis, M; Ishengoma, D; Kaaya, RD; Kavishe, AA; Kavishe, RA; Krogsgaard, C; Nag, S; Notland, JG; Roper, C | 1 |
| Abdul-Ghani, R; Alareqi, LMQ; Fong, MY; Lau, YL; Mahdy, MAK; Mahmud, R | 1 |
| Barnwell, JW; Boncy, J; Chang, MA; Griffing, S; Huber, C; Ljolje, D; Lucchi, N; McMorrow, M; Morton, LC; Okoth, SA; Oscar, R; Townes, D; Udhayakumar, V | 1 |
| Ahmed, I; ElMohammady, H; Jamil, M; Kakar, Q; Khan, MA; Sheikh, S; Warsame, M | 1 |
| Grobusch, MP; Hakizimana, E; Kateera, F; Kumar, N; Mens, PF; Mutesa, L; Nsobya, SL; Tukwasibwe, S; van Vugt, M | 1 |
| Basco, LK; Gaye, O; Lebatt, SM; Lo, B; Ouldabdallahi, MM; Sarr, O | 1 |
| Abdullah, NR; Imwong, M; Jelip, J; Mohd Abd Razak, MR; Mudin, RN; Muhammad, A; Muniandy, PK; Norahmad, NA; Rundi, C; Saat, MN; Sastu, UR; Syed Mohamed, AF; Tikuson, M; Yusof, N | 1 |
| Arez, AP; Berzosa, P; de Sousa, B; Guerra, M; Mendes, C; Ndong-Mabale, N; Neres, R; Salgueiro, P | 1 |
| Baba, ES; Bruce, J; Chandramohan, D; Enato, IG; Falade, CO; Hamade, P; Meek, S; Oguike, MC; Roper, C; Shu, E; Sutherland, CJ; Warhurst, D; Watila, I; Webster, J | 1 |
| Benavente, ED; Campino, S; Clark, TG; Craig, A; Jensen, AT; Kwiatkowski, DP; Mipando, M; Montgomery, J; Ocholla, H; Phiri, KS; Ravenhall, M; Roper, C; Sepúlveda, N; Sutherland, CJ; Terlouw, A | 1 |
| Rogerson, SJ; Unger, HW | 1 |
| Liu, XJ; Peng, HJ; Wei, HX; Xia, J; Zhou, LJ | 1 |
| Awandare, GA; Cisse, M; Guiguemdé, RT; Hayette, MP; Soulama, A; Tinto, H | 1 |
| Amran, JG; Arale, AM; Barrette, A; Hassan, AH; Hassan, AM; Jibril, AM; Mohamud, SA; Muse, AY; Nada, RA; Warsame, M; Yusuf, FE | 1 |
| de Jager, C; Hongoro, C; Longwe, H; Mutero, CM; Mwendera, CA; Phiri, K | 1 |
| Alifrangis, M; Baraka, V; Delgado-Ratto, C; Ishengoma, DS; Lutumba, P; Madebe, RA; Mavoko, HM; Nabasumba, C; Nag, S; Van Geertruyden, JP | 1 |
| Banura, P; Guler, JL; Houpt, E; Huang, F; Jacob, ST; Laufer, MK; Liu, J; Moore, CC; Pholwat, S; Stroup, S | 1 |
| Ahouidi, AD; Daily, JP; Ly, O; Mboup, S; Ndiaye, D; Ndir, O; Sarr, O; Wirth, DF | 1 |
| Diarra, M; Guissou, IP; Ouédraogo, LT; Somé, IT | 1 |
| Clark, TD; Dorsey, G; Jagannathan, P; Kamya, MR; Maiteki-Sebuguzi, C; Njama-Meya, D; Nzarubara, B; Rosenthal, PJ; Staedke, SG; Talisuna, AO; Yau, VM | 1 |
| Best Plummer, W; Pinto Pereira, L | 1 |
| Abacassamo, F; Alifrangis, M; Enosse, S; Gómez-Olivé, X; Magnussen, P; Rønn, AM; Thompson, R | 1 |
| Lalou, R; Le Hesran, JY; Sene, I; Souares, A; Sow, D | 2 |
| Bacon, DJ; Cabezas, C; Cairo, J; Durand, S; Lachira, A; Marquiño, W; Quintana, F; Ruebush, TK; Utz, G; Vegas, W | 1 |
| Brooker, S; Clarke, SE; Crudder, C; Cundill, B; Estambale, BB; Jukes, MC; Khasakhala, L; Njagi, JK; Otido, J | 1 |
| Alonso, P; Aponte, J; Bardaji, A; Berenguera, A; David, C; Lahuerta, M; Mandomando, I; Menendez, C; Naniche, D; Ordi, J; Romagosa, C; Sanz, S; Sigauque, B | 1 |
| Afrane, Y; Cui, L; Githeko, A; Menge, DM; Yan, G; Zhong, D | 1 |
| Ashley, EA; Balkan, S; Bukirwa, H; Checchi, F; Dorsey, G; Guthmann, JP; Olliaro, P; Pinoges, L; Taylor, WR; Turyakira, E; Urruta, PP; van den Broek, I; van Herp, M; Zongo, I | 1 |
| Adam, I; Elmardi, KA; Malik, EM | 1 |
| Arango, E; Blair, S; Carmona-Fonseca, J | 1 |
| Affipunguh, PK; Bruce, J; Chandramohan, D; Clerk, CA; Greenwood, B; Hodgson, A; Mensah, N | 1 |
| Basco, LK; Escalante, AA; McCollum, AM; Tahar, R; Udhayakumar, V | 1 |
| Lepère, JF | 1 |
| Barnes, KI; McIntyre, D; Zikusooka, CM | 1 |
| Adjei, O; Adjei, S; Busch, W; Gabor, JJ; Grobusch, MP; Issifou, S; Kobbe, R; Kremsner, PG; Kreuels, B; Lell, B; May, J; Schwarz, NG | 1 |
| Bedu-Addo, G; Bienzle, U; Eggelte, TA; Holmberg, V; Hommerich, L; Mockenhaupt, FP; von Oertzen, C | 1 |
| Badiane, M; Brasseur, P; Cisse, M; Delenne, H; Olliaro, A; Olliaro, PL; Vaillant, M | 1 |
| Benchimol, C; Bernardino, L; do Rosário, VE; Figueiredo, P; Lopes, D; Nogueira, F; Varandas, L | 1 |
| Alker, AP; Bloland, PB; Kazadi, WM; Kutelemeni, AK; Meshnick, SR; Tshefu, AK | 1 |
| Drakeley, CJ; Nosten, F; Price, RN; Stepniewska, K; Sutherland, CJ; von Seidlein, L; White, NJ | 1 |
| Al-Harazy, AH; Al-Kabsi, AM; Al-Shamahy, HA; Harmal, NS | 1 |
| Davis, TM; Gomorrai, PS; Griffin, S; Ilett, KF; Karunajeewa, HA; Kotab, K; Lautu, D; Law, I; Lin, E; Mueller, I; Oa, O; Page-Sharp, M; Salman, S; Senn, M; Siba, P; Suano, P; Tarongka, N; Ura, A; Wong, R | 1 |
| Dietmann, A; Helbok, R; Issifou, S; Kremsner, PG; Lackner, P; Lell, B; Reindl, M; Schmutzhard, E; Spora, K | 1 |
| Plowe, CV | 1 |
| Avellino, P; Bancone, G; d'Alessandro, U; Fanello, CI; Karema, C; Lee, SJ; Modiano, D; Uwimana, A | 1 |
| Djimde, A; Doumbo, OK; Guirou, EA; Hoppe, A; Kayentao, K; Kone, Y; Maiga, H; McMorrow, ML; Newman, RD; Saye, R; Traore, B; Traore, H; Yattara, O | 1 |
| Alonso, PL; Aponte, JJ; Bardají, A; Cisteró, P; Mandomando, I; Mayor, A; Menéndez, C; Puyol, L; Sanz, S; Serra-Casas, E; Sigauque, B | 1 |
| Coulibaly, SO; D'Alessandro, U; Gies, S; Ouattara, FT | 1 |
| Dankyau, M; Madaki, AJ; Ogunfowokan, O; Thacher, TD | 1 |
| Alifrangis, M; Bousema, T; Gouagna, LC; Howitt, C; Oesterholt, MJ; Omar, SA; Sauerwein, RW; Sawa, P; Sutherland, CJ | 1 |
| Björkman, A; Fidock, DA; Gil, JP; Mårtensson, A; Petersen, I; Premji, Z; Sisowath, C; Veiga, MI | 1 |
| Beavogui, AH; Dama, S; Dembele, D; Dicko, A; Djimde, AA; Doumbo, OK; Fofana, B; Kone, A; Maiga, H; Ouologuem, D; Sagara, I; Tekete, M; Wele, M | 1 |
| Ahounou, D; Akogbeto, M; Bonou, D; Coosemans, M; D'Alessandro, U; Erhart, A; Massougbodji, A; Menten, J; Nahum, A; Van Overmeir, C | 1 |
| Abdelgadir, T; Adam, I; Ali, SH; Elhassan, AH; Elmardi, KA; Elsyed, AH; Malik, EM; Mudather, MA | 1 |
| Das, A; Garg, S; Kanchan, S; Kochar, D; Mahajan, S; Saxena, V; Sharma, P | 1 |
| Anderson, T | 1 |
| A-Elbasit, IE; Agboghoroma, CO; Bâ, el-H; Barnes, KI; Bonnet, M; Chanda, P; Chandramohan, D; Cissé, B; Clarke, S; Dejene, S; Diallo, DA; Dunyo, S; Elegba, OY; Evehe, MS; Getachew, A; Giha, HA; Grobusch, MP; Guthmann, JP; Hawela, M; Inojosa, W; Kachur, SP; Katokele, ST; Kweku, M; Lynch, C; Malisa, AL; Matondo, A; Mbacham, W; Mombo-Ngoma, G; Naidoo, I; Njie, F; Ord, R; Owusu-Agyei, S; Pearce, RJ; Pota, H; Roper, C; Rwakimari, JB; Sharp, B; Streat, E; Swarthout, TD; Uusiku, P; van den Broek, IV | 1 |
| Abdel-Muhsin, AM; Al-Ghazali, A; Al-Saai, S; Babiker, HA; Kheir, A; Nwakanma, D; Swedberg, G | 1 |
| Afrane, Y; Amenya, DA; Baliraine, FN; Bonizzoni, M; Githeko, AK; Yan, G | 1 |
| bin Reza, F; Chiodini, PL; Doherty, JF; Fifer, H; Gothard, P; Haustein, T; Nicholas, M; Njimgye-Tekumafor, NE; Pearce, RJ; Polley, SD; Sutherland, CJ | 1 |
| Abdirahman, A; Borrmann, S; Kiara, SM; Kokwaro, G; Mackinnon, M; Marsh, K; Mwai, L; Nzila, A; Ochong, E; Sasi, P; Ward, S | 1 |
| Bolla, MC; Duffy, PE; Fried, M; Harrington, WE; Muehlenbachs, A; Mutabingwa, TK; Sorensen, B | 1 |
| Adeothy, A; Amedome, H; Aubouy, A; Cot, M; Cottrell, G; Deloron, P; Doritchamou, J; Faucher, JF; Gourmel, B; Houzé, P; Kossou, H; Massougbodji, A | 1 |
| Juliano, JJ; Meshnick, SR; Taylor, SM | 1 |
| Abdou, AS; Abro, AH; Abro, HA; Akaila, SI; Ustadi, AM; Younis, NJ | 1 |
| Barger, B; Dara, A; Djimde, AA; Doumbo, OK; Gantt, S; Maiga, H; Tekete, M; Tembine, I; Traore, OB; Traore, ZI | 1 |
| Allen, EN; Barnes, KI; Boulle, A; Camba, T; Cassam, Y; Little, F; Raman, J | 1 |
| Donegan, S; Garner, P; Olliaro, P; Sinclair, D; Zani, B | 1 |
| Daniel-Ribeiro, CT; de Oliveira, NK; de Souza, JM; Ferreira-da-Cruz, Mde F; Gama, BE; Santos, F; Zalis, MG | 1 |
| Mita, T | 1 |
| Ashley, E; Bonnet, M; Broek, Iv; Guthmann, JP; Kyomuhendo, J; Ndosimao, CN; Urrutia, PP; van Herp, M; van Overmeir, C | 1 |
| Geita, J; Hiawalyer, G; Hombhanje, FW; Jones, R; Kevau, I; Kuanch, C; Linge, D; Masta, A; Sapuri, M; Saweri, A; Toraso, S | 1 |
| Boly, MD; Deloron, P; Faucher, JF; Houzé, S; Le Bras, J | 1 |
| McGready, R | 1 |
| Carneiro, I; Chandramohan, D; Gesase, S; Gosling, RD; Greenwood, B; Hashim, R; Lemnge, M; Mosha, FW; Mosha, JF | 1 |
| Adjei, S; Alonso, P; Anemana, S; Aponte, JJ; Breckenridge, A; Carneiro, I; Chandramohan, D; Critchley, J; Danquah, I; Dodoo, A; Egan, A; Greenwood, B; Grobusch, MP; Issifou, S; Kobbe, R; Kremsner, PG; Lell, B; Macete, E; May, J; Menendez, C; Mockenhaupt, F; Mshinda, H; Newman, RD; Owusu-Agyei, S; Premji, Z; Sanz, S; Schellenberg, D; Sevene, E; Slutsker, L; Soulaymani-Becheikh, R; Tanner, M; Winstanley, P | 1 |
| Adam, I; Barnes, KI; Cassam, Y; Doumbo, O; Guirou, E; Kayentao, K; Little, F; Mauff, K; Nyunt, MM; Smith, P; Sullivan, D; Thuma, P; Traore, B; van Dijk, J | 1 |
| Das, MK; Dev, V; Lumb, V; Sharma, YD; Singh, N | 1 |
| Abudey, S; Adjuik, M; Chandramohan, D; Greenwood, B; Kweku, M; Webster, J | 1 |
| Bougouma, EC; Diarra, A; Konaté, AT; Nébié, I; Ouedraogo, A; Sirima, SB; Tiono, AB | 1 |
| Day, NP; Dondorp, A; Fanello, CI; Imwong, M; Karema, C; Nakeesathit, S; Stepniewska, K; Uwimana, A; White, NJ | 1 |
| Eastman, RT; Fidock, DA | 1 |
| Kaur, H; Kolaczinski, K; Leslie, T; Mohammed, N; Ord, RL; Rowland, M | 1 |
| Joloba, M; Kiggundu, M; Nawaz, F; Nsobya, SL; Rosenthal, PJ | 1 |
| Achan, J; Arinaitwe, E; Clark, TD; Cohan, D; Dorsey, G; Havlir, D; Newman, PM; Rosenthal, PJ; Tumwine, G; Waldman, S; Wanzira, H | 1 |
| Gbotosho, GO; Happi, CT; Oduola, A; Sijuade, A; Sowunmi, A | 1 |
| Alonso, PL; Bardají, A; Chauhan, VS; Chitnis, CE; Dobaño, C; Jiménez, A; Mandomando, I; Mayor, A; Menéndez, C; Quintó, L; Serra-Casas, E; Sigauque, B | 1 |
| Giha, HA | 1 |
| Baisor, M; Beck, HP; Genton, B; Hastings, IM; Marfurt, J; Müller, I; Oa, O; Reeder, JC; Sie, A; Smith, TA | 1 |
| Bouyou-Akotet, MK; Kombila, M; Mawili-Mboumba, DP; Tchantchou, Tde D | 1 |
| Endo, H; Eto, H; Marma, AS; Mita, T; Sarker, S; Tsukahara, T | 1 |
| Ajua, A; Ateh, IA; Echouffo-Tcheugui, JB; Evehe, MS; Greenwood, B; Hallett, R; Irenee, D; Mbacham, WF; Mimche, PN; Netongo, PM; Nji, AM; Roper, C; Targett, G; Tawe, B | 1 |
| Parikh, S; Rosenthal, PJ | 1 |
| Chopra, M; de Sousa, A; Salama, P | 1 |
| Bouyou-Akotet, MK; Kendjo, E; Kombila, M; Lekana-Douki, JB; Mounanga, M; Ngoungou, EB; Nzenze-Afene, S; Obono-Obiang, G; Owono-Medang, M | 1 |
| Basco, LK; Foumane, VN; Gwét, H; Soula, G; Tahar, R; Thalabard, JC; Whegang, SY | 1 |
| Barnes, KI; Distiller, GB; Little, F | 1 |
| Bousema, T; Daou, M; Drakeley, C; Kavishe, R; Koenderink, JB; Luty, AJ; Sauerwein, RW; Shekalaghe, SA; ter Braak, R; van den Bijllaardt, W; van den Bosch, S; Whitty, CJ | 1 |
| Beshir, K; Dlamini, SV; Sutherland, CJ | 1 |
| Ngure, RM; Omar, SA; Yusuf, RU | 1 |
| Dokomajilar, C; Greenhouse, B; Ouédraogo, JB; Rosenthal, PJ; Rouamba, N; Séré, YY; Somé, AF; Zongo, I | 1 |
| Aitken, EH; Ashorn, P; Beeson, JG; Fowkes, FJ; Friso, MJ; Kulmala, T; Luntamo, M; Maleta, K; Mbewe, B; Rogerson, SJ | 1 |
| Alam, MT; Ariey, F; Barnwell, JW; Escalante, AA; Fandeur, T; Lim, P; McCollum, AM; Meshnick, SR; Mixson-Hayden, T; Muth, S; Rogers, WO; Sem, R; Shah, NK; Udhayakumar, V; Vinayak, S; Wongsrichanalai, C | 1 |
| Bangs, MJ; Basri, H; Chand, K; Elyazar, I; Kinzer, MH; Lederman, ER; Maguire, JD; Rogers, WO; Susanti, AI; Taleo, G | 1 |
| Afsharpad, M; Djadid, ND; Farahani, MS; Raeisi, A; Salehi, M; Zakeri, S | 1 |
| Barnes, KI; Cassam, Y; Kleinschmidt, I; Little, F; Maharaj, R; Raman, J; Roper, C | 1 |
| Cairns, ME; Chandramohan, D; Chico, RM; Gosling, RD | 1 |
| Beavogui, AH; Coulibaly, B; Dao, A; Djimde, AA; Doumbo, OK; Fofana, B; Gregson, A; Kone, A; Niare, O; Ouologuem, D; Picot, S; Plowe, CV; Sacko, A; Tekete, M; Toure, AM; Wele, M | 1 |
| Bousema, T; Drakeley, C; Ghani, AC; Griffin, JT; Okell, L; Omar, S; Sauerwein, R; Sawa, P; Shekalaghe, S; Sutherland, C | 1 |
| Benavides, J; Corredor, V; Echeverry, DF; Guerra, AP; Murillo, C; Osorio, L; Pearce, RJ; Roper, C | 1 |
| Basco, LK; Gwét, H; Thalabard, JC; Whegang, SY | 1 |
| Abdulla, S; Bloland, P; Kachur, PS; Malisa, AL; Mshinda, H; Pearce, RJ; Roper, C | 1 |
| Cairns, M; Carneiro, I; Chandramohan, D; Ghani, AC; Gosling, RD; Greenwood, B; Griffin, JT; Grobusch, MP; Newman, RD; Roper, C; Schellenberg, D | 1 |
| Ballif, M; Beck, HP; Crameri, A; Fafale, A; Felger, I; Genton, B; Hii, J; Marfurt, J | 1 |
| Diarra, A; Konaté, AT; Nébié, IO; Ouédraogo, A; Sirima, SB; Tiono, AB | 1 |
| Alonso, PL; Bardají, A; Cisteró, P; Dobaño, C; Mandomando, I; Mayor, A; Menéndez, C; Ordi, J; Quintó, L; Serra-Casas, E; Sigauque, B | 1 |
| Chandramohan, D; Färnert, A; Greenwood, B; Kweku, M; Liljander, A; Montgomery, SM; Olsson, D | 1 |
| Alonso, PL; Bardají, A; Cisteró, P; Dobaño, C; Mandomando, I; Mayor, A; Menéndez, C; Nhabomba, A; Sanz, S; Scahill, MD; Serra-Casas, E; Sigauque, B | 1 |
| Arora, U; Dash, AP; Dhillon, GP; Meshnick, SR; Shah, NK; Valecha, N | 1 |
| Alonso, PL; Aponte, JJ; Bardají, A; Mabunda, S; Maixenchs, M; Menéndez, C; Ordi, J; Sanz, S; Sigauque, B | 1 |
| Annie, A; De Sousa, A; Faye, B; Gaye, O; Lo, AC; Ndiaye, JL; Ndiaye, M; Sow, D; Tine, RC | 1 |
| Adjei, O; Adjei, S; Hogan, B; Klein, P; Kobbe, R; Kreuels, B; Loag, W; May, J | 1 |
| Aide, P; Alonso, PL; Aponte, JJ; Beeson, JG; Cisteró, P; Dobaño, C; Jiménez, A; Macete, E; Mandomando, I; Mayor, A; Menéndez, C; Nhampossa, T; Puyol, L; Quelhas, D; Quintó, L; Richards, JS; Sanz, S; Serra-Casas, E; Wilson, DW | 1 |
| Beg, MA; Ghanchi, NK; Jafri, S; Mårtensson, A; Ursing, J; Veiga, MI | 1 |
| Alemu, H; Anbessie, J; Diro, E; Mao, P; Pinchouk, N; Seboxa, T | 1 |
| Davis, TM; Griffin, S; Ilett, KF; Kose, K; Moore, B; Mueller, I; Pitus, N; Salman, S; Siba, P; Winmai, J | 1 |
| Dimbu, R; do Rosário, VE; Figueiredo, P; Fortes, F; Lopes, D; Neto, Z | 1 |
| Alam, MT; Asamoa, K; Barnwell, JW; de Souza, DK; Duah, NO; Ghansah, A; Griffing, SM; Koram, KA; Poe, AC; Slutsker, L; Udhayakumar, V; Vinayak, S; Wilson, MD | 1 |
| Terlouw, DJ; van Eijk, AM | 1 |
| Adhikari, M; Alifrangis, M; Bygbjerg, IC; Kapel, CM; Ranjitkar, S; Schousboe, ML; Thomsen, TT | 1 |
| Bera, DK; Biswas, A; Das, M; Das, S; Guha, SK; Kundu, PK; Maji, AK; Mullick, S; Ray, K; Roy, D; Saha, P; Sengupta, S | 1 |
| Gabor, JJ; Greutélaers, B; Greutélaers, KC; Grobusch, MP; Issifou, S; Kremsner, PG; Kun, JF; Kurth, F; Lell, B; Mombo-Ngoma, G; Ord, R; Oyakhirome, S; Profanter, K; Roper, C | 1 |
| Jansen, FH | 1 |
| Basco, L; Menemedengue, V; Sahnouni, K; Tahar, R | 1 |
| Bertin, G; Bonaventure, D; Briand, V; Carrieu, A; Cot, M; Deloron, P; Massougbodji, A | 1 |
| Dieng, Y; Diouf, I; Faye, B; Faye, O; Gaye, A; Gaye, O; Mengue, ML; Ndiaye, JL; Sylla, K; Tine, RC | 1 |
| Adeel, AA; Chance, ML; Hassan, AA; Mubjer, RA | 1 |
| Abdullah, S; Bloland, P; Kachur, P; Malisa, A; Mshinda, H; Mutayoba, B; Pearce, R; Roper, C | 1 |
| Chandramohan, D; Cousens, S; Diallo, DA; Diarra, A; Gansané, A; Greenwood, BM; Kaboré, Y; Kangoyé, DT; Konaté, AT; Milligan, PJ; Ouédraogo, A; Ouédraogo, AZ; Ouédraogo, E; Ouédraogo, IN; Sirima, SB; Soulama, I; Tiono, AB; Yaro, JB | 1 |
| Barry, A; Chandramohan, D; Conaré, T; Cousens, S; Dara, N; Diallo, AI; Diallo, DA; Dicko, A; Dicko, M; Dicko, Y; Doumbo, OK; Greenwood, B; Milligan, PJ; Santara, G; Sidibe, Y; Tembine, I | 1 |
| Baliraine, FN; Rosenthal, PJ | 1 |
| Egwang, TG; Kiyingi, HS; Nannyonga, M | 1 |
| Atua, B; Emch, M; Hand, CC; Meshnick, SR; Messina, JP; Muwonga, J; Mwandagalirwa, K; Taylor, SM; Ter Kuile, FO; Tshefu, AK; van Eijk, AM | 1 |
| Afsharpad, M; Djadid, ND; Pirahmadi, S; Zakeri, S | 1 |
| Culleton, R; Dysoley, L; Endo, H; Ferreira, MU; Hombhanje, F; Mita, T; Ndounga, M; Ohashi, J; Plowe, CV; Takahashi, N; Tanabe, K; Tsukahara, T; Venkatesan, M | 1 |
| Abdullah, S; Bloland, P; Kachur, PS; Malisa, AL; Mshinda, H; Mutayoba, BM; Pearce, RJ; Roper, C | 1 |
| Blackstock, AJ; Garner, K; Gatei, W; Gimnig, JE; Hamel, MJ; Hawley, WA; Kariuki, S; Lindblade, K; Nahlen, B; Phillips-Howard, P; Shah, M; Shi, YP; Slutsker, L; ter Kuile, F; Terlouw, D; Vanden Eng, J; Walker, E | 1 |
| Abubakar, I; Bojang, KA; Ceesay, SJ; Conway, DJ; Coulibaly, M; Coulibaly, TF; Dao, A; Diakité, M; Diarra, A; Diawara, S; Doumbia, SO; Duraisingh, M; Fairhurst, RM; Faye, B; Faye, O; Gaye, O; Jawara, M; Kandeh, B; Kéita, M; Koita, OA; Konaté, L; Krogstad, DJ; Long, CA; Muskavitch, MA; Ndiaye, D; Ndiaye, JL; Nwakanma, D; Okebe, J; Perry, R; Poudiougou, B; Sangaré, L; Sarr, O; Sissako, A; Sogoba, N; Sy, N; Traoré, SF; Valim, C; Volkman, SK; Wirth, DF | 1 |
| Bassene, C; Bygbjerg, IC; Faye, B; Gaye, O; Magnussen, P; Ndiaye, JL; Ndiaye, M; Ndour, CT; Ndour, JD; Sylla, K; Tine, RC | 1 |
| Browne, E; Lawson, B; Tutu, EO | 1 |
| Alonso, P; Manzi, F; Maokola, W; Mrisho, M; Mshinda, H; Mushi, A; Schellenberg, DM; Schellenberg, JR; Shirima, K; Tanner, M | 1 |
| Arango, EM; Carmona-Fonseca, J; Upegui, YA | 1 |
| Aide, P; Alonso, PL; Aponte, JJ; Dobaño, C; Doolan, DL; Macete, E; Menéndez, C; Nhampossa, T; Puyol, L; Quelhas, D; Quintó, L; Sanz, S; Serra-Casas, E | 1 |
| Ali, I; Barends, M; Beshir, K; Durrani, N; Hallett, R; Kolaczinski, K; Lee, S; Leslie, T; Ord, R; Rowland, M | 1 |
| Bera, DK; Biswas, A; Chattopadhyay, G; Das, M; Das, S; Ganguly, S; Guha, SK; Kundu, PK; Maji, AK; Mullick, S; Ray, K; Saha, P | 1 |
| Gutman, J; Kachur, SP; Mutabingwa, T; Nzila, A; Slutsker, L | 1 |
| Atasige, S; Schneider, TA; van Spronsen, JH | 1 |
| D'Alessandro, U; Drabo, MK; Guiguemde, RT; Huybregts, L; Kolsteren, P; Ouedraogo, JB; Sorgho, H; Tinto, H; Valea, I; van Geertruyden, JP | 1 |
| Escalante, AA; Griffing, SM; Kariuki, S; Lal, AA; McCollum, AM; Schneider, KA; Shi, YP; Slutsker, L; Ter-Kuile, F; Udhayakumar, V; Zhou, Z | 1 |
| Diarra, A; Dodoo, D; Konate, A; Nebie, I; Ouedraogo, A; Sirima, SB; Soulama, I; Theisen, M; Tiono, A; Traore, A | 1 |
| Antonia, AL; Chaluluka, E; Feng, G; Meshnick, SR; Molyneux, ME; Mwapasa, V; Rogerson, SJ; Taylor, SM; ter Kuile, FO | 1 |
| Amor, A; Baquero, M; Benito, A; Berzosa, P; Fernández-Martínez, A; Toro, C | 1 |
| Abdulla, SM; Charlwood, JD; Ferguson, HM; Huho, BJ; Kachur, SP; Kihonda, A; Kihonda, J; Killeen, GF; Lengeler, C; Smith, TA; Tami, A | 1 |
| Ayisi, J; Desai, M; Gatei, W; Hamel, MJ; Iriemenam, NC; Kariuki, S; Lal, AA; Moore, J; Nahlen, B; Omosun, YO; Otieno, K; Ouma, P; Owino, SO; Shah, M; Shi, YP; Slutsker, L; ter Kuile, FO; van Eijk, AM; Vanden Eng, J | 1 |
| Abdulla, SM; Bloland, PB; Elling, BF; Genton, B; Goodman, CA; Gutman, JR; Kabanywanyi, AM; Kachur, SP; Kahigwa, E; Khatib, RA; Lyimo, T; MacArthur, JR; Mills, A; Mshinda, H; Mwita, A; Njau, JD; Roberts, JM; Skarbinski, J; Smith, EE; Somi, MF; Tanner, M | 1 |
| D'Alessandro, U; Hamed, K; Juma, E; Kayentao, K; Manyando, C; Okafor, HU | 1 |
| Baret, E; Bercion, R; Briolant, S; Diatta, B; Diawara, S; Diémé, Y; Fall, B; Fall, F; Fall, KB; Mbaye, PS; Pascual, A; Pradines, B; Rogier, C; Sow, K; Wade, B; Wurtz, N | 1 |
| Al-Farsi, HM; Al-Hashami, ZS; Al-Qahtani, A; Al-Sheikh, AA; Babiker, HA; Beja-Pereira, A; Bin Dajem, SM; Idris, MA | 1 |
| Duffy, P; Fried, M; Harrington, W; McGready, R; Muehlenbachs, A; Nosten, F | 1 |
| Campos, PA; Campos, RB; Gonçalves, L; Rosário, VE; Silveira, H; Valente, B; Varandas, L | 1 |
| Boncy, J; Carter, TE; Existe, A; Fukuda, MM; Memnon, G; Mulligan, CJ; Okech, BA; Oscar, R; Victor, YS; Warner, M | 1 |
| Chakraborty, SP; Das, S; Hati, A; Roy, S; Tripathy, S | 1 |
| Baird, JK; de Monbrison, F; Laihad, F; Picot, S; Ruckert, P; Suprianto, S; Sutanto, I; von Bethmann, A; Widiaty, A | 1 |
| McGready, R; Nosten, F | 1 |
| Anglewicz, PA; Bennett, A; Eisele, TP; Hutchinson, P; Keating, J; Larsen, DA; Steketee, RW; Yukich, J | 1 |
| Abuaku, BK; Duah, NO; Koram, KA; Kronmann, KC; Quashie, NB; Sebeny, PJ | 1 |
| Akbari, S; Vaidya, NK; Wahl, LM | 1 |
| Abdul-Ghani, R; Allam, AF; Farag, HF | 1 |
| Ashorn, P; Lin, JT; Luntamo, M; Mbewe, B; Meshnick, SR; Taylor, SM | 1 |
| Anvikar, AR; Arora, U; Bhatt, RM; Das, MK; Dhariwal, AC; Ghosh, SK; Gupta, R; Kaitholia, K; Kumar, A; Mishra, N; Shah, NK; Sharma, SK; Singh, JP; Sonal, GS; Srivastava, B; Valecha, N | 1 |
| Ensom, MH; Pawluk, SA; Wilby, KJ | 1 |
| Das Sutar, SK; Dhangadamajhi, G; Kar, SK; Ranjit, M | 1 |
| Alam, MT; Antonia, AL; Emch, M; Janko, M; Juliano, JJ; Meshnick, SR; Parobek, CM; Taylor, SM; Tshefu, AK; Udhayakumar, V | 1 |
| Diallo, D; Dicko, A; Dolo, G; Doumbo, O; Guindo, A; Kaslow, DC; Klion, AD; Miller, LH; Niambélé, MB; Sagara, I; Sangaré, D; Sissoko, M; Sogoba, M; Touré, Y; Yalcoué, D | 1 |
| Arévalo-Herrera, M; Carrasquilla, G; Cortese, JF; Jurado, D; Méndez, F; Muñoz, A; Plowe, CV | 1 |
| Basco, LK; Metoh, T; Ndounga, M; Ngane, VF; Ringwald, P; Same-Ekobo, A; Soula, G | 1 |
| Atmosoedjono, S; Baird, JK; Bangs, MJ; Fryauff, DJ; Leksana, B; Masbar, S; Nagesha, HS; Sismadi, P; Susanti, AI; Wiady, I | 1 |
| Ebrahim, GJ | 1 |
| Broder, JS; Colletti, JE; Geroff, AJ; Grundmann, KA; Hanna, JR; Jerrard, DA; Mattu, A | 1 |
| Basco, LK; Ringwald, P | 2 |
| Aché, A; Díaz, O; Escorihuela, M; Izarra, E; Matos, A; Miranda, L; Páez, E; Pérez, W; Vivas, E | 1 |
| Caraballo, A; Contreras, CE; Cortese, JF; Plowe, CV | 1 |
| Alonso, PL; Aponte, JJ; Drakeley, C; Kahigwa, E; Malende, A; Menendez, C; Mshinda, H; Msokame, C; Schellenberg, D; Tanner, M; Wigayi, J | 1 |
| Hyde, JE; Nirmalan, N; Sims, PF; Wang, P | 1 |
| Andrianantenaina, BH; Ariey, F; Rafidimanantsoa, L; Randrianarivelojosia, M; Rason, MA; Sahondra Harisoa, JL | 1 |
| Abdillahi, A; Duale, ON; Hassan, AM; Ismail, AN; Mohamed, A; Warsame, A; Warsame, M | 1 |
| Cheng, Q; Rieckmann, K | 1 |
| Chimpeni, P; Hatcher, J; Kublin, JG; Marsh, K; Molyneux, ME; Plowe, CV; Sulo, J; Taylor, TE; Watkins, WM; Winstanley, PA | 1 |
| Coulibaly, SO; D'Alessandro, U; Guiguemde, TR; Ouedraogo, JB; Tinto, H; Traoré, M; Van Marck, E; Zoungrana, EB | 1 |
| Alifrangis, M; Bygbjerg, IC; Gabar, HA; Jelinek, T; Khalil, I; Rønn, AM; Satti, GM | 1 |
| Aidoo, MA; Kager, PA; Kolczak, MS; Kuile, FO; Lal, AA; Nahlen, BL; Oloo, AJ; Terlouw, DJ; Udhayakumar, V | 1 |
| Faizal, HM; Fernando, WP; Galappaththy, G; Weerasinghe, KL; Wickremasinghe, AR; Wickremasinghe, DR | 1 |
| Dosekun, E; Ladhani, S; Patel, V; Shingadia, D | 1 |
| Ariey, F; Jaureguiberry, S; Raharimalala, AL; Rakotomalala, E; Ranarivelo, LA; Randriamanantena, A; Randrianarivelojosia, M; Rason, MA | 1 |
| Aida, AO; Christophel, EM; el Valy, AO; Heuschkel, C; Jelinek, T; Jordan, S; Mayor, A; Peyerl-Hoffmann, G; von Sonnenburg, F | 1 |
| Aubouy, A; Bakary, M; Cot, M; Deloron, P; Keundjian, A; Le Bras, J; Makita, JR; Mbomat, B; Migot-Nabias, F | 1 |
| Cissoko, Y; Coulibaly, D; Coulibaly, S; Diallo, DA; Dicko, A; Djimdé, A; Doumbo, OK; Guindo, AB; Koné, AK; Lyke, K; Plowe, CV; Thera, MA | 1 |
| Crandall, I; Kain, KC; Labbé, AC; Patel, S | 1 |
| Christophel, EM; Jelinek, T; Jordan, S; Phetsouvanh, R; Phompida, S; Schwöbel, B; Vanisaveth, V; von Sonnenburg, F | 1 |
| Baird, JK; Bangs, MJ; Barcus, MJ; Basuki, W; Edstein, MD; Lacy, MD; Laksana, B; Maguire, JD; Marwoto, H; Masbar, S; Sismadi, P; Susanti, I; Tjokrosonto, S; Wiady, I | 1 |
| Arróspide, N; Arrunátegui, M; Barat, LM; Cabezas, C; Carrillo, C; Chafloque, ML; Garavito, G; Gutierrez, S; MacArthur, JR; Marquiño, W; Oblitas, FE; Pardavé, B; Ruebush, TK | 1 |
| Castillo, CM; Ferro, BE; Osorio, L | 1 |
| Chen, YZ; Jin, T | 1 |
| Jelinek, T; Peyerl-Hoffmann, G; Restrepo, M; Schmider, N | 1 |
| Alpers, MP; Batty, KT; Davis, TM; Ilett, KF; Karunajeewa, HA; Kemiki, A; Lorry, K | 1 |
| Dorsey, G; Gasasira, AF; Kamya, MR; Nassali, A; Nzarubara, B; Rosenthal, PJ; Staedke, SG | 1 |
| Cattamanchi, A; Dorsey, G; Hubbard, A; Kyabayinze, D; Rosenthal, PJ | 1 |
| Alkadru, AM; Awad, MI; Baraka, OZ; Behrens, RH; Eltayeb, IB | 1 |
| Bergqvist, Y; Björkman, A; Bwijo, B; Kaneko, A; Kobayakawa, T; Lum, JK; Mita, T; Moriyama, Y; Takahashi, N; Takechi, M; Tsukahara, T; Zungu, IL | 1 |
| Mishra, SS; Nagpal, AC; Singh, N; Subbarao, SK; Valecha, N; Varma, HS | 1 |
| Bredenkamp, B; Chandramohan, D; Drakeley, C; Gumede, J; Mosha, F; Pearce, R; Roper, C; Sharp, B | 1 |
| Bereckzy, S; Bjorkman, A; Djadid, ND; Gil, JP; Zakeri, S | 1 |
| Akim, NI; Beier, JC; Bousema, JT; Githure, JI; Gouagna, LC; Meutstege, AM; Okech, BE; Sauerwein, RW | 1 |
| Pfeifer, C; Strauss, R | 1 |
| Tumwesigire, S; Watson, S | 1 |
| Nahlen, B; Newman, RD; Parise, ME; Slutsker, L; Steketee, RW | 1 |
| Cortese, JF; Djimdé, AA; Kazembe, PN; Kouriba, B; Kublin, JG; Mukadam, RA; Njunju, EM; Plowe, CV; Taylor, TE; Wirima, JJ | 1 |
| Sowunmi, A | 2 |
| Mussano, P; Olliaro, P | 1 |
| Alifrangis, M; Bygbjerg, IC; Gabar, HA; Khalil, I; Rønn, AM; Satti, GM | 1 |
| Benito, A; Guerra-Neira, A; Raso, J; Roche, J | 1 |
| D'Alessandro, U; Dujardin, JC; Karema, C; Mugisha, V; Niyitegeka, F; Rwagacondo, CE; Sarushi, J; van den Ende, J; Van Overmeir, C | 1 |
| Fateye, BA; Sowunmi, A | 3 |
| Berens, N; Christophel, EM; Jelinek, T; Jordan, S; Phetsouvanh, R; Phompida, S; Schwoebel, B; Vanisaveth, V | 1 |
| D'Alessandro, U; Egwang, TG; Hastings, IM; Langi, P; Mutabingwa, TK; Speybroeck, N; Talisuna, AO; Van Marck, E; Watkins, WW | 1 |
| BRADY, J; CHARLES, LJ; VAN DER KAAY, HJ; VINCKE, IH | 1 |
| LAING, AB | 1 |
| Kabuya, W; Kazadi, WM; Kebela, BI; Makina, BN; Mantshumba, JC; Ngimbi, NP; Vong, S | 1 |
| Gonzaga, V; Levin, A; Marquiño, W; Neyra, D; Ruebush, TK | 1 |
| Brockman, A; Khanthavong, M; Mayxay, M; Newton, PN; Phetsouvanh, R; Phompida, S; Tiengkham, P; White, NJ | 1 |
| Dorsey, G; Kamya, MR; Rosenthal, PJ; Staedke, SG; Vlahos, J | 1 |
| Cox-Singh, J; Davis, TM; Hackett, LP; Ilett, KF; Lu, HY; Matusop, A; Singh, B | 1 |
| Fischer, PR; Stauffer, W | 1 |
| Cox-Singh, J; Davis, TM; Doan, HN; Hewitt, S; Le, DC; Nguyen, MH; Nguyen, TH; Tran, BK; Tran, QT; Vo, NP | 1 |
| Zimmerman, PA | 1 |
| Alifrangis, M; Bygbjerg, IC; Khalil, IF; Lemnge, MM; Magesa, SM; Rønn, AM; Segeja, MD | 1 |
| Cattamanchi, A; Dorsey, G; Kamya, MR; Kyabayinze, D; Rosenthal, PJ | 1 |
| Björkman, A; Hugosson, E; Montgomery, SM; Premji, Z; Tarimo, D; Troye-Blomberg, M | 1 |
| Dev, V; Dua, VK; Gupta, NC; Phookan, S; Sharma, VP; Subbarao, SK | 1 |
| Clarke, S; Magnussen, P; Ndyomugyenyi, R | 2 |
| Balkan, S; Depoortere, E; Fermon, F; Guthmann, JP; Legros, D; Nkandu, E; Sipilanyambe, N | 1 |
| Alfrangis, M; Gjedde, SB; Kofoed, PE; Poulsen, A; Rodrigues, A; Rombo, L; Rønn, A | 1 |
| Attaran, A; Barnes, KI; Curtis, C; d'Alessandro, U; Fanello, CI; Galinski, MR; Kokwaro, G; Looareesuwan, S; Makanga, M; Mutabingwa, TK; Talisuna, A; Trape, JF; Watkins, WM | 1 |
| Alifrangis, M; Bygbjerg, IC; Enosse, S; Khalil, IF; Lemnge, MM; Rønn, AM; Tarimo, DS; Thompson, R | 1 |
| Evans, J; Horstmann, RD; Marks, F; May, J; Meyer, CG; Sievertsen, J; Timmann, C | 1 |
| Barman, K; Dev, V; Phookan, S | 1 |
| Chimpeni, P; Dzinjalamala, FK; Kamwendo, DS; Kublin, JG; Molyneux, ME; Mukadam, RA; Plowe, CV; Taylor, TE | 1 |
| Ahmed, A; Ansari, MA; Bararia, D; Biswas, S; Dev, V; Kumar, A; Sharma, YD; Vinayak, S; Yameen, M | 1 |
| Ebata-Mongo, S; Kiori, J; Le Bras, J; Louya, F; Malanda, M; Malonga, DA; Mouata, AM; Nsimba, B; Oko-Ossho, J; Yocka, D | 1 |
| Bienzle, U; Ehrhardt, S; Jelinek, T; Mockenhaupt, FP; Muehlen, M; Otchwemah, R; Schreiber, J | 1 |
| Asha, AW; Ezard, N; Nellepalli, P | 1 |
| Abdel-Muhsin, AM; Ahmed, S; Ali, E; Babiker, HA; Mackinnon, MJ; Nassir, el-KA; Suleiman, S; Walliker, D | 1 |
| Hayton, K; Su, XZ | 1 |
| Abacassamo, F; Alonso, PL; Aponte, JJ; Barreto, A; Enosse, S; Gómez-Olivé, FX; Mabunda, S; Magnussen, P; Quintó, L; Rønn, AM; Thompson, R | 1 |
| Bakyaita, N; D'Alessandro, U; Egwang, TG; Langi, P; Mutabingwa, TK; Nalunkuma-Kazibwe, A; Talisuna, AO; Van Marck, E; Watkins, WW | 1 |
| Ardizzoni, E; Bakyaita, N; Balkan, S; Brockman, A; Checchi, F; Guthmann, JP; Klarkowski, D; Kosack, C; Kwezi, E; Piola, P; Priotto, G | 1 |
| Ringwald, P | 2 |
| Eriksen, J; Gustafsson, LL; Kitua, A; Mduma, S; Mwankusye, S; Swedberg, G; Tomson, G; Warsame, M | 1 |
| Adedeji, AA; Falade, CO; Fateye, BA; Fehintola, FA; Gbotosho, GO; Happi, TC; Oduola, AM; Sowunmi, A; Tambo, E | 1 |
| Dorsey, G; Kamya, MR; Lamola, S; Rosenthal, PJ; Sendagire, H; Staedke, SG | 1 |
| Ayisi, JG; Kager, PA; Misore, AO; Nahlen, BL; Odondi, JO; Otieno, JA; Rosen, DH; Slutsker, L; Steketee, RW; ter Kuile, FO; van Eijk, AM | 1 |
| Kouyate, B; Müller, O; Traore, C | 1 |
| Bangali, M; Das, S; Rahman, M; Rahman, R; Ringwald, P; Talukder, MR | 1 |
| Barnes, KI; Folb, PI; Gomes, M; Little, F; McIlleron, H; Molyneux, ME; Mwenechanya, J; Ribeiro, I; Tembo, M | 1 |
| White, N | 1 |
| Bangs, MJ; Maguire, JD; Ruckert, P; Supriyanto, S; Sutanto, I | 1 |
| Imwong, M; Looareesuwan, S; Wilairatana, P | 1 |
| Alloueche, A; Bailey, W; Barton, S; Bwika, J; Chimpeni, P; Falade, CO; Fehintola, FA; Horton, J; Jaffar, S; Kanyok, T; Kremsner, PG; Kublin, JG; Lang, T; Missinou, MA; Mkandala, C; Oduola, AM; Premji, Z; Robertson, L; Sowunmi, A; Ward, SA; Winstanley, PA | 1 |
| Anderson, TC; Brockman, A; Chakma, S; Nair, S; Talukder, L; van den Broek, IV; van der Wardt, S | 1 |
| Akim, IN; Beier, JC; Bousema, JT; Drakeley, CJ; Githure, JI; Gouagna, LC; Meutstege, AM; Okech, BA; Sauerwein, RW | 1 |
| Alvarez, T; Arango, E; Blair, S; Carmona, J | 1 |
| Diakité, S; Djimdé, AA; Dolo, A; Doumbo, OK; Ouattara, A; Plowe, CV | 1 |
| John, CC; Koech, DK; Ouma, JH; Sumba, PO | 1 |
| Dorman, EK; Hviid, L; Kawuondo, K; Marsh, K; Shulman, CE; Staalsoe, T | 1 |
| Domarle, O; Ranarivelo, L; Randriamanantena, A; Randrianarivelojosia, M; Randrianasolo, L; Ratsimbasoa, A | 1 |
| Cassano, F; Cavailler, P; Guthmann, JP; Kariuki, D; Mwangi, J; Omar, SA; Piola, P; Stivanello, E | 1 |
| Garner, P; Omari, A | 1 |
| D'Alessandro, U; Egwang, TG; Langi, P; Mutabingwa, TK; Nalunkuma-Kazibwe, A; Talisuna, AO; Van Marck, E; Watkins, WW | 1 |
| Adam, I; Elbashir, MI | 1 |
| Basco, LK; Djaman, JA; Kauffy, PC; Kone, M; Yavo, W | 1 |
| Adedeji, AA; Fateye, BA; Fehintola, FA; Happi, TC; Sowunmi, A | 1 |
| Annerberg, A; Barends, M; Keola, S; Khanthavong, M; Lindegårdh, N; Mayxay, M; Newton, PN; Phetsouvanh, R; Phompida, S; Pongvongsa, T; White, NJ; Yapom, R | 1 |
| Adedeji, AA; Babalola, CP; Fateye, BA; Sowunmi, A | 1 |
| Alloueche, A; Bates, SJ; Bwika, J; Happi, TC; Kremsner, PG; Kublin, JG; Premji, Z; Sibley, CH; Watkins, WM; Winstanley, PA | 1 |
| Engl, M; Kollaritsch, H; Ogwang, S; Vigl, M; Wernsdorfer, WH; Wiedermann, G | 1 |
| Adam, I; Ahmed, GI; Elbashir, MI; Elghzali, G; Gustafssons, LL; Osman, ME | 1 |
| Drakeley, C; Marchant, T; Nganda, RY; Reyburn, H | 1 |
| Kyaw, MK; Lwin, S; Savran, O; Shahmanesh, M; Smithuis, F; White, NJ | 1 |
| Cobelens, FG; Gikunda, S; Hoogstraatte, SR; Kager, PA; Scheper, FY; Smolders, M; Vreugdenhil, CJ | 1 |
| Abdulla, S; Beck, HP; Kataraihya, J; Lemnge, M; Malisa, A; Mshinda, H; Mugittu, K; Mwita, A; Ndejembi, M; Nkya, W; Premji, Z | 1 |
| Abdulla, SM; Bloland, PB; Fox, SS; Kachur, SP; Kaizer, E; Khatib, RA | 1 |
| Ariey, F; Domarle, O; Paul, RE; Robert, V; Sokhna, CS; Talman, AM; Trape, JF | 1 |
| Dokomajilar, C; Dorsey, G; Kamya, MR; Kiggundu, M; Rosenthal, PJ; Staedke, SG | 1 |
| Adedeji, AA; Fateye, BA; Fehintola, FA; Sowunmi, A | 1 |
| Rakotondrajaona, N; Rakotoson, JD; Randriamanantena, A; Randriambelosoa, J; Randrianarivelojosia, M; Randrianasolo, L; Ratsimbasoa, A; Raveloson, A; Tuseo, L | 1 |
| Balkan, S; de Pécoulas, PE; Depoortere, E; Guthmann, JP; Legros, D; Nkandu, E; Pressé, J; Sipilanyambe, N | 1 |
| Baerwaldt, T; Checchi, F; Danks, A; Durand, R; Heinzelmann, A; Hora, B; Kamara, S; Lamotte, Nd; Morineau, G; Oloo, A; Pinoges, L; Ranford-Cartwright, L; Roddy, P; Smet, M; Williams, A; Wurie, AR | 1 |
| Meshnick, SR; Prajakwong, S; Shanks, GD; Thimasarn, K; Wongsrichanalai, C | 1 |
| Arroyave, M; Blair, S; Franco, L; González, L; Maestre, A; Ochoa, J; Restrepo, E | 1 |
| Amankwa, J; Ansah, NA; Ansah, P; Anto, F; Anyorigiya, T; Atuguba, F; Hodgson, A; Mumuni, G; Oduro, AR | 1 |
| Al-Faith, M; Alemu, E; Amsalu, R; Balasegaram, M; Checchi, F; Hepple, P; Hussein, el B; Montgomery, J; van den Broek, I | 1 |
| Alifrangis, M; Bygbjerg, IC; Drakeley, C; Enosse, S; Khalil, IF; Nkya, WM; Pearce, R; Roper, C; Rønn, AM; Theander, TG | 1 |
| Hastings, IM; Sibley, CH; Watkins, WM | 1 |
| Adam, I; Elbashir, MI; Himeidan, YE; Malik, EM; Mohammed, MM; Salah, MT | 1 |
| Barnes, KI; Dzinjalamala, FK; Kublin, JG; Macheso, A; Molyneux, ME; Plowe, CV; Smith, PJ; Taylor, TE | 2 |
| Gilbert, K; Marsh, K; Nduati, E; Nzila, A; Ochong, E; Ward, S; Winstanley, P | 1 |
| Kaniaru, S; Mens, PF; Mwangi, J; Omar, SA; Omer, GA; Schallig, HD; Schoone, GJ; Yusuf, A | 1 |
| Diallo, TO; Doui-Doumgba, K; Flori, P; Garraud, O; Gbagba, FE; Nambei, WS; Ndadjimbaye, V; Ndémanga, J; Perraut, R | 1 |
| Midia, B; Ochola, SA; Snow, RW; Zurovac, D | 1 |
| Adak, T; Ansari, MA; Bannerjee, S; Bista, MB; Chand, PB; Jha, J; Pandey, S; Shahi, B; Valecha, N; Wijeyaratne, PM | 1 |
| Alexander, N; Coleman, R; Drakeley, CJ; Dunyo, S; Jawara, M; Ord, R; Pinder, M; Sutherland, CJ; Targett, GA; Walraven, G | 1 |
| Bhattacharyya, DR; Borgohain, BK; Gohain, AC; Goswami, BK; Mahanta, J; Mohapatra, PK; Namchoom, NS; Negmu, K; Prakash, A; Taison, K; Wange, D | 1 |
| Kokwaro, GO; Lowe, B; Marsh, K; Mithwani, S; Newton, CR; Nzila, AM; Ochong, E; Ogutu, BR; Olola, CH; Wamola, B | 1 |
| Göbels, K; Graupner, J; Grobusch, MP; Häussinger, D; Lund, A; Richter, J | 1 |
| Atkin, S; Checchi, F; Ford, N; Hamour, S; Hook, C; Keus, K; Melaku, Y; Montgomery, J; Wambugu, J | 1 |
| Ampuero, J; Balkan, S; D'Alessandro, U; Denoncin, A; Dujardin, JC; Dunand, J; Fortes, F; Franco, J; Gaboulaud, V; Gillet, P; Guthmann, JP; Legros, D; Saraiva, N; Tobback, S; van Herp, M; van Overmeir, C | 1 |
| Barnes, KI; White, NJ | 1 |
| Degefa, T | 1 |
| Arróspide, N; Cabezas, C; Falconí, E; Gutierrez, S; Hermenegildo, Y; Marquiño, W; Palacios, AM; Ruebush, TK; Ylquimiche, L | 1 |
| Bakyaita, N; Banek, K; Dorsey, G; Kamya, MR; Kilian, A; Kironde, F; Nsobya, S; Reingold, A; Rosenthal, PJ; Staedke, SG; Talisuna, A; Wabwire-Mangen, F; Yeka, A | 1 |
| Barnes, K; Kachur, SP; Malisa, A; Pearce, R; Roper, C; Sharp, B | 1 |
| Allen, E; Barnes, K; Durrheim, D; Govere, J; La Grange, K; Mabuza, A; Mbokazi, F; Mngomezulu, N; Zitha, A | 1 |
| Anemana, SD; Bienzle, U; Cramer, JP; Dzisi, SY; Eggelte, TA; Ehrhardt, S; Mockenhaupt, FP; Otchwemah, RN; Sauerwein, RW; Schreiber, J; Teun Bousema, J; Wassilew, N | 1 |
| Ahmad, F; Durrani, N; Graham, K; Leslie, T; Rahim, S; Rowland, M | 1 |
| Kironde, F; Kyabayinze, D; Sendagire, H; Swedberg, G | 1 |
| Oduro-Boatey, C; Rodrigues, O | 1 |
| A-Elbasit, IE; Adam, I; Elbashir, MI; Idris, SM; Malik, EM | 1 |
| Benito, A; Berzosa, PJ; Puente, S | 1 |
| Aguttu, C; Kaddumukasa, M; Kironde, F; Nassejje, M; Ndagire, D; Pettersson, M; Sendagire, H; Swedberg, G | 1 |
| Akinboye, DO; Ebong, OO; Folarin, OA; Gbotosho, GO; Happi, CT; Kyle, DE; Milhous, W; Oduola, AM; Sowunmi, A; Wirth, DF; Yusuf, BO | 1 |
| De Koning, L; Gerrish, SJ | 1 |
| Abuaku, B; Duah, N; Koram, KA; Quashie, N | 1 |
| Bangali, AM; Barends, M; Das, S; Faiz, AM; Kamal, M; Liem, L; Maung, UA; Peters, A; Rahman, M; Rahman, MR; van den Broek, IV | 1 |
| Adedeji, AA; Babalola, CP; Bamgboye, AE; Fateye, BA; Fehintola, FA; Gbotosho, GO; Happi, TC; Sowunmi, A | 1 |
| Imada, Y; Kobayashi, J; Manivong, K; Miyagi, M; Pethuvang, R; Phompida, S; Sato, Y; Toma, H; Uechi, G; Vannachone, B | 1 |
| Alker, AP; Chaluluka, E; Kamwendo, DD; Meshnick, SR; Molyneux, ME; Mwapasa, V; Purfield, A; Rogerson, SJ; Tadesse, E | 1 |
| Bienzle, U; Eggelte, TA; Ehrhardt, S; Mockenhaupt, FP; Otchwemah, RN; Sauerwein, RW; Schreiber, J; Teun Bousema, J; Wassilew, N | 1 |
| Garner, P; Jones, K; Taylor-Robinson, D | 1 |
| Abdelgadir, T; Adam, I; Ahmed, ES; Elamin, SB; Khamiss, AH; Malik, EM; Mohammed, MM | 1 |
| Demirev, PA; Feldman, AB; Kumar, N; Lin, JS; Nyunt, M; Pisciotta, J; Scholl, PF; Shi, L; Sullivan, DJ; Thuma, P | 1 |
| Alker, AP; Kazadi, W; Meshnick, SR; Wilson, PE | 1 |
| Durand, R; Jafari-Guemouri, S; Kiori, J; Le Bras, J; Louya, F; Malanda, M; Malonga, DA; Mouata, AM; Nsimba, B; Yocka, D | 1 |
| Eriksen, J; Gustafsson, LL; Minzi, OM; Nsimba, SE; Petzold, M; Sanga, AJ; Tomson, G; Warsame, MY | 1 |
| A/elbasit, IA; Adam, I; Elbashir, MI; Ibrahim, MH | 1 |
| Abdulla, KH; Abdulla, R; Ali, AS; Fakih, K; Juma, MS; Lemnge, MM; Malecela, EK; Njau, RJ; Sambu, E | 1 |
| Kremsner, PG; Krishna, S; Lell, B; Ramharter, M; Uhlemann, AC | 1 |
| Jones, KL; McIntosh, HM | 1 |
| Gonzalez-Block, MA; Mubyazi, GM | 1 |
| Abdel-Muhsin, AM; Ahmed, S; Ali, E; Babiker, HA; Mackinnon, MJ; Walliker, D | 1 |
| Argaw, D; Babaniyi, O; Jima, D; Kebede, A; Medhin, A; Tesfaye, G | 1 |
| Adazu, K; Ayisi, JG; Bles, HM; Blokland, IE; Lindblade, KA; Odhiambo, F; Rosen, DH; Slutsker, L; van Eijk, AM | 1 |
| Adedeji, AA; Fateye, BA; Fehintola, FA; Gbotosho, GO; Happi, TC; Oduola, AM; Sowunmi, A; Tambo, E | 1 |
| Breman, JG; O'Meara, WP | 1 |
| Adjei, O; Adjei, S; Horstmann, RD; Kobbe, R; Marks, F; May, J; Meyer, CG; von Kalckreuth, V | 1 |
| Adjetey, TA; Affoumou, GB; Barro-Kiki, P; Kone, M; Loukou, DD; Menan, EI; Nebavi, NG; Yavo, W | 1 |
| Dokomajilar, C; Dorsey, G; Lankoande, M; Ouedraogo, JB; Rosenthal, PJ; Rouamba, N; Zongo, I | 1 |
| Baruah, S; Campbell, P; Narain, K; Rogers, CC | 1 |
| Abdulla, S; Beck, HP; Falk, N; Felger, I; Genton, B; Masanja, H; Mshinda, H; Mugittu, K | 1 |
| Bachy, C; D'Alessandro, U; Donam, I; Grandesso, F; Guthmann, JP; Habimana, J; Kerah, CH; Maikere, J; Ntambi, J; Vanlerberghe, V | 1 |
| Ali, MS; Kadaru, AG | 1 |
| Gebru-Woldearegai, T; Grobusch, MP; Hailu, A; Kun, JF | 1 |
| Asfaw, M; Kassa, M; Mohammed, H; Sileshi, M; Taye, G | 1 |
| Barugahare, B; Cao, H; Dorsey, G; Eggena, MP; Hopkins, H; Mugyenyi, P; Okello, M; Rosenthal, PJ; Ssali, F | 1 |
| Ahmed, OA; Elamin, SB; Eltaib, EH; Malik, EM; Mohamed, AO | 1 |
| Abdalla, MA; Adam, I; Ali, DM | 1 |
| Bukirwa, H; Critchley, J | 1 |
| Hatabu, T; Hongvangthong, B; Kano, S; Keokhamphavanh, B; Kobayashi, J; Mannoor, MK; Phetsouvanh, R; Phompida, S; Sato, Y; Taguchi, N; Toma, H; Vanisaveth, V; Watanabe, H | 1 |
| Abeyewickreme, W; Abeysundara, S; Bandara, KB; Dayanath, MY; de Silva, NR; Hapuarachchi, HC; Hunt, SY; Sibley, CH | 1 |
| Djalle, D; Manirakiza, A; Menard, D; Talarmin, A; Yapou, F | 1 |
| Bousema, T; Gouagna, L; Omar, S; Sauerwein, R; Sawa, P; Schallig, H; Schneider, P | 1 |
| Alexander, N; Bâ, el H; Boulanger, D; Cissé, B; Gaye, O; Greenwood, B; Hallett, R; Lines, J; Milet, J; Richardson, K; Simondon, F; Simondon, K; Sokhna, C; Sutherland, C; Targett, G; Trape, JF | 1 |
| Adedeji, AA; Bamgboye, AE; Bolaji, OM; Fateye, BA; Gbotosho, GO; Happi, TC; Oduola, AM; Sowunmi, A | 1 |
| Dokomajilar, C; Dorsey, G; Francis, D; Kamya, MR; Machekano, R; Nsobya, SL; Rosenthal, PJ; Talisuna, A; Yeka, A | 1 |
| Auliff, AM; Baker, J; Burns, M; Cheng, Q; Edstein, MD; Gatton, ML | 1 |
| Hill, J; Kazembe, P | 1 |
| Abdulla, S; Bloland, PB; Causer, LM; Elling, BF; Goodman, CA; Kassala, H; Khatib, RA; Mkikima, S; Patrick Kachur, S; Schulden, J | 1 |
| Abdulla, S; Bloland, P; Mandike, R; Mills, A; Mulligan, JA; Palmer, N; Williams, H | 1 |
| English, M; Midia, B; Ochola, SA; Snow, RW; Zurovac, D | 1 |
| Benga-De, E; Doumbo, O; Faye, O; Gaye, O; Kayentao, K; Lo, Y; Moran, AC; Moreira, PM; Newman, RD; Parise, ME; Steketee, RW; Yameogo, M | 1 |
| Björkman, A; Hwaihwanje, I; Kaneko, A; Kobayakawa, T; Mita, T; Osawa, H; Takahashi, N; Tanabe, K; Tsukahara, T | 1 |
| Ayala, E; Cabrera, L; Calderón, M; Gilman, RH; Lescano, AG; Pinedo, VV; Terry, H; Vinetz, JM | 1 |
| Ericsson, O; Gustafsson, LL; Justin-Temu, M; Massele, A; Minzi, OM | 1 |
| Brabin, BJ; Hill, J; Kalanda, GC; Verhoeff, FH | 1 |
| D'Alessandro, U; Fanello, CI; Karema, C; Rwagacondo, CE; van Doren, W | 1 |
| A-Elbasit, IE; Alifrangis, M; Elbashir, MI; Giha, HA; Khalil, IF | 1 |
| Cheng, Q; Gatton, ML | 1 |
| Kokwaro, G; Marsh, K; Nzila, AM; Ward, SA; Winstanley, PA | 1 |
| Dokomajilar, C; Dorsey, G; Hopkins, H; Kamya, MR; Leemann, E; Myrick, A; Rosenthal, PJ | 1 |
| Balajo, B; Dunyo, S; Greenwood, B; Mbaye, A; Milligan, P; Richardson, K; Shulman, C; Walraven, G | 2 |
| Bennett, S; Fielding, K; Greenwood, B; Malunga, P; Mulenga, M; Shulman, C; Thuma, P | 1 |
| de Radiguès, X; Diallo, KI; Diallo, M; Djimdé, A; Doumbo, O; Guthmann, JP; Maiga, H; Ngwakum, PA; Sacko, M | 1 |
| Bitarakwate, E; Dorsey, G; Hwang, J; Pai, M; Reingold, A; Rosenthal, PJ | 1 |
| Coulibaly, SO; Koné, B; Magnussen, P; Nezien, D; Traoré, S | 1 |
| Barnwell, JW; Bloland, P; Escalante, AA; Hamel, M; Huber, C; McCollum, AM; Ouma, P; Poe, AC; Shi, YP; Slutsker, L; Udhayakumar, V; Vulule, J; Zhou, Z | 1 |
| Alano, A; Bienzle, U; Kumma, WP; Löscher, T; Miranda, IB; Mockenhaupt, FP; Osman, ME; Roewer, S; Schunk, M | 1 |
| Aide, P; Alonso, P; Aponte, JJ; DgeDge, M; Dobaño, C; Espasa, M; Mabunda, S; Macete, E; Mandomando, I; Menendez, C; Sanz, S; Sigauque, B | 1 |
| Meshnick, SR; Mwapasa, V; Rogerson, SJ | 1 |
| Filler, SJ; Hamel, M; Kazembe, P; Macheso, A; Newman, RD; Parise, ME; Steketee, RW; Thigpen, M | 1 |
| Shen, WJ; Thiero, M | 1 |
| Ahmed, ES; Elamin, SB; Elhassan, AH; Elmardi, KA; Malik, EM; Mannan, AA; Mohamed, TA; Mowien, RM | 1 |
| Aubouy, A; Deloron, P; Migot-Nabias, F | 1 |
| Chalwe, V; Chilengi, R; D'Alessandro, U; Dujardin, JC; Moerman, F; Mulenga, M; Mwananyanda, L; Van Overmeir, C; VangGeertruyden, JP | 1 |
| Chalwe, V; Chilengi, R; Colebunders, R; D'Alessandro, U; Dujardin, JC; Kasongo, W; Kestens, L; Moerman, F; Mulenga, M; Mwananyanda, L; Van Geertruyden, JP; Van Overmeir, C | 1 |
| Björkman, A; Hugosson, E; Montgomery, SM; Premji, Z; Troye-Blomberg, M | 1 |
| Laufer, MK; Plowe, CV | 1 |
| Dorsey, G; Downing, R; Hubbard, A; Hunt, BM; Kigozi, A; Lule, JR; Malamba, SS; Mermin, J; Ransom, R; Reingold, A; Rosenthal, PJ | 1 |
| Abodo, RT; Basco, LK; Ndounga, M; Ngane, VF; Same-Ekobo, A; Soula, G; Youmba, JC | 1 |
| Juma, EA; Lau, J; Obonyo, CO; Ogutu, BR; Vulule, JM | 1 |
| Ahmed, A; Das, MK; Dev, V; Lumb, V; Sharma, YD | 1 |
| Bisser, S; Mazier, D; Mezui-Me-Ndong, J; Ollomo, B; Ouwe-Missi-Oukem-Boyer, O; Touré, FS | 1 |
| Kayembe, G; Montgomery, J; Pota, H; Roper, C; Swarthout, TD; van den Broek, IV | 1 |
| D'Alessandro, U; Fanello, CI; Karema, C; Ngamije, D; van Doren, W; Van Overmeir, C | 1 |
| Anstey, NM; Brockman, A; Ebsworth, EP; Edstein, MD; Kenangalem, E; Laihad, F; Price, RN; Ratcliff, A; Siswantoro, H; Tjitra, E; Wuwung, M | 1 |
| Méndez, F; Muñoz, A; Plowe, CV | 1 |
| Akther, S; Attlmayr, B; Fukuda, M; Haque, R; Miller, RS; Noedl, H; Salam, MA; Schaecher, K; Thriemer, K; Wagatsuma, Y | 1 |
| Browne, E; Bruce, J; Chandramohan, D; Greenwood, B; Randal, A; Tagbor, H | 1 |
| Alloueche, A; Bennett, S; Fielding, K; Greenwood, BM; Malunga, F; Mulenga, M; Shulman, C; Thuma, PE | 1 |
| Balthazary, ST; Malisa, AL; Mbugi, EV; Mshinda, H; Mutayoba, BM; Nyambo, TB | 1 |
| Bloland, PB; Hamel, MJ; Kain, KC; Obonyo, CO; Shah, SN; Slutsker, L; Smith, EE | 1 |
| Bedu-Addo, G; Bienzle, U; Eggelte, TA; Hommerich, L; Junge, C; Mockenhaupt, FP | 1 |
| Dzinjalamala, FK; Eddington, ND; Laufer, MK; Masonga, R; Plowe, CV; Takala, SL; Taylor, TE; Thesing, PC | 1 |
| Baird, JK; Bangs, MJ; Chand, K; Elyazar, I; Estiana, L; Lederman, ER; Maguire, JD; Sismadi, P; Sumawinata, IW | 1 |
| Goodman, C; Hetzel, MW; Kachur, SP; Lengeler, C; Makemba, A; Msechu, JJ; Mshinda, H; Nathan, R; Obrist, B; Schulze, A | 1 |
| Aguttu, C; Anokbonggo, WW; Chiria, J; Gustafsson, LL; Hellgren, U; Obua, C; Ogwal-Okeng, JW | 1 |
| Carnevale, EP; DaRe, JT; Kouri, D; McNamara, DT; Mueller, I; Zimmerman, PA | 1 |
| Issifou, S; Kremsner, PG; Matsiegui, PB; Missinou, MA; Necek, M | 1 |
| Dike, N; Ezumah, N; Ojukwu, J; Okonkwo, P; Onwujekwe, O; Shu, E; Uzochukwu, B | 1 |
| Aaby, P; Kofoed, PE; Rodrigues, A; Rombo, L | 1 |
| Barnes, KI; Evans, A; Little, F; Smith, PJ; Watkins, WM; White, NJ | 1 |
| Ariey, F; Bischoff, E; Bouchier, C; Cojean, S; Durand, R; Ekala, MT; Fandeur, T; Guillotte, M; Le Bras, J; Marrama, L; Mercereau-Puijalon, O; Noranate, N; Patarapotikul, J; Pradines, B; Rogier, C; Sokhna, C; Spiegel, A; Tall, A; Trape, JF | 1 |
| Barreto Miranda, I; Berens-Riha, N; Hoelscher, M; Kitua, A; Löscher, T; Maboko, L; Maduhu, I; Schönfeld, M; Schunk, M | 1 |
| Bjorkman, A; Farnert, A; Isabel Veiga, M; Martensson, A; Membi, C; Montgomery, SM; Ngasala, B; Premji, Z; Ursing, J; Wiklund, L | 1 |
| Adam, I; Alifrangis, M; Elmardi, KA; Ibrahium, AM; Khalil, IF; Kheir, MM; Malik, EM; Osman, ME | 1 |
| Asamoa, K; Ba-Nguz, A; Crawley, J; Hill, J; Palmer, A; Robalo, M; Roman, E; Serufilira, A; Steketee, R; Yartey, J | 1 |
| Ayede, I; Dada-Adegbola, HO; Fadero, FF; Falade, AG; Falade, CO; Gbotosho, GO; Happi, CT; Oduola, AM; Salako, LA | 1 |
| Escalante, AA; McCollum, AM; Mueller, K; Udhayakumar, V; Villegas, L | 1 |
| Morrow, RH | 1 |
| Dokomajilar, C; Dorsey, G; Guiguemde, RT; Ouedraogo, JB; Rosenthal, PJ; Rouamba, N; Tinto, H; Zongo, I | 1 |
| Adedeji, AA; Fateye, BA; Gbotosho, GO; Happi, TC; Sowunmi, A | 1 |
| Cousens, SN; Diallo, DA; Greenwood, BM; Ilboudo-Sanogo, E; Konaté, AT; Nebié, I; Ord, R; Pota, H; Roper, C; Sutherland, C | 1 |
| Adjuik, M; Beck, HP; Guthmann, JP; Kiguli, J; Mshinda, H; Mugittu, K; Olliaro, PL; Priotto, G; Snounou, G; Taylor, WR | 1 |
| Keola, S; Khanthavong, M; Mayxay, M; Newton, PN; Phetsouvanh, R; Phompida, S; Pongvongsa, T; Taylor, AM; White, NJ | 1 |
| Basco, L; Djaman, JA; Mazabraud, A | 1 |
| Barondi, F; Issifou, S; Kremsner, PG; Kun, JF; Lell, B; Missinou, MA; Oyakhirome, S; Pongratz, P; Ramharter, M | 1 |
| Gupta, A; Gustafsson, LL; Haule, AF; Kagashe, GA; Massele, AY; Minzi, OM | 1 |
| Singh, RK | 1 |
| Cravo, P; do Rosário, VE; Fernandes, N; Figueiredo, P | 1 |
| D'Alessandro, U; Guiguemdé, TR; Ouédraogo, JB; Tinto, H; van Marck, E; van Overmeir, C; Zongo, I | 1 |
| Arrospide, N; Bacon, DJ; Cabezas, C; Cairo, J; Durand, S; Fiestas, V; Gutierrez, S; Lucas, C; Marquiño, W; Puray, M; Ruebush, TK; Salas, C; Utz, G | 1 |
| Abebe, W | 1 |
| Bonnet, M; Coulibaly, L; Félix, M; Guthmann, JP; Kankolongo, GM; Roper, C | 1 |
| Ayisi, J; Brouwer, KC; Kolczak, MS; Lal, AA; Lal, RB; Mirel, LB; Nahlen, BL; Otieno, JA; Shi, YP; Steketee, R; Van Eijk, AM; Yang, C | 1 |
| Andrianina, NN; Jahevitra, M; Ménard, D; Ramiandrasoa, Z; Randriamanantena, A; Rasoarilalao, N; Ratsimbasoa, A; Raveloson, A; Tuseo, L | 1 |
| Clark, TD; Dokomajilar, C; Dorsey, G; Kamya, MR; Maiteki-Sebuguzi, C; Njama-Meya, D; Nzarubara, B; Rosenthal, PJ; Staedke, S | 1 |
| Bjorkman, A; Ekvall, H; Kaneko, A; Obonyo, CO; Olliaro, P; Oloo, AJ; Taylor, W; Ter Kuile, F | 1 |
| Bygbjerg, I; Magnussen, P; Mbonye, AK | 1 |
| Newman, RD; Parise, ME; Peters, PJ; Thigpen, MC | 1 |
| Molyneux, M; Nkhoma, S; Ward, S | 1 |
| González, IJ; Osorio, L; Pérez, Ldel P | 1 |
| Chivenga, J; Gemperli, A; Kumar, N; Mbedzi, J; Mlambo, G; Mutambu, SL; Soko, W; Sullivan, D | 1 |
| Abruquah, HH; Adjei, O; Adjei, S; Amoah, K; Ayim, M; Busch, W; Kobbe, R; Kreuels, B; Kreuzberg, C; Langefeld, I; Marks, F; May, J; Meyer, CG; Opoku, E; Thompson, B; Thompson, PA | 1 |
| Madaki, JK; Sagay, AS; Thacher, TD; Tukur, IU | 1 |
| Ariey, F; Bedja, SA; Rabarijaona, LP; Randrianarivelojosia, M; Robert, V; Tall, A | 1 |
| Dieng, Y; Faye, B; Faye, O; Gaye, O; Ndiaye, D; Ndiaye, JL | 1 |
| Al Harthi, SA | 1 |
| Aubouy, A; Bertin, G; Deloron, P; Fievet, N; Kinde-Gazard, D; Kiniffo, R; Kossou, H; Massougbodji, A; Sagbo, JC | 1 |
| Anderson, TJ; Imwong, M; Mayxay, M; Nair, S; Newton, PN; Phetsouvanh, R; Phompida, S; Pongvongsa, T; Sudimack, D; Tanomsing, N; White, NJ | 1 |
| Basco, LK; Tahar, R | 1 |
| Basco, LK; Casimiro, PN; Mallanda, G; Malonga, DA; Matondo Maya, DW; Mayengue, PI; Miakassissa-Mpassi, V; Ndounga, M; Nsonde-Ntandou, F; Ntoumi, F; Ringwald, P; Tahar, R | 1 |
| A-Elbasit, IE; Alifrangis, M; Bygbjerg, IC; Elbashir, MI; Giha, HA; Khalil, IF; Masuadi, EM | 1 |
| Enevold, A | 1 |
| Ayisi, JG; Hamel, MJ; Kager, PA; Munguti, K; Odhiambo, F; Ouma, PO; Sikuku, E; Slutsker, L; Van Eijk, AM | 1 |
| Durrani, N; Kolaczinski, K; Rahim, S; Rowland, M | 1 |
| Bista, MB; Cox-Singh, J; Davis, TM; Davis, WA; Hollander, J; Linehan, M; Thakur, GD; Thapa, S | 1 |
| Gutiérrez, A; Herrera, S; Manzano, M; Méndez, F; Moreno, LA; Muñoz, A; Murrain, B; Plowe, CV | 1 |
| Alifrangis, M; Bousema, T; Drakeley, C; Enevold, A; Gosling, R; Mosha, F; Ndaro, A; Sauerwein, R; Shekalaghe, S; van Meegeren, M | 1 |
| Browne, E; Bruce, J; Chandramohan, D; Greenwood, B; Ord, R; Randall, A; Tagbor, H | 1 |
| Adjei, O; Adjei, S; Klinkert, MQ; Kobbe, R; May, J; Schreiber, N | 1 |
| Basco, LK; Casimiro, PN; Malonga, DA; Ndounga, M; Ntoumi, F; Tahar, R | 1 |
| Issifou, S; Matsiegui, PB; Mavoungou, E; Missinou, MA; Necek, M | 1 |
| Batty, KT; Davis, TM; Ilett, KF; Karunajeewa, HA; Lammey, J; Law, I; Lin, E; Mueller, I; Page-Sharp, M; Siba, P | 1 |
| Gatarayiha, JP; Kabarisa, T; Ndayisaba, G; Rulisa, S | 1 |
| Beck, HP; Genton, B; Goroti, M; Maku, P; Marfurt, J; Müeller, I; Reeder, JC; Sie, A | 1 |
| Dokomajilar, C; Dorsey, G; Ouédraogo, JB; Rosenthal, PJ; Rouamba, N; Séré, Y; Zongo, I | 1 |
| Acquah, PA; Bedu-Addo, G; Bienzle, U; Eggelte, TA; Holmberg, V; Hommerich, L; Mockenhaupt, FP; von Oertzen, C | 1 |
| Dash, AP; Dua, VK; Edwards, G; Gupta, NC; Sethi, P | 1 |
| Afsharpad, M; Djadid, ND; Raeisi, A; Zakeri, S | 1 |
| Chalwe, V; Champo, D; Chilengi, R; Gill, CJ; Hamer, DH; Macleod, WB; Mubikayi, L; Mukwamataba, D; Mulele, CK; Mulenga, M; Mwanakasale, V; Mwananyanda, L; Thea, DM | 1 |
| Adegnika, AA; Agnandji, ST; Altun, H; Borchert, L; Decker, M; Dornemann, J; Gabor, J; Glasenapp, Iv; Goesch, J; Grobusch, MP; Issifou, S; Kiessling, GC; Klein Klouwenberg, P; Klopfer, A; Kombila, DU; Koster, KB; Kremsner, PG; Langin, MU; Lell, B; Naumann, B; Necek, M; Oyakhirome, S; Pongratz, P; Potschke, M; Salazar, CL; Schwarz, NG; Supan, C | 1 |
| Alifrangis, M; Bygbjerg, IC; Enevold, A; Jensen, AT; Nkya, WM; Staalsoe, T; Theander, TG; Theisen, M; Vestergaard, LS | 1 |
| Arrospide, N; de Oliveira, AM; Escalante, AA; Griffing, SM; McCollum, AM; Quezada, WM; Udhayakumar, V; Zhou, Z | 1 |
| Adjei, O; Adjei, S; Busch, W; Kobbe, R; Kreuels, B; Kreuzberg, C; Marks, F; May, J; Meyer, CG; Opoku, E; Schreiber, N; Thompson, B; Thompson, PA; Tosun, M | 1 |
| Ageep, T; Babiker, A; Babiker, H; Baraka, O; El-Sayed, B; El-Zaki, SE; Gadalla, N; Mansour, F; Milligan, P | 1 |
| Eriksen, J; Gustafsson, LL; Kitua, A; Mduma, S; Mwankusye, S; Petzold, MG; Swedberg, G; Tomson, G; Veiga, MI; Warsame, M | 1 |
| Agbowai, C; Akogbeto, M; Coosemans, M; D'Alessandro, U; Erhart, A; Gazard, D; Massougbodji, A; Menten, J; Nahum, A; van Loen, H; Van Overmeir, C | 1 |
| Dabo, CA; Diallo, M; Diarra, MA; Doumbo, O; Kayentao, K; Ongoiba, A; Sangho, H; Saye, R; Yattara, O | 1 |
| Bouyou-Akotet, M; Durand, R; Guiyedi, V; Kombila, M; Le Bras, J; Loembet, R; Mabika-Mamfoumbi, M; Mourou-Mbina, JR; Ngoungou, E; Nsimba, B | 1 |
| Gordi, T; Gustafsson, LL; Hellgren, U; Jerling, M; Ntale, M; Obua, C; Ogwal-Okeng, JW | 1 |
| Ajanga, AA; Gikandi, PW; Gitonga, CW; Noor, AM; Snow, RW | 1 |
| Bloland, P; Escalante, A; Hamel, MJ; McCollum, A; Otieno, K; Ouma, P; Poe, A; Shi, YP; Slutsker, L; Udhayakumar, V; Vulule, J; Zhou, Z | 1 |
| Dama, S; Dembele, D; Dicko, A; Djimdé, AA; Doumbo, OK; Fofana, B; Ouologuem, D; Sagara, I; Sidibe, B; Toure, S | 1 |
| Kolawole, SO; Ogungbamigbe, TO; Ogunro, PS; Ojurongbe, O; Okanlawon, BM | 1 |
| Aide, P; Alonso, P; Aponte, JJ; Benito, A; Berzosa, P; Dobaño, C; Macete, E; Mandomando, I; Mayor, A; Menéndez, C; Puyol, L; Sacarlal, J; Sanz, S; Serra-Casas, E | 1 |
| Beck, HP; Genton, B; Marfurt, J; Müller, I; Oa, O; Reeder, JC; Sie, A; Smith, TA | 1 |
| Kar, SK; Kerketta, AS; Mohapatra, SS | 1 |
| Balema, MB; Blanke, CH; Heide, L; Mbaruku, GM; Müller, MS; Naisabha, GB | 1 |
| Barnes, KI; Durrheim, D; Govere, J; Little, F; Mabuza, A; Mngomezulu, N; Roper, C; Watkins, B; White, NJ | 1 |
| Aide, P; Alonso, PL; Aponte, JJ; Chauhan, VS; Chitnis, CE; Dobaño, C; Macete, E; Mandomando, I; Mayor, A; Menéndez, C; Nhampossa, T; Puyol, L; Quelhas, D; Quintó, L; Sanz, S; Serra-Casas, E | 1 |
| Brown, N | 1 |
| Hansen, MB; Puta, C | 1 |
| Alvar, J; Amela, C; Benito, A; Molina, R; Roche, J | 1 |
| Bekobita, D; Munafu, CG; Nevill, CG; Ochen, K; Sezi, CL | 1 |
| Bales, JD; Beadle, C; Beier, JC; Chumo, DK; Hoffman, SL; McElroy, PD; Oloo, AJ; Onyango, FK; Oster, CN; Sherwood, JA | 1 |
| Adagu, SI; Faji, JT; Lege-Oguntoye, L; Ogala, WN; Ogunrinde, GO; Okoyeh, JN; Sani, AH | 1 |
| Del Nero, L; Lamizana, L; Nebié, I; Pietra, V | 1 |
| Deacon, HE; Freese, JA; Sharp, BL | 1 |
| Chitsulo, L; Schultz, LJ; Steketee, RW; Wirima, JJ | 1 |
| Cimino, D; Gereige, RS | 1 |
| Dua, VK; Sarin, R; Sharma, VP | 1 |
| Barreto, J; Dgedge, M; Fleck, SL; Hetzel, C; Hogh, B; Jones, I; Kruse, NA; Sinden, RE; Thompson, R | 1 |
| Al-Yaman, F; Alpers, MP; Genton, B; Mokela, D | 1 |
| Burnham, G; Kamugisha, J; Kipp, W | 1 |
| Mharakurwa, S; Mugochi, T | 2 |
| Brooks, DR; Hyde, JE; Read, M; Sims, PF; Wang, P; Watkins, WM | 1 |
| Chatnugrob, P; Eamsila, C; Lasserre, R; Mittelholzer, ML; Nopavong Na Ayuthya, A; Singharaj, P; Stürchler, D; Webster, HK; Yooyen, P | 1 |
| Chitsulo, L; Kazembe, P; Macheso, A; Schultz, LJ; Steketee, RW; Wirima, JJ | 2 |
| Aouba, A; Guiguemde, TR; Lamizana, L; Ouedraogo, JB | 1 |
| Adio, R; Oduola, AM; Omokhodion, SJ; Salako, LA; Sowunmi, A; Walker, O | 1 |
| Fuchs, E; Funk, M; Naef, U; Nevill, C; Phillips-Howard, P; Schildknecht, J; Schlagenhauf, P; Steffen, R; Stürchler, D | 1 |
| Bangchang, KN; Bunnag, D; Harinasuta, T; Karbwang, J; Rooney, W; Thimasarn, K | 1 |
| Del Nero, L; Nebie, I; Pietra, V; Soudouem, G | 1 |
| Hagos, B; Kariuki, D; Khan, B; Martin, SK; Ofulla, AV | 1 |
| Fernando, R; Handunnetti, SM; Jayasinghe, S; Mendis, KN; Pathirana, PP; Sheriff, MH | 1 |
| Angel, VH; Friman, G; Hellgren, U; Mittelholzer, ML; Rombo, L; Stürchler, D | 1 |
| Banmairuroi, V; Bunnag, D; Harinasuta, T; Karbwang, J; Na Bangchang, K | 1 |
| Wezam, A | 1 |
| Alvar, J; Amela, C; Ayecaba, S; Benito, A; Molina, R; Roche, J | 1 |
| Afshar, A; Edrissian, GH; Mohsseni, G; Satvat, MT; Sayedzadeh, A | 1 |
| Marsh, K; Watkins, WM; Woodrow, C | 1 |
| Emembolu, JO; Lege-Oguntoye, L; Okoyeh, JN; Sarki, U; Slotboom, AB | 1 |
| Bergqvist, Y; Breyer, S; Burgmann, H; Feistauer, S; Feucht, M; Graninger, W; Hellgren, U; Uhl, F; Winkler, S | 1 |
| Bloland, PB; Campbell, CC; Kazembe, PN; Lackritz, EM; Steketee, R; Were, JB | 1 |
| Schubarth, P | 1 |
| Mharakurwa, S | 1 |
| Batchelor, R; Burans, JP; Iriye, C; Lobel, HO; Longer, CF; Magill, AJ; Rozmajzl, P; Sharp, TW; Smoak, B; Thornton, SA; Wallace, MR | 1 |
| Bienzle, U; Graninger, W; Kremsner, PG; Metzger, W; Mordmüller, B | 1 |
| Garner, P | 1 |
| Lynen, L; Van Damme, W; Van den Ende, J; Van Gompel, A | 1 |
| Laomiphol, A; Palananth, C; Rooney, W; Sirichaisinthop, J; Tansophalaks, S; Tháithong, S; Thamewat, U; Thimasarn, K; Vijaykadga, S; Yamokgul, P | 1 |
| Chitsulo, L; Kazembe, P; Kumwenda, N; Nwanyanwu, OC; Redd, SC; Wirima, JJ; Ziba, C | 1 |
| Drakeley, C; Greenwood, B; Jaffar, S; Joof, D; Müller, O; Okorie, C; Pinder, M; van Hensbroek, MB | 1 |
| Anabwani, GM; Esamai, FO; Menya, DA | 1 |
| Corrah, PT; de Veer, GE; Giadom, B; Greenwood, BM; Jaffar, S; van Hensbroek, MB | 1 |
| Ezedinachi, E | 1 |
| Handschin, J; Kremsner, PG; Nkeyi, M; Philipps, J; Radloff, PD; Stürchler, D | 1 |
| Bakker, DA; Docters van Leeuwen, B; Eggelte, TA; Henry, MC; Kluin, J; Watson, P | 1 |
| Diop, S; Djimde, A; Doumbo, OK; Kouriba, B; Plowe, CV; Wellems, TE | 1 |
| Alene, GD; Bennett, S | 1 |
| Adak, T; Ansari, MA; Biswas, S; Devi, CU; Pillai, CR; Sharma, YD | 1 |
| Gamadzi, G; Gandwe, J; Kazembe, PN; Nwanyanwu, OC; Redd, SC; Ziba, C | 1 |
| Hyde, JE; Read, M; Sims, PF; Wang, P | 1 |
| Kathuria, R; Kshirsagar, NA; Potkar, CN | 1 |
| Chambo, O; Curtis, CF; Hills, E; Mbwana, H; Trigg, JK; Watkins, W | 1 |
| Oduola, AM; Sowunmi, A | 2 |
| Lege-Oguntoye, L; Ogunrinde, GO; Okoyeh, JN; Ugbode, RO | 1 |
| Mboera, LE; Ndawi, BT; Wakibara, JV | 1 |
| Magnussen, P; Ndyomugyenyi, R | 2 |
| Garg, MR; Gogtay, NJ; Kshirsagar, NA | 1 |
| Singh, PS | 1 |
| Davis, TM; Martin, RB | 1 |
| Brabin, BJ; Kachale, B; Kazembe, P; Masache, P; Van der Kaay, HJ; Verhoeff, FH | 1 |
| Amukoye, E; Hatcher, J; Lowe, B; Marsh, K; Minyiri, G; Mosobo, M; Ngumbao, E; Snow, RW; Ton, M; Watkins, WM; Winstanley, PA | 1 |
| Ansaloni, L; Falaschi, F | 1 |
| Bayoumi, R; Dao, LD; Djimde, A; Doumbo, O; Hyde, JE; Lee, CS; Mshinda, H; Sims, PF; Swedberg, G; Tanner, M; Wang, P; Watkins, WM | 1 |
| Falade, CO; Fehintola, FA; Kyle, DE; Makler, MT; Milhous, WK; Oduola, AM; Ogundahunsi, OA; Omitowoju, GO; Piper, RC; Schuster, BG; Sowunmi, A | 1 |
| Durrani, N; Hewitt, S; Rowland, M; Sondorp, E | 1 |
| Bygbjerg, IC; Curtis, J; Duraisingh, MT; Jelinek, T; Lemnge, MM; Mhina, J; Rønn, AM; Warhurst, DC | 2 |
| Avila, JC; Carter, D; Cespedes, JL; Cortese, JF; Djimde, A; Doumbo, OK; Estrada-Franco, JG; Mollinedo, RE; Nwanyanwu, OC; Plowe, CV; Watkins, WM; Winstanley, PA | 1 |
| Aung, H; Aung, S; Kyaw, MP; Lwin, M; Oo, H; Sint, N; Thein, H; Tun, SM; Win, Y | 1 |
| Kyaw, MP; Lin, H; Linn, N; Lwin, M; Maung, NS; Ohn, M; Oo, T; Soe, K | 1 |
| Manyando, C; Puta, C | 1 |
| Barreto, J; Begtrup, K; Butcher, GA; Dgedge, M; Eling, W; Enosse, SM; Gamage-Mendis, A; Hogh, B; Mendis, C; Sinden, RE; Thompson, R | 1 |
| Hyde, JE; Lee, CS; Shaio, MF; Sims, PF; Wang, P | 1 |
| Curtis, J; Duraisingh, MT; Warhurst, DC | 1 |
| Durrheim, DN; Sharp, BL | 1 |
| Kremsner, PG; Philipps, J; Radloff, PD; Wernsdorfer, W | 1 |
| Handschin, J; Kremsner, PG; Lehman, LG; Lell, B; Schmidt-Ott, JR; Sturchler, D | 1 |
| Bojang, K; Doherty, T; Gathmann, I; Gemperli, B; Greenwood, B; Haywood, M; Jaffar, S; Jones, P; McAdam, K; Obaro, S; Pinder, M; Royce, C; Snounou, G; von Seidlein, L | 1 |
| Anumudu, CA; Gordon, DM; Lyon, JA; Nwagwu, M; Obi, TU; Ologunde, CA; Sodeinde, O; Wirtz, RA | 1 |
| Cortese, JF; Gilman, RH; Guarda, JA; Kublin, JG; Plowe, CV; Shankar, AH; Witzig, RS; Zurita, JQ | 1 |
| Brabin, BJ; Broadhead, RL; Chimsuku, L; Kazembe, P; Russell, WB; Verhoeff, FH | 1 |
| Basco, LK; Ringwald, P; Tahar, R | 2 |
| Barat, LM; Bloland, PB; Ettling, M; Himonga, B; Kapelwa, W; Nkunika, S; Ruebush, TK | 1 |
| Barat, LM; Bloland, PB; Himonga, B; Kazembe, PN; Oloo, AJ; Ruebush, TK | 1 |
| Greenwood, BM; McIntosh, HM | 1 |
| Bulmer, JN; Cutts, F; Dorman, EK; Kawuondo, K; Marsh, K; Peshu, N; Shulman, CE | 1 |
| Bourgeade, A; Delmont, J | 1 |
| Brabin, BJ; Broadhead, RL; Chimsuku, L; Hart, CA; Kazembe, P; Verhoeff, FH | 1 |
| Aung, S; Ejov, MN; Sein, K; Tun, T | 1 |
| Bustos, DG; Canete-Miguel, E; Canfield, CJ; Hutchinson, DB | 1 |
| Mberu, EK; Plowe, CV; Watkins, WM; Winstanley, PA | 1 |
| Hyde, JE; Sims, P; Wang, P | 1 |
| Bangs, MJ; Fryauff, DJ; Ingkokusumo, G; Kadir, A; Richie, TL; Sumawinata, I; Tjitra, E | 1 |
| Anderson, RM; Danis, M; Greenwood, BM; Hien, TT; Kokwaro, G; Looareesuwan, S; Marsh, K; Molyneux, ME; Newbold, CI; Nosten, F; Olliaro, P; Ouma, J; Ruebush, TK; Snow, RW; Taylor, TE; Watkins, WM; White, NJ | 1 |
| Brobey, RK; Horii, T; Hyde, JE; Sims, PF; Wang, P | 1 |
| Canfield, CJ; Hutchinson, DB; Mulenga, M; Sukwa, TY | 1 |
| Barat, L; Chipipa, J; Kolczak, M; Sukwa, T | 1 |
| Alaribe, AA; Chukwuani, CM; Ekanem, OJ; Ezedinachi, EN; Haller, L; Meremikwu, MM; Ojar, EA; Umotong, AB | 1 |
| Caraballo, A; Rodriguez-Acosta, A | 1 |
| Giraldo, LE; Osorio, LE; Rallón, NI | 1 |
| Cortese, JF; Coulibaly, Y; Diakité, M; Diallo, M; Dicko, A; Diourté, Y; Djimdé, A; Doumbo, OK; Plowe, CV; Sagara, I | 1 |
| Jelinek, T; Kabagambe, G; Kilian, AH; Löscher, T; Nothdurft, HD; Pröll, S; von Sonnenburg, F; Westermeier, A | 1 |
| Kremsner, PG; Kun, JF; Lehman, LG; Lell, B; Schmidt-Ott, R | 1 |
| Goldman, I; Lal, AA; Plowe, C; Urdaneta, L | 1 |
| Jelinek, T; Kabagambe, G; Kilian, AH; von Sonnenburg, F | 1 |
| Makwaya, C; Minjas, JN; Premji, Z | 1 |
| Carter, JY; Eggelte, TA; Hodgins, E; Kok, FJ; Lema, O; Verhoef, H; West, CE | 1 |
| Alpers, M; Klabunde, J; Kremsner, PG; Kun, JF; Lell, B; Luckner, D; May, J; Meyer, C | 1 |
| Watt, G | 1 |
| Alloueche, A; Anyalebechi, C; Bojang, K; Coleman, R; Doherty, T; Duraisingh, M; Gosling, R; Greenwood, B; McAdam, K; Milligan, P; Olliaro, P; Pinder, M; Sadiq, A; Targett, G; Ude, JI; von Seidlein, L; Walraven, G; Warhurst, D | 1 |
| Andrade, AL; Arriaga, AL; Barat, LM; Giraldo, LE; Grajales, LF; Osorio, LE; Ruebush, TK | 1 |
| Ali, I; Bendavid, C; Condomines, P; Crassard, N; Djermakoye, F; Faugère, B; Parola, P | 1 |
| Curtis, J; Maxwell, CA; Ortelli, F; Watkins, WM | 1 |
| Dayo, H; Mberu, EK; Nzila, AM; Sibley, CH; Sulo, J; Watkins, WM; Winstanley, PA | 1 |
| Abdel-Muhsin, AA; Babiker, HA; Hamad, A; Hill, WG; Mackinnon, MJ; Walliker, D | 1 |
| Addiss, DG; Boyd, HA; Cetron, MS; Cookson, ST; Gonzaga, PS; Gushulak, BD; Miller, JM; Nguyen-Dinh, P; Ostrowski, SR; Parise, ME; Wahlquist, SP; Wainwright, RB; Weld, LH; Wilson, M | 1 |
| Algarin, E; Banguero, M; Barker, RH; Carrasquilla, G; Carvajal, F; Gervais, GW; Sanchez, P; Serrano, AE | 1 |
| McIntosh, HM | 2 |
| Awono-Ambene, HP; Le Hesran, JY; Robert, V; Trape, JF | 1 |
| Challand, S | 1 |
| Faiz, MA; Hassan, MR; Jalil, MA; Paul, B; Rahman, MR; Samad, R | 1 |
| Adedeji, AA; Akinyinka, OO; Falade, AG; Falade, CO; Fehintola, FA; Oduola, AM; Sowunmi, A | 1 |
| Kazembe, P; MacHeso, A; Nwanyanwu, OC; Ziba, C | 1 |
| Basco, LK; Keundjian, A; Ringwald, P; Tahar, R | 1 |
| Ashruf, G; Bennebroek, J; Gikunda, S; Gorissen, E; Kager, PA; Lamboo, M; Mbaruku, G | 1 |
| Dalvi, SS; Desai, S; Gogtay, NJ; Kadam, VS; Kamtekar, KD; Kshirsagar, NA | 1 |
| Bijl, HM; Kager, J; Koetsier, DW; van der Werf, TS | 1 |
| Björkman, A; Ekvall, H; Premji, Z | 1 |
| Basco, LK; Keundjian, A; Ringwald, P; Same Ekobo, A | 1 |
| Adedeji, AA; Falade, AG; Oduola, AM; Sijuade, AO; Sowunmi, A; Sowunmi, CO | 1 |
| Saul, A | 1 |
| Coleman, R; Doherty, T; Jawara, M; Targett, G; von Seidlein, L; Walraven, G | 1 |
| Blair, S; Fonseca, JC; Lacharme, LL; Tobón, A | 1 |
| Jambou, R; Raharimalala, L; Randriamanantena, A; Randrianarivelojosia, M | 1 |
| Coleman, R; Deen, J; Doherty, T; Drakeley, C; Jawara, M; Milligan, P; Pinder, M; Sutherland, C; Targett, G; von Seidlein, L; Walraven, G | 1 |
| Alonso, P; Aponte, J; Kahigwa, E; Menendez, C; Mshinda, H; Schellenberg, D; Tanner, M; Vidal, J | 1 |
| Kamya, MR; Kigonya, CN; McFarland, W | 1 |
| Hattori, Y; Kawauchi, S; Kohno, M; Nakamura, Y; Oga, A; Sadamitu, D; Sasaki, K | 1 |
| Bustos, MD; Butao, D; Chakanika, I; MacHeso, A; Matsuo, M; Takechi, M; Ziba, C; Zungu, IL | 1 |
| Campos, P; Canfield, CJ; Clendenes, M; Hutchinson, DB; Llanos-Cuentas, A | 1 |
| Charlebois, ED; Dorsey, G; Gasasira, A; Kamya, MR; Ndeezi, G; Rosenthal, PJ; Staedke, SG | 1 |
| Athan, E; Barnes, K; Dürrheim, DN; Govere, J; Mabuza, A; Mngomezulu, NM | 1 |
| Babiker, HA; Elkadaru, AE; Elkarim, EF; Elkheir, HK; Eltayeb, IB; Ibrahim, AM | 1 |
| Robert, V; Sokhna, CS; Trape, JF | 1 |
| Hills, E; Mberu, E; Mutabingwa, T; Nduati, E; Nzila, A; Watkins, W; Winstanley, P | 1 |
| Aida, AO; Christophel, EM; Eberl, KJ; el Valy, AO; Heuschkel, C; Jelinek, T; Peyerl-Hoffmann, G | 1 |
| Anstey, NM; Currie, BJ; Morris, PS; Saunders, JR; Suprianto, S; Tjitra, E | 1 |
| Buttiëns, H; D'Alessandro, U | 1 |
| Cowman, AF; Hyde, JE; Kublin, JG; Mberu, EK; Nzila, AM; Plowe, CV; Sibley, CH; Sims, PF; Watkins, WM; Winstanley, PA | 1 |
| Ali, D; Barat, LM; Green, MD; Kazembe, PN; Kolczak, MS; MacArthur, J; Macheso, A; Ruebush, TK; Stennies, GM | 1 |
| Basco, LK; Blackett, KN; Keundjian, A; Ngouesse, B; Ringwald, P | 1 |
| Chimpeni, P; Cortese, JF; Dzinjalamala, FK; Kamwendo, DD; Kublin, JG; Lescano, AG; Malkin, EM; Martino, LM; Molyneux, ME; Mukadam, RA; Plowe, CV; Rogerson, SJ; Taylor, TE; Winstanley, PA | 1 |
| Barnes, KI; Bredenkamp, BL; Durrheim, DN; Mthembu, SD; Sharp, BL | 1 |
| Barnes, K; Bredenkamp, B; Durrheim, D; Govere, J; Mabuza, A; Mngomezulu, N; Sharp, B | 1 |
| D'Acremont, V; Darioli, R; Genton, B; Landry, P; Pécoud, A; Stuerchler, D | 1 |
| Adjetey, TA; Barro-Kiki, PC; Konan, YJ; Koné, M; Menan, EI; Nebavi, NG; Nigué, L; Yavo, W | 1 |
| Bonsu, G; Driessen, GJ; Schouwenberg, BJ; van Kerkhoven, S; Verhave, JP | 1 |
| Bygbjerg, IC; Minjas, JN; Tarimo, DS | 1 |
| Bustos, DG; Diquet, B; Gay, F; Laracas, CJ; Lazaro, JE; Pottier, A; Traore, B | 1 |
| Garber, G; Thind, J | 1 |
| Ghosh, SK; Sharma, VP; Yadav, RS | 1 |
| Bunnag, D; Chindanond, D; Chittamas, S; Fernex, M; Harinasuta, T; Kristiansen, S; Malikul, S; Mittelholzer, ML; Sturchler, D | 1 |
| Adio, RA; Dickschat, U; Mittelholzer, ML; Reber-Liske, R; Salako, LA; Sowunmi, A; Stürchler, D; Walker, O | 1 |
| Alexander, M; Held, T; Mravak, S; Pohle, HD; Rögler, G; Trautmann, M; Weinke, T | 1 |
| Nzala, S; Puta, C; Sijumbila, G | 1 |
| Bunnag, D; Chitamas, S; Harinasuta, T; Karbwang, J; Viravan, C | 1 |
| Ameh, JO; Daniel, HI; Gadzama, NM; Molta, NB; Oguche, SO; Otu, TI; Watila, IM | 1 |
| Brandling-Bennett, AD; Kamsteeg, H; Keuter, M; Khalumi, G; Ngwawe, W; Ronday, M; Sanders, J; Schouten, E; Veltkamp, S; Wetsteyn, JC | 1 |
| Breman, JG; Koplan, JP; McFarland, D; Sudre, P | 1 |
| Marsh, K; Mberu, E; Mwangi, IN; Nevill, C; Newton, CR; Warn, PA; Warrell, DA; Waruiru, CM; Watkins, WM; Winstanley, PA | 1 |
| Reisinger, EC | 1 |
| Salako, LA; Sowunmi, A | 1 |
| Chen, C; Zheng, X | 1 |
| Chongsuphajaisiddhi, T; Frejacques, L; Luxemburger, C; Nosten, F; ter Kuiile, F; White, NJ | 1 |
| Irare, SG; Lemnge, MM; Mhina, JI | 1 |
| Denis, MB; Giboda, M; Kouznetsov, RL | 1 |
| Boudreau, EF; Chaikummao, S; Pang, LW; Witayarut, C | 1 |
61 review(s) available for sulfadoxine and Plasmodium falciparum Malaria
| Article | Year |
|---|---|
Using genetic methods to define the targets of compounds with antimalarial activity.
Topics: Animals; Anopheles; Antimalarials; Drug Resistance; Genetic Association Studies; Genome, Protozoan; Humans; Malaria, Falciparum; Molecular Targeted Therapy; Plasmodium falciparum | 2013 |
Effectiveness of seasonal malaria chemoprevention (SMC) treatments when SMC is implemented at scale: Case-control studies in 5 countries.
Topics: Africa, Western; Age Factors; Amodiaquine; Antimalarials; Case-Control Studies; Child, Preschool; Communicable Disease Control; Drug Combinations; Female; Humans; Incidence; Infant; Malaria, Falciparum; Male; Parasite Load; Plasmodium falciparum; Program Evaluation; Pyrimethamine; Risk Assessment; Risk Factors; Seasons; Sulfadoxine; Time Factors; Treatment Outcome | 2021 |
The efficacy and safety of intermittent preventive treatment with sulphadoxine-pyrimethamine vs artemisinin-based drugs for malaria: a systematic review and meta-analysis.
Topics: Antimalarials; Artemisinins; Drug Combinations; Humans; Infant, Newborn; Malaria; Malaria, Falciparum; Pyrimethamine; Sulfadoxine | 2022 |
Molecular assays for determining sulphadoxine-pyrimethamine drug resistance in India: a systematic review.
Topics: Antimalarials; Drug Combinations; Drug Resistance; Humans; India; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2022 |
[Progress of researches on genes associated with sulfadoxine-pyrimethamine resistance in
Topics: Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mutation; Plasmodium vivax; Pyrimethamine; Research; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2019 |
Efficacy and tolerability of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: a systematic review and individual patient data meta-analysis.
Topics: Amodiaquine; Anti-Bacterial Agents; Antimalarials; Artemisinins; Artesunate; Atovaquone; Clindamycin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Proguanil; Pyrimethamine; Quinine; Quinolines; Sulfadoxine | 2020 |
Animal Embryotoxicity Studies of Key Non-Artemisinin Antimalarials and Use in Women in the First Trimester.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Drug Combinations; Female; Humans; Malaria; Malaria, Falciparum; Naphthyridines; Pregnancy; Pregnancy Trimester, First; Pyrimethamine; Quinine; Quinolines; Rabbits; Rats; Sulfadoxine; Teratogens | 2017 |
Anti-malarial treatment outcomes in Ethiopia: a systematic review and meta-analysis.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Chloroquine; Drug Combinations; Ethanolamines; Ethiopia; Fluorenes; Humans; Malaria, Falciparum; Malaria, Vivax; Primaquine; Pyrimethamine; Sulfadoxine; Treatment Failure | 2017 |
Mapping sulphadoxine-pyrimethamine-resistant Plasmodium falciparum malaria in infected humans and in parasite populations in Africa.
Topics: Africa; Animals; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Models, Statistical; Mutation; Plasmodium falciparum; Population Surveillance; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2017 |
Primaquine or other 8-aminoquinolines for reducing Plasmodium falciparum transmission.
Topics: Adult; Antimalarials; Artemisinins; Child; Chloroquine; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Non-Randomized Controlled Trials as Topic; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Randomized Controlled Trials as Topic; Sulfadoxine; Time Factors | 2018 |
Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis.
Topics: Africa; Antimalarials; Drug Combinations; Drug Resistance; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2019 |
Monitoring antifolate resistance in intermittent preventive therapy for malaria.
Topics: Antimalarials; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2013 |
Malaria.
Topics: Africa South of the Sahara; Amodiaquine; Animals; Anopheles; Antimalarials; Artemisinins; Artesunate; Asia, Southeastern; Chloroquine; Drug Administration Schedule; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Insecticide-Treated Bednets; Insecticides; Malaria; Malaria Vaccines; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Pregnancy; Pregnancy Complications, Infectious; Primary Prevention; Pyrimethamine; Quinine; Quinolines; Seasons; Sulfadoxine | 2014 |
Mapping 'partially resistant', 'fully resistant', and 'super resistant' malaria.
Topics: Africa; Antimalarials; Drug Combinations; Drug Resistance; Geographic Mapping; Malaria, Falciparum; Plasmodium falciparum; Prevalence; Pyrimethamine; Sulfadoxine | 2013 |
On the pathway to better birth outcomes? A systematic review of azithromycin and curable sexually transmitted infections.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Clinical Trials as Topic; Drug Combinations; Drug Resistance, Bacterial; Female; Humans; Malaria, Falciparum; Male; Pregnancy; Pregnancy Outcome; Pyrimethamine; Reproductive Tract Infections; Sexually Transmitted Diseases; Sulfadoxine; Treatment Outcome; Vaginosis, Bacterial | 2013 |
Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Randomized Controlled Trials as Topic; Sulfadoxine | 2014 |
Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Randomized Controlled Trials as Topic; Sulfadoxine | 2015 |
Fighting fire with fire: mass antimalarial drug administrations in an era of antimalarial resistance.
Topics: Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Drug Therapy, Combination; History, 20th Century; History, 21st Century; Humans; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2015 |
Influence of malaria transmission intensity and the 581G mutation on the efficacy of intermittent preventive treatment in pregnancy: systematic review and meta-analysis.
Topics: Africa South of the Sahara; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Gravidity; Humans; Infant, Low Birth Weight; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2015 |
Prevention and control of malaria in pregnancy - new threats, new opportunities?
Topics: Adult; Animals; Antimalarials; Artemisinins; Culicidae; Drug Combinations; Drug Resistance; Female; Humans; Insecticide-Treated Bednets; Malaria, Falciparum; Malaria, Vivax; Pregnancy; Pregnancy Complications, Parasitic; Primary Prevention; Pyrimethamine; Quinolines; Sulfadoxine | 2017 |
Risk of drug resistance in Plasmodium falciparum malaria therapy-a systematic review and meta-analysis.
Topics: Amodiaquine; Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Risk; Sulfadoxine | 2017 |
Changing the policy for intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy in Malawi.
Topics: Antimalarials; Chemoprevention; Drug Combinations; Female; Health Policy; Humans; Malaria, Falciparum; Malawi; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Sulfadoxine | 2017 |
Artemisinin-based combination therapy for treating uncomplicated malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Parasitemia; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Sulfadoxine | 2009 |
Origins and spread of pfdhfr mutant alleles in Plasmodium falciparum.
Topics: Africa; Alleles; Antimalarials; Dihydropteroate Synthase; Drug Resistance; Evolution, Molecular; Humans; Malaria, Falciparum; Microsatellite Repeats; Molecular Epidemiology; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2010 |
Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials.
Topics: Africa; Anemia; Antimalarials; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Follow-Up Studies; Humans; Immunization Schedule; Incidence; Infant; Infant Mortality; Malaria, Falciparum; Patient Admission; Pyrimethamine; Randomized Controlled Trials as Topic; Regression Analysis; Research Design; Risk Factors; Safety; Sulfadoxine; Treatment Outcome | 2009 |
Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria.
Topics: Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Drug Design; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Health Care Surveys; Health Knowledge, Attitudes, Practice; Malaria; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Population Density; Pyrimethamine; Sulfadoxine; Travel; Treatment Outcome | 2009 |
Artemisinin derivatives for treatment of uncomplicated Plasmodium falciparum malaria in Sudan: too early for too much hope.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Drug Therapy, Combination; Humans; Malaria, Falciparum; Pyrimethamine; Sudan; Sulfadoxine; Treatment Failure | 2010 |
Intermittent preventive treatment against malaria: an update.
Topics: Africa South of the Sahara; Animals; Antimalarials; Child; Child, Preschool; Clinical Trials as Topic; Drug Administration Schedule; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2010 |
Following the path of most resistance: dhps K540E dispersal in African Plasmodium falciparum.
Topics: Africa; Animals; Antimalarials; Chloroquine; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Plasmodium falciparum; Point Mutation; Population Surveillance; Prevalence; Pyrimethamine; Sulfadoxine | 2010 |
Antimalarial drug resistance of Plasmodium falciparum in India: changes over time and space.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Drug Resistance; Geography; Humans; India; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Time Factors; Treatment Outcome | 2011 |
Azithromycin for treating uncomplicated malaria.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Atovaquone; Azithromycin; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Proguanil; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine; Treatment Failure | 2011 |
Combination of probenecid-sulphadoxine-pyrimethamine for intermittent preventive treatment in pregnancy.
Topics: Antimalarials; Chemoprevention; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Infectious; Probenecid; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2012 |
A systematic review of the safety and efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria during pregnancy.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Quinine; Sulfadoxine; Treatment Outcome | 2012 |
Primaquine for reducing Plasmodium falciparum transmission.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Randomized Controlled Trials as Topic; Sulfadoxine | 2012 |
Malaria prevention in pregnancy, birthweight, and neonatal mortality: a meta-analysis of 32 national cross-sectional datasets in Africa.
Topics: Adolescent; Adult; Africa; Animals; Antimalarials; Cohort Studies; Drug Combinations; Female; Humans; Infant Mortality; Infant, Low Birth Weight; Infant, Newborn; Logistic Models; Malaria, Falciparum; Plasmodium falciparum; Poisson Distribution; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Retrospective Studies; Sulfadoxine; Young Adult | 2012 |
Sulfadoxine-pyrimethamine resistance in Plasmodium falciparum: a zoomed image at the molecular level within a geographic context.
Topics: Antimalarials; Biomarkers; Clinical Trials as Topic; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Evolution, Molecular; Genes, Protozoan; Geography; Humans; Malaria, Falciparum; Plasmodium falciparum; Point Mutation; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2013 |
Pharmacokinetic profile of artemisinin derivatives and companion drugs used in artemisinin-based combination therapies for the treatment of Plasmodium falciparum malaria in children.
Topics: Antimalarials; Artemisinins; Child; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Pyrimethamine; Quinolines; Sulfadoxine | 2013 |
Malaria: a rising incidence in the United States.
Topics: Antimalarials; Chemoprevention; Chloroquine; Drug Combinations; Drug Resistance; Female; Global Health; Humans; Incidence; Malaria; Malaria, Falciparum; Male; Medical History Taking; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Sulfadoxine; Travel; United States | 2002 |
Safety, efficacy and determinants of effectiveness of antimalarial drugs during pregnancy: implications for prevention programmes in Plasmodium falciparum-endemic sub-Saharan Africa.
Topics: Africa South of the Sahara; Antimalarials; Drug Combinations; Endemic Diseases; Female; Humans; Infectious Disease Transmission, Vertical; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2003 |
Amodiaquine for treating malaria.
Topics: Amodiaquine; Antimalarials; Chloroquine; Drug Combinations; Humans; Malaria, Falciparum; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine | 2003 |
WHO, the Global Fund, and medical malpractice in malaria treatment.
Topics: Africa; Antimalarials; Artemisinins; Child; Chloroquine; Drug Combinations; Drug Costs; Drug Resistance; Drug Therapy, Combination; Humans; International Agencies; Malaria; Malaria, Falciparum; Malpractice; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Failure; World Health Organization | 2004 |
Genetic and biochemical aspects of drug resistance in malaria parasites.
Topics: Animals; Antimalarials; Chloroquine; Dihydropteroate Synthase; Drug Resistance; Drug Resistance, Multiple; Humans; Linkage Disequilibrium; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Membrane Proteins; Membrane Transport Proteins; Mutation; Phenanthrenes; Plasmodium falciparum; Plasmodium vivax; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2004 |
Malaria in endemic areas.
Topics: Antimalarials; Artemether; Artemisinins; Blood Transfusion; Chloroquine; Deferoxamine; Drug Combinations; Humans; Malaria; Malaria, Falciparum; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine | 2003 |
Why has the dihydrofolate reductase 164 mutation not consistently been found in Africa yet?
Topics: Africa; Animals; Antimalarials; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Plasmodium falciparum; Point Mutation; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2005 |
Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum.
Topics: Animals; Antimalarials; Artemisinins; Disease Transmission, Infectious; Drug Combinations; Drug Resistance, Multiple; Humans; Malaria, Falciparum; Plasmodium falciparum; Population Density; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2005 |
Malaria: uncomplicated, caused by Plasmodium falciparum.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Dapsone; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Mefloquine; Proguanil; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2005 |
Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine for treating uncomplicated malaria.
Topics: Adult; Amodiaquine; Chloroquine; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Pyrimethamine; Sulfadoxine | 2005 |
Sulfadoxine-pyrimethamine plus artesunate versus sulfadoxine-pyrimethamine plus amodiaquine for treating uncomplicated malaria.
Topics: Amodiaquine; Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Humans; Malaria, Falciparum; Pyrimethamine; Randomized Controlled Trials as Topic; Sesquiterpenes; Sulfadoxine | 2006 |
Comparative efficacy of chloroquine and sulphadoxine--pyrimethamine in pregnant women and children: a meta-analysis.
Topics: Adolescent; Adult; Africa; Antimalarials; Child; Chloroquine; Drug Combinations; Endemic Diseases; Female; Gravidity; Hemoglobins; Humans; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2006 |
Therapeutic potential of folate uptake inhibition in Plasmodium falciparum.
Topics: Animals; Antimalarials; Drug Combinations; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Folic Acid; Folic Acid Antagonists; Malaria, Falciparum; Plasmodium falciparum; Probenecid; Pyrimethamine; Sulfadoxine | 2004 |
Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine for uncomplicated malaria: a systematic review.
Topics: Amodiaquine; Antimalarials; Chloroquine; Drug Combinations; Drug Therapy, Combination; Humans; Malaria, Falciparum; Pyrimethamine; Randomized Controlled Trials as Topic; Research Design; Risk Factors; Sulfadoxine; Treatment Failure | 2006 |
Amodiaquine combined with sulfadoxine/pyrimethamine versus artemisinin-based combinations for the treatment of uncomplicated falciparum malaria in Africa: a meta-analysis.
Topics: Africa; Amodiaquine; Artemisinins; Drug Combinations; Humans; Malaria, Falciparum; Multicenter Studies as Topic; Pyrimethamine; Randomized Controlled Trials as Topic; Sesquiterpenes; Sulfadoxine | 2007 |
From evidence to action? Challenges to policy change and programme delivery for malaria in pregnancy.
Topics: Africa South of the Sahara; Animals; Antimalarials; Delivery of Health Care; Drug Combinations; Female; Health Policy; Humans; Malaria, Falciparum; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Sulfadoxine; World Health Organization | 2007 |
Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment.
Topics: Abnormalities, Drug-Induced; Africa; Animals; Antimalarials; Drug Administration Schedule; Drug Combinations; Drug Resistance; Female; Humans; Infant, Newborn; Kernicterus; Malaria, Falciparum; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2007 |
[Malaria: the most important emergency in subjects returning from the tropics].
Topics: Animals; Antimalarials; Chloroquine; Drug Combinations; Emergencies; Humans; Malaria; Malaria, Falciparum; Mefloquine; Plasmodium; Pyrimethamine; Quinidine; Quinine; Sulfadoxine | 1993 |
Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine as a treatment for uncomplicated malaria--a systematic review.
Topics: Amodiaquine; Antimalarials; Chloroquine; Drug Therapy, Combination; Humans; Malaria, Falciparum; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine | 1998 |
Studies on anti-folate antimalarials in east Africa.
Topics: Africa, Eastern; Animals; Antimalarials; Dapsone; Drug Therapy, Combination; Folic Acid Antagonists; Half-Life; Humans; Malaria, Falciparum; Plasmodium falciparum; Proguanil; Pyrimethamine; Sulfadoxine | 1999 |
Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine for treating uncomplicated malaria.
Topics: Adult; Amodiaquine; Chloroquine; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Pyrimethamine; Sulfadoxine | 2000 |
Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine for treating uncomplicated malaria.
Topics: Adult; Amodiaquine; Chloroquine; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Pyrimethamine; Sulfadoxine | 2001 |
Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next?
Topics: Africa South of the Sahara; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Microbial Sensitivity Tests; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2001 |
Development of the new antimalarial drug pyronaridine: a review.
Topics: Administration, Oral; Animals; Antimalarials; Cardiovascular System; Chloroquine; Dogs; Drug Evaluation; Drug Evaluation, Preclinical; Drug Resistance; Drug Therapy, Combination; Haplorhini; Humans; Injections, Intramuscular; Lethal Dose 50; Malaria, Falciparum; Mice; Naphthyridines; Pyrimethamine; Rabbits; Sulfadoxine | 1992 |
308 trial(s) available for sulfadoxine and Plasmodium falciparum Malaria
| Article | Year |
|---|---|
Overall and Gender-Specific Effects of Intermittent Preventive Treatment of Malaria with Artemisinin-Based Combination Therapies among Schoolchildren in Mali: A Three-Group Open Label Randomized Controlled Trial.
Topics: Amodiaquine; Anemia; Antimalarials; Artemisinins; Artesunate; Child; Drug Combinations; Drug Therapy, Combination; Female; Hemoglobins; Humans; Malaria; Malaria, Falciparum; Mali; Pyrimethamine; Sulfadoxine | 2022 |
Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial.
Topics: Amodiaquine; Anemia, Sickle Cell; Antimalarials; Artemisinins; Chemoprevention; Child; Child, Preschool; Drug Combinations; Female; Humans; Hydroxyurea; Infant; Kenya; Malaria; Malaria, Falciparum; Male; Proguanil; Pyrimethamine; Sulfadoxine | 2022 |
A Randomized Open-Label Evaluation of the Antimalarial Prophylactic Efficacy of Azithromycin-Piperaquine versus Sulfadoxine-Pyrimethamine in Pregnant Papua New Guinean Women.
Topics: Adult; Antimalarials; Asymptomatic Diseases; Azithromycin; Chemoprevention; Drug Combinations; Erythrocytes; Female; Gestational Age; Humans; Live Birth; Malaria, Falciparum; Malaria, Vivax; Papua New Guinea; Parasitemia; Plasmodium falciparum; Plasmodium vivax; Pregnancy; Pyrimethamine; Quinolines; Random Allocation; Severity of Illness Index; Stillbirth; Sulfadoxine | 2019 |
Microscopic and submicroscopic Plasmodium falciparum infection, maternal anaemia and adverse pregnancy outcomes in Papua New Guinea: a cohort study.
Topics: Adult; Anemia; Anti-Bacterial Agents; Antimalarials; Artemisinins; Asymptomatic Infections; Azithromycin; Female; Hemoglobin A; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria, Falciparum; Papua New Guinea; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Premature Birth; Prospective Studies; Pyrimethamine; Sulfadoxine; Young Adult | 2019 |
Counter-Selection of Antimalarial Resistance Polymorphisms by Intermittent Preventive Treatment in Pregnancy.
Topics: Adult; Antimalarials; Drug Combinations; Drug Resistance, Multiple; Female; Humans; Infant, Newborn; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Polymorphism, Genetic; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pyrimethamine; Real-Time Polymerase Chain Reaction; Sulfadoxine | 2020 |
Interactions Between Antenatal Sulfadoxine-Pyrimethamine, Drug-Resistant Plasmodium falciparum Parasites, and Delivery Outcomes in Malawi.
Topics: Adolescent; Adult; Animals; Birth Weight; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Infant, Newborn; Linear Models; Malaria, Falciparum; Malawi; Mutation, Missense; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Young Adult | 2020 |
Infant sex modifies associations between placental malaria and risk of malaria in infancy.
Topics: Adult; Antimalarials; Artemisinins; Drug Combinations; Female; Humans; Incidence; Infant; Infant, Newborn; Malaria, Falciparum; Male; Placenta Diseases; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Quinolines; Sulfadoxine; Young Adult | 2020 |
Effect of seasonal malaria chemoprevention plus azithromycin on Plasmodium falciparum transmission: gametocyte infectivity and mosquito fitness.
Topics: Amodiaquine; Animals; Antimalarials; Azithromycin; Chemoprevention; Child, Preschool; Culicidae; Drug Combinations; Genetic Fitness; Humans; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Seasons; Sulfadoxine | 2021 |
Efficacies of DHA-PPQ and AS/SP in patients with uncomplicated Plasmodium falciparum malaria in an area of an unstable seasonal transmission in Sudan.
Topics: Adolescent; Antimalarials; Artemisinins; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Pyrimethamine; Quinolines; Sudan; Sulfadoxine; Time Factors; Treatment Outcome; Young Adult | 2017 |
Assessment of Clinical Pharmacokinetic Drug-Drug Interaction of Antimalarial Drugs α/β-Arteether and Sulfadoxine-Pyrimethamine.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Chromatography, Liquid; Drug Combinations; Drug Interactions; Healthy Volunteers; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tandem Mass Spectrometry; Young Adult | 2017 |
Placental but Not Peripheral Plasmodium falciparum Infection During Pregnancy Is Associated With Increased Risk of Malaria in Infancy.
Topics: Chloroquine; Drug Combinations; Female; Follow-Up Studies; Humans; Infant; Logistic Models; Longitudinal Studies; Malaria, Falciparum; Multivariate Analysis; Placenta; Placenta Diseases; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Risk Factors; Sulfadoxine | 2017 |
Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trial.
Topics: Adolescent; Adult; Amodiaquine; Artemisinins; Child; Child, Preschool; Drug Combinations; Humans; Malaria, Falciparum; Mali; Methylene Blue; Middle Aged; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinolines; Sulfadoxine; Young Adult | 2018 |
Low risk of recurrence following artesunate-Sulphadoxine-pyrimethamine plus primaquine for uncomplicated Plasmodium falciparum and Plasmodium vivax infections in the Republic of the Sudan.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Malaria, Vivax; Male; Primaquine; Pyrimethamine; Recurrence; Sudan; Sulfadoxine | 2018 |
Efficacy of two artemisinin-based combinations for the treatment of malaria in pregnancy in India: a randomized controlled trial.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Female; Humans; Incidence; India; Intention to Treat Analysis; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2018 |
Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria.
Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Chemoprevention; Drug Combinations; Female; Humans; Incidence; Malaria, Falciparum; Mass Screening; Nigeria; Parasitemia; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Pyrimethamine; Sulfadoxine; Young Adult | 2018 |
Dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria during pregnancy and risk of malaria in early childhood: A randomized controlled trial.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child, Preschool; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Humans; Incidence; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Quinolines; Sulfadoxine; Time Factors; Treatment Outcome; Uganda; Young Adult | 2018 |
A Balanced Proinflammatory and Regulatory Cytokine Signature in Young African Children Is Associated With Lower Risk of Clinical Malaria.
Topics: Antimalarials; Artemisinins; Cell Extracts; Chemoprevention; Child, Preschool; Cytokines; Double-Blind Method; Erythrocytes; Humans; Infant; Infant, Newborn; Inflammation; Leukocytes, Mononuclear; Malaria, Falciparum; Mozambique; Pyrimethamine; Risk Factors; Schizonts; Sulfadoxine; Transcriptome | 2019 |
The prevalence and antifolate drug resistance profiles of Plasmodium falciparum in study participants randomized to discontinue or continue cotrimoxazole prophylaxis.
Topics: Adolescent; Adult; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Folic Acid Antagonists; Haplotypes; HIV Infections; Humans; Kenya; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pre-Exposure Prophylaxis; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2019 |
Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial.
Topics: Adult; Antimalarials; Artemisinins; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pyrimethamine; Quinolines; Sulfadoxine; Uganda; Young Adult | 2019 |
Intermittent screening and treatment with dihydroartemisinin-piperaquine and intermittent preventive therapy with sulfadoxine-pyrimethamine have similar effects on malaria antibody in pregnant Malawian women.
Topics: Adolescent; Adult; Antibodies, Protozoan; Antimalarials; Artemisinins; Drug Combinations; Female; Humans; Malaria, Falciparum; Malawi; Mass Screening; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Quinolines; Sulfadoxine; Young Adult | 2019 |
The effect of antenatal monthly sulphadoxine-pyrimethamine, alone or with azithromycin, on foetal and neonatal growth faltering in Malawi: a randomised controlled trial.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antimalarials; Azithromycin; Birth Weight; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Fetal Development; Humans; Infant, Newborn; Malaria, Falciparum; Malawi; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Reproductive Tract Infections; Sulfadoxine; Young Adult | 2013 |
Artesunate/amodiaquine malaria treatment for Equatorial Guinea (Central Africa).
Topics: Amodiaquine; Artemisinins; Child, Preschool; DNA, Protozoan; Drug Combinations; Equatorial Guinea; Female; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Failure; World Health Organization | 2013 |
Nonrandomized controlled trial of artesunate plus sulfadoxine-pyrimethamine with or without primaquine for preventing posttreatment circulation of Plasmodium falciparum gametocytes.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; India; Infant; Infant, Newborn; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Plasmodium falciparum; Primaquine; Pyrimethamine; Secondary Prevention; Sulfadoxine; Young Adult | 2013 |
A clinical and molecular study of artesunate + sulphadoxine-pyrimethamine in three districts of central and eastern India.
Topics: Adolescent; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Endemic Diseases; Female; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Point Mutation; Prevalence; Prospective Studies; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2013 |
Effectiveness of two antifolate prophylactic strategies against malaria in HIV-positive pregnant women in Bangui, Central African Republic: study protocol for a randomized controlled trial (MACOMBA).
Topics: Antimalarials; Central African Republic; Clinical Protocols; Coinfection; Drug Administration Schedule; Drug Combinations; Female; Folic Acid Antagonists; HIV Infections; Hospitals, Maternity; Humans; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Research Design; Sulfadoxine; Time Factors; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2013 |
Effectiveness of co-trimoxazole to prevent Plasmodium falciparum malaria in HIV-positive pregnant women in sub-Saharan Africa: an open-label, randomized controlled trial.
Topics: Adolescent; Adult; Antimalarials; Drug Combinations; Female; HIV Infections; Humans; Incidence; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Togo; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2014 |
Blood oxidative stress markers and Plasmodium falciparum malaria in non-immune African children.
Topics: Aldehydes; Anemia; Antigens, Protozoan; Antimalarials; Artemisinins; Biomarkers; Child, Preschool; Double-Blind Method; Endemic Diseases; Erythrocytes; Humans; Infant; Malaria, Falciparum; Mozambique; Oxidative Stress; Pyrimethamine; Sulfadoxine | 2014 |
Intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine during pregnancy in Burkina Faso: effect of adding a third dose to the standard two-dose regimen on low birth weight, anaemia and pregnancy outcomes.
Topics: Adolescent; Adult; Anemia; Antimalarials; Burkina Faso; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Pyrimethamine; Regression Analysis; Sulfadoxine; Young Adult | 2010 |
Pharmacokinetics of artesunate alone and in combination with sulfadoxine/pyrimethamine in healthy Sudanese volunteers.
Topics: Administration, Oral; Adult; Antimalarials; Artemisinins; Artesunate; Cross-Over Studies; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sudan; Sulfadoxine; Volunteers; Young Adult | 2014 |
Impact of age of first exposure to Plasmodium falciparum on antibody responses to malaria in children: a randomized, controlled trial in Mozambique.
Topics: Adaptive Immunity; Age Factors; Antibodies, Protozoan; Antigens, Protozoan; Antimalarials; Artemisinins; Chemoprevention; Child, Preschool; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Erythrocytes; Female; Humans; Incidence; Infant; Malaria, Falciparum; Male; Mozambique; Plasmodium falciparum; Prevalence; Pyrimethamine; Sulfadoxine | 2014 |
Host candidate gene polymorphisms and associated clearance of P. falciparum amodiaquine and fansidar resistance mutants in children less than 5 years in Cameroon.
Topics: Amodiaquine; Antimalarials; Cameroon; Child, Preschool; Drug Combinations; Drug Resistance; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Infant; Infant, Newborn; Interleukin-22; Interleukin-4; Interleukins; Malaria, Falciparum; Male; Plasmodium falciparum; Polymorphism, Single Nucleotide; Pyrimethamine; Sulfadoxine | 2014 |
Efficacy of sulphadoxine-pyrimethamine + artesunate, sulphadoxine-pyrimethamine + amodiaquine, and sulphadoxine-pyrimethamine alone in uncomplicated falciparum malaria in Mali.
Topics: Amodiaquine; Antimalarials; Artemisinins; Child, Preschool; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Mali; Pyrimethamine; Sulfadoxine | 2015 |
In vivo efficacy of sulphadoxine-pyrimethamine for the treatment of asymptomatic parasitaemia in pregnant women in Machinga District, Malawi.
Topics: Adolescent; Adult; Antimalarials; Asymptomatic Infections; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Malawi; Parasitemia; Parity; Plasmodium falciparum; Polymerase Chain Reaction; Pregnancy; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2015 |
Malaria preventive therapy in pregnancy and its potential impact on immunity to malaria in an area of declining transmission.
Topics: Adult; Antibodies, Protozoan; Antimalarials; Azithromycin; Chloroquine; Drug Combinations; Erythrocytes; Female; Humans; Malaria, Falciparum; Papua New Guinea; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Young Adult | 2015 |
Insights Into Circulating Cytokine Dynamics During Pregnancy in HIV-Infected Beninese Exposed to Plasmodium falciparum Malaria.
Topics: Adult; Antimalarials; Benin; Drug Combinations; Female; HIV Infections; Humans; Interleukin-10; Interleukin-2; Interleukin-4; Interleukin-5; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Complications, Parasitic; Prospective Studies; Pyrimethamine; Sulfadoxine; Trimethoprim, Sulfamethoxazole Drug Combination; Tumor Necrosis Factor-alpha; Young Adult | 2015 |
High efficacy of two artemisinin-based combinations: artesunate + sulfadoxine-pyrimethamine and artemether-lumefantrine for falciparum malaria in Yemen.
Topics: Adolescent; Adult; Aged; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Fluorenes; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Prospective Studies; Pyrimethamine; Sulfadoxine; Treatment Outcome; Yemen; Young Adult | 2015 |
Frequent Malaria Drives Progressive Vδ2 T-Cell Loss, Dysfunction, and CD16 Up-regulation During Early Childhood.
Topics: Artemisinins; Child, Preschool; Drug Combinations; GPI-Linked Proteins; Humans; Immune Tolerance; Infant; Longitudinal Studies; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Quinolines; Receptors, Antigen, T-Cell, gamma-delta; Receptors, IgG; Sulfadoxine; T-Lymphocyte Subsets; Up-Regulation | 2016 |
Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introduction.
Topics: Adolescent; Adult; Afghanistan; Aged; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Clinical Trials as Topic; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2016 |
Malaria illness mediated by anaemia lessens cognitive development in younger Ugandan children.
Topics: Age Factors; Anemia; Antimalarials; Artemisinins; Child, Preschool; Cognition; Cognition Disorders; Coinfection; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Quinolines; Risk Factors; Sulfadoxine; Trimethoprim, Sulfamethoxazole Drug Combination; Uganda | 2016 |
Efficacy and Safety of Azithromycin-Chloroquine versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment of Plasmodium falciparum Malaria Infection in Pregnant Women in Africa: An Open-Label, Randomized Trial.
Topics: Adolescent; Adult; Azithromycin; Chloroquine; Drug Combinations; Female; Humans; Infant, Newborn; Intention to Treat Analysis; Malaria, Falciparum; Pregnancy; Pregnancy Outcome; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2016 |
Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children.
Topics: Amodiaquine; Anorexia; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Infant; Longitudinal Studies; Malaria, Falciparum; Muscle Weakness; Pyrimethamine; Single-Blind Method; Sulfadoxine; Uganda | 2008 |
Effect of intermittent preventive treatment of malaria on health and education in schoolchildren: a cluster-randomised, double-blind, placebo-controlled trial.
Topics: Adolescent; Amodiaquine; Anemia; Animals; Antimalarials; Child; Child, Preschool; Cluster Analysis; Cognition; Cross-Sectional Studies; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Feces; Female; Humans; Kenya; Malaria, Falciparum; Male; Plasmodium falciparum; Prevalence; Pyrimethamine; Sulfadoxine | 2008 |
Mother-to-child transmission of HIV-1: association with malaria prevention, anaemia and placental malaria.
Topics: Adult; Anemia; Anti-HIV Agents; Antimalarials; CD4 Lymphocyte Count; Drug Combinations; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Malaria, Falciparum; Mozambique; Nevirapine; Placenta Diseases; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Complications, Infectious; Pyrimethamine; RNA, Viral; Sulfadoxine; Viral Load | 2008 |
[Gametocytemia in falciparum malaria treated with amodiaquine or artesunate].
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Colombia; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome | 2008 |
A randomized, controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana.
Topics: Amodiaquine; Anemia; Animals; Antimalarials; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Ghana; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria, Falciparum; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2008 |
Therapeutic and prophylactic effect of intermittent preventive anti-malarial treatment in infants (IPTi) from Ghana and Gabon.
Topics: Antimalarials; Drug Administration Schedule; Drug Combinations; Gabon; Ghana; Humans; Infant; Malaria, Falciparum; Pyrimethamine; Regression Analysis; Sulfadoxine; Time Factors; Treatment Outcome | 2008 |
dhfr and dhps genotype and sulfadoxine-pyrimethamine treatment failure in children with falciparum malaria in the Democratic Republic of Congo.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Democratic Republic of the Congo; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Genetic Markers; Genotype; Humans; Infant; Malaria, Falciparum; Male; Point Mutation; Pyrimethamine; Rural Health; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Failure | 2008 |
A trial of combination antimalarial therapies in children from Papua New Guinea.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Child, Preschool; Chloroquine; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Kaplan-Meier Estimate; Lumefantrine; Malaria, Falciparum; Malaria, Vivax; Male; Proportional Hazards Models; Pyrimethamine; Quinolines; Recurrence; Sulfadoxine | 2008 |
High risk of severe anaemia after chlorproguanil-dapsone+artesunate antimalarial treatment in patients with G6PD (A-) deficiency.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Dapsone; Drug Combinations; Drug Therapy, Combination; Female; Glucosephosphate Dehydrogenase Deficiency; Humans; Infant; Malaria, Falciparum; Male; Oxidants; Polymorphism, Genetic; Proguanil; Pyrimethamine; Sulfadoxine | 2008 |
Artemisinin-based combinations versus amodiaquine plus sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje, Mali.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Mali; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Single-Blind Method; Sulfadoxine; Treatment Outcome | 2009 |
Individual efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine in primi- and secundigravidae in rural Burkina Faso: impact on parasitaemia, anaemia and birth weight.
Topics: Adult; Anemia; Animals; Antimalarials; Birth Weight; Burkina Faso; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Logistic Models; Malaria, Falciparum; Parasitemia; Placenta; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Young Adult | 2009 |
Short report: comparison of chlorproguanil-dapsone with a combination of sulfadoxine-pyrimethamine and chloroquine in children with malaria in northcentral Nigeria.
Topics: Animals; Antimalarials; Child, Preschool; Chloroquine; Dapsone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Parasitemia; Plasmodium falciparum; Proguanil; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2009 |
Submicroscopic gametocytes and the transmission of antifolate-resistant Plasmodium falciparum in Western Kenya.
Topics: Animals; Artemisinins; Artesunate; Carrier State; Child, Preschool; Drug Combinations; Drug Resistance; Folic Acid Antagonists; Genotype; Germ Cells; Humans; Infant; Kenya; Malaria, Falciparum; Mutation; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2009 |
In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa.
Topics: Alleles; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Chloroquine; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Humans; Malaria, Falciparum; Membrane Transport Proteins; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Selection, Genetic; Sulfadoxine | 2009 |
Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali.
Topics: Amodiaquine; Animals; Antigens, Protozoan; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Genes, Protozoan; Genetic Markers; Genotype; Humans; Infant; Malaria, Falciparum; Male; Mali; Merozoite Surface Protein 1; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2009 |
Extended high efficacy of the combination sulphadoxine-pyrimethamine with artesunate in children with uncomplicated falciparum malaria on the Benin coast, West Africa.
Topics: Analysis of Variance; Animals; Antimalarials; Artemisinins; Artesunate; Benin; Child, Preschool; Cohort Studies; Drug Combinations; Female; Fever; Follow-Up Studies; Genotype; Humans; Infant; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2009 |
Comparison of sulfadoxine-pyrimethamine, unsupervised artemether-lumefantrine, and unsupervised artesunate-amodiaquine fixed-dose formulation for uncomplicated plasmodium falciparum malaria in Benin: a randomized effectiveness noninferiority trial.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Benin; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Polymerase Chain Reaction; Pyrimethamine; Sulfadoxine | 2009 |
Intermittent preventive treatment using artemisinin-based combination therapy reduces malaria morbidity among school-aged children in Mali.
Topics: Adolescent; Anemia; Artemisinins; Artesunate; Child; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mali; Parasitemia; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2009 |
Efficacy of sulphadoxine-pyrimethamine with or without artesunate for the treatment of uncomplicated Plasmodium falciparum malaria in southern Mozambique: a randomized controlled trial.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Mozambique; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Genetic; Proportional Hazards Models; Pyrimethamine; Sulfadoxine; Time Factors; Treatment Outcome | 2009 |
Varying efficacy of artesunate+amodiaquine and artesunate+sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in the Democratic Republic of Congo: a report of two in-vivo studies.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Democratic Republic of the Congo; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome | 2009 |
Artemisinin-naphthoquine combination (ARCO) therapy for uncomplicated falciparum malaria in adults of Papua New Guinea: a preliminary report on safety and efficacy.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Blood; Chloroquine; Drug Combinations; Humans; Malaria, Falciparum; Male; Middle Aged; Naphthoquinones; Papua New Guinea; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2009 |
Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.
Topics: Antimalarials; Dapsone; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Resistance; Female; Follow-Up Studies; Half-Life; Humans; Immunization Schedule; Incidence; Infant; Infant Mortality; Logistic Models; Malaria, Falciparum; Male; Mefloquine; Multivariate Analysis; Proguanil; Pyrimethamine; Safety; Sulfadoxine; Tanzania; Treatment Outcome | 2009 |
Pharmacokinetics of sulfadoxine and pyrimethamine in intermittent preventive treatment of malaria in pregnancy.
Topics: Adult; Africa; Antimalarials; Drug Administration Schedule; Drug Combinations; Female; Humans; Malaria, Falciparum; Plasmodium falciparum; Postpartum Period; Pregnancy; Pregnancy Complications, Parasitic; Prospective Studies; Pyrimethamine; Sulfadoxine; Young Adult | 2010 |
Options for the delivery of intermittent preventive treatment for malaria to children: a community randomised trial.
Topics: Amodiaquine; Antimalarials; Child, Preschool; Community Health Services; Drug Combinations; Female; Ghana; Home Care Services; Humans; Infant; Malaria, Falciparum; Male; Program Evaluation; Pyrimethamine; Seasons; Sulfadoxine; Treatment Outcome | 2009 |
Placental malaria and low birth weight in pregnant women living in a rural area of Burkina Faso following the use of three preventive treatment regimens.
Topics: Adult; Animals; Antimalarials; Burkina Faso; Chemoprevention; Chloroquine; Drug Combinations; Female; Fetal Blood; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria, Falciparum; Placenta; Placenta Diseases; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Rural Population; Sulfadoxine; Treatment Outcome; Young Adult | 2009 |
Molecular correlates of high-level antifolate resistance in Rwandan children with Plasmodium falciparum malaria.
Topics: Analysis of Variance; Antimalarials; Child; Child, Preschool; Drug Combinations; Drug Resistance; Folic Acid Antagonists; Gene Frequency; Genes, Protozoan; Haplotypes; Humans; Infant; Malaria, Falciparum; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Pyrimethamine; Rwanda; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2010 |
Selection of parasites with diminished drug susceptibility by amodiaquine-containing antimalarial regimens in Uganda.
Topics: Amino Acid Sequence; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Cohort Studies; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Humans; Infant; Malaria, Falciparum; Molecular Sequence Data; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Genetic; Pyrimethamine; Sequence Alignment; Sulfadoxine; Uganda | 2009 |
The effect of intermittent preventive treatment during pregnancy on malarial antibodies depends on HIV status and is not associated with poor delivery outcomes.
Topics: Antibodies, Protozoan; Antimalarials; Chemoprevention; Drug Administration Schedule; Drug Combinations; Female; Fetal Blood; HIV Infections; Humans; Infant; Infant, Newborn; Insecticide-Treated Bednets; Malaria, Falciparum; Mozambique; Placebos; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Young Adult | 2010 |
Efficacy of amodiaquine, sulphadoxine-pyrimethamine and their combination for the treatment of uncomplicated Plasmodium falciparum malaria in children in Cameroon at the time of policy change to artemisinin-based combination therapy.
Topics: Administration, Oral; Amodiaquine; Antimalarials; Cameroon; Child, Preschool; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Monitoring; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Health Policy; Humans; Infant; Malaria, Falciparum; Male; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Time Factors; Treatment Outcome | 2010 |
Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon.
Topics: Administration, Oral; Amodiaquine; Antimalarials; Artemisinins; Cameroon; Child, Preschool; Drug Administration Schedule; Drug Combinations; Drug Monitoring; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant, Newborn; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Pyrimethamine; Regression Analysis; Sulfadoxine; Time Factors; Treatment Outcome | 2010 |
In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.
Topics: Anemia; Anti-Infective Agents; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Follow-Up Studies; Glucosephosphate Dehydrogenase; Glucosephosphate Dehydrogenase Deficiency; Hemoglobins; Hemolysis; Humans; Infant; Malaria, Falciparum; Multivariate Analysis; Prevalence; Primaquine; Pyrimethamine; Regression Analysis; Risk Factors; Sulfadoxine; Tanzania | 2010 |
The effect of point mutations in dihydrofolate reductase genes and multidrug resistance gene 1-86 on treatment of falciparum malaria in Sudan.
Topics: Alleles; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Genes, MDR; Humans; Infant; Malaria, Falciparum; Male; Point Mutation; Prevalence; Pyrimethamine; Sudan; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2010 |
Protective efficacy of intermittent preventive treatment of malaria in infants (IPTi) using sulfadoxine-pyrimethamine and parasite resistance.
Topics: Alcohol Dehydrogenase; Antimalarials; Drug Combinations; Drug Resistance; Female; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Malaria, Falciparum; Male; Mutation; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2010 |
The effects of a pre-season treatment with effective antimalarials on subsequent malaria morbidity in under five-year-old children living in high and seasonal malaria transmission area of Burkina Faso.
Topics: Age Distribution; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Burkina Faso; Child, Preschool; Disease Susceptibility; Drug Administration Schedule; Drug Combinations; Epidemiologic Methods; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Pyrimethamine; Recurrence; Seasons; Sex Distribution; Sulfadoxine; Treatment Outcome | 2010 |
Persistence of Plasmodium falciparum parasites in infected pregnant Mozambican women after delivery.
Topics: Adult; Aging; Antimalarials; Delivery, Obstetric; Drug Administration Schedule; Drug Combinations; Female; Humans; Malaria, Falciparum; Mozambique; Odds Ratio; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Risk Factors; Sulfadoxine; Time Factors | 2011 |
Influences of intermittent preventive treatment and persistent multiclonal Plasmodium falciparum infections on clinical malaria risk.
Topics: Amodiaquine; Antigens, Protozoan; Antimalarials; Child, Preschool; Cross-Sectional Studies; Drug Combinations; Ghana; Humans; Infant; Malaria, Falciparum; Placebos; Protozoan Proteins; Pyrimethamine; Risk Factors; Sulfadoxine | 2010 |
HIV and placental infection modulate the appearance of drug-resistant Plasmodium falciparum in pregnant women who receive intermittent preventive treatment.
Topics: Adult; Alleles; Antimalarials; Chemoprevention; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Genetic Markers; HIV Infections; Humans; Infant, Newborn; Malaria, Falciparum; Mozambique; Placebos; Placenta; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Sulfadoxine | 2011 |
Impact of malaria at the end of pregnancy on infant mortality and morbidity.
Topics: Antimalarials; Drug Combinations; Female; Humans; Infant Mortality; Infant, Newborn; Malaria, Falciparum; Morbidity; Mozambique; Placebos; Placenta; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Proportional Hazards Models; Pyrimethamine; Risk Factors; Sulfadoxine; Surveys and Questionnaires | 2011 |
IgG against Plasmodium falciparum variant surface antigens and growth inhibitory antibodies in Mozambican children receiving intermittent preventive treatment with sulfadoxine-pyrimethamine.
Topics: Age Factors; Antibodies, Protozoan; Antibody Formation; Antigenic Variation; Antigens, Protozoan; Antigens, Surface; Drug Combinations; Growth Inhibitors; Humans; Immunoglobulin G; Infant; Infant, Newborn; Malaria, Falciparum; Membrane Proteins; Mozambique; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2011 |
Pharmacokinetic properties of conventional and double-dose sulfadoxine-pyrimethamine given as intermittent preventive treatment in infancy.
Topics: Antimalarials; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Pyrimethamine; Sulfadoxine | 2011 |
Efficacy of chloroquine and sulphadoxine-pyrimethamine either alone or in combination before introduction of ACT as first-line therapy in uncomplicated Plasmodium falciparum malaria in Jalpaiguri District, West Bengal, India.
Topics: Adolescent; Adult; Anti-Infective Agents; Antimalarials; Artemisinins; Child; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; India; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2011 |
High prevalence of dhfr triple mutant and correlation with high rates of sulphadoxine-pyrimethamine treatment failures in vivo in Gabonese children.
Topics: Amino Acid Substitution; Antimalarials; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Gabon; Genotype; Humans; Infant; Malaria, Falciparum; Male; Mutation, Missense; Plasmodium falciparum; Polymorphism, Genetic; Prevalence; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Failure | 2011 |
Morbidity from malaria in children in the year after they had received intermittent preventive treatment of malaria: a randomised trial.
Topics: Amodiaquine; Anemia; Antimalarials; Body Weight; Burkina Faso; Child, Preschool; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Incidence; Infant; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Morbidity; Mosquito Nets; Plasmodium falciparum; Prevalence; Pyrimethamine; Seasons; Sulfadoxine; Treatment Outcome | 2011 |
Malaria morbidity in children in the year after they had received intermittent preventive treatment of malaria in Mali: a randomized control trial.
Topics: Amodiaquine; Anemia; Antimalarials; Body Weight; Child, Preschool; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Incidence; Infant; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Mali; Morbidity; Mosquito Nets; Parasitemia; Plasmodium falciparum; Prevalence; Pyrimethamine; Seasons; Sulfadoxine; Treatment Outcome | 2011 |
Effect of transmission reduction by insecticide-treated bednets (ITNs) on antimalarial drug resistance in western Kenya.
Topics: Adolescent; Adult; Antimalarials; Child; Chloroquine; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Insecticide-Treated Bednets; Kenya; Malaria, Falciparum; Male; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Multivariate Analysis; Mutation; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Young Adult | 2011 |
Impact of combining intermittent preventive treatment with home management of malaria in children less than 10 years in a rural area of Senegal: a cluster randomized trial.
Topics: Amodiaquine; Anemia; Animals; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Community Health Workers; Disease Management; Drug Combinations; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Health Promotion; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Prevalence; Preventive Health Services; Pyrimethamine; Rural Population; Seasons; Senegal; Sulfadoxine | 2011 |
Cluster-randomized study of intermittent preventive treatment for malaria in infants (IPTi) in southern Tanzania: evaluation of impact on survival.
Topics: Adolescent; Adult; Antimalarials; Drug Combinations; Drug Therapy; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Middle Aged; Pregnancy; Pyrimethamine; Sulfadoxine; Survival Analysis; Tanzania; Young Adult | 2011 |
Efficacy of different primaquine-based antimalarial regimens against Plasmodium falciparum gametocytemia.
Topics: Adolescent; Adult; Aged; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Colombia; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Germ Cells; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Plasmodium falciparum; Primaquine; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2012 |
Intermittent preventive treatment with sulfadoxine-pyrimethamine does not modify plasma cytokines and chemokines or intracellular cytokine responses to Plasmodium falciparum in Mozambican children.
Topics: Antimalarials; Chemokines; Child; Drug Combinations; Flow Cytometry; Humans; Incidence; Infant; Intracellular Space; Malaria, Falciparum; Mozambique; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Th1 Cells; Th2 Cells | 2012 |
Defining Plasmodium falciparum treatment in South West Asia: a randomized trial comparing artesunate or primaquine combined with chloroquine or SP.
Topics: Adolescent; Antimalarials; Artemisinins; Artesunate; Child; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Pakistan; Patient Selection; Plasmodium falciparum; Polymerase Chain Reaction; Primaquine; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2012 |
Comparative efficacies of artemisinin combination therapies in Plasmodium falciparum malaria and polymorphism of pfATPase6, pfcrt, pfdhfr, and pfdhps genes in tea gardens of Jalpaiguri District, India.
Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Biomarkers; Calcium-Transporting ATPases; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Humans; India; Malaria, Falciparum; Male; Mefloquine; Membrane Transport Proteins; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2012 |
An analysis of timing and frequency of malaria infection during pregnancy in relation to the risk of low birth weight, anaemia and perinatal mortality in Burkina Faso.
Topics: Adult; Anemia; Antimalarials; Burkina Faso; Drug Administration Schedule; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria, Falciparum; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Trimesters; Prospective Studies; Pyrimethamine; Risk; Sulfadoxine; Time Factors; Young Adult | 2012 |
Good efficacy of artemether-lumefantrine for uncomplicated falciparum malaria in eastern Sumba, East Nusatenggara, Indonesia.
Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Fluorenes; Humans; Indonesia; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Recurrence; Sulfadoxine; Time Factors | 2012 |
Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon.
Topics: Administration, Oral; Amodiaquine; Antimalarials; Cameroon; Child; Child, Preschool; Drug Administration Schedule; Drug Combinations; Drug Monitoring; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Hematocrit; Humans; Malaria, Falciparum; Male; Parasitic Sensitivity Tests; Pyrimethamine; Sulfadoxine; Time Factors; Treatment Outcome | 2002 |
In vivo drug resistance of falciparum malaria in mining areas of Venezuela.
Topics: Adult; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Female; Health Promotion; Humans; Malaria, Falciparum; Male; Mining; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine; Treatment Failure; Treatment Outcome; Venezuela | 2002 |
The safety and efficacy of sulfadoxine-pyrimethamine, amodiaquine, and their combination in the treatment of uncomplicated Plasmodium falciparum malaria.
Topics: Amodiaquine; Animals; Antimalarials; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2002 |
Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial.
Topics: Antimalarials; Cause of Death; Child, Preschool; Dapsone; Developing Countries; Drug Combinations; Drug Therapy, Combination; Female; Hemoglobinometry; Humans; Infant; Kenya; Malaria, Falciparum; Malawi; Male; Proguanil; Pyrimethamine; Recurrence; Retreatment; Sulfadoxine; Survival Rate | 2002 |
Chloroquine and sulphadoxine-pyrimethamine efficacy for uncomplicated malaria treatment and haematological recovery in children in Bobo-Dioulasso, Burkina Faso during a 3-year period 1998-2000.
Topics: Anemia; Animals; Antimalarials; Burkina Faso; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Humans; Infant; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2002 |
[Chemosensitivity of Plasmodium falciparum in Sainte Marie island, east coast of Madagascar: in vivo and in vitro studies].
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Evaluation, Preclinical; Drug Monitoring; Drug Resistance; Female; Geography; Humans; Infant; Madagascar; Malaria, Falciparum; Male; Middle Aged; Parasitic Sensitivity Tests; Patient Selection; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2000 |
Combination of drug level measurement and parasite genotyping data for improved assessment of amodiaquine and sulfadoxine-pyrimethamine efficacies in treating Plasmodium falciparum malaria in Gabonese children.
Topics: Amodiaquine; Animals; Child; Child, Preschool; Drug Combinations; Female; Gabon; Genotype; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2003 |
Impact of preseason treatment on incidence of falciparum malaria and parasite density at a site for testing malaria vaccines in Bandiagara, Mali.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Cohort Studies; Drug Combinations; Humans; Incidence; Infant; Malaria Vaccines; Malaria, Falciparum; Mali; Plasmodium falciparum; Pyrimethamine; Research Design; Seasons; Sulfadoxine; Treatment Outcome | 2002 |
Therapeutic efficacy of chloroquine plus sulphadoxine/ pyrimethamine compared with monotherapy with either chloroquine or sulphadoxine/pyrimethamine in uncomplicated Plasmodium falciparum malaria in Laos.
Topics: Adolescent; Adult; Aged; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Sulfadoxine | 2003 |
Efficacy of chloroquine, sulfadoxine-pyrimethamine, and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria on the north coast of Peru.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Peru; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2003 |
Effects of chloroquine and sulfadoxine/pyrimethamine on gametocytes in patients with uncomplicated Plasmodium falciparum malaria in Colombia.
Topics: Adolescent; Adult; Animals; Antimalarials; Chi-Square Distribution; Child, Preschool; Chloroquine; Colombia; Drug Combinations; Female; Gametogenesis; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Statistics, Nonparametric; Sulfadoxine; Treatment Failure | 2002 |
Comparative efficacy of aminoquinoline-antifolate combinations for the treatment of uncomplicated falciparum malaria in Kampala, Uganda.
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Single-Blind Method; Sulfadoxine; Treatment Outcome; Uganda | 2003 |
Treatment failure of pyrimethamine-sulphadoxine and induction of Plasmodium falciparum gametocytaemia in children in western Kenya.
Topics: Adolescent; Animals; Antimalarials; Child; Child, Preschool; Cohort Studies; Drug Combinations; Drug Resistance; Female; Humans; Infant; Infant, Newborn; Kenya; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Pyrimethamine; Rural Health; Sulfadoxine; Treatment Failure | 2003 |
A randomized comparison of chloroquine and chloroquine plus ketotifen in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children.
Topics: Acute Disease; Administration, Oral; Amodiaquine; Analysis of Variance; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant; Ketotifen; Malaria, Falciparum; Male; Pyrimethamine; Recurrence; Sulfadoxine; Treatment Outcome | 2003 |
Plasmodium falciparum gametocytaemia in Nigerian children: before, during and after treatment with antimalarial drugs.
Topics: Age Factors; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2003 |
Assessing the efficacy of chloroquine and sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in the Democratic Republic of Congo.
Topics: Antimalarials; Child, Preschool; Chloroquine; Democratic Republic of the Congo; Drug Combinations; Drug Resistance; Hematocrit; Humans; Infant; Malaria, Falciparum; Parasitic Sensitivity Tests; Pyrimethamine; Sulfadoxine; Treatment Failure | 2003 |
Chloroquine versus sulfadoxine-pyrimethamine for treatment of Plasmodium falciparum malaria in Savannakhet Province, Lao People's Democratic Republic: an assessment of national antimalarial drug recommendations.
Topics: Adolescent; Adult; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Female; Health Planning Guidelines; Humans; Laos; Malaria, Falciparum; Male; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome | 2003 |
Treatment of uncomplicated falciparum malaria in southern Vietnam: can chloroquine or sulfadoxine-pyrimethamine be reintroduced in combination with artesunate?
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Child; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Genotype; Humans; Malaria, Falciparum; Male; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome; Vietnam | 2003 |
Validation of a simplified method for using molecular markers to predict sulfadoxine-pyrimethamine treatment failure in African children with falciparum malaria.
Topics: Animals; Antimalarials; Biomarkers; Child, Preschool; Dihydropteroate Synthase; DNA Primers; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Mutation; Outcome Assessment, Health Care; Plasmodium falciparum; Polymerase Chain Reaction; Population Surveillance; Prevalence; Prognosis; Pyrimethamine; Reproducibility of Results; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Failure; Uganda | 2003 |
Antipyretic, parasitologic, and immunologic effects of combining sulfadoxine/pyrimethamine with chloroquine or paracetamol for treating uncomplicated Plasmodium falciparum malaria.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Antimalarials; Body Temperature; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Immunoglobulin G; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Severity of Illness Index; Sulfadoxine; Treatment Outcome | 2003 |
The efficacy of chloroquine, sulfadoxine-pyrimethamine and a combination of both for the treatment of uncomplicated Plasmodium falciparum malaria in an area of low transmission in western Uganda.
Topics: Adolescent; Adult; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Infant; Malaria, Falciparum; Middle Aged; Parasitemia; Pyrimethamine; Sulfadoxine; Treatment Outcome; Uganda | 2004 |
Adherence to the combination of sulphadoxine-pyrimethamine and artesunate in the Maheba refugee settlement, Zambia.
Topics: Antimalarials; Artemisinins; Artesunate; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Family; Female; Health Education; Humans; Infant; Malaria, Falciparum; Male; Patient Compliance; Pyrimethamine; Refugees; Sesquiterpenes; Sulfadoxine; Surveys and Questionnaires; Treatment Refusal; Zambia | 2004 |
Efficacy of sulfadoxine/pyrimethamine in the treatment of uncomplicated Plasmodium falciparum malaria in Republic of Congo.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Antimalarials; Child, Preschool; Congo; Drug Combinations; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2004 |
Efficacy of chloroquine, amodiaquine, sulphadoxine-pyrimethamine and combination therapy with artesunate in Mozambican children with non-complicated malaria.
Topics: Amodiaquine; Animals; Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Mozambique; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2004 |
Efficacy of sulphadoxine-pyrimethamine alone or combined with amodiaquine or chloroquine for the treatment of uncomplicated falciparum malaria in Ugandan children.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Therapy, Combination; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome; Uganda | 2004 |
Antimalarial efficacy of sulfadoxine-pyrimethamine, amodiaquine and a combination of chloroquine plus sulfadoxine-pyrimethamine in Bundi Bugyo, western Uganda.
Topics: Amodiaquine; Antimalarials; Child, Preschool; Chloroquine; Developing Countries; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome; Uganda | 2004 |
Patterns of resistance and DHFR/DHPS genotypes of Plasmodium falciparum in rural Tanzania prior to the adoption of sulfadoxine-pyrimethamine as first-line treatment.
Topics: Animals; Antimalarials; Child, Preschool; Chloroquine; Developing Countries; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Point Mutation; Pyrimethamine; Rural Health; Sulfadoxine; Tanzania; Tetrahydrofolate Dehydrogenase | 2004 |
Open randomized study of pyrimethamine-sulphadoxine vs. pyrimethamine-sulphadoxine plus probenecid for the treatment of uncomplicated Plasmodium falciparum malaria in children.
Topics: Acute Disease; Antimalarials; Child; Child, Preschool; Drug Combinations; Drug Interactions; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Multidrug Resistance-Associated Proteins; Organic Anion Transporters; Parasitemia; Probenecid; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2004 |
Relationship between age, molecular markers, and response to sulphadoxine-pyrimethamine treatment in Kampala, Uganda.
Topics: Adolescent; Adult; Age Distribution; Aged; Animals; Antimalarials; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Genetic Markers; Humans; Infant; Malaria, Falciparum; Middle Aged; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2004 |
Efficacy of pyrimethamine-sulfadoxine in young children with uncomplicated falciparum malaria in rural Burkina Faso.
Topics: Antimalarials; Burkina Faso; Child, Preschool; Cohort Studies; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2004 |
Efficacy of combined chloroquine and sulfadoxine-pyrimethamine in uncomplicated Plasmodium falciparum malaria in Bangladesh.
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2004 |
Efficacy of rectal artesunate compared with parenteral quinine in initial treatment of moderately severe malaria in African children and adults: a randomised study.
Topics: Administration, Rectal; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Infusions, Intravenous; Injections, Intramuscular; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine; Suppositories | 2004 |
Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial.
Topics: Africa; Animals; Antimalarials; Child; Child, Preschool; Dapsone; Double-Blind Method; Drug Combinations; Drug Resistance; Female; Hemoglobins; Humans; Infant; Malaria, Falciparum; Male; Methemoglobin; Plasmodium falciparum; Proguanil; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2004 |
[Gametocyte levels in response to differing malaria treatments in two municipalities of Colombia].
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Colombia; Drug Combinations; Drug Therapy, Combination; Female; Gametogenesis; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2004 |
Intermittent preventive sulfadoxine-pyrimethamine treatment of primigravidae reduces levels of plasma immunoglobulin G, which protects against pregnancy-associated Plasmodium falciparum malaria.
Topics: Animals; Antibodies, Protozoan; Antigens, Protozoan; Antimalarials; Drug Administration Schedule; Drug Combinations; Female; Humans; Immunoglobulin G; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Trimester, Third; Pyrimethamine; Sulfadoxine | 2004 |
Efficacy of chloroquine, sulphadoxine-pyrimethamine and amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria in Kajo Keji county, Sudan.
Topics: Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Sudan; Sulfadoxine; Treatment Outcome | 2004 |
[In vivo evaluation of sulfadoxine-pyrimethamine efficacy during uncomplicated falciparum malaria in children of Yopougon (Abidjan, Côte d'Ivoire)].
Topics: Antimalarials; Child, Preschool; Cote d'Ivoire; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Sulfadoxine | 2004 |
Risk factors for gametocyte carriage in uncomplicated falciparum malaria in children.
Topics: Amodiaquine; Animals; Antimalarials; Carrier State; Child; Child, Preschool; Chloroquine; Chlorpheniramine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Nigeria; Parasitemia; Plasmodium falciparum; Prospective Studies; Pyrimethamine; Regression Analysis; Risk Factors; Sulfadoxine | 2004 |
Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Laos; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2004 |
Plasmodium falciparum hyperparasitaemia in children. Risk factors, treatment outcomes, and gametocytaemia following treatment.
Topics: Age Factors; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Gametogenesis; Humans; Malaria, Falciparum; Male; Nigeria; Parasitemia; Plasmodium falciparum; Prospective Studies; Pyrimethamine; Risk Factors; Sulfadoxine; Treatment Failure; Treatment Outcome | 2004 |
Clinical and parasitological response of Plasmodium falciparum to chloroquine and sulfadoxine/pyrimethamine in rural Uganda.
Topics: Adult; Animals; Antimalarials; Cell Proliferation; Child, Preschool; Chloroquine; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Rural Population; Sulfadoxine; Treatment Outcome; Uganda | 2003 |
Efficacies of chloroquine, sulfadoxine-pyrimethamine and quinine in the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan.
Topics: Adolescent; Adult; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Humans; Infant; Malaria, Falciparum; Pyrimethamine; Quinine; Sudan; Sulfadoxine; Treatment Failure; Treatment Outcome | 2004 |
Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar.
Topics: Adolescent; Adult; Age Distribution; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Hemoglobins; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Myanmar; Pyrimethamine; Recurrence; Sesquiterpenes; Sulfadoxine; Treatment Failure | 2004 |
Comparison of the parasitologic efficacy of amodiaquine and sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria in the Bungoma District of western Kenya.
Topics: Amodiaquine; Animals; Antimalarials; Drug Administration Schedule; Drug Combinations; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Infant; Kenya; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2004 |
Efficacy and effectiveness of the combination of sulfadoxine/pyrimethamine and a 3-day course of artesunate for the treatment of uncomplicated falciparum malaria in a refugee settlement in Zambia.
Topics: Antimalarials; Artemisinins; Artesunate; Child, Preschool; Developing Countries; Drug Administration Schedule; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Genetic Markers; Genomics; Humans; Infant; Malaria, Falciparum; Male; Patient Compliance; Pyrimethamine; Refugees; Sesquiterpenes; Sulfadoxine; Treatment Outcome; Zambia | 2005 |
Evidence basis for antimalarial policy change in Sierra Leone: five in vivo efficacy studies of chloroquine, sulphadoxine-pyrimethamine and amodiaquine.
Topics: Amodiaquine; Animals; Antimalarials; Child, Preschool; Chloroquine; Developing Countries; Drug Combinations; Drug Resistance; Evidence-Based Medicine; Female; Health Policy; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sierra Leone; Sulfadoxine; Treatment Failure; Treatment Outcome | 2005 |
A randomized comparative study of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Ghana.
Topics: Amodiaquine; Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Female; Fever; Ghana; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Patient Dropouts; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome | 2005 |
Efficacy of two artemisinin combination therapies for uncomplicated falciparum malaria in children under 5 years, Malakal, Upper Nile, Sudan.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Sesquiterpenes; Sudan; Sulfadoxine | 2005 |
A randomized comparison of sulphadoxine-pyrimethamine and combination of sulphadoxine pyrimethamine with chloroquine in the treatment of uncomplicated falciparum malaria in Eastern Sudan.
Topics: Adolescent; Antimalarials; Chloroquine; Drug Combinations; Drug Therapy, Combination; Humans; Malaria, Falciparum; Pyrimethamine; Sudan; Sulfadoxine | 2005 |
Blood folate concentrations and in vivo sulfadoxine-pyrimethamine failure in Malawian children with uncomplicated Plasmodium falciparum malaria.
Topics: Analysis of Variance; Biomarkers; Child; Child, Preschool; Drug Therapy, Combination; Enzyme Inhibitors; Female; Folic Acid; Humans; Infant; Malaria, Falciparum; Malawi; Male; Odds Ratio; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Failure; Treatment Outcome | 2005 |
Efficacy comparison between anti-malarial drugs in Africans presenting with mild malaria in the Central Republic of Africa: a preliminary study.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Central African Republic; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Parasitemia; Parasitic Sensitivity Tests; Patient Compliance; Plasmodium falciparum; Pyrimethamine; Quinine; Quinolines; Sesquiterpenes; Sulfadoxine; Treatment Outcome; Trimethoprim | 2005 |
Therapeutic efficacy of antimalarial drugs along the eastern Indo-Nepal border: a cross-border collaborative study.
Topics: Adolescent; Adult; Age Distribution; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; India; Infant; Malaria, Falciparum; Male; Middle Aged; Nepal; Pyrimethamine; Sex Distribution; Sulfadoxine; Treatment Failure | 2005 |
Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether.
Topics: Animals; Anopheles; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Female; Gametogenesis; Humans; Infant; Malaria, Falciparum; Male; Mosquito Control; Plasmodium falciparum; Pyrimethamine; Single-Blind Method; Sulfadoxine | 2005 |
Malaria in the Nuba Mountains of Sudan: baseline genotypic resistance and efficacy of the artesunate plus sulfadoxine-pyrimethamine and artesunate plus amodiaquine combinations.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Membrane Proteins; Membrane Transport Proteins; Protozoan Proteins; Pyrimethamine; Sesquiterpenes; Sudan; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2005 |
Antimalarial efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, and the combinations of amodiaquine + artesunate and sulfadoxine-pyrimethamine + artesunate in Huambo and Bie provinces, central Angola.
Topics: Amodiaquine; Angola; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Failure | 2005 |
In vivo sulphadoxine-pyrimethamine sentitivity study Tigray Region, Southern Zone, Alamata Town, September--November 2001.
Topics: Animals; Antimalarials; Disease Susceptibility; Drug Combinations; Drug Resistance; Ethiopia; Humans; Malaria, Falciparum; Malaria, Vivax; Microbial Sensitivity Tests; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2004 |
Efficacy and tolerability of artesunate plus sulfadoxine-pyrimethamine and sulfadoxine-pyrimethamine alone for the treatment of uncomplicated Plasmodium falciparum malaria in Peru.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Peru; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2005 |
Sulfadoxine-pyrimethamine plus chloroquine or amodiaquine for uncomplicated falciparum malaria: a randomized, multisite trial to guide national policy in Uganda.
Topics: Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Health Policy; Humans; Infant; Malaria, Falciparum; Pyrimethamine; Sulfadoxine; Uganda | 2005 |
Therapeutic efficacy of sulfadoxine-pyrimethamine for Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Prevalence; Pyrimethamine; South Africa; Sulfadoxine; Treatment Outcome | 2005 |
A randomized, placebo-controlled, double-blind trial on sulfadoxine-pyrimethamine alone or combined with artesunate or amodiaquine in uncomplicated malaria.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Genotype; Humans; Infant; Malaria, Falciparum; Male; Parasite Egg Count; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2005 |
Efficacy of combination therapy with artesunate plus amodiaquine compared to monotherapy with chloroquine, amodiaquine or sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum in Afghanistan.
Topics: Adolescent; Adult; Afghanistan; Aged; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Parasite Egg Count; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Failure; Treatment Outcome | 2005 |
A comparison of the efficacy of artesunate plus sulfadoxine-pyrimethamine with that of sulfadoxine-pyrimethamine alone, in the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan.
Topics: Adolescent; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Parasitemia; Pyrimethamine; Recurrence; Sesquiterpenes; Sudan; Sulfadoxine; Treatment Failure; Treatment Outcome | 2005 |
Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Ghana; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2005 |
Efficacy of chloroquine + sulfadoxine--pyrimethamine, mefloquine + artesunate and artemether + lumefantrine combination therapies to treat Plasmodium falciparum malaria in the Chittagong Hill Tracts, Bangladesh.
Topics: Adolescent; Antimalarials; Artemether; Artemisinins; Artesunate; Bangladesh; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2005 |
Efficacy of sulfadoxin pyrimethamine for uncomplicated Plasmodium falciparum malaria in a small sample of Sudanese children.
Topics: Adolescent; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Endemic Diseases; Female; Genotype; Humans; Infant; Malaria, Falciparum; Male; Parasite Egg Count; Parasitic Sensitivity Tests; Plasmodium falciparum; Prospective Studies; Pyrimethamine; Recurrence; Seasons; Sesquiterpenes; Sudan; Sulfadoxine; Treatment Failure | 2004 |
Therapeutic efficacy of sulfadoxine-pyrimethamine and amodiaquine among children with uncomplicated Plasmodium falciparum malaria in Zanzibar, Tanzania.
Topics: Amodiaquine; Anemia; Animals; Antimalarials; Child, Preschool; Drug Combinations; Drug Resistance; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tanzania; Treatment Failure; Treatment Outcome | 2005 |
Amplification of Plasmodium falciparum multidrug resistance gene 1 in isolates from Gabon.
Topics: Adolescent; Animals; Antimalarials; ATP-Binding Cassette Transporters; Child; Child, Preschool; Double-Blind Method; Drug Combinations; Drug Resistance; Gabon; Genes, MDR; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2005 |
Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Parasitemia; Polymerase Chain Reaction; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Failure; Treatment Outcome | 2005 |
Parasitological rebound effect and emergence of pyrimethamine resistance in Plasmodium falciparum after single-dose sulfadoxine-pyrimethamine.
Topics: Animals; Antimalarials; Drug Combinations; Drug Resistance; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2005 |
[Evaluation of the therapeutic efficacy of amodiaquine versus chloroquine in the treatment of uncomplicated malaria in Abie, Côte-d'Ivoire].
Topics: Amodiaquine; Animals; Antimalarials; Child, Preschool; Chloroquine; Cote d'Ivoire; Drug Combinations; Drug Resistance, Multiple; Endemic Diseases; Female; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2005 |
Amodiaquine, sulfadoxine-pyrimethamine, and combination therapy for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso.
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Burkina Faso; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2005 |
A randomized trial comparing the efficacy of four treatment regimens for uncomplicated falciparum malaria in Assam state, India.
Topics: Adolescent; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; India; Infant; Malaria, Falciparum; Male; Mefloquine; Prospective Studies; Pyrimethamine; Quinolines; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2006 |
(Sub)microscopic Plasmodium falciparum gametocytaemia in Kenyan children after treatment with sulphadoxine-pyrimethamine monotherapy or in combination with artesunate.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Carrier State; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Nucleic Acid Amplification Techniques; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2006 |
Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial.
Topics: Antimalarials; Artemisinins; Artesunate; Bedding and Linens; Child, Preschool; Double-Blind Method; Drug Combinations; Drug Resistance; Humans; Infant; Malaria, Falciparum; Prevalence; Pyrimethamine; Seasons; Senegal; Sesquiterpenes; Sulfadoxine | 2006 |
Predictors of the failure of treatment with pyrimethamine-sulfadoxine in children with uncomplicated falciparum malaria.
Topics: Aging; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Nigeria; Predictive Value of Tests; Pyrimethamine; Risk Factors; Sulfadoxine; Time Factors; Treatment Failure | 2006 |
Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance.
Topics: Adolescent; Adult; Aged; Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Endemic Diseases; Geography; Humans; Infant; Malaria, Falciparum; Membrane Proteins; Membrane Transport Proteins; Middle Aged; Mutation, Missense; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Failure; Treatment Outcome; Uganda | 2006 |
Efficacy of sulfadoxine-pyrimethamine in the treatment of uncomplicated Plasmodium falciparum malaria in East Timor.
Topics: Adolescent; Adult; Aged; Alleles; Animals; Antigens, Protozoan; Antimalarials; Child; Child, Preschool; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Merozoite Surface Protein 1; Middle Aged; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Timor-Leste; Treatment Outcome | 2006 |
Existence of antimalarial formulations with low bioavailability in Tanzania.
Topics: Adult; Antimalarials; Area Under Curve; Biological Availability; Cross-Over Studies; Drug Combinations; Drugs, Generic; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Quality Control; Single-Blind Method; Sulfadoxine; Tanzania; Therapeutic Equivalency | 2006 |
Tolerability of amodiaquine and sulphadoxine-pyrimethamine, alone or in combination for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan adults.
Topics: Adult; Amodiaquine; Antimalarials; Blood Cell Count; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Fatigue; Female; Hematocrit; Humans; Malaria, Falciparum; Male; Neutropenia; Pruritus; Pyrimethamine; Rwanda; Sulfadoxine; Treatment Outcome | 2006 |
Lack of inhibition of the anti-malarial action of sulfadoxine-pyrimethamine by folic acid supplementation when used for intermittent preventive treatment in Gambian primigravidae.
Topics: Adolescent; Adult; Anemia; Animals; Antimalarials; Dietary Supplements; Drug Combinations; Female; Folic Acid; Gambia; Gravidity; Hematinics; Hemoglobins; Humans; Malaria, Falciparum; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2006 |
Folic acid treatment of Zambian children with moderate to severe malaria anemia.
Topics: Anemia; Animals; Antimalarials; Atovaquone; Child; Child, Preschool; Drug Combinations; Folic Acid; Hematinics; Humans; Infant; Malaria, Falciparum; Naphthoquinones; Parasitemia; Population Density; Proguanil; Pyrimethamine; Sulfadoxine; Treatment Failure; Zambia | 2006 |
Efficacy of chloroquine and sulfadoxine/pyrimethamine for the treatment of uncomplicated falciparum malaria in Koumantou, Mali.
Topics: Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Recurrence; Sesquiterpenes; Sulfadoxine; Treatment Failure | 2006 |
Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: a randomized, placebo-controlled trial.
Topics: Animals; Antimalarials; Chemoprevention; Child, Preschool; Cross-Sectional Studies; Double-Blind Method; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Placebos; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2006 |
Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi.
Topics: Adolescent; Adult; Antimalarials; Drug Administration Schedule; Drug Combinations; Female; HIV Infections; Humans; Infant, Newborn; Malaria, Falciparum; Malawi; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Trimethoprim, Sulfamethoxazole Drug Combination | 2006 |
A randomized, placebo-controlled trial of intermittent preventive treatment with sulphadoxine-pyrimethamine in Gambian multigravidae.
Topics: Adolescent; Adult; Anemia; Antimalarials; Bedding and Linens; Drug Combinations; Female; Gambia; Gravidity; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria, Falciparum; Middle Aged; Parasitemia; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Complications, Parasitic; Pregnancy Outcome; Prevalence; Pyrimethamine; Rural Health; Seasons; Sulfadoxine | 2006 |
[Coartem and fansimef in the treatment of falciparum malaria].
Topics: Abdominal Pain; Adolescent; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fever; Fluorenes; Humans; Malaria, Falciparum; Male; Mali; Mefloquine; Nausea; Pyrimethamine; Skin; Sulfadoxine; Time Factors; Treatment Outcome | 2006 |
Safety and efficacy of lumefantrine-artemether (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adults.
Topics: Adult; Animals; Antimalarials; Artemether; Artemisinins; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Odds Ratio; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Zambia | 2006 |
HIV-1 immune suppression and antimalarial treatment outcome in Zambian adults with uncomplicated malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; CD4 Lymphocyte Count; Drug Combinations; Ethanolamines; Female; Fluorenes; HIV Infections; HIV-1; Humans; Immunosuppression Therapy; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome; Zambia | 2006 |
Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Democratic Republic of the Congo; DNA, Protozoan; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Haplotypes; Humans; Infant; Malaria; Malaria, Falciparum; Male; Plasmodium; Polymerase Chain Reaction; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2006 |
A randomised trial to assess the safety and efficacy of artemether-lumefantrine (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwanda.
Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fever; Fluorenes; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2007 |
Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Plasmodium falciparum; Plasmodium vivax; Prospective Studies; Pyrimethamine; Recurrence; Sulfadoxine; Treatment Failure; Treatment Outcome | 2007 |
Efficacy, safety, and tolerability of amodiaquine plus sulphadoxine-pyrimethamine used alone or in combination for malaria treatment in pregnancy: a randomised trial.
Topics: Adult; Amodiaquine; Antimalarials; Chloroquine; Drug Administration Schedule; Drug Combinations; Female; Ghana; Humans; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2006 |
A randomised, double-blind, placebo-controlled trial of atovaquone-proguanil vs. sulphadoxine-pyrimethamine in the treatment of malarial anaemia in Zambian children.
Topics: Anemia; Antimalarials; Atovaquone; Child; Child, Preschool; Double-Blind Method; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Prevalence; Proguanil; Pyrimethamine; Sulfadoxine; Time Factors; Treatment Failure; Zambia | 2006 |
Return of chloroquine antimalarial efficacy in Malawi.
Topics: Animals; Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Endemic Diseases; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Malawi; Male; Membrane Proteins; Membrane Transport Proteins; Mutation; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2006 |
Combined chloroquine, sulfadoxine/pyrimethamine and primaquine against Plasmodium falciparum in Central Java, Indonesia.
Topics: Adolescent; Adult; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Indonesia; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Primaquine; Pyrimethamine; Sulfadoxine | 2006 |
Improved efficacy with amodiaquine instead of chloroquine in sulfadoxine/pyrimethamine combination treatment of falciparum malaria in Uganda: experience with fixed-dose formulation.
Topics: Amodiaquine; Animals; Antimalarials; Child, Preschool; Chloroquine; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome; Uganda | 2006 |
Short course of quinine plus a single dose of sulfadoxine/pyrimethamine for Plasmodium falciparum malaria.
Topics: Animals; Antimalarials; Child; Child, Preschool; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Gabon; Humans; Malaria, Falciparum; Male; Pyrimethamine; Quinine; Sulfadoxine; Treatment Outcome | 2006 |
Continued efficacy of sulfadoxine-pyrimethamine as second line treatment for malaria in children in Guinea-Bissau.
Topics: Adolescent; Animals; Antimalarials; Child; Child, Preschool; Drug Combinations; Female; Guinea-Bissau; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tablets; Treatment Failure; Urban Population | 2006 |
Influence of consecutive-day blood sampling on polymerase chain reaction-adjusted parasitological cure rates in an antimalarial-drug trial conducted in Tanzania.
Topics: Animals; Antigens, Protozoan; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; DNA, Protozoan; Drug Combinations; Ethanolamines; Fluorenes; Genotype; Humans; Malaria, Falciparum; Merozoite Surface Protein 1; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Recurrence; Sulfadoxine; Tanzania | 2007 |
Efficacies of artesunate plus either sulfadoxine-pyrimethamine or amodiaquine, for the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Humans; Malaria, Falciparum; Parasitemia; Pyrimethamine; Sesquiterpenes; Sudan; Sulfadoxine; Treatment Outcome | 2007 |
Dihydroartemisinin suppository in moderately severe malaria: comparative efficacy of dihydroartemisinin suppository versus intramuscular artemeter followed by oral sulfadoxine-pyrimethamine in the management of moderately severe malaria in Nigerian childr
Topics: Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Combinations; Humans; Infant; Injections, Intramuscular; Malaria, Falciparum; Nigeria; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Suppositories | 2007 |
Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial.
Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Burkina Faso; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Male; Parasitemia; Pyrimethamine; Recurrence; Sulfadoxine; Treatment Outcome | 2007 |
Molecular genotyping in a malaria treatment trial in Uganda - unexpected high rate of new infections within 2 weeks after treatment.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Child; Drug Combinations; Drug Therapy, Combination; Endemic Diseases; Genes, Protozoan; Genotype; Humans; Malaria, Falciparum; Merozoite Surface Protein 1; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Recurrence; Sesquiterpenes; Sulfadoxine; Uganda | 2007 |
Thiamin deficiency and uncomplicated falciparum malaria in Laos.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Artesunate; Beriberi; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Enzyme Activation; Erythrocytes; Female; Humans; Infant; Laos; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Thiamine Deficiency; Transketolase; Treatment Outcome | 2007 |
Randomized controlled trial of fosmidomycin-clindamycin versus sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria.
Topics: Adolescent; Antimalarials; Child; Child, Preschool; Clindamycin; Drug Combinations; Female; Fosfomycin; Humans; Malaria, Falciparum; Male; Pyrimethamine; Sulfadoxine | 2007 |
Lack of impact of artesunate on the disposition kinetics of sulfadoxine/pyrimethamine when the two drugs are concomitantly administered.
Topics: Adult; Antimalarials; Area Under Curve; Artemisinins; Artesunate; Chromatography, High Pressure Liquid; Cross-Over Studies; Drug Combinations; Drug Interactions; Half-Life; Humans; Malaria, Falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2007 |
Sulfadoxine-pyrimethamine efficacy and selection of Plasmodium falciparum DHFR mutations in Burkina Faso before its introduction as intermittent preventive treatment for pregnant women.
Topics: Adolescent; Animals; Antimalarials; Burkina Faso; Child; Child, Preschool; Chloroquine; Drug Administration Schedule; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Infant; Malaria, Falciparum; Male; Mutation; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Selection, Genetic; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2007 |
Unusual pattern of Plasmodium falciparum drug resistance in the northwestern Peruvian Amazon region.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Peru; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2007 |
Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zérékoré.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Genes, Protozoan; Genetic Markers; Genotype; Guinea; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2007 |
Randomized clinical trial of artemisinin versus non-artemisinin combination therapy for uncomplicated falciparum malaria in Madagascar.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Humans; Infant; Madagascar; Malaria, Falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2007 |
Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial.
Topics: Amodiaquine; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Infant; Longitudinal Studies; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Single-Blind Method; Sulfadoxine; Treatment Outcome; Uganda; Urban Population | 2007 |
Effect of artesunate plus sulfadoxine-pyrimethamine on haematological recovery and anaemia, in Kenyan children with uncomplicated, Plasmodium falciparum malaria.
Topics: Anemia; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Drug Combinations; Female; Humans; Infant; Kenya; Malaria, Falciparum; Male; Prevalence; Pyrimethamine; Risk Factors; Sesquiterpenes; Sulfadoxine | 2007 |
Intermittent preventive treatment of malaria in pregnancy: a community-based delivery system and its effect on parasitemia, anemia and low birth weight in Uganda.
Topics: Adolescent; Adult; Anemia; Antimalarials; Case-Control Studies; Community Health Workers; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria, Falciparum; Middle Aged; Midwifery; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Prenatal Care; Pyrimethamine; Sulfadoxine; Uganda | 2008 |
A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants.
Topics: Animals; Antimalarials; Double-Blind Method; Drug Combinations; Female; Ghana; Humans; Infant; Malaria, Falciparum; Male; Placebos; Plasmodium falciparum; Prevalence; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2007 |
A comparison of sulfadoxine-pyrimethamine with chloroquine and pyrimethamine for prevention of malaria in pregnant Nigerian women.
Topics: Adult; Animals; Antimalarials; Birth Weight; Chloroquine; Drug Combinations; Female; Hematocrit; Humans; Infant, Newborn; Malaria, Falciparum; Nigeria; Parasitemia; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2007 |
Efficacy of artesunate plus amodiaquine, artesunate plus sulfadoxine-pyrimethamine, and chloroquine plus sulfadoxine-pyrimethamine in patients with uncomplicated Plasmodium falciparum in the Comoros Union.
Topics: Adolescent; Adult; Aged; Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Comoros; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2007 |
Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal.
Topics: Adolescent; Adult; Aged; Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Follow-Up Studies; Humans; Infant; Lumefantrine; Malaria, Falciparum; Mefloquine; Middle Aged; Plasmodium falciparum; Pyrimethamine; Senegal; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2007 |
Dramatically decreased therapeutic efficacy of chloroquine and sulfadoxine-pyrimethamine, but not mefloquine, in southern Benin.
Topics: Administration, Oral; Animals; Antigens, Protozoan; Antimalarials; Benin; Child, Preschool; Chloroquine; DNA, Protozoan; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Merozoite Surface Protein 1; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome | 2007 |
Efficacy of sulfadoxine-pyrimethamine, amodiaquine, and sulfadoxine-pyrimethamine-amodiaquine combination for the treatment of uncomplicated falciparum malaria in the urban and suburban areas of Brazzaville (Congo).
Topics: Amodiaquine; Antimalarials; Carrier State; Child, Preschool; Congo; DNA, Protozoan; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2007 |
Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan.
Topics: Adolescent; Afghanistan; Antimalarials; Artemisinins; Artesunate; Child; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Endemic Diseases; Humans; Malaria, Falciparum; Malaria, Vivax; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2007 |
Comparison of artemether-lumefantrine with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in eastern Nepal.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Drug Resistance; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Nepal; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2007 |
Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate.
Topics: Adolescent; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Female; Humans; Malaria; Malaria, Falciparum; Male; Plasmodium falciparum; Primaquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Tanzania; Treatment Outcome | 2007 |
Comparison of the therapeutic efficacy of chloroquine and sulphadoxine-pyremethamine in children and pregnant women.
Topics: Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Female; Humans; Malaria, Falciparum; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Treatment Failure | 2007 |
Immune responses after single-dose sulphadoxine-pyrimethamine indicate underestimation of protective efficacy of intermittent preventive treatment in infants.
Topics: Animals; Antimalarials; Child; Double-Blind Method; Drug Combinations; Ghana; Humans; Immunoglobulin G; Incidence; Infant; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2007 |
Ibuprofen does not affect levels of tumor necrosis factor alpha and soluble tumor necrosis factor receptor types I and II in Gabonese children with uncomplicated Plasmodium falciparum malaria.
Topics: Animals; Antimalarials; Child; Double-Blind Method; Etanercept; Gabon; Humans; Ibuprofen; Immunoglobulin G; Malaria, Falciparum; Placebos; Plasmodium falciparum; Pyrimethamine; Quinine; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type II; Sulfadoxine; Tumor Necrosis Factor-alpha | 2007 |
Pharmacokinetics and efficacy of piperaquine and chloroquine in Melanesian children with uncomplicated malaria.
Topics: Animals; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Papua New Guinea; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Quinolines; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2008 |
Comparison of different artemisinin-based combinations for the treatment of Plasmodium falciparum malaria in children in Kigali, Rwanda, an area of resistance to sulfadoxine-pyrimethamine: artesunate plus sulfadoxine/pyrimethamine versus artesunate plus s
Topics: Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance, Multiple; Female; Hemoglobins; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Rwanda; Sesquiterpenes; Sulfadoxine; Sulfalene | 2007 |
Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
Topics: Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Papua New Guinea; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Sulfadoxine | 2007 |
Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
Topics: Amodiaquine; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Burkina Faso; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine | 2007 |
Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women.
Topics: Adult; AIDS-Related Opportunistic Infections; Anemia; Antimalarials; Birth Weight; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Fetal Blood; Hemoglobins; HIV Seropositivity; Humans; Incidence; Malaria, Falciparum; Odds Ratio; Parasitemia; Placenta; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pyrimethamine; Risk Factors; Sulfadoxine; Treatment Outcome; Zambia | 2007 |
Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial.
Topics: Anemia; Antimalarials; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Gabon; Hematocrit; Hemoglobins; Humans; Incidence; Infant; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Parasitemia; Patient Selection; Pyrimethamine; Research Design; Sulfadoxine; Treatment Outcome | 2007 |
Malaria incidence and efficacy of intermittent preventive treatment in infants (IPTi).
Topics: Animals; Antimalarials; Drug Combinations; Drug Resistance; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2007 |
A randomized open-label trial of artesunate- sulfadoxine-pyrimethamine with or without primaquine for elimination of sub-microscopic P. falciparum parasitaemia and gametocyte carriage in eastern Sudan.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemisinins; Artesunate; Carrier State; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Primaquine; Pyrimethamine; Sudan; Sulfadoxine | 2007 |
Antimalarial resistance and DHFR/DHPS genotypes of Plasmodium falciparum three years after introduction of sulfadoxine-pyrimethamine and amodiaquine in rural Tanzania.
Topics: Amodiaquine; Animals; Antimalarials; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Follow-Up Studies; Genotype; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Point Mutation; Pyrimethamine; Rural Health; Sulfadoxine; Tanzania; Tetrahydrofolate Dehydrogenase; Treatment Failure | 2008 |
Adding artesunate to sulphadoxine-pyrimethamine greatly improves the treatment efficacy in children with uncomplicated falciparum malaria on the coast of Benin, West Africa.
Topics: Analysis of Variance; Anemia; Animals; Antimalarials; Artemisinins; Artesunate; Benin; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Fever; Follow-Up Studies; Humans; Infant; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Respiratory Tract Infections; Sesquiterpenes; Sulfadoxine; Time Factors; Treatment Outcome | 2007 |
[Randomized clinical trial of two malaria prophylaxis regimens for pregnant women in Faladie, Mali].
Topics: Adult; Anemia; Antimalarials; Chloroquine; Drug Combinations; Endemic Diseases; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria, Falciparum; Mali; Placenta Diseases; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Sulfadoxine | 2007 |
Sulphadoxine/pyrimethamine versus amodiaquine for treating uncomplicated childhood malaria in Gabon: a randomized trial to guide national policy.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Dihydropteroate Synthase; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Gabon; Health Policy; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2008 |
Population pharmacokinetics of chloroquine and sulfadoxine and treatment response in children with malaria: suggestions for an improved dose regimen.
Topics: Animals; Anti-Infective Agents; Antimalarials; Child, Preschool; Chloroquine; Dose-Response Relationship, Drug; Female; Humans; Infant; Malaria, Falciparum; Male; Sulfadoxine; Treatment Outcome; Uganda | 2008 |
Dihydrofolate reductase I164L mutations in Plasmodium falciparum isolates: clinical outcome of 14 Kenyan adults infected with parasites harbouring the I164L mutation.
Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Animals; Antimalarials; CD4 Lymphocyte Count; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Mutation; Plasmodium falciparum; Prospective Studies; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2008 |
Efficacy, safety, and selection of molecular markers of drug resistance by two ACTs in Mali.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Biomarkers; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mali; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Time Factors; Vomiting | 2008 |
Molecular markers of resistance to sulfadoxine-pyrimethamine during intermittent preventive treatment for malaria in Mozambican infants.
Topics: Animals; Antimalarials; Biomarkers; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Mozambique; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2008 |
Herba Artemisiae annuae tea preparation compared to sulfadoxine-pyrimethamine in the treatment of uncomplicated falciparum malaria in adults: a randomized double-blind clinical trial.
Topics: Adult; Animals; Antimalarials; Artemisia annua; Double-Blind Method; Drug Combinations; Drugs, Chinese Herbal; Female; Humans; Malaria, Falciparum; Male; Parasitemia; Phytotherapy; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tanzania; Treatment Outcome | 2008 |
Impact of intermittent preventive treatment with sulfadoxine-pyrimethamine on antibody responses to erythrocytic-stage Plasmodium falciparum antigens in infants in Mozambique.
Topics: Animals; Antibodies, Protozoan; Antigens, Protozoan; Antimalarials; Child, Preschool; Drug Administration Schedule; Drug Combinations; Erythrocytes; Humans; Immunoglobulin G; Immunoglobulin M; Infant; Malaria, Falciparum; Mozambique; Plasmodium falciparum; Pyrimethamine; Recombinant Proteins; Sulfadoxine; Treatment Outcome | 2008 |
Response of Plasmodium falciparum to chloroquine and Fansidar in vivo and chloroquine and amodiaquine in vitro in Uganda.
Topics: Amodiaquine; Animals; Antimalarials; Child; Chloroquine; Drug Combinations; Drug Evaluation, Preclinical; Drug Resistance; Drug Therapy, Combination; Follow-Up Studies; Humans; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Uganda | 1995 |
Sulphadoxine concentrations in plasma, red blood cells and whole blood in healthy and Plasmodium falciparum malaria cases after treatment with Fansidar using high-performance liquid chromatography.
Topics: Adult; Animals; Antimalarials; Chromatography, High Pressure Liquid; Drug Combinations; Erythrocytes; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Spectrophotometry, Ultraviolet; Sulfadoxine | 1994 |
Specific and nonspecific responses to Plasmodium falciparum blood-stage parasites and observations on the gametocytemia in schoolchildren living in a malaria-endemic area of Mozambique.
Topics: Adolescent; Animals; Antibodies, Protozoan; Antigens, Protozoan; Antimalarials; Blotting, Western; C-Reactive Protein; Child; Chloroquine; Computer Simulation; Drug Combinations; Drug Resistance; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Haptoglobins; Humans; Luminescent Measurements; Malaria, Falciparum; Models, Biological; Mozambique; Parasitemia; Plasmodium falciparum; Prevalence; Pyrimethamine; Recombinant Proteins; Sulfadoxine | 1995 |
In vivo sensitivity of Plasmodium falciparum to chloroquine, amodiaquine and sulfadoxine-pyrimethamine in western Uganda.
Topics: Adult; Amodiaquine; Animals; Antimalarials; Child; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Microbial Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Uganda | 1994 |
Prevention of Plasmodium falciparum malaria by Fansimef and Lariam in the northeastern part of Thailand.
Topics: Adult; Animals; Antibodies, Protozoan; Blood; Chloroquine; Drug Combinations; Humans; Malaria, Falciparum; Male; Mefloquine; Military Personnel; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Thailand | 1993 |
The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi.
Topics: Analysis of Variance; Antimalarials; Chi-Square Distribution; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Gestational Age; Humans; Infant, Newborn; Malaria, Falciparum; Malawi; Parasitemia; Placenta Diseases; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pyrimethamine; Seasons; Sulfadoxine | 1994 |
Artemether in moderately severe and cerebral malaria in Nigerian children.
Topics: Antimalarials; Antiprotozoal Agents; Artemether; Artemisinins; Child; Child, Preschool; Drug Combinations; Humans; Infant; Malaria, Cerebral; Malaria, Falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 1994 |
Chloroquine and sulfadoxine/pyrimethamine sensitivity in Burkina Faso. In vivo sensitivity of Plasmodium falciparum to chloroquine and sulfadoxine/pyrimethamine in Burkina Faso.
Topics: Animals; Burkina Faso; Child; Child, Preschool; Chloroquine; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Urban Health | 1994 |
Response of falciparum malaria to chloroquine and three second line antimalarial drugs in a Kenyan coastal school age population.
Topics: Adolescent; Amodiaquine; Child; Chloroquine; Drug Combinations; Drug Resistance; Humans; Kenya; Malaria, Falciparum; Microbial Sensitivity Tests; Pyrimethamine; Rural Health; Sulfadoxine; Sulfalene | 1993 |
Comparative tolerability and kinetics during long-term intake of Lariam and Fansidar for malaria prophylaxis in nonimmune volunteers.
Topics: Adult; Antimalarials; Double-Blind Method; Drug Combinations; Half-Life; Humans; Linear Models; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Patient Dropouts; Pyrimethamine; Sulfadoxine | 1993 |
Mefloquine monitoring in acute uncomplicated malaria treated with Fansimef and Lariam.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Drug Combinations; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Pyrimethamine; Sulfadoxine | 1993 |
Plasmodium falciparum sensitivity to antimalarials at Humera, northwestern Ethiopia.
Topics: Adolescent; Adult; Animals; Child; Chloroquine; Drug Combinations; Drug Resistance; Ethiopia; Female; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 1993 |
Resistance of Plasmodium falciparum to antimalarial drugs in Equatorial Guinea.
Topics: Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Equatorial Guinea; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1993 |
Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa.
Topics: Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Follow-Up Studies; Hemoglobin A; Humans; Infant; Kenya; Malaria, Falciparum; Malawi; Male; Pyrimethamine; Sulfadoxine | 1993 |
Sulfadoxine/pyrimethamine or chloroquine/clindamycin treatment of Gabonese school children infected with chloroquine resistant malaria.
Topics: Adolescent; Animals; Anti-Bacterial Agents; Antimalarials; Child; Child, Preschool; Chloroquine; Clindamycin; Drug Combinations; Drug Resistance; Female; Gabon; Humans; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 1995 |
In vivo study of the response of Plasmodium falciparum to standard mefloquine/sulfadoxine/pyrimethamine (MSP) treatment among gem miners returning from Cambodia.
Topics: Adult; Animals; Antimalarials; Cambodia; Chi-Square Distribution; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Mining; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Thailand; Transients and Migrants | 1995 |
Efficacy of sulphadoxine/pyrimethamine for Plasmodium falciparum malaria in Malawian children under five years of age.
Topics: Age Factors; Antimalarials; Child, Preschool; Drug Combinations; Drug Resistance; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Malawi; Pyrimethamine; Sulfadoxine; Treatment Failure | 1996 |
A randomized trial of chloroquine, amodiaquine and pyrimethamine-sulphadoxine in Gambian children with uncomplicated malaria.
Topics: Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Follow-Up Studies; Gambia; Hematocrit; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Rural Health; Sulfadoxine; Treatment Failure | 1996 |
A randomised controlled trial to assess the relative efficacy of chloroquine, amodiaquine, halofantrine and Fansidar in the treatment of uncomplicated malaria in children.
Topics: Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Phenanthrenes; Pyrimethamine; Sulfadoxine; Treatment Outcome | 1996 |
A comparative study of parenteral chloroquine, quinine and pyrimethamine-sulfadoxine in the treatment of Gambian children with complicated, non-cerebral malaria.
Topics: Antimalarials; Child; Child, Preschool; Chloroquine; Data Interpretation, Statistical; Drug Combinations; Drug Resistance; Gambia; Humans; Infant; Infusions, Parenteral; Malaria, Falciparum; Pyrimethamine; Quinine; Sulfadoxine; Time Factors | 1996 |
In vivo efficacy of chloroquine, halofantrine, pyrimethamine-sulfadoxine and qinghaosu (artesunate) in the treatment of malaria in Calabar, Nigeria.
Topics: Adolescent; Antimalarials; Artemisinins; Artesunate; Child; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Nigeria; Phenanthrenes; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Time Factors; Urban Health | 1996 |
Response of childhood malaria to chloroquine and Fansidar in an area of intermediate chloroquine resistance in Côte d'Ivoire.
Topics: Animals; Antimalarials; Body Temperature; Child; Child, Preschool; Chloroquine; Cote d'Ivoire; Drug Combinations; Drug Resistance, Microbial; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 1996 |
The effect of oral iron therapy during treatment for Plasmodium falciparum malaria with sulphadoxine-pyrimethamine on Malawian children under 5 years of age.
Topics: Antimalarials; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Follow-Up Studies; Hemoglobins; Humans; Iron Compounds; Malaria, Falciparum; Malawi; Parasitemia; Prospective Studies; Pyrimethamine; Sulfadoxine | 1996 |
Efficacy of artemether in severe falciparum malaria in African children.
Topics: Adolescent; Animals; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 1996 |
Responses of multidrug-resistant Plasmodium falciparum parasites to mefloquine in Nigerian children.
Topics: Animals; Anti-Infective Agents; Antimalarials; Child; Child, Preschool; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Microbial Sensitivity Tests; Nigeria; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 1997 |
Clearance of young parasite forms following treatment of falciparum malaria in humans: comparison of three simple mathematical models.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Drug Therapy, Combination; Humans; Kinetics; Lactones; Linear Models; Malaria, Falciparum; Mefloquine; Middle Aged; Models, Biological; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 1997 |
Chlorproguanil-dapsone: effective treatment for uncomplicated falciparum malaria.
Topics: Antimalarials; Child; Child, Preschool; Dapsone; Double-Blind Method; Drug Combinations; Drug Resistance; Female; Hemoglobins; Humans; Infant; Malaria, Falciparum; Male; Proguanil; Pyrimethamine; Sulfadoxine | 1997 |
Chloroquine versus pyrimethamine/sulphadoxine in the treatment of uncomplicated P. falciparum malaria in northern Kenya.
Topics: Adolescent; Adult; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Follow-Up Studies; Humans; Infant; Kenya; Malaria, Falciparum; Male; Pyrimethamine; Rural Health; Sulfadoxine | 1997 |
The differing impact of chloroquine and pyrimethamine/sulfadoxine upon the infectivity of malaria species to the mosquito vector.
Topics: Animals; Anopheles; Antimalarials; Carrier State; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Insect Vectors; Malaria; Malaria, Falciparum; Mice; Mozambique; Plasmodium berghei; Plasmodium falciparum; Prevalence; Pyrimethamine; Risk Factors; Sulfadoxine | 1998 |
In vivo selection for a specific genotype of dihydropteroate synthetase of Plasmodium falciparum by pyrimethamine-sulfadoxine but not chlorproguanil-dapsone treatment.
Topics: Amino Acid Sequence; Animals; Antimalarials; Arginine; Asparagine; Child; Dapsone; Dihydropteroate Synthase; Drug Therapy, Combination; Genes, Protozoan; Genetic Variation; Genotype; Humans; Isoleucine; Malaria, Falciparum; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Proguanil; Pyrimethamine; Sulfadoxine | 1998 |
Malaria chemotherapy trial at a minimal effective dose of mefloquine/sulfadoxine/pyrimethamine compared with equivalent doses of sulfadoxine/pyrimethamine or mefloquine alone.
Topics: Adolescent; Antimalarials; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Pyrimethamine; Sulfadoxine | 1998 |
A randomized controlled trial of artemether/benflumetol, a new antimalarial and pyrimethamine/sulfadoxine in the treatment of uncomplicated falciparum malaria in African children.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 1998 |
Viability of Plasmodium falciparum ex vivo: comparison of the effects of artemether and sulfadoxine-pyrimethamine.
Topics: Adolescent; Animals; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Regression Analysis; Sesquiterpenes; Sulfadoxine; Time Factors; Treatment Outcome | 1998 |
Chloroquine in Africa: critical assessment and recommendations for monitoring and evaluating chloroquine therapy efficacy in sub-Saharan Africa.
Topics: Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Drug Monitoring; Drug Resistance; Female; Humans; Infant; Kenya; Malaria, Falciparum; Malawi; Male; Parasitemia; Pyrimethamine; Sulfadoxine; Time Factors; Treatment Failure; Zambia | 1998 |
Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial.
Topics: Anemia; Antimalarials; Bedding and Linens; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Endemic Diseases; Female; Hemoglobins; Humans; Insecticides; Kenya; Malaria, Falciparum; Parasitemia; Parity; Placebos; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Treatment Outcome | 1999 |
Response of falciparum malaria to different antimalarials in Myanmar.
Topics: Adolescent; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Therapy, Combination; Humans; Infant; Malaria, Falciparum; Mefloquine; Myanmar; Pyrimethamine; Sulfadoxine | 1999 |
Atovaquone-proguanil compared with chloroquine and chloroquine-sulfadoxine-pyrimethamine for treatment of acute Plasmodium falciparum malaria in the Philippines.
Topics: Antimalarials; Atovaquone; Chloroquine; Drug Therapy, Combination; Folic Acid Antagonists; Humans; Malaria, Falciparum; Naphthoquinones; Philippines; Proguanil; Pyrimethamine; Sulfadoxine | 1999 |
Atovaquone and proguanil versus pyrimethamine/sulfadoxine for the treatment of acute falciparum malaria in Zambia.
Topics: Adolescent; Adult; Animals; Blood Cells; Blood Chemical Analysis; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Polypharmacy; Proguanil; Pyrimethamine; Sulfadoxine; Zambia | 1999 |
Population structure of recrudescent Plasmodium falciparum isolates from western Uganda.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antigens, Protozoan; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Infant; Malaria, Falciparum; Male; Merozoite Surface Protein 1; Middle Aged; Parasitemia; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Uganda | 1999 |
Low-dose treatment with sulfadoxine-pyrimethamine combinations selects for drug-resistant Plasmodium falciparum strains.
Topics: Africa; Animals; Antimalarials; Child; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Genotype; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Point Mutation; Polymorphism, Genetic; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 1999 |
Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Gambia; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2000 |
Assessment of therapeutic response of Plasmodium falciparum to chloroquine and sulfadoxine-pyrimethamine in an area of low malaria transmission in Colombia.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Colombia; Disease Transmission, Infectious; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Failure | 1999 |
Monitoring efficacy of commonly used antimalarials by a 14-day in-vivo test in a new settler's camp in endemic zone at Cox's Bazar.
Topics: Adolescent; Adult; Antimalarials; Bangladesh; Child; Chloroquine; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Prospective Studies; Pyrimethamine; Sulfadoxine; Transients and Migrants; Treatment Failure | 1998 |
Comparative efficacy of chloroquine plus chlorpheniramine alone and in a sequential combination with sulfadoxine-pyrimethamine, for the treatment of acute, uncomplicated, falciparum malaria in children.
Topics: Animals; Antimalarials; Antipruritics; Child; Child, Preschool; Chloroquine; Chlorpheniramine; Drug Administration Schedule; Drug Therapy, Combination; Fever; Germ Cells; Humans; Infant; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2000 |
In vivo efficacy study of amodiaquine and sulfadoxine/ pyrimethamine in Kibwezi, Kenya and Kigoma, Tanzania.
Topics: Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Drug Resistance, Microbial; Female; Fever; Humans; Infant; Kenya; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tanzania; Treatment Outcome | 2000 |
A randomized, parallel-group study in Mumbai (Bombay), comparing chloroquine with chloroquine plus sulfadoxine-pyrimethamine in the treatment of adults with acute, uncomplicated, Plasmodium falciparum malaria.
Topics: Acute Disease; Adolescent; Adult; Aged; Antimalarials; Chloroquine; Cost of Illness; Cost-Benefit Analysis; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Health Care Costs; Humans; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2000 |
Micronutrient and iron supplementation and effective antimalarial treatment synergistically improve childhood anaemia.
Topics: Anemia, Iron-Deficiency; Antimalarials; Child, Preschool; Dietary Supplements; Drug Combinations; Drug Synergism; Female; Hemoglobins; Humans; Infant; Iron, Dietary; Linear Models; Malaria, Falciparum; Male; Micronutrients; Pyrimethamine; Sulfadoxine; Tanzania; Treatment Outcome | 2000 |
Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae.
Topics: Adolescent; Animals; Anopheles; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Gambia; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2001 |
Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial.
Topics: Anemia, Iron-Deficiency; Antimalarials; Developing Countries; Drug Administration Schedule; Drug Combinations; Female; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Sulfadoxine; Survival Rate; Tanzania; Treatment Outcome; Vaccination | 2001 |
Atovaquone and proguani hydrochloride compared with chloroquine or pyrimethamine/sulfodaxine for treatment of acute Plasmodium falciparum malaria in Peru.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Atovaquone; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Microbial Sensitivity Tests; Middle Aged; Naphthoquinones; Peru; Proguanil; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2001 |
Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial.
Topics: Adolescent; Amodiaquine; Antimalarials; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Pyrimethamine; Sulfadoxine; Time Factors; Treatment Outcome; Uganda | 2001 |
Effectiveness of short-course quinine and single-dose sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria in Mpumalanga Province, South Africa.
Topics: Adolescent; Adult; Aged; Antimalarials; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Quinine; South Africa; Sulfadoxine; Time Factors | 2001 |
Efficacy of Sulphadoxine and Pyrimethamine, Doxycycline and their combination in the treatment of chloroquine resistant Falciparum Malaria.
Topics: Antimalarials; Chi-Square Distribution; Chloroquine; Doxycycline; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2001 |
Gametocytaemia in Senegalese children with uncomplicated falciparum malaria treated with chloroquine, amodiaquine or sulfadoxine + pyrimethamine.
Topics: Adolescent; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Resistance; Drug Therapy, Combination; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Senegal; Sulfadoxine | 2001 |
Therapy of uncomplicated falciparum malaria: a randomized trial comparing artesunate plus sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine alone in Irian Jaya, Indonesia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Fever; Humans; Indonesia; Infant; Malaria, Falciparum; Male; Middle Aged; Parasite Egg Count; Parasitemia; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Risk; Sesquiterpenes; Sulfadoxine; Time Factors; Treatment Failure; Treatment Outcome | 2001 |
Efficacy of mefloquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated Plasmodium falciparum infection in Machinga District, Malawi, 1998.
Topics: Animals; Antimalarials; Child, Preschool; Disease-Free Survival; Drug Administration Schedule; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Malawi; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2001 |
Cardiac effects of amodiaquine and sulfadoxine-pyrimethamine in malaria-infected African patients.
Topics: Administration, Oral; Adolescent; Adult; Amodiaquine; Antimalarials; Bradycardia; Cameroon; Drug Administration Schedule; Drug Combinations; Electrocardiography; Female; Heart Rate; Humans; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Sulfadoxine | 2001 |
Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria.
Topics: Antimalarials; Biomarkers; Child; Child, Preschool; Dapsone; Dihydropteroate Synthase; Double-Blind Method; Drug Combinations; Drug Resistance, Bacterial; Humans; Infant; Malaria, Falciparum; Mutation; Proguanil; Prospective Studies; Pyrimethamine; Sensitivity and Specificity; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Failure | 2002 |
Therapeutic efficacy of sulfadoxine-pyrimethamine in uncomplicated Plasmodium falciparum malaria 3 years after introduction in Mpumalanga.
Topics: Adolescent; Adult; Aged; Antimalarials; Child; Child, Preschool; Drug Combinations; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Middle Aged; Parasite Egg Count; Pyrimethamine; South Africa; Sulfadoxine; Time Factors; Treatment Outcome | 2001 |
A randomized comparison of chloroquine, amodiaquine and their combination with pyrimethamine-sulfadoxine in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children.
Topics: Acute Disease; Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Therapy, Combination; Gametogenesis; Humans; Infant; Malaria, Falciparum; Pyrimethamine; Recurrence; Sulfadoxine; Treatment Failure; Treatment Outcome | 2002 |
Sulphadoxine/pyrimethamine: an appropriate first-line alternative for the treatment of uncomplicated falciparum malaria in Ghanaian children under 5 years of age.
Topics: Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Follow-Up Studies; Ghana; Humans; Infant; Malaria, Falciparum; Male; Outpatients; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome | 2002 |
Sulfadoxine-pyrimethamine monotherapy in Tanzanian children gives rapid parasite clearance but slow fever clearance that is improved by chloroquine in combination therapy.
Topics: Acetaminophen; Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Fever; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Prospective Studies; Pyrimethamine; Secondary Prevention; Sulfadoxine; Tanzania; Treatment Failure; Treatment Outcome | 2002 |
Pharmacokinetics of sequential and simultaneous treatment with the combination chloroquine and sulfadoxine-pyrimethamine in acute uncomplicated Plasmodium falciparum malaria in the Philippines.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Area Under Curve; Child; Chloroquine; Drug Administration Schedule; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Philippines; Pyrimethamine; Recurrence; Sulfadoxine; Treatment Failure; Treatment Outcome | 2002 |
Fansimef for prophylaxis of malaria: a double-blind randomized placebo controlled trial.
Topics: Adolescent; Adult; Antimalarials; Chloroquine; Double-Blind Method; Drug Combinations; Humans; Incidence; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Pyrimethamine; Sulfadoxine; Treatment Outcome | 1992 |
Mefloquine-sulphadoxine-pyrimethamine (Fansimef, Roche) in the prophylaxis of Plasmodium falciparum malaria: a double-blind, comparative, placebo-controlled study.
Topics: Adolescent; Adult; Antimalarials; Chloroquine; Double-Blind Method; Drug Combinations; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Pyrimethamine; Sulfadoxine | 1992 |
Clinical trials of mefloquine with tetracycline.
Topics: Acute Disease; Adolescent; Adult; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Prospective Studies; Pyrimethamine; Sulfadoxine; Tetracycline | 1992 |
Parasitological, clinical and haematological response of children with Plasmodium falciparum to 4-aminoquinolines and to pyrimethamine-sulfadoxine with quinine in western Kenya.
Topics: Amodiaquine; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Erythrocyte Count; Female; Hematocrit; Hemoglobins; Hospitals; Humans; Infant; Kenya; Malaria, Falciparum; Male; Pyrimethamine; Quinine; Reticulocytes; Seroepidemiologic Studies; Sulfadoxine | 1992 |
[Self-medication of 193 travelers in the tropics. Recommendations for clinical counseling of tropical travelers and organization of a tropical travel pharmacy].
Topics: Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Nonprescription Drugs; Pharmaceutical Services; Prospective Studies; Pyrimethamine; Self Medication; Sulfadoxine; Travel; Tropical Medicine | 1992 |
Evaluation of the relative efficacy of various antimalarial drugs in Nigerian children under five years of age suffering from acute uncomplicated falciparum malaria.
Topics: Acute Disease; Amodiaquine; Antimalarials; Child, Preschool; Chloroquine; Drug Administration Schedule; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Mefloquine; Nigeria; Pyrimethamine; Quinine; Sulfadoxine | 1992 |
Development of the new antimalarial drug pyronaridine: a review.
Topics: Administration, Oral; Animals; Antimalarials; Cardiovascular System; Chloroquine; Dogs; Drug Evaluation; Drug Evaluation, Preclinical; Drug Resistance; Drug Therapy, Combination; Haplorhini; Humans; Injections, Intramuscular; Lethal Dose 50; Malaria, Falciparum; Mice; Naphthyridines; Pyrimethamine; Rabbits; Sulfadoxine | 1992 |
Falciparum malaria fully cleared by amodiaquine, pyrimethamine-sulfadoxine and pyrimethamine-sulfalene in areas of chloroquine resistance in Dodoma, Tanzania.
Topics: Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Pyrimethamine; Sulfadoxine; Sulfalene; Tanzania; Time Factors | 1991 |
Comparison of mefloquine, chloroquine plus pyrimethamine-sulfadoxine (Fansidar), and chloroquine as malarial prophylaxis in eastern Thailand.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Animals; Antimalarials; Cambodia; Chloroquine; Confidence Intervals; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Pyrimethamine; Sulfadoxine; Survival Analysis; Thailand | 1991 |
580 other study(ies) available for sulfadoxine and Plasmodium falciparum Malaria
| Article | Year |
|---|---|
Risk factors for Plasmodium falciparum infection in pregnant women in Burkina Faso: a community-based cross-sectional survey.
Topics: Adolescent; Adult; Antimalarials; Burkina Faso; Cross-Sectional Studies; Drug Combinations; Female; Humans; Malaria, Falciparum; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnant Women; Prevalence; Pyrimethamine; Risk Factors; Sulfadoxine; Young Adult | 2021 |
High Frequency Mutations in
Topics: Africa; Antimalarials; China; Cross-Sectional Studies; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2021 |
Modeled Impact of Seasonal Malaria Chemoprevention on District-Level Suspected and Confirmed Malaria Cases in Chad Based on Routine Clinical Data (2013-2018).
Topics: Amodiaquine; Antimalarials; Chad; Chemoprevention; Child, Preschool; Disability-Adjusted Life Years; Drug Combinations; Female; Humans; Incidence; Infant; Malaria, Falciparum; Male; Mass Drug Administration; Pyrimethamine; Seasons; Sulfadoxine | 2021 |
Prevalence of Molecular Markers of Plasmodium Falciparum Resistance to Proguanil and Pyrimethamine in Children with Haemoglobin Phenotypes SS and AA in Benin City, Nigeria.
Topics: Anemia, Sickle Cell; Antimalarials; Drug Combinations; Hemoglobin, Sickle; Humans; Malaria, Falciparum; Mutation; Nigeria; Phenotype; Plasmodium falciparum; Prevalence; Proguanil; Pyrimethamine; Sulfadoxine | 2021 |
Identification of polymorphisms in genes associated with drug resistance in Plasmodium falciparum isolates from school-age children in Kinshasa, Democratic Republic of Congo.
Topics: Antimalarials; Child; Democratic Republic of the Congo; Drug Combinations; Drug Resistance; Genetic Markers; Humans; Malaria, Falciparum; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2022 |
Risk of Plasmodium falciparum infection in south-west Burkina Faso: potential impact of expanding eligibility for seasonal malaria chemoprevention.
Topics: Adolescent; Adult; Amodiaquine; Antigens, Protozoan; Antimalarials; Burkina Faso; Child; Child, Preschool; Cross-Sectional Studies; Drug Combinations; Drug Therapy, Combination; Female; Humans; Insecticide-Treated Bednets; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Prevalence; Pyrimethamine; Risk Factors; Rural Population; Seasons; Sulfadoxine; Treatment Outcome; Young Adult | 2022 |
Effect of three years' seasonal malaria chemoprevention on molecular markers of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine and amodiaquine in Ouelessebougou, Mali.
Topics: Amodiaquine; Antimalarials; Chemoprevention; Child; Child, Preschool; Cross-Sectional Studies; Drug Combinations; Drug Resistance; Humans; Infant; Infant, Newborn; Malaria; Malaria, Falciparum; Mali; Plasmodium falciparum; Pyrimethamine; Seasons; Sulfadoxine | 2022 |
Targeted Amplicon Deep Sequencing for Monitoring Antimalarial Resistance Markers in Western Kenya.
Topics: Antimalarials; Child; Chloroquine; Codon; Drug Combinations; Drug Resistance; Folic Acid Antagonists; High-Throughput Nucleotide Sequencing; Humans; Kenya; Malaria, Falciparum; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2022 |
Intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine and parasite resistance: cross-sectional surveys from antenatal care visit and delivery in rural Ghana.
Topics: Antimalarials; Cross-Sectional Studies; Drug Combinations; Drug Resistance; Female; Ghana; Humans; Infant, Newborn; Malaria, Falciparum; Placenta; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Sulfadoxine | 2022 |
Molecular Markers for Sulfadoxine/Pyrimethamine and Chloroquine Resistance in Plasmodium falciparum in Thailand.
Topics: Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Thailand | 2022 |
Impact of antimalarial resistance and COVID-19 pandemic on malaria care among pregnant women in Northern Uganda (ERASE): protocol of a prospective observational study.
Topics: Antimalarials; Artemisinins; COVID-19; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Observational Studies as Topic; Pandemics; Pregnancy; Pregnant Women; Prospective Studies; Pyrimethamine; Retrospective Studies; Sulfadoxine; Uganda | 2022 |
The prevalence of molecular markers of resistance to sulfadoxine-pyrimethamine among pregnant women at first antenatal clinic attendance and delivery in the forest-savannah area of Ghana.
Topics: Adolescent; Adult; Antimalarials; Drug Combinations; Drug Resistance; Female; Forests; Ghana; Humans; Malaria, Falciparum; Plasmodium falciparum; Polymorphism, Single Nucleotide; Pregnancy; Pregnant Women; Prevalence; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2022 |
Spatiotemporal spread of Plasmodium falciparum mutations for resistance to sulfadoxine-pyrimethamine across Africa, 1990-2020.
Topics: Antimalarials; Bayes Theorem; Drug Combinations; Drug Resistance; Female; Humans; Malaria; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pregnancy; Pyrimethamine; South Africa; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2022 |
Intermittent preventive treatment with Sulphadoxine-Pyrimethamine (IPTp-SP) is associated with protection against sub-microscopic P. falciparum infection in pregnant women during the low transmission dry season in southwestern Cameroon: A Semi - longitudi
Topics: Antimalarials; Birth Weight; Cameroon; Drug Combinations; Female; Humans; Infant, Newborn; Insecticides; Longitudinal Studies; Malaria; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Pregnancy; Pregnancy Outcome; Pregnant Women; Pyrimethamine; Seasons; Sulfadoxine | 2022 |
Drug resistance and population structure of Plasmodium falciparum and Plasmodium vivax in the Peruvian Amazon.
Topics: Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Nucleotides; Peru; Plasmodium falciparum; Plasmodium vivax; Protozoan Proteins; Sulfadoxine | 2022 |
Molecular surveillance for anti-malarial drug resistance and genetic diversity of Plasmodium falciparum after chloroquine and sulfadoxine-pyrimethamine withdrawal in Quibdo, Colombia, 2018.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Chloroquine; Codon; Colombia; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Plasmodium falciparum; Polymorphism, Genetic; Pyrimethamine; Sulfadoxine | 2022 |
Prevalence of Plasmodium falciparum haplotypes associated with resistance to sulfadoxine-pyrimethamine and amodiaquine before and after upscaling of seasonal malaria chemoprevention in seven African countries: a genomic surveillance study.
Topics: Amodiaquine; Antimalarials; Chemoprevention; Child; Drug Combinations; Drug Resistance; Genomics; Haplotypes; Humans; Malaria; Malaria, Falciparum; Nigeria; Plasmodium falciparum; Prevalence; Pyrimethamine; Seasons; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2023 |
Ten-year persistence and evolution of Plasmodium falciparum antifolate and anti-sulfonamide resistance markers pfdhfr and pfdhps in three Asian countries.
Topics: Antimalarials; Dihydropteroate Synthase; DNA Copy Number Variations; Drug Combinations; Drug Resistance; Folic Acid Antagonists; Humans; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamide; Tetrahydrofolate Dehydrogenase; Thailand | 2022 |
Molecular surveillance of anti-malarial drug resistance genes in Plasmodium falciparum isolates in Odisha, India.
Topics: Antimalarials; Artesunate; Chloroquine; Drug Combinations; Drug Resistance; Humans; India; Malaria, Falciparum; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2022 |
Genomic characterization of
Topics: Antimalarials; Drug Combinations; Drug Resistance; Genomics; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2022 |
Distinct pattern and prevalence of
Topics: Antimalarials; Cross-Sectional Studies; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Genotype; Humans; Malaria, Falciparum; Male; Mutation; Nigeria; Plasmodium falciparum; Prevalence; Pyrimethamine; Sulfadoxine | 2022 |
Effect of sulfadoxine-pyrimethamine chemoprophylaxis in pregnant women on selection of the new P. falciparum dhps quintuple mutant carrying the I431V mutation.
Topics: Antimalarials; Cameroon; Chemoprevention; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pregnancy; Pregnant Women; Pyrimethamine; Sulfadoxine | 2023 |
Baseline prevalence of molecular marker of sulfadoxine/pyrimethamine resistance in Ebonyi and Osun states, Nigeria: amplicon deep sequencing of dhps-540.
Topics: Antimalarials; Biomarkers; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; High-Throughput Nucleotide Sequencing; Humans; Malaria; Malaria, Falciparum; Nigeria; Plasmodium falciparum; Pregnancy; Prevalence; Pyrimethamine; Sulfadoxine | 2023 |
Molecular Markers of Sulfadoxine-Pyrimethamine Resistance in Samples from Children with Uncomplicated Plasmodium falciparum at Three Sites in Angola in 2019.
Topics: Angola; Antimalarials; Child; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Plasmodium falciparum; Pregnancy; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2023 |
Evolution of Plasmodium falciparum antimalarial drug resistance markers post-adoption of artemisinin-based combination therapies in Yaounde, Cameroon.
Topics: Antimalarials; Artemisinins; Cameroon; Drug Combinations; Humans; Malaria, Falciparum; Plasmodium falciparum; Protozoan Proteins; Sulfadoxine | 2023 |
Polymorphism analysis of drug resistance markers in Plasmodium falciparum isolates from Benin.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Benin; Drug Combinations; Drug Resistance; Humans; Malaria; Malaria, Falciparum; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2023 |
Drug resistance profiling of asymptomatic and low-density Plasmodium falciparum malaria infections on Ngodhe island, Kenya, using custom dual-indexing next-generation sequencing.
Topics: Antimalarials; Drug Combinations; Drug Resistance; Female; High-Throughput Nucleotide Sequencing; Humans; Kenya; Malaria; Malaria, Falciparum; Plasmodium falciparum; Pregnancy; Pyrimethamine; Sulfadoxine | 2023 |
Plasmodium falciparum drug resistance-associated mutations in isolates from children living in endemic areas of Burkina Faso.
Topics: Antimalarials; Burkina Faso; Child; Codon; Drug Combinations; Drug Resistance; Female; Humans; Malaria; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pregnancy; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2023 |
Peripheral and Placental Prevalence of Sulfadoxine-Pyrimethamine Resistance Markers in Plasmodium falciparum among Pregnant Women in Southern Province, Rwanda.
Topics: Antimalarials; Birth Weight; Drug Combinations; Drug Resistance; Female; Humans; Malaria; Malaria, Falciparum; Placenta; Plasmodium falciparum; Polymorphism, Single Nucleotide; Pregnancy; Pregnant Women; Prevalence; Pyrimethamine; Rwanda; Sulfadoxine | 2023 |
Fixed prevalence of sulfadoxine-pyrimethamine resistance markers after 3 years of drug pressure.
Topics: Antimalarials; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Plasmodium falciparum; Prevalence; Pyrimethamine; Sulfadoxine | 2023 |
Prevalence of molecular markers of resistance to sulfadoxine-pyrimethamine before and after community delivery of intermittent preventive treatment of malaria in pregnancy in sub-Saharan Africa: a multi-country evaluation.
Topics: Antimalarials; Biomarkers; Child; Child, Preschool; Cross-Sectional Studies; Drug Combinations; Drug Resistance; Female; Humans; Malaria; Malaria, Falciparum; Mozambique; Plasmodium falciparum; Pregnancy; Prevalence; Pyrimethamine; Sulfadoxine | 2023 |
Effect of Seasonal Malaria Chemoprevention on Immune Markers of Exhaustion and Regulation.
Topics: Amodiaquine; Antigens, CD; Antimalarials; Biomarkers; CD4-Positive T-Lymphocytes; Child, Preschool; Drug Combinations; Female; Forkhead Transcription Factors; Humans; Infant; Lymphocyte Activation Gene 3 Protein; Malaria, Falciparum; Male; Programmed Cell Death 1 Receptor; Pyrimethamine; Seasons; Sulfadoxine; T-Lymphocytes, Regulatory | 2020 |
The changing landscape of Plasmodium falciparum drug resistance in the Democratic Republic of Congo.
Topics: Adolescent; Adult; Alcohol Dehydrogenase; Antimalarials; Chloroquine; Cross-Sectional Studies; Democratic Republic of the Congo; Drug Combinations; Drug Resistance; Gene Frequency; Humans; Longitudinal Studies; Malaria, Falciparum; Membrane Transport Proteins; Middle Aged; Mutation; Plasmodium falciparum; Prevalence; Protozoan Proteins; Pyrimethamine; Spatio-Temporal Analysis; Sulfadoxine; Young Adult | 2019 |
Widespread resistance mutations to sulfadoxine-pyrimethamine in malaria parasites imported to China from Central and Western Africa.
Topics: Adolescent; Adult; Africa, Central; Africa, Western; Antimalarials; China; Cohort Studies; Communicable Diseases, Imported; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Malaria, Falciparum; Male; Middle Aged; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Young Adult | 2020 |
Antimalarial Drug Resistance Profiling of Plasmodium falciparum Infections in Ghana Using Molecular Inversion Probes and Next-Generation Sequencing.
Topics: Adolescent; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Ghana; High-Throughput Nucleotide Sequencing; Humans; Infant; Malaria, Falciparum; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2020 |
Molecular characterization of Plasmodium falciparum antifolate resistance markers in Thailand between 2008 and 2016.
Topics: Antimalarials; Cambodia; DNA, Protozoan; Dried Blood Spot Testing; Drug Combinations; Drug Resistance; Folic Acid Antagonists; Genotype; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Prevalence; Pyrimethamine; Sulfadoxine; Thailand | 2020 |
Nationwide Monitoring for Plasmodium falciparum Drug-Resistance Alleles to Chloroquine, Sulfadoxine, and Pyrimethamine, Haiti, 2016-2017.
Topics: Alleles; Antimalarials; Chloroquine; Drug Resistance; Haiti; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2020 |
The impact of antimalarial resistance on the genetic structure of Plasmodium falciparum in the DRC.
Topics: Antimalarials; Chloroquine; Democratic Republic of the Congo; Drug Combinations; Drug Resistance; Genome, Protozoan; Genotype; Geography; Haplotypes; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Polymorphism, Single Nucleotide; Principal Component Analysis; Pyrimethamine; Sulfadoxine | 2020 |
Prevalence of pfdhfr and pfdhps mutations in Plasmodium falciparum associated with drug resistance among pregnant women receiving IPTp-SP at Msambweni County Referral Hospital, Kwale County, Kenya.
Topics: Adult; Antimalarials; Drug Combinations; Drug Resistance; Female; Genetic Markers; Humans; Kenya; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pregnancy; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2020 |
Occurrence of septuple and elevated Pfdhfr-Pfdhps quintuple mutations in a general population threatens the use of sulfadoxine-pyrimethamine for malaria prevention during pregnancy in eastern-coast of Tanzania.
Topics: Antimalarials; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance, Microbial; Female; Haplotypes; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tanzania; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2020 |
Modelling the incremental benefit of introducing malaria screening strategies to antenatal care in Africa.
Topics: Antimalarials; Drug Combinations; Female; Health Policy; Humans; Malaria, Falciparum; Mass Screening; Parasitic Sensitivity Tests; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Trimester, First; Prenatal Care; Pyrimethamine; Sulfadoxine; Tanzania; World Health Organization | 2020 |
Stable high frequencies of sulfadoxine-pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine-pyrimethamine in Ujjain, Madhya Pradesh, India.
Topics: Adolescent; Adult; Aged; Antimalarials; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance; Humans; India; Infant; Malaria, Falciparum; Middle Aged; Mutation; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Young Adult | 2020 |
Antibodies to full-length and the DBL5 domain of VAR2CSA in pregnant women after long-term implementation of intermittent preventive treatment in Etoudi, Cameroon.
Topics: Adult; Antibodies, Protozoan; Antigens, Protozoan; Antimalarials; Cameroon; Drug Combinations; Female; Humans; Immunoglobulin G; Malaria; Malaria, Falciparum; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Young Adult | 2020 |
Analysis of sulphadoxine-pyrimethamine resistance-associated mutations in Plasmodium falciparum isolates obtained from asymptomatic pregnant women in Ogun State, Southwest Nigeria.
Topics: Adult; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Malaria, Falciparum; Mutation; Nigeria; Plasmodium falciparum; Polymorphism, Genetic; Pregnancy; Pregnant Women; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2020 |
Suboptimal Intermittent Preventive Treatment in Pregnancy (IPTp) is Associated With an Increased Risk of Submicroscopic Plasmodium falciparum Infection in Pregnant Women: A Prospective Cohort Study in Benin.
Topics: Antimalarials; Benin; Drug Combinations; Female; Humans; Infant, Newborn; Malaria, Falciparum; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Prospective Studies; Pyrimethamine; Sulfadoxine | 2021 |
Establishing a National Molecular Surveillance Program for the Detection of
Topics: Adolescent; Adult; Aged; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Haiti; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sentinel Surveillance; Sulfadoxine; Young Adult | 2020 |
Surveillance of molecular markers for antimalarial resistance in Zambia: Polymorphism of Pfkelch 13, Pfmdr1 and Pfdhfr/Pfdhps genes.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Cross-Sectional Studies; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2020 |
A snapshot of Plasmodium falciparum malaria drug resistance markers in Sudan: a pilot study.
Topics: Antimalarials; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Pilot Projects; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sudan; Sulfadoxine | 2020 |
Prevalence and factors associated with carriage of Pfmdr1 polymorphisms among pregnant women receiving intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) and artemether-lumefantrine for malaria treatment in Burkina Faso.
Topics: Adolescent; Adult; Artemether, Lumefantrine Drug Combination; Burkina Faso; Carrier State; Drug Combinations; Female; Humans; Malaria, Falciparum; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Genetic; Pregnancy; Prevalence; Pyrimethamine; Risk Factors; Sulfadoxine; Young Adult | 2020 |
Topics: Antimalarials; Drug Combinations; Female; Humans; Kenya; Malaria, Falciparum; Mali; Nigeria; Plasmodium falciparum; Pregnancy; Pyrimethamine; Sulfadoxine | 2020 |
Molecular surveillance of anti-malarial resistance Pfdhfr and Pfdhps polymorphisms in African and Southeast Asia Plasmodium falciparum imported parasites to Wuhan, China.
Topics: Africa; Antimalarials; Asia, Southeastern; China; Communicable Diseases, Imported; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2020 |
Increased prevalence of pfdhfr and pfdhps mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Jazan Region, Southwestern Saudi Arabia: important implications for malaria treatment policy.
Topics: Adolescent; Adult; Antimalarials; Cross-Sectional Studies; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mutation; Plasmodium falciparum; Prevalence; Protozoan Proteins; Pyrimethamine; Saudi Arabia; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2020 |
Assessment of antimalarial drug resistant markers in asymptomatic Plasmodium falciparum infections after 4 years of indoor residual spraying in Northern Ghana.
Topics: Amodiaquine; Antimalarials; Biomarkers, Pharmacological; Carrier State; Child, Preschool; Chloroquine; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Genotype; Ghana; Humans; Infant; Malaria; Malaria, Falciparum; Male; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2020 |
Multiple Single-Nucleotide Polymorphism Detection for Antimalarial Pyrimethamine Resistance via Allele-Specific PCR Coupled with Gold Nanoparticle-Based Lateral Flow Biosensor.
Topics: Alleles; Antimalarials; Biosensing Techniques; DNA Primers; Drug Resistance; Gold; Humans; Malaria, Falciparum; Metal Nanoparticles; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2021 |
Evidence that seasonal malaria chemoprevention with SPAQ influences blood and pre-erythrocytic stage antibody responses of Plasmodium falciparum infections in Niger.
Topics: Amodiaquine; Antibodies, Protozoan; Antibody Formation; Antimalarials; Chemoprevention; Child, Preschool; Drug Combinations; Humans; Infant; Malaria, Falciparum; Niger; Plasmodium falciparum; Pyrimethamine; Seasons; Sulfadoxine | 2021 |
High Prevalence of Molecular Markers of Plasmodium falciparum Resistance to Sulphadoxine-Pyrimethamine in Parts of Ghana: A Threat to ITPTp-SP?
Topics: Antimalarials; Drug Combinations; Drug Resistance; Female; Ghana; Humans; Malaria, Falciparum; Plasmodium falciparum; Pregnancy; Prevalence; Pyrimethamine; Sulfadoxine | 2021 |
Polymorphisms in Plasmodium falciparum dihydropteroate synthetase and dihydrofolate reductase genes in Nigerian children with uncomplicated malaria using high-resolution melting technique.
Topics: Antigens, Protozoan; Antimalarials; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Genotype; Haplotypes; Humans; Infant; Malaria, Falciparum; Male; Merozoite Surface Protein 1; Nigeria; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Genetic; Population Surveillance; Protozoan Proteins; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2021 |
Sulfadoxine-pyrimethamine parasitological efficacy against Plasmodium falciparum among pregnant women and molecular markers of resistance in Zambia: an observational cohort study.
Topics: Adult; Antimalarials; Cohort Studies; Drug Combinations; Female; Genetic Markers; Humans; Malaria, Falciparum; Mutation; Parasitemia; Plasmodium falciparum; Pregnancy; Pregnant Women; Prevalence; Pyrimethamine; Sulfadoxine; Young Adult; Zambia | 2021 |
Low prevalence of highly sulfadoxine-resistant dihydropteroate synthase alleles in Plasmodium falciparum isolates in Benin.
Topics: Alleles; Antimalarials; Benin; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Prevalence; Pyrimethamine; Sulfadoxine | 2021 |
Predictors for the uptake of optimal doses of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Tanzania: further analysis of the data of the 2015-2016 Tanzania demographic and health survey and malaria indicat
Topics: Adolescent; Adult; Antimalarials; Cross-Sectional Studies; Dose-Response Relationship, Drug; Drug Combinations; Female; Health Facilities; Humans; Malaria, Falciparum; Middle Aged; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Sulfadoxine; Tanzania; Young Adult | 2021 |
Reduced Birth Weight Caused by Sextuple Drug-Resistant Plasmodium falciparum Infection in Early Second Trimester.
Topics: Adult; Antimalarials; Birth Weight; Drug Combinations; Drug Resistance; Female; Humans; Infant, Newborn; Malaria, Falciparum; Male; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pregnancy Trimester, Second; Pyrimethamine; Sulfadoxine | 2021 |
Temporal evolution of sulfadoxine-pyrimethamine resistance genotypes and genetic diversity in response to a decade of increased interventions against Plasmodium falciparum in northern Ghana.
Topics: Adolescent; Antimalarials; Child; Child, Preschool; Drug Combinations; Drug Resistance; Female; Genetic Variation; Genotype; Ghana; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Seasons; Sulfadoxine; Young Adult | 2021 |
Malaria Infection Is Common and Associated With Perinatal Mortality and Preterm Delivery Despite Widespread Use of Chemoprevention in Mali: An Observational Study 2010 to 2014.
Topics: Antimalarials; Chemoprevention; Drug Combinations; Female; Humans; Infant, Newborn; Longitudinal Studies; Malaria; Malaria, Falciparum; Mali; Perinatal Death; Perinatal Mortality; Placenta; Pregnancy; Pregnancy Complications, Parasitic; Premature Birth; Pyrimethamine; Sulfadoxine | 2021 |
Intermittent preventive treatment comparing two versus three doses of sulphadoxine pyrimethamine (IPTp-SP) in the prevention of anaemia in pregnancy in Ghana: A cross-sectional study.
Topics: Adult; Anemia; Antimalarials; Cross-Sectional Studies; Drug Combinations; Educational Status; Female; Ghana; Health Knowledge, Attitudes, Practice; Humans; Malaria, Falciparum; Odds Ratio; Parasitemia; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Prevalence; Pyrimethamine; Sample Size; Sulfadoxine | 2021 |
Artemisinin combination therapy fails even in the absence of Plasmodium falciparum kelch13 gene polymorphism in Central India.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Drug Resistance; Drug Therapy, Combination; Female; Humans; India; Kelch Repeat; Malaria; Malaria, Falciparum; Male; Middle Aged; Mutation; Phenotype; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2021 |
Evaluation of the usefulness of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in a context with increased resistance of Plasmodium falciparum in Kingasani Hospital, Kinshasa in the Democratic Republic of Congo.
Topics: Adolescent; Adult; Antimalarials; Democratic Republic of the Congo; Drug Combinations; Drug Resistance; Female; Hospitals; Humans; Malaria, Falciparum; Pregnancy; Pregnancy Complications; Pyrimethamine; Sulfadoxine; Young Adult | 2021 |
Herbicidal properties of antimalarial drugs.
Topics: Antimalarials; Arabidopsis; Herbicides; Humans; Malaria, Falciparum; Plasmodium falciparum; Proguanil; Pyrimethamine; Sulfadiazine; Sulfadoxine; Triazines | 2017 |
Increase in the prevalence of mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates collected from early to late pregnancy in Nanoro, Burkina Faso.
Topics: Adolescent; Adult; Antimalarials; Burkina Faso; Child; Child, Preschool; Cross-Sectional Studies; Drug Combinations; Drug Resistance; Female; Humans; Longitudinal Studies; Malaria, Falciparum; Male; Mutation; Plasmodium falciparum; Pregnancy; Prevalence; Pyrimethamine; Sulfadoxine; Young Adult | 2017 |
IgG isotypic antibodies to crude Plasmodium falciparum blood-stage antigen associated with placental malaria infection in parturient Cameroonian women.
Topics: Adolescent; Adult; Age Factors; Antibodies, Protozoan; Antigens, Protozoan; Cameroon; Drug Combinations; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunoglobulin G; Immunoglobulin M; Malaria, Falciparum; Parity; Placenta; Pregnancy; Pyrimethamine; Sulfadoxine; Young Adult | 2016 |
Polymorphisms in pfdhfr and pfdhps genes after five years of artemisinin combination therapy (ACT) implementation from urban Kolkata, India.
Topics: Adult; Antimalarials; Artemisinins; Child; Cities; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Gene Expression; Genotype; Humans; India; Malaria, Falciparum; Male; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Retrospective Studies; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2017 |
Clinical and molecular monitoring of Plasmodium falciparum resistance to antimalarial drug (artesunate+sulphadoxine-pyrimethamine) in two highly malarious district of Madhya Pradesh, Central India from 2012-2014.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance; Epidemiological Monitoring; Female; Genes, Protozoan; Genotype; Genotyping Techniques; Humans; India; Infant; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2017 |
Surveillance for sulfadoxine-pyrimethamine resistant malaria parasites in the Lake and Southern Zones, Tanzania, using pooling and next-generation sequencing.
Topics: Adolescent; Adult; Aged; Antimalarials; Child; Child, Preschool; Cross-Sectional Studies; Drug Combinations; Drug Resistance; High-Throughput Nucleotide Sequencing; Humans; Infant; Malaria, Falciparum; Middle Aged; Mutation; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tanzania; Young Adult | 2017 |
Pooled-DNA sequencing identifies genomic regions of selection in Nigerian isolates of Plasmodium falciparum.
Topics: Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Gene Frequency; Genetic Variation; Haplotypes; Humans; Malaria, Falciparum; Nigeria; Plasmodium falciparum; Polymorphism, Single Nucleotide; Pyrimethamine; Selection, Genetic; Sequence Analysis, DNA; Sulfadoxine | 2017 |
Optimal antimalarial dose regimens for chloroquine in pregnancy based on population pharmacokinetic modelling.
Topics: Adult; Antimalarials; Chloroquine; Drug Combinations; Female; Humans; Malaria, Falciparum; Metabolic Clearance Rate; Models, Biological; Papua New Guinea; Plasmodium falciparum; Pregnancy; Pyrimethamine; Sulfadoxine | 2017 |
Presence of quintuple dhfr N51, C59, S108 - dhps A437, K540 mutations in Plasmodium falciparum isolates from pregnant women and the general population in Nanoro, Burkina Faso.
Topics: Adolescent; Adult; Amino Acid Substitution; Antimalarials; Burkina Faso; Child; Child, Preschool; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Parasomnias; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2017 |
Impact of Intermittent Preventive Treatment During Pregnancy on Plasmodium falciparum Drug Resistance-Mediating Polymorphisms in Uganda.
Topics: Antimalarials; Artemisinins; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Plasmodium falciparum; Polymorphism, Genetic; Pregnancy; Pyrimethamine; Quinolines; Sulfadoxine | 2017 |
Antifolate drug resistance: Novel mutations and haplotype distribution in
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child; Child, Preschool; Contraindications, Drug; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Gene Expression; Haplotypes; Humans; India; Malaria, Falciparum; Male; Middle Aged; Mutation; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2017 |
Molecular identification of sulfadoxine-pyrimethamine resistance in malaria infected women who received intermittent preventive treatment in the Democratic Republic of Congo.
Topics: Adolescent; Adult; Amino Acid Substitution; Antimalarials; Democratic Republic of the Congo; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Malaria, Falciparum; Mutation, Missense; Plasmodium falciparum; Point Mutation; Polymorphism, Genetic; Pregnancy; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2018 |
High prevalence of dihydrofolate reductase gene mutations in Plasmodium falciparum parasites among pregnant women in Nigeria after reported use of sulfadoxine-pyrimethamine.
Topics: Adolescent; Adult; Animals; Antimalarials; Asymptomatic Diseases; Cross-Sectional Studies; Drug Combinations; Female; Humans; Malaria, Falciparum; Microscopy; Mutation, Missense; Nigeria; Plasmodium falciparum; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2018 |
Prevalence of the Pfdhfr and Pfdhps mutations among asymptomatic pregnant women in Southeast Nigeria.
Topics: Adult; Antimalarials; Drug Combinations; Female; Genotype; Humans; Malaria, Falciparum; Mutation; Mutation Rate; Nigeria; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Genetic; Pregnancy; Pregnancy Complications, Parasitic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2018 |
Population Pharmacokinetic Properties of Sulfadoxine and Pyrimethamine: a Pooled Analysis To Inform Optimal Dosing in African Children with Uncomplicated Malaria.
Topics: Africa; Age Factors; Amodiaquine; Antimalarials; Biomarkers, Pharmacological; Body Weight; Chemoprevention; Child, Preschool; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Nutritional Status; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2018 |
Molecular markers of resistance to amodiaquine plus sulfadoxine-pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger.
Topics: Amodiaquine; Antimalarials; Chemoprevention; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Infant; Malaria, Falciparum; Male; Mass Drug Administration; Multidrug Resistance-Associated Proteins; Mutant Proteins; Niger; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Seasons; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2018 |
Prevalence of Low Birth Weight before and after Policy Change to IPTp-SP in Two Selected Hospitals in Southern Nigeria: Eleven-Year Retrospective Analyses.
Topics: Adult; Drug Combinations; Female; Gravidity; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria, Falciparum; Nigeria; Plasmodium falciparum; Pregnancy; Pregnancy Complications; Pyrimethamine; Sulfadoxine | 2018 |
Molecular Markers of
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Cross-Sectional Studies; Drug Combinations; Drug Resistance; Female; Genetic Markers; Ghana; Haplotypes; Humans; Infant, Newborn; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum; Polymorphism, Single Nucleotide; Pregnancy; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2018 |
Additional Screening and Treatment of Malaria During Pregnancy Provides Further Protection Against Malaria and Nonmalarial Fevers During the First Year of Life.
Topics: Adult; Antimalarials; Burkina Faso; Cohort Studies; Drug Combinations; Female; Humans; Incidence; Infant; Malaria, Falciparum; Male; Mass Screening; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2018 |
Malaria-related ideational factors and other correlates associated with intermittent preventive treatment among pregnant women in Madagascar.
Topics: Adult; Antimalarials; Cross-Sectional Studies; Drug Combinations; Female; Humans; Madagascar; Malaria, Falciparum; Middle Aged; Patient Acceptance of Health Care; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Young Adult | 2018 |
Drug-Resistance and Population Structure of Plasmodium falciparum Across the Democratic Republic of Congo Using High-Throughput Molecular Inversion Probes.
Topics: Child; Democratic Republic of the Congo; Drug Resistance; Female; High-Throughput Nucleotide Sequencing; Humans; Malaria, Falciparum; Male; Microsatellite Repeats; Mutation; Plasmodium falciparum; Population Surveillance; Sulfadoxine; Surveys and Questionnaires | 2018 |
Spatio-temporal distribution of PfMDR1 polymorphism among uncomplicated Plasmodium falciparum malaria cases along international border of north east India.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Bangladesh; Chloroquine; Drug Combinations; Drug Resistance; Erythrocytes; Gene Expression; Haplotypes; Humans; India; Lumefantrine; Malaria, Falciparum; Multidrug Resistance-Associated Proteins; Myanmar; Phylogeny; Phylogeography; Plasmodium falciparum; Polymorphism, Single Nucleotide; Pyrimethamine; Sulfadoxine | 2018 |
Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine/pyrimethamine in the Democratic Republic of the Congo: emergence of highly resistant pfdhfr/pfdhps alleles.
Topics: Adolescent; Adult; Alleles; Ambulatory Care Facilities; Antimalarials; Child; Child, Preschool; Democratic Republic of the Congo; Drug Resistance, Multiple; Female; Genotype; Humans; Malaria, Falciparum; Male; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2018 |
RETROSPECTIVE INVESTIGATION OF PYRIMETHAMINE-SULFADOXINE RESISTANCE INDICATORS IN FALCIPARUM-MALARIA POSITIVE BLOOD SAMPLES FROM SOUTH-WESTERN SAUDI ARABIA.
Topics: Alleles; Codon; DNA, Protozoan; Drug Combinations; Drug Resistance; Genotype; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Pyrimethamine; Retrospective Studies; Saudi Arabia; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2016 |
Dynamics of Plasmodium falciparum gametocyte carriage in pregnant women under intermittent preventive treatment with sulfadoxine-pyrimethamine in Benin.
Topics: Adolescent; Adult; Antigens, Protozoan; Antimalarials; Benin; Drug Combinations; Female; Humans; Malaria, Falciparum; Membrane Proteins; Plasmodium falciparum; Pregnancy; Protozoan Proteins; Pyrimethamine; Real-Time Polymerase Chain Reaction; Reproducibility of Results; Sulfadoxine; Young Adult | 2018 |
Intermittent Preventive Treatment (IPT): Its Role in Averting Disease-Induced Mortality in Children and in Promoting the Spread of Antimalarial Drug Resistance.
Topics: Antimalarials; Basic Reproduction Number; Child; Computer Simulation; Drug Administration Schedule; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mathematical Concepts; Models, Biological; Mosquito Vectors; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2019 |
Molecular Evidence for
Topics: Adolescent; Adult; Aged; Alleles; Antimalarials; Artemisinins; Artesunate; Child; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Epidemiological Monitoring; Female; Gene Expression; Humans; India; Kelch Repeat; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Molecular Epidemiology; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2018 |
A decade since sulfonamide-based anti-malarial medicines were limited for intermittent preventive treatment of malaria among pregnant women in Tanzania.
Topics: Antimalarials; Clinical Competence; Cross-Sectional Studies; Drug Combinations; Female; Humans; Malaria; Malaria, Falciparum; Pharmacies; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Sulfalene; Sulfonamides; Tanzania | 2018 |
Has doxycycline, in combination with anti-malarial drugs, a role to play in intermittent preventive treatment of Plasmodium falciparum malaria infection in pregnant women in Africa?
Topics: Africa; Antimalarials; Artemisinins; Doxycycline; Drug Combinations; Female; Humans; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnant Women; Pyrimethamine; Quinolines; Sulfadoxine | 2018 |
Relationship between weight status and anti-malarial drug efficacy and safety in children in Mali.
Topics: Adolescent; Amodiaquine; Antimalarials; Artesunate; Body Weight; Child; Child, Preschool; Clinical Trials as Topic; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Mali; Sulfadoxine; Treatment Outcome; Young Adult | 2019 |
Trends in comparative efficacy and safety of malaria control interventions for maternal and child health outcomes in Africa: a study protocol for a Bayesian network meta-regression exploring the effect of HIV and malaria endemicity spectrum.
Topics: Africa South of the Sahara; Antimalarials; Bayes Theorem; Child Health; Child, Preschool; Clinical Protocols; Drug Combinations; Drug Resistance; Endemic Diseases; Female; HIV Infections; Humans; Insecticide-Treated Bednets; Malaria, Falciparum; Mass Screening; Maternal Health; Meta-Analysis as Topic; Network Meta-Analysis; Pregnancy; Propensity Score; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine; Systematic Reviews as Topic | 2019 |
High prevalence of Pfdhfr-Pfdhps quadruple mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Bioko Island, Equatorial Guinea.
Topics: Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Equatorial Guinea; Gene Frequency; Genotype; Humans; Linkage Disequilibrium; Malaria, Falciparum; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2019 |
Absence of K13 gene mutations among artesunate/sulfadoxine-pyrimethamine treatment failures of Sudanese Plasmodium falciparum isolates from Damazin, southeast Sudan.
Topics: Antimalarials; Artemisinins; Drug Resistance, Multiple; Humans; Malaria, Falciparum; Plasmodium falciparum; Polymorphism, Genetic; Pyrimethamine; Sudan; Sulfadoxine; Treatment Failure | 2019 |
An analysis of large structural variation in global Plasmodium falciparum isolates identifies a novel duplication of the chloroquine resistance associated gene.
Topics: Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Gene Deletion; Gene Duplication; Genome; Genome-Wide Association Study; Genotype; Humans; Malaria, Falciparum; Plasmodium falciparum; Polymorphism, Single Nucleotide; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2019 |
Evolution of Plasmodium falciparum drug resistance genes following artemisinin combination therapy in Sudan.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; DNA, Protozoan; Drug Resistance; Drug Therapy, Combination; Genetic Markers; Genotype; Humans; Lumefantrine; Malaria, Falciparum; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sudan; Sulfadoxine | 2019 |
High prevalence of asymptomatic malaria in a tribal population in eastern India.
Topics: Antimalarials; Artemisinins; Asymptomatic Infections; Base Sequence; Drug Combinations; Drug Resistance; Genotype; Humans; India; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Population Groups; Prevalence; Protozoan Proteins; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine | 2013 |
Malaria control aimed at the entire population in KwaZulu-Natal negates the need for policies to prevent malaria in pregnancy.
Topics: Adolescent; Adult; Antimalarials; Communicable Disease Control; Drug Combinations; Female; Humans; Incidence; Insecticides; Malaria, Falciparum; Outcome Assessment, Health Care; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prenatal Care; Prevalence; Pyrimethamine; Socioeconomic Factors; South Africa; Sulfadoxine | 2013 |
Prevalence of antifolate resistance mutations in Plasmodium falciparum isolates in Afghanistan.
Topics: Adult; Afghanistan; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; DNA, Protozoan; Drug Combinations; Drug Resistance; Folic Acid Antagonists; Humans; Malaria, Falciparum; Mutation, Missense; Plasmodium falciparum; Polymerase Chain Reaction; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2013 |
Weighing for results: assessing the effect of IPTp - authors' reply.
Topics: Animals; Antimalarials; Female; Humans; Infant, Low Birth Weight; Malaria, Falciparum; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2013 |
Weighing for results: assessing the effect of IPTp.
Topics: Animals; Antimalarials; Female; Humans; Infant, Low Birth Weight; Malaria, Falciparum; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2013 |
Selection of antimalarial drug resistance after intermittent preventive treatment of infants and children (IPTi/c) in Senegal.
Topics: Antimalarials; Artemisinins; Artesunate; Child, Preschool; Cross-Sectional Studies; DNA, Protozoan; Drug Resistance; Follow-Up Studies; Haplotypes; Humans; Infant; Malaria, Falciparum; Mutation; Pilot Projects; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Senegal; Sequence Analysis, DNA; Sulfadoxine | 2013 |
Prevalence of molecular markers of drug resistance in an area of seasonal malaria chemoprevention in children in Senegal.
Topics: Amodiaquine; Antimalarials; Chemoprevention; Child; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Genetic Markers; Humans; Infant; Malaria, Falciparum; Male; Mutation Rate; Plasmodium falciparum; Prevalence; Pyrimethamine; Senegal; Sulfadoxine | 2013 |
Prevalence of the molecular marker of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in Benin seven years after the change of malaria treatment policy.
Topics: Adolescent; Antimalarials; Benin; Blood; Child; Child, Preschool; Chloroquine; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Genetic Markers; Humans; Infant; Malaria, Falciparum; Male; Mutation Rate; Plasmodium falciparum; Point Mutation; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2013 |
Changing the malaria treatment protocol policy in Timor-Leste: an examination of context, process, and actors' involvement.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Clinical Protocols; Cooperative Behavior; Drug Combinations; Drug Substitution; Ethanolamines; Fluorenes; Health Planning Organizations; Health Policy; Humans; Interinstitutional Relations; Malaria, Falciparum; Policy Making; Pyrimethamine; Sulfadoxine; Time Factors; Timor-Leste | 2013 |
Saving babies' lives by antenatal malaria prevention.
Topics: Animals; Antimalarials; Female; Humans; Infant, Low Birth Weight; Malaria, Falciparum; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2013 |
Haplotypes associated with resistance to sulfadoxine-pyrimethamine in Plasmodium falciparum in two malaria endemic locations in Colombia.
Topics: Adult; Antimalarials; Colombia; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Endemic Diseases; Female; Genes, Protozoan; Haplotypes; Humans; Malaria, Falciparum; Male; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2013 |
High rates of parasite recrudescence following intermittent preventive treatment with sulphadoxine-pyrimethamine during pregnancy in Benin.
Topics: Adolescent; Adult; Antimalarials; Benin; Dihydropteroate Synthase; Drug Combinations; Female; Haplotypes; Humans; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Point Mutation; Polymorphism, Single Nucleotide; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Prospective Studies; Protozoan Proteins; Pyrimethamine; Recurrence; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2013 |
Malaria risk factors in women on intermittent preventive treatment at delivery and their effects on pregnancy outcome in Sanaga-Maritime, Cameroon.
Topics: Adolescent; Adult; Antimalarials; Cameroon; Drug Combinations; Female; Fetus; Humans; Infant, Newborn; Malaria, Falciparum; Middle Aged; Mosquito Nets; Placenta; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Prevalence; Pyrimethamine; Risk Factors; Social Class; Sulfadoxine | 2013 |
Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on maternal and birth outcomes in Machinga district, Malawi.
Topics: Adult; Antimalarials; Dose-Response Relationship, Drug; Drug Combinations; Female; HIV Infections; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria, Falciparum; Malawi; Placenta; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Prevalence; Pyrimethamine; Sulfadoxine; Young Adult | 2013 |
Selection of pfdhfr/pfdhps alleles and declining artesunate/sulphadoxine-pyrimethamine efficacy against Plasmodium falciparum eight years after deployment in eastern Sudan.
Topics: Adolescent; Adult; Aged; Artemisinins; Child; Child, Preschool; DNA, Protozoan; Drug Resistance; Female; Gene Dosage; Gene Frequency; Humans; Malaria, Falciparum; Male; Middle Aged; Mutant Proteins; Plasmodium falciparum; Prevalence; Protozoan Proteins; Pyrimethamine; Real-Time Polymerase Chain Reaction; Sequence Analysis, DNA; Sudan; Sulfadoxine; Young Adult | 2013 |
[Prevalence of Plasmodium falciparum, anemia and molecular markers of chloroquine and sulfadoxine-pyriméthamine resistance in delivered women in Fana, Mali].
Topics: Adolescent; Adult; Anemia; Chloroquine; Delivery, Obstetric; Drug Combinations; Drug Resistance; Female; Genetic Markers; Humans; Malaria, Falciparum; Mali; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Pyrimethamine; Sulfadoxine; Young Adult | 2013 |
Ordered accumulation of mutations conferring resistance to sulfadoxine-pyrimethamine in the Plasmodium falciparum parasite.
Topics: Amino Acid Sequence; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Evolution, Molecular; Haplotypes; Humans; Malaria, Falciparum; Molecular Sequence Data; Mutation; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2014 |
Trends in antimalarial drug use in Africa.
Topics: Africa; Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Drug Resistance; Health Surveys; Humans; Malaria, Falciparum; Models, Statistical; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Time Factors | 2013 |
Prevalence of sulfadoxine-pyrimethamine resistance-associated mutations in dhfr and dhps genes of Plasmodium falciparum three years after SP withdrawal in Bahir Dar, Northwest Ethiopia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiprotozoal Agents; Child; Child, Preschool; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Ethiopia; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Middle Aged; Mutation, Missense; Nucleic Acid Hybridization; Plasmodium falciparum; Polymerase Chain Reaction; Prevalence; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2013 |
Low prevalence of the molecular markers of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in asymptomatic children in Northern Benin.
Topics: Adolescent; Animals; Antimalarials; Benin; Child; Child, Preschool; Chloroquine; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Genetic Variation; Genotype; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2013 |
Prevailing Plasmodium falciparum dihydrofolate reductase 108-asparagine in Hodeidah, Yemen: a questionable sulfadoxine-pyrimethamine partner within the artemisinin-based combination therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Asparagine; Child; Child, Preschool; Cross-Sectional Studies; DNA, Protozoan; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Gene Frequency; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Middle Aged; Mutation, Missense; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Yemen; Young Adult | 2014 |
Submicroscopic infections among children with adequate clinical and parasitological response (ACPR).
Topics: Amodiaquine; Antimalarials; Artemisinins; Blood; Child; Child, Preschool; DNA, Protozoan; Drug Combinations; Female; Gabon; Humans; Malaria, Falciparum; Male; Microscopy; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2014 |
Molecular analysis of chloroquine and sulfadoxine-pyrimethamine resistance-associated alleles in Plasmodium falciparum isolates from Nicaragua.
Topics: Alleles; Antimalarials; Chloroquine; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Membrane Transport Proteins; Nicaragua; Plasmodium falciparum; Polymorphism, Genetic; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2014 |
High levels of sulphadoxine-pyrimethamine resistance Pfdhfr-Pfdhps quintuple mutations: a cross sectional survey of six regions in Tanzania.
Topics: Adult; Antimalarials; Child; Cross-Sectional Studies; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Pregnancy; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tanzania; Tetrahydrofolate Dehydrogenase | 2014 |
A cohort study of Plasmodium falciparum malaria in pregnancy and associations with uteroplacental blood flow and fetal anthropometrics in Kenya.
Topics: Adult; Anthropometry; Antimalarials; Cohort Studies; Drug Combinations; Female; Fetal Development; Humans; Infant, Newborn; Kenya; Malaria, Falciparum; Male; Middle Aged; Placental Circulation; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Young Adult | 2014 |
Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Chloroquine; Clinical Trials as Topic; Drug Combinations; Drug Resistance; Ethanolamines; Female; Fluorenes; Genetic Markers; Humans; Infant; Malaria, Falciparum; Male; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Time Factors; Uganda | 2014 |
Placental malaria is rare among Zanzibari pregnant women who did not receive intermittent preventive treatment in pregnancy.
Topics: Adolescent; Adult; Antimalarials; Dried Blood Spot Testing; Drug Administration Schedule; Drug Combinations; Female; Humans; Malaria, Falciparum; Middle Aged; Placenta; Plasmodium falciparum; Polymerase Chain Reaction; Pregnancy; Prospective Studies; Pyrimethamine; Sulfadoxine; Tanzania | 2014 |
Efficacy of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy, Mansa, Zambia.
Topics: Adolescent; Adult; Animals; Antimalarials; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Sulfadoxine; Survival Analysis; Treatment Failure; Young Adult; Zambia | 2014 |
Independent lineages of highly sulfadoxine-resistant Plasmodium falciparum haplotypes, eastern Africa.
Topics: Africa, Eastern; Antimalarials; Cross-Sectional Studies; Dihydropteroate Synthase; Drug Resistance; Female; Haplotypes; Humans; Malaria, Falciparum; Malawi; Microsatellite Repeats; Mutation; Plasmodium falciparum; Pregnancy; Sulfadoxine | 2014 |
Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on placental malaria, maternal anaemia and birthweight in areas with high and low malaria transmission intensity in Tanzania.
Topics: Adult; Anemia; Antimalarials; Birth Weight; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria; Malaria, Falciparum; Numbers Needed To Treat; Parasitemia; Placenta; Placenta Diseases; Pregnancy; Pregnancy Complications; Pregnancy Complications, Parasitic; Prevalence; Prospective Studies; Pyrimethamine; Risk; Sulfadoxine; Tanzania; Treatment Outcome; Young Adult | 2014 |
HIV treatments reduce malaria liver stage burden in a non-human primate model of malaria infection at clinically relevant concentrations in vivo.
Topics: Animals; Antimalarials; Disease Models, Animal; Drug Combinations; HIV Protease Inhibitors; Liver; Lopinavir; Macaca mulatta; Malaria, Falciparum; Plasmodium falciparum; Ritonavir; Sulfadoxine; Trimethoprim | 2014 |
Declining efficacy of artesunate plus sulphadoxine-pyrimethamine in northeastern India.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; India; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Risk Factors; Sulfadoxine; Treatment Failure | 2014 |
Molecular evidence of increased resistance to anti-folate drugs in Plasmodium falciparum in North-East India: a signal for potential failure of artemisinin plus sulphadoxine-pyrimethamine combination therapy.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; Codon; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Haplotypes; Humans; India; Malaria, Falciparum; Male; Membrane Transport Proteins; Middle Aged; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2014 |
Two novel mutations of pfdhps K540T and I588F, affecting sulphadoxine-pyrimethamine-resistant response in uncomplicated falciparum malaria at Banjar district, South Kalimantan Province, Indonesia.
Topics: Adolescent; Adult; Amino Acid Substitution; Dihydropteroate Synthase; Drug Combinations; Female; Genotype; Humans; Indonesia; Malaria, Falciparum; Male; Middle Aged; Mutation, Missense; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome; Young Adult | 2014 |
Prevalence and risk factors for Plasmodium falciparum malaria in pregnant women attending antenatal clinic in Bobo-Dioulasso (Burkina Faso).
Topics: Adolescent; Adult; Age Factors; Anemia; Antimalarials; Burkina Faso; Cross-Sectional Studies; Drug Combinations; Female; Gestational Age; Humans; Insecticide-Treated Bednets; Logistic Models; Malaria, Falciparum; Parity; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Prevalence; Pyrimethamine; Risk Factors; Sulfadoxine; Young Adult | 2014 |
Coverage and efficacy of intermittent preventive treatment with sulphadoxine pyrimethamine against malaria in pregnancy in Côte d'Ivoire five years after its implementation.
Topics: Adolescent; Adult; Antimalarials; Blood; Chemoprevention; Cote d'Ivoire; Cross-Sectional Studies; Drug Combinations; Drug Utilization; Female; Health Services Research; Humans; Infant, Newborn; Malaria, Falciparum; Male; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2014 |
The A581G Mutation in the Gene Encoding Plasmodium falciparum Dihydropteroate Synthetase Reduces the Effectiveness of Sulfadoxine-Pyrimethamine Preventive Therapy in Malawian Pregnant Women.
Topics: Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Infant, Newborn; Malaria, Falciparum; Malawi; Mutation, Missense; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Pregnancy; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2015 |
Treatment of uncomplicated malaria with artesunate plus sulfadoxine-pyrimethamine is failing in Somalia: evidence from therapeutic efficacy studies and Pfdhfr and Pfdhps mutant alleles.
Topics: Adolescent; Adult; Age Factors; Alleles; Antimalarials; Artemisinins; Child; Child, Preschool; Dihydropteroate Synthase; Drug Resistance, Multiple; Female; Genes, Bacterial; Health Policy; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Mutation; Plasmodium falciparum; Pyrimethamine; Somalia; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Failure; Young Adult | 2015 |
High prevalence of pfdhfr-pfdhps triple mutations associated with anti-malarial drugs resistance in Plasmodium falciparum isolates seven years after the adoption of sulfadoxine-pyrimethamine in combination with artesunate as first-line treatment in Iran.
Topics: Adolescent; Adult; Alcohol Dehydrogenase; Antimalarials; Artemisinins; Child; Child, Preschool; Codon; Drug Resistance; Gene Frequency; Genotype; Haplotypes; Humans; Iran; Malaria, Falciparum; Middle Aged; Mutation; Plasmodium falciparum; Polymorphism, Restriction Fragment Length; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2015 |
Persistence of Sulfadoxine-Pyrimethamine Resistance Despite Reduction of Drug Pressure in Malawi.
Topics: Antimalarials; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Gene Frequency; Genotype; Haplotypes; Humans; Malaria, Falciparum; Malawi; Mutation, Missense; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Selection, Genetic; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2015 |
Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia.
Topics: Adolescent; Adult; Antimalarials; Cohort Studies; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Malaria, Falciparum; Multivariate Analysis; Poisson Distribution; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Pyrimethamine; Retrospective Studies; Sulfadoxine; Treatment Outcome; Young Adult; Zambia | 2015 |
Increasing prevalence of a novel triple-mutant dihydropteroate synthase genotype in Plasmodium falciparum in western Kenya.
Topics: Adult; Antimalarials; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Genotype; Haplotypes; Humans; Kenya; Malaria, Falciparum; Microsatellite Repeats; Mutation; Plasmodium falciparum; Polymorphism, Single Nucleotide; Pregnancy; Prevalence; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2015 |
High prevalence of sulphadoxine-pyrimethamine resistance-associated mutations in Plasmodium falciparum field isolates from pregnant women in Brazzaville, Republic of Congo.
Topics: Adolescent; Adult; Alleles; Antimalarials; Congo; Drug Combinations; Drug Resistance; Female; Gene Frequency; Haplotypes; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pregnancy; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2015 |
High prevalence of dhfr and dhps molecular markers in Plasmodium falciparum in pregnant women of Nchelenge district, Northern Zambia.
Topics: Adult; Antimalarials; Cross-Sectional Studies; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pregnancy; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult; Zambia | 2015 |
Population pharmacokinetics, tolerability, and safety of dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine-piperaquine in pregnant and nonpregnant Papua New Guinean women.
Topics: Adolescent; Adult; Antimalarials; Area Under Curve; Artemisinins; Biological Availability; Dietary Fats; Drug Combinations; Female; Follow-Up Studies; Food-Drug Interactions; Humans; Infant, Newborn; Malaria, Falciparum; Models, Statistical; Papua New Guinea; Pregnancy; Pregnancy Outcome; Pyrimethamine; Quinolines; Sulfadoxine; Young Adult | 2015 |
Use of bacterial surrogates as a tool to explore antimalarial drug interaction: Synergism between inhibitors of malarial dihydrofolate reductase and dihydropteroate synthase.
Topics: Antimalarials; Dapsone; Dihydropteroate Synthase; Drug Interactions; Drug Resistance; Drug Synergism; Escherichia coli; Folic Acid Antagonists; Malaria, Falciparum; Organisms, Genetically Modified; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfamethoxazole; Tetrahydrofolate Dehydrogenase | 2015 |
Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine/pyrimethamine in pregnant women in Yaoundé, Cameroon: emergence of highly resistant pfdhfr/pfdhps alleles.
Topics: Adult; Antimalarials; Cameroon; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Gene Frequency; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2015 |
Changing Malaria Prevalence on the Kenyan Coast since 1974: Climate, Drugs and Vector Control.
Topics: Adolescent; Adult; Aged; Antimalarials; Bayes Theorem; Child; Child, Preschool; Chloroquine; Climate; Drug Combinations; Drug Resistance; Female; Health Surveys; Humans; Insecticide-Treated Bednets; Kenya; Malaria, Falciparum; Male; Middle Aged; Mosquito Control; Plasmodium falciparum; Prevalence; Pyrimethamine; Rainforest; Retrospective Studies; Sulfadoxine | 2015 |
Monitoring artemisinin resistance in Plasmodium falciparum: comparison of parasite clearance time by microscopy and real-time PCR and evaluation of mutations in Pfatpase6 gene in Odisha state of India.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Child; Child, Preschool; Drug Resistance; Female; Gene Dosage; Humans; India; Malaria, Falciparum; Male; Microscopy; Middle Aged; Mutation; Plasmodium falciparum; Pyrimethamine; Real-Time Polymerase Chain Reaction; Sulfadoxine; Young Adult | 2015 |
Prevalence of Plasmodium falciparum resistance markers to sulfadoxine-pyrimethamine among pregnant women receiving intermittent preventive treatment for malaria in Uganda.
Topics: Antimalarials; Bacterial Proteins; Birth Weight; Drug Combinations; Female; Humans; Malaria, Falciparum; Plasmodium falciparum; Pregnancy; Pregnancy Outcome; Pyrimethamine; Sulfadoxine; Uganda | 2015 |
Malaria in pregnancy: challenges for control and the need for urgent action.
Topics: Africa South of the Sahara; Antimalarials; Chemoprevention; Comorbidity; Drug Combinations; Early Diagnosis; Female; Guideline Adherence; Health Policy; HIV Infections; Humans; Infant, Newborn; Insecticide-Treated Bednets; Malaria, Falciparum; Mosquito Control; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; World Health Organization | 2015 |
Frequencies of dhfr/dhps multiple mutations and Plasmodium falciparum submicroscopic gametocyte carriage in Gabonese pregnant women following IPTp-SP implementation.
Topics: Antimalarials; Carrier State; Chemoprevention; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Female; Gabon; Gene Frequency; Humans; Malaria, Falciparum; Mutant Proteins; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2015 |
Defending the Use of Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment for Malaria in Pregnancy: A Short-Sighted Strategy.
Topics: Dihydropteroate Synthase; Drug Resistance; Female; Humans; Malaria, Falciparum; Mutation, Missense; Plasmodium falciparum; Pregnancy; Pyrimethamine; Sulfadoxine | 2016 |
Reply to Harrington et al.
Topics: Dihydropteroate Synthase; Drug Resistance; Female; Humans; Malaria, Falciparum; Mutation, Missense; Plasmodium falciparum; Pregnancy; Pyrimethamine; Sulfadoxine | 2016 |
Emergence of sulfadoxine-pyrimethamine resistance in Indian isolates of Plasmodium falciparum in the last two decades.
Topics: Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Humans; India; Malaria, Falciparum; Plasmodium falciparum; Polymorphism, Single Nucleotide; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2015 |
Prevalence of the dhfr and dhps Mutations among Pregnant Women in Rural Burkina Faso Five Years after the Introduction of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine.
Topics: Adult; Antimalarials; Burkina Faso; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2015 |
Disagreement in genotyping results of drug resistance alleles of the Plasmodium falciparum dihydrofolate reductase (Pfdhfr) gene by allele-specific PCR (ASPCR) assays and Sanger sequencing.
Topics: Alleles; Antimalarials; Artemisinins; Codon; Dihydropteroate Synthase; DNA Primers; DNA, Protozoan; Drug Resistance; Drug Therapy, Combination; Genotyping Techniques; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Pyrimethamine; Sensitivity and Specificity; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2016 |
Declining trend of Plasmodium falciparum dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant alleles after the withdrawal of Sulfadoxine-Pyrimethamine in North Western Ethiopia.
Topics: Alleles; Animals; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Ethiopia; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2015 |
Characterization of asymptomatic Plasmodium falciparum infection and its risk factors in pregnant women from the Republic of Congo.
Topics: Adolescent; Adult; Antimalarials; Asymptomatic Infections; Child; Congo; Cross-Sectional Studies; Female; Humans; Malaria, Falciparum; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Risk Factors; Sulfadoxine; Young Adult | 2016 |
Comparative Study of Effectiveness and Resistance Profile of Chloroquine and Sulfadoxine-Pyrimethamine in Uncomplicated Plasmodium falciparum Malaria in Kolkata.
Topics: Adolescent; Adult; Antimalarials; Child; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; India; Malaria, Falciparum; Male; Middle Aged; Parasite Load; Parasitemia; Pilot Projects; Pyrimethamine; Sulfadoxine; Young Adult | 2015 |
Frequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, Yemen.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Child; Child, Preschool; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Gene Frequency; Genotype; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Middle Aged; Mutant Proteins; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Yemen; Young Adult | 2015 |
Influence of Intermittent Preventive Treatment on Antibodies to VAR2CSA in Pregnant Cameroonian Women.
Topics: Adolescent; Adult; Antibodies, Protozoan; Antigens, Protozoan; Antimalarials; Cameroon; Drug Administration Schedule; Drug Combinations; Female; Humans; Insecticide-Treated Bednets; Malaria, Falciparum; Parity; Pregnancy; Protein Structure, Tertiary; Pyrimethamine; Sulfadoxine; Young Adult | 2016 |
In Vivo Efficacy and Parasite Clearance of Artesunate + Sulfadoxine-Pyrimethamine Versus Artemether-Lumefantrine in Mali.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Male; Mali; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2016 |
Treatment of Malaria in Pregnancy.
Topics: Antimalarials; Artemisinins; Female; Humans; Malaria; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Quinolines; Sulfadoxine | 2016 |
Comparative assessment on the prevalence of mutations in the Plasmodium falciparum drug-resistant genes in two different ecotypes of Odisha state, India.
Topics: Alleles; Antimalarials; Chloroquine; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Ecotype; Gene Expression; Haplotypes; Humans; India; Linkage Disequilibrium; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2016 |
Absence of Association Between Sickle Trait Hemoglobin and Placental Malaria Outcomes.
Topics: Adult; Antimalarials; Cross-Sectional Studies; Drug Combinations; Female; Genotype; Hemoglobin, Sickle; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria, Falciparum; Malawi; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Prevalence; Pyrimethamine; Real-Time Polymerase Chain Reaction; Risk Factors; Sickle Cell Trait; Sulfadoxine; Young Adult | 2016 |
A link between poor quality antimalarials and malaria drug resistance?
Topics: Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2016 |
High efficacy of artemether-lumefantrine and declining efficacy of artesunate + sulfadoxine-pyrimethamine against Plasmodium falciparum in Sudan (2010-2015): evidence from in vivo and molecular marker studies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Ethanolamines; Female; Fluorenes; Genetic Markers; Genotype; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sudan; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome; Young Adult | 2016 |
Sustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytes.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Female; Gene Frequency; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Mutation; Plasmodium falciparum; Primaquine; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Treatment Outcome; Yemen; Young Adult | 2016 |
Malaria research and its influence on anti-malarial drug policy in Malawi: a case study.
Topics: Antimalarials; Artemether; Artemisinins; Biomedical Research; Chloroquine; Drug Combinations; Drug Resistance; Ethanolamines; Evidence-Based Medicine; Fluorenes; Health Policy; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Malawi; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2016 |
Low-grade sulfadoxine-pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, Angola.
Topics: Angola; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2016 |
Decrease of microscopic Plasmodium falciparum infection prevalence during pregnancy following IPTp-SP implementation in urban cities of Gabon.
Topics: Adult; Anemia; Antimalarials; Birth Weight; Cities; Cross-Sectional Studies; Drug Combinations; Female; Gabon; Gravidity; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Malaria, Falciparum; Parasitemia; Placenta; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Prevalence; Pyrimethamine; Sulfadoxine; Urban Population; Young Adult | 2016 |
Determinants of timely uptake of ITN and SP (IPT) and pregnancy time protected against malaria in Bukoba, Tanzania.
Topics: Adolescent; Adult; Antimalarials; Cross-Sectional Studies; Drug Combinations; Female; Health Facilities; Humans; Insecticide-Treated Bednets; Malaria, Falciparum; Multivariate Analysis; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Prevalence; Pyrimethamine; Sulfadoxine; Tanzania; Time Factors; Urban Health; Young Adult | 2016 |
Molecular monitoring of Plasmodium falciparum super-resistance to sulfadoxine-pyrimethamine in Tanzania.
Topics: Antimalarials; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Gene Frequency; Genotyping Techniques; Humans; Malaria, Falciparum; Mutation, Missense; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Pyrimethamine; Sulfadoxine; Tanzania | 2016 |
Molecular markers associated with resistance to commonly used antimalarial drugs among Plasmodium falciparum isolates from a malaria-endemic area in Taiz governorate-Yemen during the transmission season.
Topics: Alleles; Antimalarials; Artemisinins; Artesunate; Chloroquine; Cross-Sectional Studies; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Genotype; Malaria, Falciparum; Membrane Transport Proteins; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Yemen | 2016 |
Plasmodium falciparum Drug-Resistant Haplotypes and Population Structure in Postearthquake Haiti, 2010.
Topics: Alleles; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Earthquakes; Genetics, Population; Haiti; Haplotypes; Humans; Malaria, Falciparum; Membrane Transport Proteins; Microsatellite Repeats; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2016 |
Efficacy of artemisinin-based combination therapies for the treatment of falciparum malaria in Pakistan (2007-2015): In vivo response and dhfr and dhps mutations.
Topics: Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Ethanolamines; Female; Fluorenes; Humans; Infant; Infant, Newborn; Lumefantrine; Malaria, Falciparum; Male; Mutation; Pakistan; Plasmodium falciparum; Prospective Studies; Pyrimethamine; Sulfadoxine | 2016 |
Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.
Topics: Adolescent; Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Genotype; Haplotypes; Humans; Infant; Infant, Newborn; Kenya; Malaria; Malaria, Falciparum; Malawi; Male; Plasmodium falciparum; Polymorphism, Genetic; Pyrimethamine; Rwanda; Sulfadoxine; Tanzania; Uganda | 2016 |
Efficacy of sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in southern Mauritania.
Topics: Adolescent; Adult; Antimalarials; Child; Child, Preschool; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Mauritania; Middle Aged; Pyrimethamine; Sulfadoxine; Treatment Failure; Young Adult | 2016 |
Prevalence of Plasmodium falciparum Molecular Markers of Antimalarial Drug Resistance in a Residual Malaria Focus Area in Sabah, Malaysia.
Topics: Adult; Alleles; Antimalarials; Biomarkers; Child; Chloroquine; Drug Combinations; Drug Resistance; Gene Dosage; Humans; Malaria, Falciparum; Malaysia; Plasmodium falciparum; Point Mutation; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2016 |
Plasmodium falciparum Genetic Diversity in Continental Equatorial Guinea before and after Introduction of Artemisinin-Based Combination Therapy.
Topics: Amodiaquine; Antigens, Protozoan; Antimalarials; Artemisinins; Artesunate; Chloroquine; DNA Copy Number Variations; Drug Combinations; Drug Resistance; Equatorial Guinea; Female; Genetic Loci; Genetic Variation; Genotype; Humans; Malaria, Falciparum; Male; Membrane Transport Proteins; Microsatellite Repeats; Plasmodium falciparum; Point Mutation; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2017 |
Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V.
Topics: Adult; Antimalarials; Child; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Gene Frequency; Humans; Malaria, Falciparum; Mutant Proteins; Mutation, Missense; Nigeria; Plasmodium falciparum; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Young Adult | 2016 |
Characterizing the impact of sustained sulfadoxine/pyrimethamine use upon the Plasmodium falciparum population in Malawi.
Topics: Antimalarials; Child, Preschool; Drug Combinations; Drug Resistance; Female; Gene Frequency; Genetic Variation; Genome, Protozoan; Genotype; Humans; Infant; Malaria, Falciparum; Malawi; Male; Mutation; Plasmodium falciparum; Polymorphism, Single Nucleotide; Pyrimethamine; Selection, Genetic; Sequence Analysis, DNA; Sulfadoxine | 2016 |
Recent uptake of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine is associated with increased prevalence of Pfdhfr mutations in Bobo-Dioulasso, Burkina Faso.
Topics: Adolescent; Adult; Anemia; Antimalarials; Burkina Faso; Drug Combinations; Female; Hemoglobins; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Pregnancy; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Young Adult | 2017 |
Efficacy of artesunate + sulphadoxine/pyrimethamine and artemether + lumefantrine and dhfr and dhps mutations in Somalia: evidence for updating the malaria treatment policy.
Topics: Adolescent; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Dihydropteroate Synthase; Drug Resistance, Multiple; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Mutation; Plasmodium falciparum; Prospective Studies; Protozoan Proteins; Pyrimethamine; Somalia; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2017 |
Different origin and dispersal of sulfadoxine-resistant Plasmodium falciparum haplotypes between Eastern Africa and Democratic Republic of Congo.
Topics: Africa, Eastern; Antimalarials; Child; Child, Preschool; Democratic Republic of the Congo; Dihydropteroate Synthase; Drug Resistance; Female; Genetic Variation; Genotyping Techniques; Haplotypes; Humans; Infant; Malaria, Falciparum; Male; Microsatellite Repeats; Plasmodium falciparum; Sulfadoxine | 2017 |
The Malaria TaqMan Array Card Includes 87 Assays for Plasmodium falciparum Drug Resistance, Identification of Species, and Genotyping in a Single Reaction.
Topics: Antimalarials; Artemisinins; Atovaquone; Chloroquine; Drug Resistance; Epidemiological Monitoring; Genotyping Techniques; Humans; Malaria, Falciparum; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Pyrimethamine; Reagent Kits, Diagnostic; Sulfadoxine | 2017 |
Mutations in PFCRT K76T do not correlate with sulfadoxine-pyrimethamine-amodiaquine failure in Pikine, Senegal.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Membrane Transport Proteins; Middle Aged; Mutation, Missense; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Senegal; Sulfadoxine; Treatment Failure | 2008 |
[Self-medication in the treatment of acute malaria: study based on users of private health drug stores in Ouagadougou, Burkina Faso].
Topics: Acute Disease; Adult; Antimalarials; Artemisinins; Burkina Faso; Child; Chloroquine; Cross-Sectional Studies; Drug Administration Schedule; Drug Combinations; Drug Resistance; Drug Utilization; Educational Status; Female; Health Knowledge, Attitudes, Practice; Humans; Malaria, Falciparum; Male; Middle Aged; Motivation; Pharmacies; Pyrimethamine; Self Medication; Sulfadoxine; Urban Population | 2008 |
Diminished Plasmodium falciparum sensitivity to quinine exposure in vitro and in a sequential multi-drug regimen: A preliminary investigation in Guyana, South America.
Topics: Animals; Antimalarials; Child; Chloroquine; Doxycycline; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Guyana; Humans; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine; Treatment Outcome; Young Adult | 2008 |
Rapid increase of Plasmodium falciparum dhfr/dhps resistant haplotypes, after the adoption of sulphadoxine-pyrimethamine as first line treatment in 2002, in southern Mozambique.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Cross-Sectional Studies; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Enzyme-Linked Immunosorbent Assay; Gene Frequency; Haplotypes; Humans; Infant; Malaria, Falciparum; Membrane Transport Proteins; Mozambique; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2008 |
Adherence and effectiveness of drug combination in curative treatment among children suffering uncomplicated malaria in rural Senegal.
Topics: Amodiaquine; Animals; Antimalarials; Attitude to Health; Caregivers; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Medication Adherence; Patient Compliance; Plasmodium falciparum; Pyrimethamine; Rural Health; Senegal; Sulfadoxine; Treatment Outcome | 2008 |
Surveillance for adverse drug reactions to combination antimalarial therapy with sulfadoxine-pyrimethamine plus artesunate in Peru.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Humans; Malaria, Falciparum; Peru; Pyrimethamine; Sulfadoxine | 2008 |
Molecular epidemiology of drug-resistant malaria in western Kenya highlands.
Topics: Adolescent; Animals; Antimalarials; Child; Chloroquine; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Genotype; Humans; Kenya; Malaria, Falciparum; Membrane Transport Proteins; Molecular Epidemiology; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Point Mutation; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2008 |
Different methodological approaches to the assessment of in vivo efficacy of three artemisinin-based combination antimalarial treatments for the treatment of uncomplicated falciparum malaria in African children.
Topics: Africa; Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child, Preschool; Databases as Topic; Drug Combinations; Ethanolamines; Fluorenes; Genotype; Humans; Infant; Lumefantrine; Malaria, Falciparum; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2008 |
Predictors of antimalarial treatment failure in an area of unstable malaria transmission in eastern Sudan.
Topics: Adolescent; Age Factors; Antimalarials; Child; Child, Preschool; Chloroquine; Cross-Sectional Studies; Female; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Predictive Value of Tests; Pyrimethamine; Risk Factors; Sudan; Sulfadoxine; Treatment Failure | 2009 |
Hitchhiking and selective sweeps of Plasmodium falciparum sulfadoxine and pyrimethamine resistance alleles in a population from central Africa.
Topics: Alleles; Animals; Antimalarials; Cameroon; Dihydropteroate Synthase; Drug Resistance; Gene Frequency; Genes, Protozoan; Genetic Variation; Haplotypes; Humans; Linkage Disequilibrium; Malaria, Falciparum; Microsatellite Repeats; Mutation; Plasmodium falciparum; Pyrimethamine; Selection, Genetic; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2008 |
[Is the antimalarial fight effective in Mayotte?].
Topics: Adolescent; Adult; Animals; Antimalarials; Chloroquine; Comoros; Drug Combinations; Female; Humans; Incidence; Malaria; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2008 |
Should countries implementing an artemisinin-based combination malaria treatment policy also introduce rapid diagnostic tests?
Topics: Adolescent; Animals; Artemisinins; Child; Child, Preschool; Cost-Benefit Analysis; Diagnostic Tests, Routine; Ethanolamines; Fluorenes; Health Policy; Humans; Infant; Lumefantrine; Malaria, Falciparum; Mozambique; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2008 |
Rapid increase in the prevalence of sulfadoxine-pyrimethamine resistance among Plasmodium falciparum isolated from pregnant women in Ghana.
Topics: Adolescent; Adult; Animals; Antimalarials; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Gene Frequency; Ghana; Humans; Malaria, Falciparum; Middle Aged; Mutation; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2008 |
Implementation of intermittent preventive treatment in pregnancy with sulphadoxine/pyrimethamine (IPTp-SP) at a district health centre in rural Senegal.
Topics: Adolescent; Adult; Analysis of Variance; Antimalarials; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Logistic Models; Malaria, Falciparum; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pyrimethamine; Senegal; Sulfadoxine; Young Adult | 2008 |
Prevalence of pfmdr1, pfcrt, pfdhfr and pfdhps mutations associated with drug resistance, in Luanda, Angola.
Topics: Adolescent; Angola; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Humans; Infant; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2008 |
Plasmodium falciparum gametocyte dynamics in areas of different malaria endemicity.
Topics: Adolescent; Animals; Antimalarials; Artemisinins; Carrier State; Child; Child, Preschool; Drug Combinations; Endemic Diseases; Female; Gambia; Humans; Infant; Infant, Newborn; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Multivariate Analysis; Parasitemia; Plasmodium falciparum; Proportional Hazards Models; Pyrimethamine; Retrospective Studies; Sulfadoxine; Tanzania; Thailand | 2008 |
The therapeutic efficacy of sulfadoxine/pyrimethamine against Plasmodium falciparum in Yemen.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Microbial Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Schizonts; Sex Distribution; Sulfadoxine; Yemen; Young Adult | 2009 |
Opposed circulating plasma levels of endothelin-1 and C-type natriuretic peptide in children with Plasmodium falciparum malaria.
Topics: Analysis of Variance; Animals; Antimalarials; Case-Control Studies; Child; Child, Preschool; Drug Combinations; Endothelin-1; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Female; Gabon; Humans; Infant; Malaria, Falciparum; Male; Natriuretic Peptide, C-Type; Plasmodium falciparum; Pyrimethamine; Quinine; Statistics, Nonparametric; Sulfadoxine | 2008 |
The evolution of drug-resistant malaria.
Topics: Africa; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Evolution, Molecular; Humans; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2009 |
Sub-microscopic infections and long-term recrudescence of Plasmodium falciparum in Mozambican pregnant women.
Topics: Adult; Animals; Antigens, Protozoan; Antimalarials; Chloroquine; Drug Combinations; Female; Genotype; Humans; Malaria, Falciparum; Merozoite Surface Protein 1; Mozambique; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Protozoan Proteins; Pyrimethamine; Recurrence; Sensitivity and Specificity; Sulfadoxine | 2009 |
Feasibility and acceptability of home-based management of malaria strategy adapted to Sudan's conditions using artemisinin-based combination therapy and rapid diagnostic test.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antimalarials; Artemisinins; Community Health Workers; Community-Institutional Relations; Drug Combinations; Drug Therapy, Combination; Feasibility Studies; Female; Fever; Humans; Malaria, Falciparum; Male; Middle Aged; Outcome and Process Assessment, Health Care; Patient Acceptance of Health Care; Patient Compliance; Plasmodium falciparum; Pyrimethamine; Sudan; Sulfadoxine; Surveys and Questionnaires; Volunteers; Young Adult | 2009 |
Novel point mutations in sulfadoxine resistance genes of Plasmodium falciparum from India.
Topics: Amino Acid Substitution; Animals; Antimalarials; Dihydropteroate Synthase; DNA, Protozoan; Drug Resistance; Humans; India; Malaria, Falciparum; Models, Molecular; Molecular Sequence Data; Plasmodium falciparum; Point Mutation; Protein Structure, Tertiary; Protozoan Proteins; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2009 |
Mapping the spread of malaria drug resistance.
Topics: Africa; Alleles; Animals; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Maps as Topic; Plasmodium falciparum; Polymorphism, Single Nucleotide; Population Surveillance; Protozoan Proteins; Pyrimethamine; Selection, Genetic; Sulfadoxine | 2009 |
Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria.
Topics: Africa; Alleles; Animals; Antimalarials; Chloroquine; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Membrane Transport Proteins; Microsatellite Repeats; Phylogeny; Plasmodium falciparum; Polymorphism, Single Nucleotide; Population Surveillance; Protozoan Proteins; Pyrimethamine; Selection, Genetic; Sulfadoxine | 2009 |
Distinct haplotypes of dhfr and dhps among Plasmodium falciparum isolates in an area of high level of sulfadoxine-pyrimethamine (SP) resistance in eastern Sudan.
Topics: Animals; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance, Multiple; Endemic Diseases; Haplotypes; Humans; Malaria, Falciparum; Microsatellite Repeats; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sudan; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2009 |
Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.
Topics: Adolescent; Animals; Antimalarials; Child; Chloroquine; Drug Combinations; Drug Resistance; Endemic Diseases; Genetics, Population; Haplotypes; Humans; Kenya; Malaria, Falciparum; Membrane Transport Proteins; Microsatellite Repeats; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Travel | 2009 |
Novel pfdhps haplotypes among imported cases of Plasmodium falciparum malaria in the United Kingdom.
Topics: Adult; Alleles; Amino Acid Sequence; Animals; Antimalarials; Atovaquone; Chloroquine; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Folic Acid Antagonists; Haplotypes; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Polymerase Chain Reaction; Proguanil; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase; United Kingdom | 2009 |
Chloroquine resistance before and after its withdrawal in Kenya.
Topics: Animals; Antimalarials; Chloroquine; Drug Approval; Drug Combinations; Drug Resistance; Genotype; Humans; Kenya; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Restriction Mapping; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Time Factors | 2009 |
Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment.
Topics: Adult; Alleles; Animals; Antimalarials; Cohort Studies; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Mice; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Prospective Studies; Pyrimethamine; Selection, Genetic; Sulfadoxine; Tanzania; Tetrahydrofolate Dehydrogenase; Young Adult | 2009 |
Polymerase chain reaction adjustment in antimalarial trials: molecular malarkey?
Topics: Antimalarials; Drug Therapy, Combination; Humans; Malaria, Falciparum; Polymerase Chain Reaction; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine | 2009 |
Jaundice with hepatic dysfunction in P. falciparum malaria.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Animals; Antimalarials; Female; Humans; Jaundice; Liver Diseases; Liver Function Tests; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Risk Factors; Sulfadoxine; United Arab Emirates; Young Adult | 2009 |
Chloroquine and sulphadoxine-pyrimethamine sensitivity of Plasmodium falciparum parasites in a Brazilian endemic area.
Topics: Animals; Antimalarials; Brazil; Chloroquine; Drug Combinations; Drug Resistance; Endemic Diseases; Haplotypes; Humans; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine | 2009 |
PfHRP2 and PfLDH antigen detection for monitoring the efficacy of artemisinin-based combination therapy (ACT) in the treatment of uncomplicated falciparum malaria.
Topics: Amodiaquine; Antigens, Protozoan; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Benin; Blood; Child, Preschool; Drug Combinations; Drug Monitoring; Drug Therapy, Combination; Ethanolamines; Fluorenes; Follow-Up Studies; Humans; Infant; L-Lactate Dehydrogenase; Malaria, Falciparum; Microscopy; Molecular Diagnostic Techniques; Protozoan Proteins; Pyrimethamine; Sensitivity and Specificity; Sulfadoxine; Treatment Outcome | 2009 |
Intermittent preventive treatment of malaria in infancy.
Topics: Africa; Antimalarials; Drug Combinations; Global Health; Humans; Immunization Programs; Infant; Infant Mortality; Infant Welfare; Malaria, Falciparum; Pyrimethamine; Sulfadoxine | 2009 |
Characteristics of genetic hitchhiking around dihydrofolate reductase gene associated with pyrimethamine resistance in Plasmodium falciparum isolates from India.
Topics: Antimalarials; Drug Combinations; Drug Resistance; Geography; Haplotypes; India; Malaria, Falciparum; Microsatellite Repeats; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2009 |
Epidemic of Plasmodium falciparum malaria involving substandard antimalarial drugs, Pakistan, 2003.
Topics: Adolescent; Adult; Afghanistan; Animals; Anopheles; Antimalarials; Child; Child, Preschool; Disease Outbreaks; Drug Combinations; Drug Resistance; Female; Genes, Protozoan; Humans; Infant; Insect Control; Insect Vectors; Malaria, Falciparum; Male; Pakistan; Plasmodium falciparum; Population Surveillance; Pyrimethamine; Refugees; Sulfadoxine; Young Adult | 2009 |
Placental malaria among HIV-infected and uninfected women receiving anti-folates in a high transmission area of Uganda.
Topics: Adult; AIDS-Related Opportunistic Infections; Antimalarials; Cross-Sectional Studies; Drug Combinations; Female; Folic Acid; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Pyrimethamine; Risk Factors; Sulfadoxine; Trimethoprim, Sulfamethoxazole Drug Combination; Uganda; Young Adult | 2009 |
Pharmacokinetic disposition of sulfadoxine in children with acute uncomplicated falciparum malaria treated with sulfadoxine-pyrimethamine in South West Nigeria.
Topics: Acute Disease; Age Factors; Antimalarials; Area Under Curve; Child; Child, Preschool; Chromatography, High Pressure Liquid; Drug Combinations; Female; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome | 2012 |
Plasmodium falciparum resistance to anti-malarial drugs in Papua New Guinea: evaluation of a community-based approach for the molecular monitoring of resistance.
Topics: Adolescent; Aged; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Oligonucleotide Array Sequence Analysis; Papua New Guinea; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Treatment Failure; Young Adult | 2010 |
High prevalence of sulfadoxine/pyrimethamine-resistant alleles of Plasmodium falciparum isolates in pregnant women at the time of introduction of intermittent preventive treatment with sulfadoxine/pyrimethamine in Gabon.
Topics: Alleles; Amino Acid Substitution; Animals; Antimalarials; Blood; Dihydropteroate Synthase; DNA Restriction Enzymes; Drug Combinations; Drug Resistance; Female; Gabon; Genotype; Humans; Malaria, Falciparum; Mutation, Missense; Placenta; Plasmodium falciparum; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2010 |
High prevalence of sulfadoxine/pyrimethamine resistance alleles in Plasmodium falciparum parasites from Bangladesh.
Topics: Adolescent; Alleles; Animals; Antimalarials; Bangladesh; Child; Child, Preschool; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Malaria, Falciparum; Male; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymerase Chain Reaction; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2010 |
Intermittent preventive therapy for malaria in pregnancy: is sulfadoxine-pyrimethamine the right drug?
Topics: Africa; Antimalarials; Clinical Trials as Topic; Drug Administration Schedule; Drug Combinations; Female; Humans; Malaria, Falciparum; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2010 |
Implementing intermittent preventive treatment in infants.
Topics: Antimalarials; Drug Combinations; Humans; Immunization Programs; Infant; Malaria, Falciparum; Meta-Analysis as Topic; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine | 2010 |
Burden of malaria during pregnancy at the time of IPTp/SP implementation in Gabon.
Topics: Adolescent; Adult; Age Distribution; Anemia; Antimalarials; Cross-Sectional Studies; Drug Combinations; Female; Gabon; Humans; Malaria, Falciparum; Mosquito Nets; Odds Ratio; Placenta; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Complications, Parasitic; Prevalence; Pyrimethamine; Risk Factors; Sulfadoxine; Young Adult | 2010 |
Nonlinear mixed effects modeling of gametocyte carriage in patients with uncomplicated malaria.
Topics: Animals; Antimalarials; Carrier State; Drug Combinations; Drug Resistance; Follow-Up Studies; Host-Parasite Interactions; Humans; Malaria, Falciparum; Models, Biological; Mozambique; Plasmodium falciparum; Pyrimethamine; Sporozoites; Sulfadoxine; Time Factors | 2010 |
Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolates.
Topics: Alleles; Amplified Fragment Length Polymorphism Analysis; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Eswatini; Genotype; Humans; Malaria, Falciparum; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Pyrimethamine; Retrospective Studies; Sequence Analysis, DNA; Sulfadoxine | 2010 |
Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Burkina Faso; Drug Combinations; Drug Resistance, Bacterial; Ethanolamines; Fluorenes; Genotype; Humans; Infant; Lumefantrine; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Recurrence; Sulfadoxine | 2010 |
Antibodies to chondroitin sulfate A-binding infected erythrocytes: dynamics and protection during pregnancy in women receiving intermittent preventive treatment.
Topics: Adolescent; Adult; Antibodies, Protozoan; Antigens, Surface; Antimalarials; Chondroitin Sulfates; Drug Combinations; Erythrocytes; Female; Humans; Immunoglobulin G; Longitudinal Studies; Malaria, Falciparum; Malawi; Parity; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2010 |
Origin and evolution of sulfadoxine resistant Plasmodium falciparum.
Topics: Africa; Antimalarials; Cambodia; Codon; Drug Resistance; Evolution, Molecular; Genes, Protozoan; Genetic Variation; Haplotypes; Humans; Linkage Disequilibrium; Malaria, Falciparum; Microsatellite Repeats; Plasmodium falciparum; Prevalence; South America; Sulfadoxine | 2010 |
Active case detection, treatment of falciparum malaria with combined chloroquine and sulphadoxine/pyrimethamine and vivax malaria with chloroquine and molecular markers of anti-malarial resistance in the Republic of Vanuatu.
Topics: Adolescent; Adult; Antigens, Protozoan; Antimalarials; Case-Control Studies; Child; Child, Preschool; Chloroquine; Cross-Sectional Studies; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Genetic Markers; Humans; Incidence; Malaria, Falciparum; Malaria, Vivax; Male; Membrane Transport Proteins; Middle Aged; Parasitemia; Plasmodium falciparum; Plasmodium vivax; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Treatment Outcome; Vanuatu; Young Adult | 2010 |
High prevalence of the 437G mutation associated with sulfadoxine resistance among Plasmodium falciparum clinical isolates from Iran, three years after the introduction of sulfadoxine-pyrimethamine.
Topics: Adolescent; Adult; Aged; Amino Acid Substitution; Antimalarials; Base Sequence; Child; Child, Preschool; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Gene Frequency; Genes, Protozoan; Haplotypes; Humans; Infant; Iran; Malaria, Falciparum; Male; Middle Aged; Mutation, Missense; Plasmodium falciparum; Polymorphism, Single Nucleotide; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Time Factors; Young Adult | 2010 |
Five years of large-scale dhfr and dhps mutation surveillance following the phased implementation of artesunate plus sulfadoxine-pyrimethamine in Maputo Province, Southern Mozambique.
Topics: Adolescent; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mozambique; Mutation; Plasmodium falciparum; Population Surveillance; Prevalence; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Time Factors | 2010 |
Low infectivity of Plasmodium falciparum gametocytes to Anopheles gambiae following treatment with sulfadoxine-pyrimethamine in Mali.
Topics: Animals; Anopheles; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Gene Expression Regulation, Enzymologic; Humans; Malaria, Falciparum; Mali; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2010 |
Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Carrier State; Child; Child, Preschool; Clinical Trials as Topic; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Germ Cells; Humans; Infant; Infant, Newborn; Kenya; Malaria, Falciparum; Male; Models, Biological; Parasitemia; Plasmodium falciparum; Prevalence; Primaquine; Pyrimethamine; Self-Sustained Sequence Replication; Sulfadoxine; Tanzania; Time Factors; Treatment Outcome | 2010 |
Origin and dissemination across the Colombian Andes mountain range of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum.
Topics: Alleles; Animals; Antimalarials; Colombia; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Emigration and Immigration; Gene Frequency; Genotype; Humans; Malaria, Falciparum; Microsatellite Repeats; Molecular Sequence Data; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2010 |
Analysis of an ordinal outcome in a multicentric randomized controlled trial: application to a 3- arm anti- malarial drug trial in Cameroon.
Topics: Amodiaquine; Antimalarials; Cameroon; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Epidemiologic Methods; Humans; Infant; Malaria, Falciparum; Models, Statistical; Multicenter Studies as Topic; Proportional Hazards Models; Pyrimethamine; Randomized Controlled Trials as Topic; Regression Analysis; Sulfadoxine; Treatment Outcome | 2010 |
Drug coverage in treatment of malaria and the consequences for resistance evolution--evidence from the use of sulphadoxine/pyrimethamine.
Topics: Alleles; Antimalarials; Cross-Sectional Studies; Drug Combinations; Drug Resistance; Haplotypes; Humans; Malaria, Falciparum; Membrane Transport Proteins; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tanzania; Tetrahydrofolate Dehydrogenase | 2010 |
Monitoring of malaria parasite resistance to chloroquine and sulphadoxine-pyrimethamine in the Solomon Islands by DNA microarray technology.
Topics: Adolescent; Adult; Aged; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Female; Gene Frequency; Haplotypes; Humans; Infant; Malaria, Falciparum; Male; Melanesia; Middle Aged; Mutation, Missense; Oligonucleotide Array Sequence Analysis; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Young Adult | 2010 |
Prevalence of molecular markers of Plasmodium falciparum resistance to sulfadoxine-pyrimethamine during the intermittent preventive treatment in infants coupled with the expanded program immunization in Senegal.
Topics: Antimalarials; Blood; Child, Preschool; Cross-Sectional Studies; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Genetic Markers; Humans; Immunization; Infant; Infant, Newborn; Malaria, Falciparum; Mutation, Missense; Pilot Projects; Plasmodium falciparum; Polymerase Chain Reaction; Prevalence; Pyrimethamine; Senegal; Specimen Handling; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2011 |
Follow-up survey of children who received sulfadoxine-pyrimethamine for intermittent preventive antimalarial treatment in infants.
Topics: Antibodies, Protozoan; Antimalarials; Chemoprevention; Child, Preschool; Drug Combinations; Female; Follow-Up Studies; Humans; Immunoglobulin G; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Seroepidemiologic Studies; Sulfadoxine | 2011 |
Prevalence of resistance associated polymorphisms in Plasmodium falciparum field isolates from southern Pakistan.
Topics: Adolescent; Adult; Antimalarials; Child; Child, Preschool; Chloroquine; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Gene Dosage; Genes, Protozoan; Humans; Malaria, Falciparum; Male; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutation; Pakistan; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2011 |
Artemether-Lumefantrin (Coartem) and artesunate with sulfadoxine-pyrimethamine therapeutic efficacy in the treatment of uncomplicated malaria at Gilgel Gibe II (GGII) South-Western Ethiopia.
Topics: Adolescent; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Ethiopia; Female; Fever; Fluorenes; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sentinel Surveillance; Sulfadoxine; Treatment Outcome; Young Adult | 2010 |
Evaluation of prevalence's of pfdhfr and pfdhps mutations in Angola.
Topics: Angola; Antimalarials; Chemoprevention; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance, Multiple; Female; Genes, Protozoan; Genotype; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pregnancy; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2011 |
Selective sweeps and genetic lineages of Plasmodium falciparum drug -resistant alleles in Ghana.
Topics: Alleles; Amino Acid Substitution; Antimalarials; Biological Evolution; Child, Preschool; Chloroquine; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Evolution, Molecular; Genotype; Ghana; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Membrane Transport Proteins; Microsatellite Repeats; Multidrug Resistance-Associated Proteins; Mutation, Missense; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2011 |
Prevalence of molecular markers of anti-malarial drug resistance in Plasmodium vivax and Plasmodium falciparum in two districts of Nepal.
Topics: Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Malaria, Vivax; Nepal; Plasmodium falciparum; Plasmodium vivax; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2011 |
Effectiveness of ACTs in cases of resistance to partner drugs.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2011 |
Molecular epidemiology of malaria in Cameroon. XXX. sequence analysis of Plasmodium falciparum ATPase 6, dihydrofolate reductase, and dihydropteroate synthase resistance markers in clinical isolates from children treated with an artesunate-sulfadoxine-pyr
Topics: Antimalarials; Artemisinins; Artesunate; Cameroon; Child; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mitochondrial Proton-Translocating ATPases; Molecular Epidemiology; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2011 |
Molecular markers of resistance to sulphadoxine-pyrimethamine during intermittent preventive treatment of pregnant women in Benin.
Topics: Adult; Antimalarials; Benin; Biomarkers; Chemoprevention; Clinical Trials as Topic; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Gene Dosage; Genotype; Humans; Malaria, Falciparum; Mefloquine; Multidrug Resistance-Associated Proteins; Mutation, Missense; Plasmodium falciparum; Pregnancy; Pregnancy Complications; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2011 |
[Effect of intermittent presumptive treatment with sulfadoxine-pyrimethamine on the acquisition of anti-VAR2CSA antibodies in pregnant women living in a hypoendemic area in Senegal].
Topics: Adolescent; Adult; Antibodies, Viral; Antigens, Protozoan; Antimalarials; Drug Combinations; Female; Humans; Immunoglobulin G; Malaria, Falciparum; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Prospective Studies; Pyrimethamine; Senegal; Sulfadoxine | 2011 |
Molecular markers of anti-malarial drug resistance in Lahj Governorate, Yemen: baseline data and implications.
Topics: Adolescent; Adult; Antimalarials; Child; Child, Preschool; Chloroquine; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Genetic Markers; Humans; Infant; Malaria, Falciparum; Membrane Transport Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Yemen; Young Adult | 2011 |
Molecular monitoring of resistant dhfr and dhps allelic haplotypes in Morogoro and Mvomero districts in south eastern Tanzania.
Topics: Adolescent; Adult; Aged; Alleles; Antimalarials; Child; Child, Preschool; Cross-Sectional Studies; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Genetic Variation; Haplotypes; Humans; Malaria, Falciparum; Male; Middle Aged; Oligonucleotide Array Sequence Analysis; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tanzania; Tetrahydrofolate Dehydrogenase; Young Adult | 2011 |
Prolonged selection of pfmdr1 polymorphisms after treatment of falciparum malaria with artemether-lumefantrine in Uganda.
Topics: Alleles; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Longitudinal Studies; Malaria, Falciparum; Male; Plasmodium falciparum; Polymorphism, Genetic; Pyrimethamine; Sulfadoxine; Time Factors; Uganda | 2011 |
Prolonged elevation of viral loads in HIV-1-infected children in a region of intense malaria transmission in Northern Uganda: a prospective cohort study.
Topics: Antimalarials; CD4 Lymphocyte Count; Child; Child, Preschool; Chloroquine; Disease Progression; Drug Combinations; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Incidence; Infant; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Prospective Studies; Pyrimethamine; RNA, Viral; Sulfadoxine; Treatment Outcome; Uganda; Viral Load | 2010 |
Quantification of the burden and consequences of pregnancy-associated malaria in the Democratic Republic of the Congo.
Topics: Anemia; Antimalarials; Birth Weight; Cross-Sectional Studies; Democratic Republic of the Congo; Drug Combinations; Female; Humans; Infant, Newborn; Insecticide-Treated Bednets; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Plasmodium malariae; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Prevalence; Pyrimethamine; Real-Time Polymerase Chain Reaction; Sulfadoxine | 2011 |
Molecular monitoring of Plasmodium falciparum resistance to antimalarial drugs after adoption of sulfadoxine-pyrimethamine plus artesunate as the first line treatment in Iran.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Child; DNA Fingerprinting; Drug Combinations; Drug Resistance; Gene Frequency; Genotype; Humans; Iran; Malaria, Falciparum; Middle Aged; Mutation, Missense; Plasmodium falciparum; Polymorphism, Restriction Fragment Length; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Young Adult | 2012 |
Limited geographical origin and global spread of sulfadoxine-resistant dhps alleles in Plasmodium falciparum populations.
Topics: Africa, Eastern; Alleles; Animals; Antimalarials; Asia, Southeastern; Dihydropteroate Synthase; Drug Resistance; Genes, Protozoan; Haplotypes; Malaria, Falciparum; Plasmodium falciparum; Sequence Analysis, DNA; South America; Sulfadoxine | 2011 |
The evolution of pyrimethamine resistant dhfr in Plasmodium falciparum of south-eastern Tanzania: comparing selection under SP alone vs SP+artesunate combination.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance; Gene Frequency; Genotype; Humans; Malaria, Falciparum; Microsatellite Repeats; Mutation; Plasmodium falciparum; Pyrimethamine; Selection, Genetic; Sulfadoxine; Tanzania; Tetrahydrofolate Dehydrogenase | 2011 |
Sahel, savana, riverine and urban malaria in West Africa: Similar control policies with different outcomes.
Topics: Africa, Western; Animals; Antimalarials; Artemisinins; Communicable Disease Control; Culicidae; Disease Transmission, Infectious; Drug Combinations; Female; Health Policy; Humans; Insect Bites and Stings; Insecticide-Treated Bednets; Insecticides; Malaria, Falciparum; National Health Programs; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Pyrimethamine; Seasons; Sulfadoxine | 2012 |
The effectiveness and perception of the use of sulphadoxine-pyrimethamine in intermittent preventive treatment of malaria in pregnancy programme in Offinso district of Ashanti region, Ghana.
Topics: Adult; Anemia; Antimalarials; Cross-Sectional Studies; Drug Administration Schedule; Drug Combinations; Evidence-Based Practice; Female; Focus Groups; Ghana; Health Promotion; Hemoglobins; Humans; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Preventive Health Services; Program Evaluation; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2011 |
Placental malaria and the relationship to pregnancy outcome at Gushegu District Hospital, Northern Ghana.
Topics: Adult; Animals; Antimalarials; Apgar Score; Drug Combinations; Female; Ghana; Hospitals, District; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria, Falciparum; Perinatal Mortality; Placenta; Placenta Diseases; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pyrimethamine; Sulfadoxine; Young Adult | 2012 |
Differences in selective pressure on dhps and dhfr drug resistant mutations in western Kenya.
Topics: Alleles; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Kenya; Longitudinal Studies; Malaria, Falciparum; Microsatellite Repeats; Mutation; Phylogeography; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Recombination, Genetic; Selection, Genetic; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2012 |
Antibodies to malaria vaccine candidates are associated with chloroquine or sulphadoxine/pyrimethamine treatment efficacy in children in an endemic area of Burkina Faso.
Topics: Adolescent; Antibodies, Protozoan; Antimalarials; Biomarkers; Burkina Faso; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Immunoglobulin G; Infant; Malaria Vaccines; Malaria, Falciparum; Male; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2012 |
Antenatal receipt of sulfadoxine-pyrimethamine does not exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM study.
Topics: Adolescent; Adult; Antibiotic Prophylaxis; Antimalarials; Cross-Sectional Studies; Drug Combinations; Drug Resistance; Female; Haplotypes; Hemoglobins; Humans; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Prenatal Care; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2012 |
Molecular markers in plasmodium falciparum linked to resistance to anti-malarial drugs in samples imported from Africa over an eight-year period (2002-2010): impact of the introduction of artemisinin combination therapy.
Topics: Africa; Alleles; Animals; Antimalarials; Artemisinins; DNA, Protozoan; Drug Combinations; Drug Resistance; Gene Frequency; Genotype; Humans; Malaria, Falciparum; Multidrug Resistance-Associated Proteins; Mutant Proteins; Mutation, Missense; Peptide Synthases; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Travel | 2012 |
Artemisinin-based combination therapy does not measurably reduce human infectiousness to vectors in a setting of intense malaria transmission.
Topics: Animals; Antigens, Protozoan; Antimalarials; Artemisinins; Artesunate; Asymptomatic Diseases; Child, Preschool; Culicidae; Disease Vectors; Drug Combinations; Enzyme-Linked Immunosorbent Assay; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Plasmodium falciparum; Pregnancy; Prevalence; Pyrimethamine; Sulfadoxine; Tanzania | 2012 |
Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya.
Topics: Adult; Antimalarials; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Kenya; Malaria, Falciparum; Mutation, Missense; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Pregnancy; Pregnancy Complications, Infectious; Protozoan Proteins; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2012 |
Routine delivery of artemisinin-based combination treatment at fixed health facilities reduces malaria prevalence in Tanzania: an observational study.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child; Child, Preschool; Cross-Sectional Studies; Drug Combinations; Drug Therapy, Combination; Health Facilities; Health Services Research; Humans; Infant; Malaria, Falciparum; Parasitemia; Prevalence; Pyrimethamine; Sulfadoxine; Tanzania; Treatment Outcome; Young Adult | 2012 |
Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal.
Topics: Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Female; Gene Dosage; Gene Frequency; Genes, Protozoan; Hospitals, Military; Humans; Malaria, Falciparum; Male; Mutation, Missense; Plasmodium falciparum; Point Mutation; Prevalence; Pyrimethamine; Senegal; Sulfadoxine | 2012 |
Source of drug resistant Plasmodium falciparum in a potential malaria elimination site in Saudi Arabia.
Topics: Antimalarials; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Haplotypes; Humans; Malaria, Falciparum; Microsatellite Repeats; Models, Genetic; Mutation; Plasmodium falciparum; Pyrimethamine; Saudi Arabia; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2012 |
Intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine: the times they are a-changin'.
Topics: Antimalarials; Female; Humans; Malaria, Falciparum; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Sulfadoxine | 2012 |
Plasmodium falciparum infection in pregnant women attending antenatal care in Luanda, Angola.
Topics: Adolescent; Adult; Angola; Antimalarials; Child; Drug Combinations; Female; Humans; Malaria, Falciparum; Middle Aged; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Diagnosis; Prevalence; Pyrimethamine; Risk Factors; Socioeconomic Factors; Sulfadoxine; Young Adult | 2012 |
Evaluation of dihydrofolate reductase and dihydropteroate synthetase genotypes that confer resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum in Haiti.
Topics: Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Genotype; Haiti; Humans; Malaria, Falciparum; Mutant Proteins; Mutation, Missense; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2012 |
Novel quadruple mutations in dihydropteroate synthase genes of Plasmodium falciparum in West Bengal, India.
Topics: Antimalarials; Dihydropteroate Synthase; DNA, Protozoan; Drug Resistance; Genotype; Humans; India; Malaria, Falciparum; Molecular Sequence Data; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Protozoan Proteins; Sulfadoxine | 2012 |
Proxies and prevention of malaria in pregnancy.
Topics: Animals; Antimalarials; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Malaria, Falciparum; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2012 |
Surveillance of molecular markers of Plasmodium falciparum resistance to sulphadoxine-pyrimethamine 5 years after the change of malaria treatment policy in Ghana.
Topics: Alcohol Oxidoreductases; Alleles; Antimalarials; Biomarkers; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Gene Expression Regulation, Enzymologic; Ghana; Health Policy; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Population Surveillance; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Time Factors | 2012 |
The time distribution of sulfadoxine-pyrimethamine protection from malaria.
Topics: Adolescent; Animals; Antimalarials; Child; Child, Preschool; Computer Simulation; Culicidae; Drug Administration Schedule; Drug Combinations; Humans; Malaria, Falciparum; Mali; Models, Biological; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2012 |
Increased prevalence of dhfr and dhps mutants at delivery in Malawian pregnant women receiving intermittent preventive treatment for malaria.
Topics: Antimalarials; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Genotype; Haplotypes; Humans; Malaria, Falciparum; Malawi; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2013 |
Monitoring antimalarial drug resistance in India via sentinel sites: outcomes and risk factors for treatment failure, 2009-2010.
Topics: Antimalarials; Artemisinins; Chloroquine; Drug Resistance, Microbial; Humans; India; Kaplan-Meier Estimate; Malaria, Falciparum; Malaria, Vivax; Pyrimethamine; Risk Factors; Sulfadoxine; Treatment Outcome | 2012 |
Molecular monitoring of antimalarial drug resistance among Plasmodium falciparum field isolates from Odisha, India.
Topics: Antimalarials; Artemisinins; Chloroquine; Cross-Sectional Studies; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; India; Malaria, Falciparum; Mutation, Missense; Plasmodium falciparum; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2013 |
Plasmodium falciparum sulfadoxine resistance is geographically and genetically clustered within the DR Congo.
Topics: Antimalarials; Cluster Analysis; Congo; Dihydropteroate Synthase; Drug Resistance; Genetics, Population; Geography, Medical; Haplotypes; Humans; Malaria, Falciparum; Microsatellite Repeats; Mutation; Plasmodium falciparum; Prevalence; Sulfadoxine | 2013 |
A high malaria reinfection rate in children and young adults living under a low entomological inoculation rate in a periurban area of Bamako, Mali.
Topics: Adolescent; Animals; Anopheles; Antimalarials; Child; Drug Combinations; Female; Humans; Insect Bites and Stings; Insect Vectors; Malaria, Falciparum; Male; Mali; Parasitemia; Plasmodium falciparum; Pyrimethamine; Seasons; Sulfadoxine | 2002 |
Determinants of treatment response to sulfadoxine-pyrimethamine and subsequent transmission potential in falciparum malaria.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Mutation; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2002 |
The drug sensitivity and transmission dynamics of human malaria on Nias Island, North Sumatra, Indonesia.
Topics: Adolescent; Adult; Age Distribution; Aged; Animals; Anopheles; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Follow-Up Studies; Humans; Indonesia; Insect Vectors; Malaria, Falciparum; Malaria, Vivax; Middle Aged; Plasmodium vivax; Prevalence; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2002 |
Resistance to antimalarials.
Topics: Africa; Antimalarials; Chloroquine; Developing Countries; Drug Combinations; Drug Resistance, Multiple; Humans; Incidence; Malaria, Falciparum; Malaria, Vivax; Pyrimethamine; Sulfadoxine; Survival Analysis | 2002 |
Molecular epidemiology of malaria in Cameroon. X. Evaluation of PFMDR1 mutations as genetic markers for resistance to amino alcohols and artemisinin derivatives.
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Base Sequence; Cameroon; Child; Child, Preschool; Chloroquine; DNA Primers; Drug Combinations; Drug Resistance, Multiple; Genetic Markers; Humans; Malaria, Falciparum; Molecular Epidemiology; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sulfadoxine | 2002 |
Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America.
Topics: Alleles; Amino Acid Sequence; Animals; Antimalarials; Chloroquine; Cloning, Molecular; Drug Resistance, Multiple; Folic Acid Antagonists; Haplotypes; Humans; Malaria, Falciparum; Microsatellite Repeats; Molecular Sequence Data; Multienzyme Complexes; Mutation; Plasmodium falciparum; Pyrimethamine; South America; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Thymidylate Synthase | 2002 |
Transcriptional analysis of genes encoding enzymes of the folate pathway in the human malaria parasite Plasmodium falciparum.
Topics: Animals; Antimalarials; Drug Combinations; Erythrocytes; Folic Acid; Glycine Hydroxymethyltransferase; Humans; Malaria, Falciparum; Multienzyme Complexes; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Reverse Transcriptase Polymerase Chain Reaction; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Thymidylate Synthase; Transcription, Genetic | 2002 |
Monitoring the drug-sensitivity of Plasmodium falciparum in coastal towns in Madagascar by use of in vitro chemosensitivity and mutation detection tests.
Topics: Animals; Antimalarials; Chloroquine; DNA, Protozoan; Drug Resistance; Drug Resistance, Multiple; Drug Therapy, Combination; Genotype; Humans; Madagascar; Malaria, Falciparum; Membrane Proteins; Membrane Transport Proteins; Mutation; Parasitic Sensitivity Tests; Phenotype; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2002 |
Therapeutic efficacy of chloroquine and sulfadoxine/pyrimethamine against Plasmodium falciparum infection in Somalia.
Topics: Adult; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Pyrimethamine; Somalia; Sulfadoxine; Treatment Outcome | 2002 |
Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum must be delayed in Africa.
Topics: Africa; Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2002 |
Pyrimethamine/sulfadoxine combination in the treatment of uncomplicated falciparum malaria: relation between dihydropteroate synthase/dihydrofolate reductase genotypes, sulfadoxine plasma levels, and treatment outcome.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Child; Dihydropteroate Synthase; Genotype; Humans; Malaria, Falciparum; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2002 |
Increased efficacy of sulfadoxine-pyrimethamine in the treatment of uncomplicated falciparum malaria among children with sickle cell trait in Western Kenya.
Topics: Animals; Antimalarials; Child, Preschool; Drug Combinations; Female; Hemoglobin A; Hemoglobin, Sickle; Humans; Infant; Kenya; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Pyrimethamine; Retrospective Studies; Sickle Cell Trait; Sulfadoxine; Treatment Outcome | 2002 |
A safety and efficacy trial of artesunate, sulphadoxine-pyrimethamine and primaquine in P falciparum malaria.
Topics: Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Humans; Malaria, Falciparum; Prospective Studies; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2002 |
Massive hepatosplenomegaly in a child with malaria.
Topics: Age Factors; Animals; Antimalarials; Child; Drug Combinations; Drug Therapy, Combination; Female; Ghana; Hepatomegaly; Humans; Liver; Malaria, Falciparum; Proguanil; Pyrimethamine; Quinine; Spleen; Splenomegaly; Sulfadoxine; Time Factors; Travel | 2002 |
Diagnostic value of molecular markers in chloroquine-resistant falciparum malaria in Southern Mauritania.
Topics: Adult; Animals; Antimalarials; Child; Chloroquine; Drug Combinations; Drug Resistance; Female; Genetic Markers; Humans; Malaria, Falciparum; Male; Mauritania; Mutation; Odds Ratio; Plasmodium falciparum; Polymorphism, Genetic; Pyrimethamine; Sensitivity and Specificity; Sulfadoxine | 2002 |
A molecular surveillance system for global patterns of drug resistance in imported malaria.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Resistance; Female; Genetic Markers; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Mutation; Plasmodium falciparum; Population Surveillance; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Travel | 2003 |
Chloroquine or sulfadoxine-pyrimethamine for the treatment of uncomplicated, Plasmodium falciparum malaria during an epidemic in Central Java, Indonesia.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Disease Outbreaks; Drug Combinations; Drug Resistance; Female; Humans; Incidence; Indonesia; Malaria, Falciparum; Male; Middle Aged; Prevalence; Pyrimethamine; Sulfadoxine; Treatment Failure | 2002 |
[Diagnosis and treatment of a case with cerebral falciparum malaria].
Topics: Adult; Antimalarials; Drug Combinations; Humans; Malaria, Cerebral; Malaria, Falciparum; Male; Pyrimethamine; Sulfadoxine | 2001 |
Short communication: point mutations in the dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum isolates from Colombia.
Topics: Adult; Aged; Animals; Antimalarials; Colombia; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Genes, Protozoan; Humans; Malaria, Falciparum; Middle Aged; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2003 |
Safety and therapeutic efficacy of artesunate suppositories for treatment of malaria in children in Papua New Guinea.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Cohort Studies; Developing Countries; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Endemic Diseases; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Monitoring, Physiologic; Papua New Guinea; Plasmodium falciparum; Plasmodium vivax; Prospective Studies; Sesquiterpenes; Sulfadoxine; Suppositories; Treatment Outcome | 2003 |
Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp.
Topics: Amodiaquine; Animals; Antigens, Protozoan; Antimalarials; Artemisinins; Artesunate; Child, Preschool; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Infant; Longitudinal Studies; Malaria, Falciparum; Male; Merozoite Surface Protein 1; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Recurrence; Sesquiterpenes; Sulfadoxine; Treatment Failure; Uganda | 2003 |
Descriptive study on the efficacy and safety of artesunate suppository in combination with other antimalarials in the treatment of severe malaria in Sudan.
Topics: Administration, Rectal; Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Doxycycline; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Pyrimethamine; Sesquiterpenes; Severity of Illness Index; Sudan; Sulfadoxine; Treatment Outcome | 2003 |
High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi.
Topics: Adolescent; Animals; Antimalarials; Child; Child, Preschool; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Genotype; Humans; Malaria, Falciparum; Malawi; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Pyrimethamine; Rural Population; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2003 |
The hospital- and field-based performances of the OptiMAL test, for malaria diagnosis and treatment monitoring in central India.
Topics: Adult; Animals; Antimalarials; Chloroquine; Drug Combinations; False Negative Reactions; False Positive Reactions; Female; Humans; Immunologic Tests; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Sensitivity and Specificity; Sulfadoxine | 2003 |
Antifolate antimalarial resistance in southeast Africa: a population-based analysis.
Topics: Adult; Alleles; Animals; Antimalarials; Child, Preschool; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Microsatellite Repeats; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; South Africa; Sulfadoxine | 2003 |
High prevalence of double Plasmodium falciparum dhfr mutations at codons 108 and 59 in the Sistan-Baluchistan province, Iran.
Topics: Animals; Antimalarials; Codon; Drug Combinations; Drug Resistance; Female; Humans; Iran; Malaria, Falciparum; Male; Mutation; Plasmodium falciparum; Prevalence; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2003 |
Malaria in Austria 1990-2000.
Topics: Adolescent; Adult; Age Distribution; Animals; Austria; Chemoprevention; Child; Child, Preschool; Chloroquine; Disease Notification; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Patient Compliance; Plasmodium falciparum; Plasmodium malariae; Plasmodium vivax; Proguanil; Pyrimethamine; Sex Distribution; Sulfadoxine | 2003 |
Health seeking behavior by families of children suspected to have malaria in Kabale: Uganda.
Topics: Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Cross-Sectional Studies; Drug Combinations; Family; Female; Health Facilities; Health Knowledge, Attitudes, Practice; Health Services Accessibility; Humans; Infant; Malaria, Falciparum; Male; Medicine, African Traditional; Patient Acceptance of Health Care; Pyrimethamine; Quinine; Sulfadoxine; Uganda | 2002 |
Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi.
Topics: Animals; Antimalarials; Child; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Malawi; Male; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Time Factors | 2003 |
Dihydrofolate reductase and dihydropteroate synthase genotypes associated with in vitro resistance of Plasmodium falciparum to pyrimethamine, trimethoprim, sulfadoxine, and sulfamethoxazole.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Child; Dihydropteroate Synthase; Drug Resistance; Genotype; Humans; Malaria, Falciparum; Middle Aged; Parasitic Sensitivity Tests; Plasmodium falciparum; Point Mutation; Pyrimethamine; Reproducibility of Results; Sulfadoxine; Sulfamethoxazole; Tetrahydrofolate Dehydrogenase; Trimethoprim; Trimethoprim Resistance | 2003 |
Surveillance of in vivo resistance of Plasmodium falciparum to antimalarial drugs from 1992 to 1999 in Malabo (Equatorial Guinea).
Topics: Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Equatorial Guinea; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 2003 |
Efficacy of amodiaquine alone and combined with sulfadoxine-pyrimethamine and of sulfadoxine pyrimethamine combined with artesunate.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Rural Health Services; Rwanda; Sesquiterpenes; Sulfadoxine; Treatment Outcome; Urban Health Services | 2003 |
Asymptomatic, recrudescent, chloroquine-resistant Plasmodium falciparum infections in Nigerian children: clinical and parasitological characteristics and implications for the transmission of drug-resistant parasites.
Topics: Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Nigeria; Plasmodium falciparum; Prevalence; Pyrimethamine; Recurrence; Statistics as Topic; Sulfadoxine; Treatment Failure | 2003 |
Plasmodium falciparum: correlation of in vivo resistance to chloroquine and antifolates with genetic polymorphisms in isolates from the south of Lao PDR.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Folic Acid Antagonists; Humans; Infant; Laos; Malaria, Falciparum; Middle Aged; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Pyrimethamine; Sensitivity and Specificity; Sulfadoxine | 2003 |
Intensity of transmission and spread of gene mutations linked to chloroquine and sulphadoxine-pyrimethamine resistance in falciparum malaria.
Topics: Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance, Multiple; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2003 |
The appearance of pyrimethamine resistance in Plasmodium falciparum following self-medication by a rural community in Ghana.
Topics: Antimalarials; Drug Combinations; Drug Resistance; Ghana; Malaria; Malaria, Falciparum; Pilot Projects; Plasmodium falciparum; Pyrimethamine; Reproducibility of Results; Rural Population; Sulfadoxine | 1962 |
TREATMENT OF ACUTE FALCIPARUM MALARIA WITH SULPHORTHODIMETHOXINE (FANASIL).
Topics: Adolescent; Africa; Africa, Eastern; Antimalarials; Child; Delayed-Action Preparations; Drug Resistance; Drug Resistance, Microbial; Humans; Infant; Malaria; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfonamides | 1965 |
Evaluation of a simple operational approach for monitoring resistance to antimalarial drugs in Peru.
Topics: Antimalarials; Chloroquine; Drug Combinations; Drug Monitoring; Drug Resistance; Humans; Malaria, Falciparum; Parasitic Sensitivity Tests; Peru; Pyrimethamine; Quality of Health Care; Sulfadoxine; Treatment Failure | 2003 |
Prevention of increasing rates of treatment failure by combining sulfadoxine-pyrimethamine with artesunate or amodiaquine for the sequential treatment of malaria.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Dihydropteroate Synthase; Drug Administration Schedule; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Infant; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Failure; Treatment Outcome | 2003 |
Application of a multi-faceted approach for the assessment of treatment response in falciparum malaria: a study from Malaysian Borneo.
Topics: Animals; Antimalarials; Borneo; Chloroquine; Drug Resistance, Multiple; Genes, MDR; Genes, Protozoan; Genetic Markers; Humans; Malaria, Falciparum; Plasmodium falciparum; Point Mutation; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2003 |
Diagnosis and treatment of malaria in children.
Topics: Animals; Antimalarials; Atovaquone; Child; Chloroquine; Drug Combinations; Humans; Malaria; Malaria, Falciparum; Mefloquine; Naphthoquinones; Plasmodium falciparum; Proguanil; Pyrimethamine; Sulfadoxine | 2003 |
Gametocyte sex ratios in children with asymptomatic, recrudescent, pyrimethamine-sulfadoxine-resistant, Plasmodium falciparum malaria.
Topics: Antimalarials; Area Under Curve; Child; Drug Combinations; Drug Resistance; Female; Germ Cells; Humans; Malaria, Falciparum; Male; Pyrimethamine; Recurrence; Sex Ratio; Sulfadoxine; Time Factors; Treatment Outcome | 2003 |
Roll back of Plasmodium falciparum antifolate resistance by insecticide-treated nets.
Topics: Animals; Antimalarials; Bedding and Linens; Culicidae; Dapsone; Drug Combinations; Drug Resistance; Folic Acid Antagonists; Humans; Insecticides; Malaria, Falciparum; Mosquito Control; Mutation; Plants; Plasmodium falciparum; Proguanil; Pyrimethamine; Sulfadoxine | 2003 |
Increasing prevalence of wildtypes in the dihydrofolate reductase gene of Plasmodium falciparum in an area with high levels of sulfadoxine/pyrimethamine resistance after introduction of treated bed nets.
Topics: Animals; Antimalarials; Bedding and Linens; Child, Preschool; Culicidae; Dihydropteroate Synthase; DNA Primers; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Folic Acid Antagonists; Genotype; Humans; Infant; Insecticides; Malaria, Falciparum; Male; Mosquito Control; Mutation; Plants; Plasmodium falciparum; Polymerase Chain Reaction; Prevalence; Pyrimethamine; Sulfadoxine; Tanzania; Tetrahydrofolate Dehydrogenase | 2003 |
Multi-drug resistant Plasmodium falciparum malaria in Assam, India: timing of recurrence and anti-malarial drug concentrations in whole blood.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Chloroquine; Drug Resistance, Multiple; Female; Humans; India; Malaria, Falciparum; Male; Plasmodium falciparum; Quinine; Recurrence; Sulfadoxine; Time Factors | 2003 |
Genetic markers of resistance to pyrimethamine and sulfonamides in Plasmodium falciparum parasites compared with the resistance patterns in isolates of Escherichia coli from the same children in Guinea-Bissau.
Topics: Adolescent; Animals; Antimalarials; Child; Child, Preschool; Drug Combinations; Drug Resistance; Escherichia coli; Escherichia coli Infections; Female; Genetic Markers; Guinea-Bissau; Humans; Infant; Malaria, Falciparum; Male; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Trimethoprim, Sulfamethoxazole Drug Combination | 2004 |
Prediction of Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in vivo by mutations in the dihydrofolate reductase and dihydropteroate synthetase genes: a comparative study between sites of differing endemicity.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Biomarkers; Child; Dihydropteroate Synthase; Drug Combinations; Drug Resistance, Multiple; Endemic Diseases; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Mutation; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Population Surveillance; Predictive Value of Tests; Prevalence; Pyrimethamine; Sulfadoxine; Tanzania; Tetrahydrofolate Dehydrogenase | 2003 |
Genotyping of Plasmodium falciparum pyrimethamine resistance by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry.
Topics: Adult; Animals; Antimalarials; DNA; Drug Resistance; Genotype; Humans; Malaria, Falciparum; Oligonucleotide Probes; Plasmodium falciparum; Pyrimethamine; Reverse Transcriptase Polymerase Chain Reaction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2004 |
Therapeutic efficacies of antimalarial drugs in the treatment of uncomplicated, Plasmodium falciparum malaria in Assam, north-eastern India.
Topics: Adolescent; Adult; Aged; Animals; Anti-Infective Agents; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Combinations; Female; Humans; India; Infant; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine | 2003 |
Sustained clinical efficacy of sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: five year prospective study.
Topics: Adolescent; Adult; Aged; Anemia; Antimalarials; Child; Child, Preschool; Drug Combinations; Drug Evaluation; Drug Resistance; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Malawi; Middle Aged; Prospective Studies; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2004 |
Plasmodium falciparum isolates in India exhibit a progressive increase in mutations associated with sulfadoxine-pyrimethamine resistance.
Topics: Alleles; Animals; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Folic Acid Antagonists; Genotype; Humans; India; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pyrimethamine; Reverse Transcriptase Polymerase Chain Reaction; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2004 |
Short communication: Prevalence of mutations associated with resistance to atovaquone and to the antifolate effect of proguanil in Plasmodium falciparum isolates from northern Ghana.
Topics: Animals; Antimalarials; Atovaquone; Child, Preschool; Cytochromes b; Drug Combinations; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Female; Folic Acid Antagonists; Ghana; Humans; Infant; Malaria, Falciparum; Male; Mutation; Naphthoquinones; Plasmodium falciparum; Polymorphism, Restriction Fragment Length; Proguanil; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Triazines | 2004 |
Sulfadoxine-pyrimethamine remains efficacious against uncomplicated, Plasmodium falciparum malaria in north-eastern Afghanistan.
Topics: Afghanistan; Antimalarials; Drug Combinations; Humans; Malaria, Falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2004 |
Evolution of drug-resistance genes in Plasmodium falciparum in an area of seasonal malaria transmission in Eastern Sudan.
Topics: Alleles; Animals; Antimalarials; Chloroquine; Cross-Sectional Studies; DNA, Protozoan; Drug Combinations; Drug Resistance; Humans; Longitudinal Studies; Malaria, Falciparum; Microsatellite Repeats; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Regression Analysis; Seasons; Sequence Analysis, DNA; Sudan; Sulfadoxine | 2004 |
Monitoring antimalarial drug efficacy.
Topics: Animals; Antimalarials; Chloroquine; Drug Monitoring; Drug Resistance; Humans; Laos; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome; World Health Organization | 2004 |
Implementation of intermittent preventive treatment with sulphadoxine-pyrimethamine for control of malaria in pregnancy in Kisumu, western Kenya.
Topics: Adult; Antimalarials; Attitude to Health; Awareness; Drug Combinations; Female; Gestational Age; Humans; Malaria, Falciparum; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Prenatal Care; Pyrimethamine; Sulfadoxine | 2004 |
Sulfadoxine-pyrimethamine for uncomplicated falciparum malaria: sulfadoxine-pyrimethamine is not working in Malawi.
Topics: Antimalarials; Drug Combinations; Humans; Malaria, Falciparum; Malawi; Pyrimethamine; Sulfadoxine; Treatment Failure | 2004 |
Sulfadoxine-pyrimethamine for uncomplicated falciparum malaria: treatment failure and resistance in Malawi remain subject for debate.
Topics: Antimalarials; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Pyrimethamine; Sulfadoxine | 2004 |
Comparative efficacy of chloroquine and sulfadoxine-pyrimethamine for uncomplicated Plasmodium falciparum malaria and impact on gametocyte carriage rates in the East Nusatenggara province of Indonesia.
Topics: Adolescent; Adult; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Sulfadoxine | 2004 |
Chlorproguanil-dapsone for malaria in Africa.
Topics: Africa; Animals; Antimalarials; Dapsone; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Plasmodium falciparum; Proguanil; Pyrimethamine; Sulfadoxine | 2004 |
Drug resistance in Plasmodium falciparum from the Chittagong Hill Tracts, Bangladesh.
Topics: Adolescent; Adult; Animals; Antimalarials; ATP-Binding Cassette Transporters; Bangladesh; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Genetic Markers; Genotype; Humans; Malaria, Falciparum; Male; Membrane Proteins; Membrane Transport Proteins; Mutation; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Quinine; Sulfadoxine; Treatment Outcome | 2004 |
Plasmodium falciparum gametocyte carriage in asymptomatic children in western Kenya.
Topics: Adolescent; Age Factors; Animals; Antimalarials; Carrier State; Child; Child, Preschool; Cohort Studies; Disease Reservoirs; Drug Combinations; Humans; Infant; Kenya; Malaria, Falciparum; Mass Screening; Parasitemia; Plasmodium falciparum; Prevalence; Pyrimethamine; Risk Factors; Sulfadoxine | 2004 |
Molecular diagnosis of resistance to antimalarial drugs during epidemics and in war zones.
Topics: Animals; Antimalarials; Chloroquine; Cross-Sectional Studies; Disease Outbreaks; DNA, Protozoan; Drug Combinations; Drug Resistance, Microbial; Genes, Protozoan; Genetic Markers; Humans; Malaria, Falciparum; Mali; Molecular Epidemiology; Plasmodium falciparum; Polymerase Chain Reaction; Prevalence; Pyrimethamine; Sulfadoxine; Warfare | 2004 |
Risk of Plasmodium falciparum infection during a malaria epidemic in highland Kenya, 1997.
Topics: Adolescent; Adult; Aged; Antimalarials; Child; Child, Preschool; Cohort Studies; Disease Outbreaks; Drug Combinations; Humans; Infant; Kenya; Malaria, Falciparum; Middle Aged; Prospective Studies; Pyrimethamine; Risk; Sulfadoxine; Time Factors | 2004 |
Monitoring susceptibility to sulfadoxine-pyrimethamine among cases of uncomplicated, Plasmodium falciparum malaria in Saharevo, Madagascar.
Topics: Animals; Antimalarials; Child; Child, Preschool; Drug Combinations; Female; Humans; Madagascar; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Pyrimethamine; Rural Health; Sulfadoxine; Treatment Outcome | 2004 |
Two mutations in dihydrofolate reductase combined with one in the dihydropteroate synthase gene predict sulphadoxine-pyrimethamine parasitological failure in Ugandan children with uncomplicated falciparum malaria.
Topics: Animals; Antimalarials; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Point Mutation; Pyrimethamine; Retrospective Studies; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Time Factors; Treatment Failure; Uganda | 2004 |
Extrapyramidal syndrome after treatment of falciparum malaria with sulphadoxine-pyrimethamine.
Topics: Adult; Animals; Antimalarials; Basal Ganglia Diseases; Drug Hypersensitivity; Drug Therapy, Combination; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Pyrimethamine; Risk Assessment; Severity of Illness Index; Sulfadoxine; Syndrome | 2004 |
Rare, highly pyrimethamine-resistant alleles of the Plasmodium falciparum dihydrofolate reductase gene from 5 African sites.
Topics: Alleles; Amino Acid Substitution; Animals; Antimalarials; Dapsone; Drug Resistance; Gabon; Genes, Protozoan; Humans; Kenya; Malaria, Falciparum; Malawi; Molecular Epidemiology; Mutation, Missense; Nigeria; Parasitic Sensitivity Tests; Plasmodium falciparum; Point Mutation; Proguanil; Pyrimethamine; Sulfadoxine; Tanzania; Tetrahydrofolate Dehydrogenase | 2004 |
Knowledge of malaria influences the use of insecticide treated nets but not intermittent presumptive treatment by pregnant women in Tanzania.
Topics: Adult; Age Factors; Anemia; Antimalarials; Bedding and Linens; Drug Combinations; Educational Status; Female; Health Knowledge, Attitudes, Practice; Humans; Logistic Models; Malaria, Falciparum; Mosquito Control; Odds Ratio; Patient Education as Topic; Postpartum Period; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Pyrimethamine; Risk Factors; Socioeconomic Factors; Sulfadoxine; Surveys and Questionnaires; Tanzania | 2004 |
Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo re
Topics: Animals; Antimalarials; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance, Multiple; Genetic Markers; Genotype; Health Policy; Humans; Infant; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tanzania; Tetrahydrofolate Dehydrogenase | 2004 |
Adherence to antimalarial combination therapy with sulfadoxine-pyrimethamine and artesunate in rural Tanzania.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Logistic Models; Malaria, Falciparum; Male; Patient Compliance; Pyrimethamine; Risk Factors; Sesquiterpenes; Socioeconomic Factors; Sulfadoxine; Tanzania | 2004 |
Influence of chemotherapy on the Plasmodium gametocyte sex ratio of mice and humans.
Topics: Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Mice; Plasmodium; Pyrimethamine; Sex Ratio; Species Specificity; Sulfadoxine; Time Factors | 2004 |
Principal role of dihydropteroate synthase mutations in mediating resistance to sulfadoxine-pyrimethamine in single-drug and combination therapy of uncomplicated malaria in Uganda.
Topics: Alleles; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Dihydropteroate Synthase; Drug Combinations; Drug Resistance, Multiple; Drug Therapy, Combination; Genetic Variation; Humans; Infant; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Time Factors; Uganda | 2004 |
Comparative effects of pyrimethamine-sulfadoxine, with and without probenecid, on Plasmodium falciparum gametocytes in children with acute, uncomplicated malaria.
Topics: Acute Disease; Animals; Antimalarials; Child; Drug Combinations; Drug Therapy, Combination; Endemic Diseases; Female; Humans; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Probenecid; Pyrimethamine; Sex Ratio; Sulfadoxine; Treatment Outcome; Uricosuric Agents | 2004 |
[Assessment of sulfadoxine-pyriméthamine (Fansidar, Paludar) efficacy in patients with uncomplicated malaria in Madagascar: preliminary study to propose a simplified study protocol].
Topics: Adolescent; Adult; Antimalarials; Child; Child, Preschool; Climate; Drug Administration Schedule; Drug Combinations; Drug Monitoring; Drug Resistance; Feasibility Studies; Female; Follow-Up Studies; Humans; Madagascar; Malaria, Falciparum; Male; Middle Aged; Observation; Parasitic Sensitivity Tests; Pyrimethamine; Research Design; Residence Characteristics; Rural Health; Sulfadoxine; Treatment Outcome | 2003 |
Mefloquine--its 20 years in the Thai Malaria Control Program.
Topics: Animals; Antimalarials; Communicable Disease Control; Contraindications; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Program Evaluation; Pyrimethamine; Sulfadoxine; Thailand | 2004 |
Nosocomial Plasmodium falciparum infections confirmed by molecular typing in Medellín, Colombia.
Topics: Adult; Animals; Antigens, Protozoan; Colombia; Cross Infection; Drug Combinations; Equipment Contamination; Fatal Outcome; Genotype; Humans; Malaria, Falciparum; Male; Merozoite Surface Protein 1; Middle Aged; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Quinine; Sulfadoxine | 2005 |
A simple, high-throughput method to detect Plasmodium falciparum single nucleotide polymorphisms in the dihydrofolate reductase, dihydropteroate synthase, and P. falciparum chloroquine resistance transporter genes using polymerase chain reaction- and enzy
Topics: Animals; Antimalarials; Chloroquine; Dihydropteroate Synthase; DNA Primers; DNA, Protozoan; Drug Combinations; Drug Resistance; Enzyme-Linked Immunosorbent Assay; Humans; Malaria, Falciparum; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Pyrimethamine; Sulfadoxine; Tanzania; Tetrahydrofolate Dehydrogenase | 2005 |
The search for effective and sustainable treatments for Plasmodium falciparum malaria in Africa: a model of the selection of resistance by antifolate drugs and their combinations.
Topics: Africa; Animals; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Health Policy; Humans; Malaria, Falciparum; Models, Theoretical; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2005 |
Plasmodium falciparum: evaluation of a quantitative nucleic acid sequence-based amplification assay to predict the outcome of sulfadoxine-pyrimethamine treatment of uncomplicated malaria.
Topics: Animals; Antimalarials; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Genotype; Humans; Infant; Malaria, Falciparum; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Pyrimethamine; Recurrence; Retrospective Studies; Self-Sustained Sequence Replication; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2005 |
The quality of sulfadoxine-pyrimethamine prescriptions, counselling and drug-dispensing practices, for children in Kenya.
Topics: Animals; Antimalarials; Child; Community Health Workers; Counseling; Drug Administration Schedule; Drug Combinations; Guideline Adherence; Humans; Kenya; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2005 |
Evaluation of chloroquine (CQ) and sulphadoxine/pyrimethamine (SP) therapy in uncomplicated falciparum malaria in Indo-Myanmar border areas.
Topics: Adolescent; Adult; Age Distribution; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Evaluation; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sex Distribution; Sulfadoxine; Treatment Failure; Treatment Outcome | 2005 |
The role of sequential administration of sulphadoxine/pyrimethamine following quinine in the treatment of severe falciparum malaria in children.
Topics: Administration, Oral; Animals; Antimalarials; Child, Preschool; Drug Administration Schedule; Drug Combinations; Female; Humans; Infant; Infusions, Parenteral; Malaria, Falciparum; Male; Pyrimethamine; Quinine; Sulfadoxine; Treatment Outcome | 2005 |
Efficacy of amodiaquine in uncomplicated falciparum malaria in Nigeria in an area with high-level resistance to chloroquine and sulphadoxine/pyrimethamine.
Topics: Amodiaquine; Animals; Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Hemoglobins; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2005 |
Reduced variation around drug-resistant dhfr alleles in African Plasmodium falciparum.
Topics: Africa; Alleles; Animals; Antimalarials; Drug Combinations; Drug Resistance; Gene Frequency; Genes, Protozoan; Genetic Variation; Genome, Protozoan; Humans; Malaria, Falciparum; Microsatellite Repeats; Mutation; Plasmodium falciparum; Pyrimethamine; Recombination, Genetic; Retrospective Studies; Selection, Genetic; Sulfadoxine | 2005 |
Plasmodium falciparum: higher incidence of molecular resistance markers for sulphadoxine than for pyrimethamine in Kasangati, Uganda.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Codon; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Genetic Markers; Haplotypes; Humans; Infant; Malaria, Falciparum; Male; Mutation; Plasmodium falciparum; Polymorphism, Restriction Fragment Length; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Treatment Outcome; Uganda | 2005 |
Stevens-Johnson syndrome in two children in Ghana following anti-malarial treatment.
Topics: Antimalarials; Child; Drug Combinations; Female; Fever; Ghana; Humans; Malaria, Falciparum; Male; Pyrimethamine; Stevens-Johnson Syndrome; Sulfadoxine | 2005 |
Malaria cure with sulphadoxine/pyrimethamine combination in 12 semi-immune adults from West-Central Africa with high rates of point mutations in Plasmodium falciparum dhfr and dhps genes.
Topics: Africa, Central; Africa, Western; Animals; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Emigration and Immigration; Humans; Malaria, Falciparum; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Pyrimethamine; Spain; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2005 |
Rapid increase in resistance of Plasmodium falciparum to chloroquine-Fansidar in Uganda and the potential of amodiaquine-Fansidar as a better alternative.
Topics: Amodiaquine; Animals; Antimalarials; Child, Preschool; Chloroquine; Clinical Trials as Topic; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Membrane Proteins; Membrane Transport Proteins; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Uganda | 2005 |
Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria.
Topics: Animals; Antimalarials; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Plasmodium falciparum; Polymorphism, Genetic; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2005 |
Effectiveness of antimalarial drugs.
Topics: Adult; Antimalarials; Child; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Pyrimethamine; Sulfadoxine | 2005 |
Effects of antifolates--co-trimoxazole and pyrimethamine-sulfadoxine--on gametocytes in children with acute, symptomatic, uncomplicated, Plasmodium falciparum malaria.
Topics: Acute Disease; Animals; Antimalarials; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Folic Acid Antagonists; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sex Ratio; Sulfadoxine; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2005 |
A molecular epidemiologic study of point mutations for pyrimethamine-sulfadoxine resistance of Plasmodium falciparum isolates from Lao PDR.
Topics: Animals; Antimalarials; Codon; Dihydropteroate Synthase; Drug Resistance; Humans; Laos; Malaria, Falciparum; Molecular Epidemiology; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2005 |
Association between the pharmacokinetics and in vivo therapeutic efficacy of sulfadoxine-pyrimethamine in Malawian children.
Topics: Animals; Antimalarials; Child; Child, Preschool; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Infant; Malaria, Falciparum; Malawi; Male; Multivariate Analysis; Mutation; Plasmodium falciparum; Pyrimethamine; Reverse Transcriptase Polymerase Chain Reaction; Sulfadoxine; Treatment Failure; Treatment Outcome | 2005 |
Mutations associated with sulfadoxine-pyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre, Malawi.
Topics: Animals; Antimalarials; DNA Primers; Drug Combinations; Drug Resistance; Folic Acid Antagonists; Humans; Malaria, Falciparum; Malawi; Mutation; Plasmodium falciparum; Proguanil; Pyrimethamine; Reverse Transcriptase Polymerase Chain Reaction; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2005 |
Plasmodium falciparum dhfr but not dhps mutations associated with sulphadoxine-pyrimethamine treatment failure and gametocyte carriage in northern Ghana.
Topics: Animals; Antimalarials; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Ghana; Humans; Infant; Malaria, Falciparum; Male; Mutation; Parasitemia; Plasmodium falciparum; Prevalence; Pyrimethamine; Risk Assessment; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Failure | 2005 |
Artesunate plus sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in Sudan.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Pyrimethamine; Sentinel Surveillance; Sesquiterpenes; Sudan; Sulfadoxine | 2005 |
Detection of Plasmodium falciparum in pregnancy by laser desorption mass spectrometry.
Topics: Adult; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Malaria, Falciparum; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Sulfadoxine | 2005 |
Rare Congolese Plasmodium falciparum DHFR alleles.
Topics: Alleles; Animals; Antimalarials; Child, Preschool; Congo; Drug Combinations; Drug Resistance; Genes, Protozoan; Humans; Infant; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2005 |
Epidemiology of drug-resistant malaria in Republic of Congo: using molecular evidence for monitoring antimalarial drug resistance combined with assessment of antimalarial drug use.
Topics: Antimalarials; Biomarkers; Child, Preschool; Chloroquine; Congo; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Genotype; Humans; Malaria, Falciparum; Membrane Proteins; Membrane Transport Proteins; Mutation; Patient Compliance; Polymerase Chain Reaction; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome; Urban Health | 2005 |
Adoption of the new antimalarial drug policy in Tanzania--a cross-sectional study in the community.
Topics: Antimalarials; Artemisinins; Child, Preschool; Chloroquine; Cross-Sectional Studies; Drug Combinations; Drug Therapy, Combination; Female; Focus Groups; Health Knowledge, Attitudes, Practice; Health Policy; Humans; Malaria, Falciparum; Male; Patient Acceptance of Health Care; Population Surveillance; Pyrimethamine; Rural Health; Self Administration; Sesquiterpenes; Sulfadoxine; Tanzania | 2005 |
Research influence on antimalarial drug policy change in Tanzania: case study of replacing chloroquine with sulfadoxine-pyrimethamine as the first-line drug.
Topics: Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Health Policy; Humans; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Research; Sulfadoxine; Tanzania; World Health Organization | 2005 |
Increased density but not prevalence of gametocytes following drug treatment of Plasmodium falciparum.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Middle Aged; Plasmodium falciparum; Prevalence; Pyrimethamine; Reverse Transcriptase Polymerase Chain Reaction; Sudan; Sulfadoxine | 2006 |
Efficacy of sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in Ethiopia.
Topics: Adolescent; Animals; Antimalarials; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethiopia; Female; Humans; Infant; Malaria, Falciparum; Male; Prospective Studies; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome | 2005 |
Use of intermittent preventive treatment for malaria in pregnancy in a rural area of western Kenya with high coverage of insecticide-treated bed nets.
Topics: Adult; Antimalarials; Bedding and Linens; Cross-Sectional Studies; Drug Combinations; Endemic Diseases; Female; Humans; Infant, Newborn; Insecticides; Kenya; Malaria, Falciparum; Patient Acceptance of Health Care; Population Surveillance; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Rural Health; Sulfadoxine | 2005 |
Intermittent preventive treatment for malaria in infants: moving forward, cautiously.
Topics: Antimalarials; Chemoprevention; Drug Administration Schedule; Drug Combinations; Humans; Infant; Malaria; Malaria, Falciparum; Pyrimethamine; Sulfadoxine | 2005 |
Efficacy of sulfadoxine-pyrimethamine in Tanzania after two years as first-line drug for uncomplicated malaria: assessment protocol and implication for treatment policy strategies.
Topics: Animals; Antigens, Protozoan; Antimalarials; Body Temperature; Child, Preschool; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Genotype; Health Policy; Hemoglobins; Humans; Infant; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tanzania; Treatment Outcome | 2005 |
Efficacy of chloroquine, sulfadoxine-pyrimethamine and amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria among children under five in Bongor and Koumra, Chad.
Topics: Amodiaquine; Animals; Chad; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Genes, Protozoan; Genotype; Humans; Infant; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Prospective Studies; Pyrimethamine; Sulfadoxine; Treatment Outcome; Urban Population | 2006 |
In vitro processing of donor blood with sulfadoxine-pyrimethamine for eradication of transfusion-induced malaria.
Topics: Adult; Animals; Antimalarials; Blood Coagulation Tests; Blood Donors; Blood Transfusion; Blood-Borne Pathogens; Drug Combinations; Hematocrit; Humans; In Vitro Techniques; Malaria, Falciparum; Male; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Sudan; Sulfadoxine | 2005 |
Molecular surveillance of mutations in dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum in Ethiopia.
Topics: Animals; Antimalarials; Dihydropteroate Synthase; DNA Primers; DNA, Protozoan; Drug Combinations; Drug Resistance, Multiple; Ethiopia; Humans; Malaria, Falciparum; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Prevalence; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2005 |
Development of resistance by Plasmodium falciparum to sulfadoxine/pyrimethamine in Amhara Region, Northwestern Ethiopia.
Topics: Animals; Antimalarials; Child; Drug Resistance; Drug Therapy, Combination; Ethiopia; Female; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2005 |
CD4 T cell activation as a predictor for treatment failure in Ugandans with Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Age Factors; Animals; Antimalarials; Body Temperature; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Child; Child, Preschool; Chloroquine; Drug Combinations; Female; Humans; Lymphocyte Activation; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Pyrimethamine; Risk Factors; Sulfadoxine; Treatment Failure; Uganda | 2006 |
The efficacies of artesunate-sulfadoxine-pyrimethamine and artemether-lumefantrine in the treatment of uncomplicated, Plasmodium falciparum malaria, in an area of low transmission in central Sudan.
Topics: Adolescent; Adult; Age Distribution; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Prospective Studies; Pyrimethamine; Sesquiterpenes; Sudan; Sulfadoxine; Treatment Outcome | 2006 |
Artesunate plus sulfadoxine-pyrimethamine in the treatment of uncomplicated Plasmodium falciparum malaria during pregnancy in eastern Sudan.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pyrimethamine; Sesquiterpenes; Sudan; Sulfadoxine; Treatment Outcome | 2006 |
Pyrimethamine-sulfadoxine treatment of uncomplicated Plasmodium falciparum malaria in Lao PDR.
Topics: Adolescent; Adult; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Laos; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2005 |
Point mutations in the dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum and resistance to sulfadoxine-pyrimethamine in Sri Lanka.
Topics: Animals; Antimalarials; Dihydropteroate Synthase; DNA Primers; Drug Combinations; Drug Resistance, Multiple; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Pyrimethamine; Sri Lanka; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Failure | 2006 |
Frequency distribution of antimalarial drug-resistant alleles among isolates of Plasmodium falciparum in Bangui, Central African Republic.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Central African Republic; Chloroquine; Drug Combinations; Drug Resistance, Multiple; Gene Frequency; Humans; Malaria, Falciparum; Membrane Proteins; Membrane Transport Proteins; Mutation; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2006 |
Reaching the Abuja target for intermittent preventive treatment of malaria in pregnancy in African women: a review of progress and operational challenges.
Topics: Africa South of the Sahara; Antimalarials; Attitude to Health; Delivery of Health Care, Integrated; Drug Combinations; Fees and Charges; Female; Health Education; Health Knowledge, Attitudes, Practice; Health Personnel; Health Policy; Health Services Accessibility; Health Services Needs and Demand; Humans; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Pyrimethamine; Sulfadoxine; Treatment Outcome; World Health Organization | 2006 |
Prevalence of malaria parasitemia among clients seeking treatment for fever or malaria at drug stores in rural Tanzania 2004.
Topics: Adult; Amodiaquine; Analgesics, Non-Narcotic; Anemia; Antimalarials; Child, Preschool; Drug Combinations; Endemic Diseases; Female; Fever; Humans; Malaria, Falciparum; Male; Parasitemia; Patient Acceptance of Health Care; Pharmacies; Prevalence; Pyrimethamine; Rural Health; Sulfadoxine; Tanzania; Trimethoprim, Sulfamethoxazole Drug Combination | 2006 |
The costs of changing national policy: lessons from malaria treatment policy guidelines in Tanzania.
Topics: Amodiaquine; Antimalarials; Chloroquine; Clinical Protocols; Drug Combinations; Health Care Costs; Health Education; Health Personnel; Health Policy; Humans; Malaria, Falciparum; Practice Guidelines as Topic; Pyrimethamine; Sulfadoxine; Tanzania | 2006 |
Microscopy and outpatient malaria case management among older children and adults in Kenya.
Topics: Adolescent; Adult; Ambulatory Care; Amodiaquine; Antimalarials; Case Management; Child; Cross-Sectional Studies; Drug Combinations; Humans; Kenya; Malaria, Falciparum; Microscopy; Parasitemia; Population Surveillance; Prevalence; Pyrimethamine; Quinine; Sensitivity and Specificity; Sulfadoxine | 2006 |
Prevention of malaria during pregnancy in West Africa: policy change and the power of subregional action.
Topics: Africa, Western; Antimalarials; Chloroquine; Communication Barriers; Drug Combinations; Drug Resistance; Evidence-Based Medicine; Female; Financing, Organized; Health Education; Health Policy; Humans; International Cooperation; Interprofessional Relations; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2006 |
Rapid selection of dhfr mutant allele in Plasmodium falciparum isolates after the introduction of sulfadoxine/pyrimethamine in combination with 4-aminoquinolines in Papua New Guinea.
Topics: Alleles; Aminoquinolines; Animals; Dihydropteroate Synthase; Drug Combinations; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mutation; Papua New Guinea; Plasmodium falciparum; Polymorphism, Genetic; Pyrimethamine; Selection, Genetic; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2006 |
Polymerase chain reaction and molecular genotyping to monitor parasitological response to anti-malarial chemotherapy in the Peruvian Amazon.
Topics: Adolescent; Adult; Animals; Anopheles; Antimalarials; Child; Cohort Studies; DNA, Protozoan; Drug Combinations; Drug Resistance, Multiple; Female; Genotype; Humans; Insect Vectors; Malaria, Falciparum; Male; Middle Aged; Peru; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sensitivity and Specificity; Sulfadoxine; Treatment Failure | 2006 |
The efficacy of sulfadoxine-pyrimethamine alone and in combination with chloroquine for malaria treatment in rural Eastern Sudan: the interrelation between resistance, age and gametocytogenesis.
Topics: Adolescent; Adult; Age Distribution; Antimalarials; Child; Chloroquine; Cohort Studies; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Gametogenesis; Humans; Malaria, Falciparum; Male; Parasitemia; Pyrimethamine; Rural Health; Sudan; Sulfadoxine; Treatment Failure; Treatment Outcome | 2006 |
Plasmodium falciparum infection dynamics and transmission potential following treatment with sulfadoxine-pyrimethamine.
Topics: Algorithms; Animals; Antimalarials; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Models, Biological; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2006 |
Short report: Dynamics of Plasmodium falciparum malaria after sub-optimal therapy in Uganda.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Disease-Free Survival; DNA, Protozoan; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Genotype; Humans; Infant; Malaria, Falciparum; Male; Medically Underserved Area; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sulfadoxine; Uganda | 2006 |
Therapeutic efficacy of sulphadoxine-pyrimethamine and chloroquine for the treatment of uncomplicated malaria in pregnancy in Burkina Faso.
Topics: Adolescent; Adult; Burkina Faso; Chloroquine; Contraindications; Drug Combinations; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2006 |
Antifolate resistance in Plasmodium falciparum: multiple origins and identification of novel dhfr alleles.
Topics: Alleles; Animals; Antimalarials; Drug Combinations; Drug Resistance; Folic Acid Antagonists; Genotype; HIV Infections; Humans; Malaria, Falciparum; Microsatellite Repeats; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2006 |
High prevalence of drug-resistance mutations in Plasmodium falciparum and Plasmodium vivax in southern Ethiopia.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Ethiopia; Female; Humans; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Mutation; Plasmodium falciparum; Plasmodium vivax; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2006 |
Protecting pregnant women from malaria in areas of high HIV infection prevalence.
Topics: Africa South of the Sahara; Antimalarials; Chemoprevention; Disease Outbreaks; Drug Combinations; Female; HIV Infections; Humans; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Pyrimethamine; Sulfadoxine; Trimethoprim, Sulfamethoxazole Drug Combination | 2006 |
From chloroquine to artemisinin-based combination therapy: the Sudanese experience.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Health Policy; Humans; Lumefantrine; Malaria, Falciparum; Product Surveillance, Postmarketing; Pyrimethamine; Sesquiterpenes; Sudan; Sulfadoxine; Time Factors | 2006 |
[Knowledge and practice among health workers from the Thiès region with regard to new malaria treatment policies].
Topics: Amodiaquine; Antimalarials; Chloroquine; Clinical Competence; Community Health Services; Drug Combinations; Drug Resistance; Education, Nursing; Guideline Adherence; Health Personnel; Health Policy; Health Promotion; Humans; Malaria, Falciparum; Patient Education as Topic; Practice Guidelines as Topic; Pyrimethamine; Rural Health Services; Senegal; Sulfadoxine; Workforce | 2006 |
Correlations between treatment outcome and both anti-MSP119 antibody response and erythrocyte-related genetic factors in Plasmodium falciparum malaria.
Topics: Amodiaquine; Animals; Antibodies, Protozoan; Antigens, Protozoan; Antimalarials; Child; Child, Preschool; Drug Combinations; Erythrocytes; Female; Follow-Up Studies; Gabon; Glucosephosphate Dehydrogenase; Humans; Immunoglobulin G; Infant; Kinetics; Malaria, Falciparum; Male; Merozoite Surface Protein 1; Plasmodium falciparum; Protein Subunits; Protozoan Proteins; Pyrimethamine; Sickle Cell Trait; Sulfadoxine; Treatment Outcome | 2007 |
Relationship between antipyretic effects and cytokine levels in uncomplicated falciparum malaria during different treatment regimes.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Antimalarials; Child, Preschool; Chloroquine; Cytokines; Drug Combinations; Enzyme-Linked Immunosorbent Assay; Fever; Humans; Infant; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Pyrimethamine; Statistics, Nonparametric; Sulfadoxine; Tanzania | 2006 |
Cotrimoxazole prophylaxis and malaria in Africa: Have the important questions been answered?
Topics: HIV Infections; Humans; Malaria, Falciparum; Pyrimethamine; Sulfadoxine; Sulfamethoxazole; Trimethoprim, Sulfamethoxazole Drug Combination | 2006 |
Effect of cotrimoxazole prophylaxis taken by human immunodeficiency virus (HIV)-infected persons on the selection of sulfadoxine-pyrimethamine-resistant malaria parasites among HIV-uninfected household members.
Topics: Animals; Antimalarials; Cohort Studies; Drug Combinations; Drug Resistance; Family; HIV Infections; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Trimethoprim, Sulfamethoxazole Drug Combination | 2006 |
Molecular epidemiology of malaria in Cameroon. XXI. Baseline therapeutic efficacy of chloroquine, amodiaquine, and sulfadoxine-pyrimethamine monotherapies in children before national drug policy change.
Topics: Amodiaquine; Antimalarials; Cameroon; Child; Chloroquine; Drug Combinations; Health Policy; Humans; Malaria, Falciparum; Molecular Epidemiology; Pyrimethamine; Sulfadoxine | 2006 |
Prevalence of mutations associated with higher levels of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Car Nicobar Island and Assam, India.
Topics: Animals; Antimalarials; Codon; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Humans; India; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2006 |
Submicroscopic Plasmodium falciparum infections before and after sulfadoxine-pyrimethamine and artesunate association treatment in Dienga, Southeastern Gabon.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemisinins; Artesunate; DNA, Protozoan; Drug Combinations; Gabon; Genotype; Humans; Malaria, Falciparum; Middle Aged; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2006 |
Use of area under the curve to characterize transmission potential after antimalarial treatment.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Area Under Curve; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Point Mutation; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2006 |
Therapeutic efficacy of quinine plus sulfadoxine-pyremethamine for the treatment of uncomplicated falciparum malaria in Bangladesh.
Topics: Adolescent; Adult; Animals; Antimalarials; Bangladesh; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine; Treatment Failure | 2006 |
Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania.
Topics: Animals; Antimalarials; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Parasitic Sensitivity Tests; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Pyrimethamine; Sulfadoxine; Tanzania; Tetrahydrofolate Dehydrogenase | 2006 |
HIV immunosuppression and antimalarial efficacy: sulfadoxine-pyrimethamine for the treatment of uncomplicated malaria in HIV-infected adults in Siaya, Kenya.
Topics: Adult; Anemia; Antimalarials; CD4 Lymphocyte Count; Drug Combinations; Female; Fever; HIV Infections; Humans; Immunocompromised Host; Kenya; Malaria, Falciparum; Male; Parasitemia; Pyrimethamine; Recurrence; Statistics as Topic; Sulfadoxine; Treatment Failure | 2006 |
Markers of sulfadoxine-pyrimethamine-resistant Plasmodium falciparum in placenta and circulation of pregnant women.
Topics: Adolescent; Adult; Animals; Antimalarials; Biomarkers; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Malaria, Falciparum; Middle Aged; Mutation; Placenta; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2007 |
Decreased availability of antimalarials in the private sector following the policy change from chloroquine to sulphadoxine-pyrimethamine in the Kilombero Valley, Tanzania.
Topics: Analgesics, Non-Narcotic; Antimalarials; Chloroquine; Drug Combinations; Health Policy; Humans; Malaria, Falciparum; Pharmacies; Pyrimethamine; Sulfadoxine; Tanzania | 2006 |
A multiplex ligase detection reaction-fluorescent microsphere assay for simultaneous detection of single nucleotide polymorphisms associated with Plasmodium falciparum drug resistance.
Topics: Animals; Antimalarials; Chloroquine; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Fluorescence; Humans; Ligases; Malaria, Falciparum; Membrane Transport Proteins; Microspheres; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2007 |
Consumers stated and revealed preferences for community health workers and other strategies for the provision of timely and appropriate treatment of malaria in southeast Nigeria.
Topics: Adult; Animals; Antimalarials; Chloroquine; Community Health Services; Community Health Workers; Consumer Behavior; Drug Combinations; Female; Health Care Surveys; Humans; Malaria, Falciparum; Male; Middle Aged; Nigeria; Patient Satisfaction; Plasmodium falciparum; Pyrimethamine; Rural Population; Sulfadoxine; Surveys and Questionnaires | 2006 |
Sulfadoxine-pyrimethamine pharmacokinetics in malaria: pediatric dosing implications.
Topics: Adolescent; Adult; Aging; Area Under Curve; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Combinations; Female; Half-Life; Humans; Infant; Malaria, Falciparum; Male; Metabolic Clearance Rate; Pyrimethamine; Regression Analysis; Sulfadoxine | 2006 |
Rapid dissemination of Plasmodium falciparum drug resistance despite strictly controlled antimalarial use.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Resistance; Female; Genotype; Humans; Malaria, Falciparum; Male; Membrane Transport Proteins; Microsatellite Repeats; Parasitic Sensitivity Tests; Plasmodium falciparum; Pregnancy; Protozoan Proteins; Pyrimethamine; Retrospective Studies; Senegal; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2007 |
Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Parasitic Sensitivity Tests; Plasmodium falciparum; Point Mutation; Pyrimethamine; Sulfadoxine; Tanzania; Tetrahydrofolate Dehydrogenase | 2007 |
Common origin and fixation of Plasmodium falciparum dhfr and dhps mutations associated with sulfadoxine-pyrimethamine resistance in a low-transmission area in South America.
Topics: Adult; Animals; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Genotype; Humans; Malaria, Falciparum; Microsatellite Repeats; Plasmodium falciparum; Point Mutation; Pyrimethamine; Selection, Genetic; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Venezuela | 2007 |
Antimalarial drug combinations in vastly different settings.
Topics: Amodiaquine; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Burkina Faso; Drug Combinations; Drug Resistance, Microbial; Ethanolamines; Fluorenes; Humans; Indonesia; Malaria, Falciparum; Malaria, Vivax; Plasmodium falciparum; Pyrimethamine; Recurrence; Sulfadoxine | 2007 |
Effects of pyrimethamine-sulphadoxine, chloroquine plus chlorpheniramine, and amodiaquine plus pyrimethamine-sulphadoxine on gametocytes during and after treatment of acute, uncomplicated malaria in children.
Topics: Acute Disease; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Chlorpheniramine; Drug Combinations; Drug Therapy, Combination; Gametogenesis; Histamine H1 Antagonists; Humans; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Time Factors; Treatment Outcome | 2006 |
Sustained use of insecticide-treated curtains is not associated with greater circulation of drug-resistant malaria parasites, or with higher risk of treatment failure among children with uncomplicated malaria in Burkina Faso.
Topics: Animals; Antimalarials; Bedding and Linens; Burkina Faso; Child, Preschool; Chloroquine; Cross-Sectional Studies; DNA, Protozoan; Drug Combinations; Drug Resistance; Humans; Infant; Insect Vectors; Insecticides; Malaria, Falciparum; Membrane Transport Proteins; Mosquito Control; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Rural Population; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2007 |
Sulfadoxine-pyrimethamine susceptibilities and analysis of the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum isolates from Côte d'Ivoire.
Topics: Animals; Antimalarials; Child, Preschool; Cote d'Ivoire; Dihydropteroate Synthase; Drug Combinations; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2007 |
Efficacy of combined treatment with alpha/beta-arteether and sulfadoxine-pyrimethamine, for cases of Plasmodium falciparum malaria in Jharkhand, India.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Child; Drug Combinations; Female; Humans; India; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2007 |
Analysis of sulphadoxine/pyrimethamine resistance-conferring mutations of Plasmodium falciparum from Mozambique reveals the absence of the dihydrofolate reductase 164L mutant.
Topics: Adolescent; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Codon; Dihydropteroate Synthase; Drug Combinations; Drug Resistance, Multiple; Female; Humans; Infant; Malaria, Falciparum; Male; Mozambique; Mutation; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2007 |
Diagnosis and treatment of malaria in peripheral health facilities in Uganda: findings from an area of low transmission in south-western Uganda.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care Facilities; Animals; Child; Child, Preschool; Chloroquine; Drug Combinations; Endemic Diseases; Female; Humans; Infant; Longitudinal Studies; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sensitivity and Specificity; Sulfadoxine; Uganda | 2007 |
Therapeutic efficacy of sulfadoxin/pyrimethamine in the treatment of uncomplicated Plasmodium falciparum malaria in Enseno, Meskan Woreda, Gurage zone, SNNPR, Ethiopia.
Topics: Adolescent; Adult; Antimalarials; Child; Child, Preschool; Cross-Sectional Studies; Drug Combinations; Ethiopia; Female; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2006 |
Subclinical Plasmodium falciparum infection and HIV-1 viral load.
Topics: Adult; Animals; Antimalarials; Drug Combinations; HIV Infections; HIV-1; Humans; Infant; Kenya; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Viral Load | 2007 |
Molecular surveillance for drug-resistant Plasmodiumfalciparum malaria in Malawi.
Topics: Animals; Antimalarials; Chloroquine; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Malawi; Membrane Transport Proteins; Plasmodium falciparum; Point Mutation; Protozoan Proteins; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2007 |
[Assessment of the efficacy of antimalarial drugs in Tarapacá, in the Colombian Amazon basin].
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Child; Child, Preschool; Colombia; Female; Humans; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Pyrimethamine; Sulfadoxine | 2007 |
High prevalence of molecular markers for resistance to chloroquine and pyrimethamine in Plasmodium falciparum from Zimbabwe.
Topics: Adolescent; Adult; Animals; Antimalarials; Chloroquine; DNA, Protozoan; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Zimbabwe | 2007 |
Detection of drug resistance markers for chloroquine and pyrimethamine-sulfadoxine in Jazan area, Saudi Arabia using PCR and restriction digestion.
Topics: Animals; Antimalarials; Biomarkers; Chloroquine; Codon; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mutation; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Saudi Arabia; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2007 |
Combined molecular and clinical assessment of Plasmodium falciparum antimalarial drug resistance in the Lao People's Democratic Republic (Laos).
Topics: Adolescent; Animals; Antimalarials; Drug Combinations; Drug Resistance; Female; Humans; Laos; Malaria, Falciparum; Male; Mutation; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2007 |
Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children.
Topics: Alleles; Animals; Antimalarials; Cameroon; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Folic Acid Antagonists; Humans; Infant; Malaria, Falciparum; Molecular Epidemiology; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2007 |
The implication of dihydrofolate reductase and dihydropteroate synthetase gene mutations in modification of Plasmodium falciparum characteristics.
Topics: Animals; Antimalarials; Chloroquine; Dihydropteroate Synthase; Drug Combinations; Drug Therapy, Combination; Gene Frequency; Genes, Protozoan; Humans; Malaria, Falciparum; Plasmodium falciparum; Point Mutation; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2007 |
The influence of genetic innate resistance and acquired immunity on drug treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania.
Topics: Animals; Antimalarials; Awards and Prizes; Child, Preschool; Comorbidity; Cross-Sectional Studies; Drug Combinations; Drug Resistance; Endemic Diseases; Genetic Predisposition to Disease; Genetic Testing; Glucosephosphate Dehydrogenase; Glycogen Storage Disease Type I; Hemoglobinopathies; Hemoglobins, Abnormal; Humans; Immunity, Innate; Infant; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tanzania; Treatment Outcome | 2006 |
The effect of health care worker training on the use of intermittent preventive treatment for malaria in pregnancy in rural western Kenya.
Topics: Adolescent; Adult; Antimalarials; Child; Cross-Sectional Studies; Drug Combinations; Endemic Diseases; Female; Health Personnel; Humans; Kenya; Malaria, Falciparum; Middle Aged; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Rural Health; Sulfadoxine | 2007 |
Selection of antifolate-resistant Plasmodium falciparum by sulfadoxine-pyrimethamine treatment and infectivity to Anopheles mosquitoes.
Topics: Animals; Anopheles; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Folic Acid Antagonists; Humans; Malaria, Falciparum; Odds Ratio; Plasmodium falciparum; Point Mutation; Pyrimethamine; Selection, Genetic; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2007 |
Therapeutic efficacy of sulfadoxine-pyrimethamine and the prevalence of molecular markers of resistance in under 5-year olds in Brazzaville, Congo.
Topics: Animals; Antimalarials; Child, Preschool; Congo; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Drug Resistance, Multiple; Female; Genetic Markers; Humans; Infant; Malaria, Falciparum; Male; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2007 |
Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancy.
Topics: Adolescent; Adult; Anemia; Animals; Antimalarials; Birth Weight; Chemoprevention; Drug Administration Schedule; Drug Combinations; Female; Ghana; Humans; Infant, Newborn; Malaria, Falciparum; Middle Aged; Placenta; Placenta Diseases; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Rural Population; Sulfadoxine; Treatment Outcome | 2007 |
High-performance liquid chromatographic assay for the determination of sulfadoxine and N-acetyl sulfadoxine in plasma from patients infected with sensitive and resistant Plasmodium falciparum malaria.
Topics: Animals; Antimalarials; Chromatography, High Pressure Liquid; Malaria, Falciparum; Plasmodium falciparum; Reproducibility of Results; Sensitivity and Specificity; Sulfadoxine | 2007 |
Prevalence of mutations associated with antimalarial drugs in Plasmodium falciparum isolates prior to the introduction of sulphadoxine-pyrimethamine as first-line treatment in Iran.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Endemic Diseases; Humans; Infant; Iran; Malaria, Falciparum; Middle Aged; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Prevalence; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2007 |
Potential impact of host immunity on malaria treatment outcome in Tanzanian children infected with Plasmodium falciparum.
Topics: Amodiaquine; Animals; Antibodies, Protozoan; Child, Preschool; Drug Combinations; Drug Resistance; Female; Humans; Immunocompetence; Immunoglobulin G; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tanzania; Treatment Outcome | 2007 |
Decline in sulfadoxine-pyrimethamine-resistant alleles after change in drug policy in the Amazon region of Peru.
Topics: Alleles; Animals; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Health Policy; Humans; Malaria, Falciparum; Mutation; Peru; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2008 |
Access and barriers to measures targeted to prevent malaria in pregnancy in rural Kenya.
Topics: Adolescent; Adult; Antimalarials; Bedding and Linens; Delivery of Health Care; Drug Combinations; Female; Health Care Surveys; Health Services Accessibility; Humans; Insecticides; Interviews as Topic; Kenya; Malaria, Falciparum; Middle Aged; Mosquito Control; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Rural Population; Sulfadoxine | 2008 |
Chloroquine resistant Plasmodium falciparum malaria in Osogbo Nigeria: efficacy of amodiaquine + sulfadoxine-pyrimethamine and chloroquine + chlorpheniramine for treatment.
Topics: Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Chlorpheniramine; Clinical Protocols; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Histamine H1 Antagonists; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2008 |
The usefulness of twenty-four molecular markers in predicting treatment outcome with combination therapy of amodiaquine plus sulphadoxine-pyrimethamine against falciparum malaria in Papua New Guinea.
Topics: Amodiaquine; Animals; Antimalarials; Biomarkers; Drug Combinations; Malaria, Falciparum; Papua New Guinea; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2008 |
Assessment of the therapeutic efficacy of chloroquine in the treatment of uncomplicated Plasmodium falciparum malaria in a tribal block of the Kalahandi district of Orissa, India.
Topics: Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Humans; India; Malaria, Falciparum; Plasmodium falciparum; Prevalence; Pyrimethamine; Rural Health; Sulfadoxine; Treatment Failure | 2008 |
Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Area Under Curve; Child; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mutation, Missense; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; South Africa; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Time Factors; Treatment Outcome | 2008 |
Severe malaria in children at Port Moresby General Hospital, Papua New Guinea.
Topics: Antimalarials; Child; Child, Preschool; Drug Combinations; Female; Glasgow Coma Scale; Hospitals, General; Humans; Infant; Malaria, Cerebral; Malaria, Falciparum; Male; New Guinea; Nutritional Status; Prognosis; Prospective Studies; Pyrimethamine; Quinine; Sulfadoxine | 1995 |
Tumour necrosis factor alpha in uncomplicated malaria in young adults.
Topics: Adolescent; Adult; Antimalarials; Case-Control Studies; Chloroquine; Drug Combinations; Enzyme-Linked Immunosorbent Assay; Female; Humans; Malaria, Falciparum; Male; Pyrimethamine; Sex Factors; Sulfadoxine; Tumor Necrosis Factor-alpha; Zambia | 1995 |
In vitro susceptibility of Plasmodium falciparum to chloroquine, amodiaquine, quinine, mefloquine, and sulfadoxine/pyrimethamine in Equatorial Guinea.
Topics: Amodiaquine; Animals; Antimalarials; Child; Chloroquine; Drug Combinations; Equatorial Guinea; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Regression Analysis; Sulfadoxine | 1995 |
Impact of transmission intensity and age on Plasmodium falciparum density and associated fever: implications for malaria vaccine trial design.
Topics: Age Factors; Animals; Anopheles; Antimalarials; Child; Child, Preschool; Clinical Trials as Topic; Cohort Studies; Disease Transmission, Infectious; Fever; Humans; Incidence; Infant; Insect Vectors; Kenya; Malaria Vaccines; Malaria, Falciparum; Parasitemia; Pyrimethamine; Recurrence; Research Design; Retrospective Studies; Rural Population; Seasons; Sulfadoxine | 1995 |
Efficacy of a 3-day oral regimen of quinine in an area of northern Nigeria with low-grade resistance of Plasmodium falciparum to chloroquine and sulphadoxine-pyrimethamine.
Topics: Administration, Oral; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Administration Schedule; Drug Combinations; Drug Resistance, Multiple; Humans; Infant; Malaria, Falciparum; Nigeria; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1995 |
Sensitivity to antimalarial drugs by Plasmodium falciparum in Goundry, Oubritenga province, Burkina Faso.
Topics: Amodiaquine; Animals; Antimalarials; Burkina Faso; Child; Child, Preschool; Chloroquine; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; National Health Programs; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 1994 |
Drug-resistant Plasmodium falciparum malaria in the eastern Transvaal.
Topics: Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1994 |
Antimalarials during pregnancy: a cost-effectiveness analysis.
Topics: Antimalarials; Chloroquine; Cost-Benefit Analysis; Decision Support Techniques; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 1995 |
Congenitally acquired chloroquine-resistant P. falciparum malaria in an infant born in the United States.
Topics: Adult; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Pyrimethamine; Quinine; Sulfadoxine; United States | 1995 |
Resistance of Plasmodium falciparum in vivo to 3 days' treatment with quinine and single-dose Fansidar.
Topics: Animals; Antimalarials; Child, Preschool; Drug Combinations; Drug Resistance; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine; Treatment Failure | 1994 |
Response of chloroquine-resistant falciparum malaria to sulfadoxine/pyrimethamine in Gokwe area of Zimbabwe.
Topics: Adult; Antimalarials; Child; Chloroquine; Drug Combinations; Drug Monitoring; Drug Resistance; Follow-Up Studies; Humans; Malaria, Falciparum; Microbial Sensitivity Tests; Pyrimethamine; Sulfadoxine; Treatment Outcome; Zimbabwe | 1994 |
Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine.
Topics: Amino Acid Sequence; Animals; Base Sequence; Chromosome Mapping; Consensus Sequence; Dihydropteroate Synthase; Diphosphotransferases; DNA Primers; DNA, Protozoan; Drug Resistance; Genetic Variation; Humans; Malaria, Falciparum; Molecular Sequence Data; Mutation; Plasmodium falciparum; Sequence Homology, Amino Acid; Sulfadoxine | 1994 |
Ten-year surveillance of drug-resistant malaria in Burkina Faso (1982-1991).
Topics: Adolescent; Animals; Antimalarials; Burkina Faso; Child; Chloroquine; Drug Resistance; Humans; Longitudinal Studies; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Prevalence; Pyrimethamine; Quinine; Retrospective Studies; Sulfadoxine | 1994 |
Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa.
Topics: Adult; Antimalarials; Chloroquine; Female; Humans; Kenya; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Proguanil; Pyrimethamine; Sulfadoxine; Travel | 1993 |
Chloroquine-resistant falciparum malaria in an area of rising endemicity in Zimbabwe.
Topics: Absenteeism; Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Disease Outbreaks; Drug Combinations; Drug Resistance; Follow-Up Studies; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Plasmodium falciparum; Prevalence; Pruritus; Pyrimethamine; Rural Population; Sulfadoxine; Zimbabwe | 1994 |
Mefloquine level monitoring in patients with multidrug resistant Plasmodium falciparum on the Thai Myanmar border.
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Cambodia; Chromatography, High Pressure Liquid; Drug Combinations; Drug Monitoring; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Primaquine; Pyrimethamine; Sulfadoxine; Thailand; Treatment Outcome | 1993 |
Sulphadoxine-pyrimethamine and chloroquine resistant Plasmodium falciparum infection in Sri Lanka.
Topics: Adult; Animals; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sri Lanka; Sulfadoxine | 1994 |
Assessment of the response in vivo and in vitro of Plasmodium falciparum to sulphadoxine-pyrimethamine in the malarious areas of Iran.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amodiaquine; Animals; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant; Iran; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Quinine; Regression Analysis; Sulfadoxine | 1993 |
Falciparum malaria: differential effects of antimalarial drugs on ex vivo parasite viability during the critical early phase of therapy.
Topics: Animals; Antimalarials; Drug Combinations; Drug Therapy, Combination; Humans; Malaria, Falciparum; Phenanthrenes; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine; Time Factors | 1993 |
Sensitivity of Plasmodium falciparum to pyrimethamine in vivo and to sulphadoxine/pyrimethamine combination in vitro in pregnant women of northern Nigeria.
Topics: Adolescent; Adult; Animals; Drug Combinations; Drug Resistance; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Nigeria; Parity; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 1993 |
[Mefloquine and sulfadoxine/pyrimethamine overdose in malaria tropica].
Topics: Adult; Diazepam; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Haloperidol; Humans; Malaria, Falciparum; Male; Mefloquine; Psychoses, Substance-Induced; Pyrimethamine; Sulfadoxine; Thioridazine | 1993 |
A case of dual chloroquine and halofantrine treatment failure in Zimbabwe.
Topics: Adult; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Male; Phenanthrenes; Pyrimethamine; Sulfadoxine; Zimbabwe | 1995 |
Malaria among United States troops in Somalia.
Topics: Anti-Bacterial Agents; Antimalarials; Chemoprevention; Chloroquine; Clothing; Cohort Studies; Doxycycline; Drug Resistance; Humans; Malaria, Cerebral; Malaria, Falciparum; Male; Mefloquine; Military Personnel; Population Surveillance; Prospective Studies; Protective Devices; Pyrimethamine; Quinine; Risk Factors; Somalia; Sulfadoxine; Treatment Failure; Treatment Refusal; United States | 1996 |
Clinical algorithm for malaria in Africa.
Topics: Antimalarials; Clinical Protocols; Drug Combinations; Humans; Malaria, Falciparum; Pyrimethamine; Sulfadoxine | 1996 |
Clinical algorithm for malaria in Africa.
Topics: Africa; Antimalarials; Child; Clinical Protocols; Drug Combinations; Humans; Malaria, Falciparum; Pyrimethamine; Sulfadoxine | 1996 |
Evaluation of maternal practices, efficacy, and cost-effectiveness of alternative antimalarial regimens for use in pregnancy: chloroquine and sulfadoxine-pyrimethamine.
Topics: Antimalarials; Chloroquine; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Health Knowledge, Attitudes, Practice; Humans; Malaria, Falciparum; Malawi; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Treatment Outcome | 1996 |
Minimal effective dose of mefloquine/sulfadoxine/pyrimethamine in mild Plasmodium falciparum malaria.
Topics: Adolescent; Antimalarials; Child; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Pilot Projects; Pyrimethamine; Sulfadoxine | 1995 |
Community pyrimethamine-sulfadoxine use and prevalence of resistant Plasmodium falciparum genotypes in Mali: a model for deterring resistance.
Topics: Adolescent; Adult; Africa; Animals; Antimalarials; Cross-Sectional Studies; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Prevalence; Proguanil; Pyrimethamine; Rural Population; Sequence Analysis, DNA; Sulfadoxine | 1996 |
Chloroquine resistance of Plasmodium falciparum malaria in Ethiopia and Eritrea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Eritrea; Ethiopia; Female; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Sulfadoxine | 1996 |
High prevalence of chloroquine resistant Plasmodium falciparum infection in Rajasthan epidemic.
Topics: Animals; Antibodies, Protozoan; Antimalarials; Chloroquine; Disease Outbreaks; Drug Resistance, Microbial; Enzyme-Linked Immunosorbent Assay; Humans; Immunoglobulin G; Immunoglobulin M; India; Malaria, Falciparum; Mefloquine; Microbial Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Quinine; Seroepidemiologic Studies; Sulfadoxine; Tumor Necrosis Factor-alpha | 1996 |
Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization.
Topics: Alleles; Animals; Antimalarials; Dihydropteroate Synthase; Drug Antagonism; Drug Combinations; Drug Resistance, Microbial; Folic Acid; Genetic Linkage; Humans; Malaria, Falciparum; Microbial Sensitivity Tests; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Recombination, Genetic; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 1997 |
Resurgence of malaria and drug resistance in plasmodium falciparum and plasmodium vivax species in Bombay.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Cross-Sectional Studies; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Female; Humans; Incidence; India; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Pyrimethamine; Sulfadoxine | 1995 |
Resistance to pyrimethamine/sulfadoxine in Plasmodium falciparum in 12 villages in north east Tanzania and a test of chlorproguanil/dapsone.
Topics: Anti-Infective Agents; Antimalarials; Child; Child, Preschool; Dapsone; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Infant; Malaria, Falciparum; Proguanil; Pyrimethamine; Sulfadoxine; Tanzania | 1997 |
Malaria in Mvumi, central Tanzania and the in vivo response of Plasmodium falciparum to chloroquine and sulphadoxine pyrimethamine.
Topics: Adolescent; Adult; Aged; Animals; Anopheles; Antimalarials; Child; Chloroquine; Cross-Sectional Studies; Culex; Drug Combinations; Drug Resistance; Humans; Insect Vectors; Malaria, Falciparum; Middle Aged; Prevalence; Pyrimethamine; Sulfadoxine; Tanzania | 1997 |
In vivo sensitivity of Plasmodium falciparum to chloroquine and sulfadoxine-pyrimethamine in school children in Hoima district, western Uganda.
Topics: Antimalarials; Child; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Pyrimethamine; Sulfadoxine | 1997 |
Efficacy of sulfadoxine-pyrimethamine in chloroquine resistant falciparum malaria in Bombay.
Topics: Adult; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; India; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 1996 |
Modified antimalarial treatment for chloroquin resistant plasmodium falciparum infection.
Topics: Antimalarials; Chloroquine; Drug Resistance; Endemic Diseases; Humans; Malaria, Falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1995 |
Parasitological and haematological responses to treatment of Plasmodium falciparum malaria with sulphadoxine-pyrimethamine in southern Malawi.
Topics: Anemia; Antimalarials; Child, Preschool; Drug Combinations; Female; Follow-Up Studies; Hemoglobins; Humans; Infant; Malaria, Falciparum; Malawi; Male; Parasitemia; Protoporphyrins; Pyrimethamine; Sulfadoxine; Treatment Outcome | 1997 |
Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins.
Topics: Africa; Alleles; Animals; Antimalarials; Dihydropteroate Synthase; DNA Mutational Analysis; Drug Combinations; Drug Resistance; Folic Acid Antagonists; Genes, Protozoan; Humans; Malaria, Falciparum; Middle East; Plasmodium falciparum; Point Mutation; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Vietnam | 1997 |
Plasmodium falciparum: evaluation of lactate dehydrogenase in monitoring therapeutic responses to standard antimalarial drugs in Nigeria.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Infant; L-Lactate Dehydrogenase; Malaria, Falciparum; Male; Monitoring, Physiologic; Nigeria; Phenanthrenes; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 1997 |
Resistance of falciparum malaria to chloroquine and sulfadoxine-pyrimethamine in Afghan refugee settlements in western Pakistan: surveys by the general health services using a simplified in vivo test.
Topics: Adolescent; Adult; Afghanistan; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Pakistan; Pyrimethamine; Refugees; Sulfadoxine | 1997 |
High prevalence of mutations in the dihydrofolate reductase gene of Plasmodium falciparum in isolates from Tanzania without evidence of an association to clinical sulfadoxine/pyrimethamine resistance.
Topics: Animals; Antimalarials; Child; Child, Preschool; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Point Mutation; Pyrimethamine; Sulfadoxine; Tanzania; Tetrahydrofolate Dehydrogenase | 1997 |
Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance.
Topics: Africa; Amino Acid Sequence; Animals; Antimalarials; Base Sequence; Bolivia; Cloning, Molecular; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Molecular Epidemiology; Molecular Sequence Data; Molecular Structure; Mutagenesis, Insertional; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Prevalence; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 1997 |
A simplified in vivo drug sensitivity test for malaria in the field.
Topics: Adult; Animals; Antimalarials; Child; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Myanmar; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Time Factors | 1997 |
The use of personal protective measures in control of malaria in a defined community.
Topics: Adult; Antimalarials; Bedding and Linens; Case-Control Studies; Child; Clothing; Female; Humans; Infant; Insecticides; Malaria, Falciparum; Male; Mosquito Control; Myanmar; Nitriles; Pyrethrins; Pyrimethamine; Sulfadoxine | 1997 |
Enhanced gametocyte production in Fansidar-treated Plasmodium falciparum malaria patients: implications for malaria transmission control programmes.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Culicidae; Drug Combinations; Female; Humans; Insect Vectors; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine; Zambia | 1997 |
Development and comparison of quantitative assays for the dihydropteroate synthetase codon 540 mutation associated with sulfadoxine resistance in Plasmodium falciparum.
Topics: Animals; Antimalarials; Codon; Dihydropteroate Synthase; DNA Primers; DNA, Protozoan; Drug Resistance; Electrophoresis, Agar Gel; Fluorescent Dyes; Humans; Malaria, Falciparum; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Reproducibility of Results; Restriction Mapping; Sensitivity and Specificity; Sequence Analysis, DNA; Sulfadoxine | 1998 |
Antifolate-resistant malaria infections in Mpumalanga.
Topics: Antimalarials; Chloroquine; Drug Resistance, Multiple; Folic Acid Antagonists; Humans; Malaria, Falciparum; Pyrimethamine; South Africa; Sulfadoxine | 1998 |
Follow-up of the susceptibility of Plasmodium falciparum to antimalarials in Gabon.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Dose-Response Relationship, Drug; Drug Resistance; Follow-Up Studies; Gabon; Malaria, Falciparum; Mefloquine; Phenanthrenes; Plasmodium falciparum; Quinine; Sesquiterpenes; Sulfadoxine | 1998 |
Identification of a subpopulation of immune Nigerian adult volunteers by antibodies to the circumsporozoite protein of Plasmodium falciparum.
Topics: Adult; Animals; Antigens, Protozoan; Antimalarials; Cohort Studies; Drug Combinations; Female; Humans; Incidence; Longitudinal Studies; Malaria, Falciparum; Male; Middle Aged; Nigeria; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Rain; Sulfadoxine | 1998 |
Molecular assays for surveillance of antifolate-resistant malaria.
Topics: Animals; Antimalarials; Child; Dihydropteroate Synthase; DNA, Protozoan; Drug Resistance; Folic Acid Antagonists; Humans; Malaria, Falciparum; Peru; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 1998 |
An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi.
Topics: Adolescent; Adult; Antimalarials; Birth Weight; Drug Therapy, Combination; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria, Falciparum; Malawi; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 1998 |
Molecular basis of in vivo resistance to sulfadoxine-pyrimethamine in African adult patients infected with Plasmodium falciparum malaria parasites.
Topics: Adolescent; Adult; Animals; Antimalarials; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Multienzyme Complexes; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Thymidylate Synthase | 1998 |
A systematic approach to the development of a rational malaria treatment policy in Zambia.
Topics: Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Evaluation; Drug Resistance; Female; Health Policy; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Policy Making; Pyrimethamine; Statistics as Topic; Sulfadoxine; Time Factors; Zambia | 1998 |
Surveillance of antifolate-resistant malaria.
Topics: Africa; Animals; Antimalarials; Codon; Dihydropteroate Synthase; Drug Resistance; Folic Acid; Genotype; Humans; Malaria, Falciparum; Phenotype; Plasmodium falciparum; Point Mutation; Pyrimethamine; South America; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 1998 |
Polymorphisms in the dihydrofolate reductase (DHFR) and dihydropteroate synthetase (DHPS) genes of Plasmodium falciparum and in vivo resistance to sulphadoxine/pyrimethamine in isolates from Tanzania.
Topics: Animals; Antimalarials; Child; Child, Preschool; Dihydropteroate Synthase; DNA Primers; Drug Resistance, Microbial; Female; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sulfadoxine; Tanzania; Tetrahydrofolate Dehydrogenase | 1998 |
[The proper use of antimalarial drugs currently available].
Topics: Animals; Antimalarials; Chemoprevention; Chloroquine; Contraindications; Drug Combinations; Drug Resistance; Endemic Diseases; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Phenanthrenes; Plasmodium; Plasmodium falciparum; Plasmodium malariae; Plasmodium vivax; Proguanil; Pyrimethamine; Quinine; Sulfadoxine; Travel | 1998 |
Increased prevalence of malaria in HIV-infected pregnant women and its implications for malaria control.
Topics: Adult; AIDS-Related Opportunistic Infections; Antimalarials; Cross-Sectional Studies; Drug Combinations; Drug Resistance; Female; Gestational Age; Humans; Malaria, Falciparum; Malawi; Parity; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Pyrimethamine; Risk Factors; Sulfadoxine | 1999 |
More on 'the efficacy of antifolate antimalarial combinations in Africa'.
Topics: Africa; Animals; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 1999 |
Selection and synergy in Plasmodium falciparum.
Topics: Africa; Animals; Antimalarials; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Drug Synergism; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 1999 |
In vivo responses to antimalarials by Plasmodium falciparum and Plasmodium vivax from isolated Gag Island off northwest Irian Jaya, Indonesia.
Topics: Adolescent; Adult; Age Distribution; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Humans; Indonesia; Infant; Malaria, Falciparum; Malaria, Vivax; Parasitemia; Plasmodium falciparum; Plasmodium vivax; Prevalence; Pyrimethamine; Sulfadoxine | 1999 |
Averting a malaria disaster.
Topics: Animals; Antimalarials; Artemisinins; Costs and Cost Analysis; Drug Resistance; Drug Therapy, Combination; Drugs, Chinese Herbal; Humans; Malaria, Falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 1999 |
Utilization of exogenous folate in the human malaria parasite Plasmodium falciparum and its critical role in antifolate drug synergy.
Topics: 4-Aminobenzoic Acid; Animals; Antimalarials; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance; Drug Synergism; Folic Acid; Humans; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 1999 |
Does the availability of blood slide microscopy for malaria at health centers improve the management of persons with fever in Zambia?
Topics: Ambulatory Care Facilities; Animals; Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Female; Fever; Humans; Interviews as Topic; Malaria, Falciparum; Male; Plasmodium falciparum; Prospective Studies; Pyrimethamine; Reproducibility of Results; Seasons; Sulfadoxine; Zambia | 1999 |
Efficacy and tolerability of a low-dose mefloquine-sulfadoxine-pyrimethamine combination compared with chloroquine in the treatment of acute malaria infection in a population with multiple drug-resistant Plasmodium falciparum.
Topics: Adolescent; Adult; Animals; Antimalarials; Blood; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance, Multiple; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Nigeria; Plasmodium falciparum; Prospective Studies; Pyrimethamine; Random Allocation; Sulfadoxine | 1999 |
Chemotherapy of malaria and resistance to antimalarial drugs in Guayana area, Venezuela.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Chloroquine; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance; Female; Humans; Leukocytes; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Plasmodium falciparum; Pyrimethamine; Random Allocation; Regression Analysis; Rural Population; Sulfadoxine; Tropical Climate; Venezuela | 1999 |
Lack of an association between the ASN-108 mutation in the dihydrofolate reductase gene and in vivo resistance to sulfadoxine/pyrimethamine in Plasmodium falciparum.
Topics: Animals; Antimalarials; Drug Combinations; Drug Resistance; Electrophoresis, Agar Gel; Gene Amplification; Genetic Markers; Humans; Malaria, Falciparum; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 1999 |
Pyrimethamine-sulfadoxine efficacy and selection for mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase in Mali.
Topics: Animals; Antimalarials; Blood; Child; Dihydropteroate Synthase; DNA Restriction Enzymes; DNA, Protozoan; Female; Humans; Malaria, Falciparum; Male; Mali; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Prospective Studies; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 1999 |
Point mutations in dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum isolates from Venezuela.
Topics: Animals; Antimalarials; Dihydropteroate Synthase; DNA Restriction Enzymes; DNA, Protozoan; Drug Combinations; Drug Resistance; Genes, Protozoan; Humans; Malaria, Falciparum; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Venezuela | 1999 |
Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in Uganda: correlation with polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes.
Topics: Animals; Antimalarials; Child, Preschool; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Uganda | 1999 |
Current clinical efficacy of chloroquine for the treatment of Plasmodium falciparum infections in urban Dar es Salaam, United Republic of Tanzania.
Topics: Age Factors; Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Drug Evaluation; Humans; Infant; Malaria, Falciparum; Pyrimethamine; Sulfadoxine; Tanzania; Urban Population | 1999 |
Anti-malarial drug use among preschool children in an area of seasonal malaria transmission in Kenya.
Topics: Adult; Animals; Antibodies, Monoclonal; Antimalarials; Child, Preschool; Chloroquine; Cluster Analysis; Enzyme-Linked Immunosorbent Assay; Female; Fever; Humans; Interviews as Topic; Kenya; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Seasons; Sulfadoxine; Surveys and Questionnaires | 1999 |
Association of the ICAM-1Kilifi mutation with protection against severe malaria in Lambaréné, Gabon.
Topics: Animals; Anti-Bacterial Agents; Antimalarials; Case-Control Studies; Child; Clindamycin; Deoxyribonucleases, Type II Site-Specific; DNA; DNA Primers; Drug Combinations; Electrophoresis, Agar Gel; Female; Gabon; Humans; Intercellular Adhesion Molecule-1; Malaria, Falciparum; Male; Nigeria; Papua New Guinea; Parasitemia; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Pyrimethamine; Quinine; Sulfadoxine; Thailand; Virulence | 1999 |
Molecular epidemiology of malaria in Yaounde, Cameroon IV. Evolution of pyrimethamine resistance between 1994 and 1998.
Topics: Adolescent; Adult; Animals; Antimalarials; Cameroon; Child; DNA Primers; DNA, Protozoan; Drug Combinations; Drug Resistance; Electrophoresis, Agar Gel; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Phenotype; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Pyrimethamine; Scintillation Counting; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 1999 |
Atovaquone-proguanil for falciparum malaria in the Philippines.
Topics: Antimalarials; Atovaquone; Chloroquine; Drug Combinations; Humans; Malaria, Falciparum; Naphthoquinones; Philippines; Proguanil; Pyrimethamine; Sulfadoxine | 2000 |
[Chloroquine sensitivity of Plasmodium falciparum at the Gamkalley Clinic and the Nigerian armed forces PMI (Niamey, Niger)].
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Resistance; Humans; Infant; Malaria, Falciparum; Nigeria; Parasitemia; Plasmodium falciparum; Pyrimethamine; Quinine; Recurrence; Sulfadoxine | 1999 |
Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites.
Topics: Alleles; Animals; Antimalarials; Child, Preschool; Dihydropteroate Synthase; Drug Resistance; Female; Genotype; Humans; Infant; Kenya; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2000 |
Population dynamics of Plasmodium falciparum in an unstable malaria area of eastern Sudan.
Topics: Alleles; Animals; Antigens, Protozoan; Antimalarials; Chloroquine; Cohort Studies; DNA Primers; DNA, Protozoan; Drug Combinations; Genetic Variation; Humans; Malaria, Falciparum; Merozoite Surface Protein 1; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Seasons; Sudan; Sulfadoxine | 2000 |
Malaria, intestinal parasites, and schistosomiasis among Barawan Somali refugees resettling to the United States: a strategy to reduce morbidity and decrease the risk of imported infections.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Child; Child, Preschool; Coccidiosis; Cryptosporidiosis; Cryptosporidium parvum; Drug Combinations; Eucoccidiida; Female; Humans; Infant; Intestinal Diseases, Parasitic; Malaria, Falciparum; Male; Mass Screening; Middle Aged; Plasmodium falciparum; Pyrimethamine; Refugees; Schistosomiasis haematobia; Schistosomiasis mansoni; Somalia; Sulfadoxine; United States | 2000 |
Epidemiologic tools for malaria surveillance in an urban setting of low endemicity along the Colombian Pacific coast.
Topics: Animals; Antimalarials; Blood; Blotting, Southern; Chloroquine; Colombia; Cross-Sectional Studies; DNA Primers; DNA, Protozoan; Drug Combinations; Electrophoresis, Agar Gel; Female; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Polymerase Chain Reaction; Prevalence; Primaquine; Pyrimethamine; Reagent Kits, Diagnostic; Sensitivity and Specificity; Sentinel Surveillance; Sulfadoxine; Urban Population | 2000 |
Gametocytemia and infectivity to mosquitoes of patients with uncomplicated Plasmodium falciparum malaria attacks treated with chloroquine or sulfadoxine plus pyrimethamine.
Topics: Acetaminophen; Adolescent; Adult; Analgesics, Non-Narcotic; Animals; Anopheles; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Female; Humans; Insect Vectors; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Plasmodium falciparum; Prevalence; Pyrimethamine; Senegal; Sulfadoxine | 2000 |
Chloroquine resistant malaria.
Topics: Africa South of the Sahara; Anti-Bacterial Agents; Antimalarials; Chloroquine; Doxycycline; Drug Antagonism; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Patient Selection; Pyrimethamine; Quinine; Sulfadoxine | 2000 |
Efficacy of sulphadoxine-pyrimethamine for acute uncomplicated malaria due to Plasmodium falciparum in Malawian children under five years old.
Topics: Acute Disease; Antimalarials; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Sulfadoxine | 2000 |
Sequence variations in the genes encoding dihydropteroate synthase and dihydrofolate reductase and clinical response to sulfadoxine-pyrimethamine in patients with acute uncomplicated falciparum malaria.
Topics: Adolescent; Adult; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Genes, Protozoan; Humans; Malaria, Falciparum; Middle Aged; Molecular Sequence Data; Mutation; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2000 |
In vivo sensitivity of Plasmodium falciparum to chloroquine and sulfadoxine-pyrimethamine among schoolchildren in rural Uganda: a comparison between 1995 and 1998.
Topics: Animals; Antimalarials; Child; Chloroquine; Drug Combinations; Humans; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Pyrimethamine; Rural Population; Students; Sulfadoxine; Time Factors; Uganda | 2000 |
Chloroquine- and sulfadoxine-pyrimethamine-resistant Falciparum malaria in vivo - a pilot study in rural Zambia.
Topics: Animals; Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Pilot Projects; Plasmodium falciparum; Pyrimethamine; Rural Health; Sulfadoxine; Zambia | 2000 |
Chemoresistance of Plasmodium falciparum in the urban region of Yaounde, Cameroon. Part 2: Evaluation of the efficacy of amodiaquine and sulfadoxine-pyrimethamine combination in the treatment of uncomplicated Plasmodium falciparum malaria in Yaounde, Came
Topics: Adolescent; Adult; Aged; Amodiaquine; Animals; Antimalarials; Cameroon; Child; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome; Urban Health | 2000 |
Comparative clinical characteristics and response to oral antimalarial therapy of children with and without Plasmodium falciparum hyperparasitaemia in an endemic area.
Topics: Adolescent; Age Factors; Analysis of Variance; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Therapy, Combination; Endemic Diseases; Female; Heart Rate; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Parasitemia; Prospective Studies; Pyrimethamine; Sulfadoxine; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2000 |
Treatment of uncomplicated Plasmodium falciparum malaria in Myanmar: a clinical decision analysis.
Topics: Antimalarials; Chloroquine; Cost-Benefit Analysis; Decision Support Techniques; Decision Trees; Drug Combinations; Humans; Malaria, Falciparum; Mefloquine; Myanmar; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome | 2000 |
Parasitaemia and gametocytaemia after treatment with chloroquine, pyrimethamine/sulfadoxine, and pyrimethamine/sulfadoxine combined with artesunate in young Gambians with uncomplicated malaria.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Child; Chloroquine; Cost-Benefit Analysis; Disease Transmission, Infectious; Drug Combinations; Female; Gambia; Gametogenesis; Humans; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Pyrimethamine; Random Allocation; Rural Health; Seasons; Sesquiterpenes; Sulfadoxine; Time Factors; Treatment Outcome | 2001 |
[Resistance of Plasmodium falciparum to 3 antimalarials in Turbo (Antioquia, Colombia), 1998].
Topics: Adolescent; Adult; Aged; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Colombia; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2001 |
[Drug resistance of Plasmodium falciparum in coastal regions of Madagascar].
Topics: Adolescent; Animals; Child; Child, Preschool; Chloroquine; Drug Resistance; Drug Therapy, Combination; Humans; Madagascar; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2000 |
HIV infection may adversely affect clinical response to chloroquine therapy for uncomplicated malaria in children.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Follow-Up Studies; HIV Antibodies; HIV-1; Humans; Infant; Malaria, Falciparum; Middle Aged; Pyrimethamine; Sulfadoxine; Treatment Outcome; Uganda | 2001 |
Imported malaria in a Japanese male: an autopsy report.
Topics: Animals; Antimalarials; DNA, Protozoan; Drug Combinations; Fatal Outcome; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sulfadoxine | 2001 |
Therapeutic efficacy of sulphadoxine/pyrimethamine and susceptibility in vitro of P. falciparum isolates to sulphadoxine-pyremethamine and other antimalarial drugs in Malawian children.
Topics: Animals; Antimalarials; Child, Preschool; Drug Monitoring; Drug Resistance; Drug Therapy, Combination; Humans; In Vitro Techniques; Infant; Infant, Newborn; Logistic Models; Malaria, Falciparum; Malawi; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2001 |
Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Dapsone; Drug Combinations; Drug Resistance; Genotype; Humans; Malaria, Falciparum; Middle Aged; Plasmodium falciparum; Point Mutation; Proguanil; Pyrimethamine; Sulfadoxine; Tanzania | 2001 |
Prevalence of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum isolates from southern Mauritania.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Dihydropteroate Synthase; Disease Outbreaks; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Mauritania; Middle Aged; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Prevalence; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2001 |
History and importance of antimalarial drug resistance.
Topics: Africa; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; History, 20th Century; History, 21st Century; Humans; Malaria, Falciparum; Mosquito Control; Pyrimethamine; Sulfadoxine; Treatment Outcome; World Health Organization | 2001 |
Failure of sulphadoxine-pyrimethamine in treating Plasmodium falciparum malaria in KwaZulu-Natal.
Topics: Antimalarials; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Pyrimethamine; Sulfadoxine; Treatment Failure | 2001 |
Treatment of imported malaria in an ambulatory setting: prospective study.
Topics: Adolescent; Adult; Africa; Aged; Ambulatory Care; Antimalarials; Follow-Up Studies; Humans; Malaria, Falciparum; Mefloquine; Middle Aged; Outpatient Clinics, Hospital; Prospective Studies; Pyrimethamine; Sulfadoxine; Switzerland; Travel | 2002 |
[In vivo sensitivity of Plasmodium falciparum to amino-4-quinolines and sulfadoxine pyrimethamine in Agou (Ivory Coast)].
Topics: Adolescent; Aminoquinolines; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Cote d'Ivoire; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Infant; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2002 |
Death from a severe case of Plasmodium falciparum in a Canadian.
Topics: Adult; Animals; Antimalarials; Cause of Death; Chloroquine; Drug Combinations; Female; Humans; Malaria, Falciparum; Multiple Organ Failure; Plasmodium falciparum; Pyrimethamine; Quinidine; Sulfadoxine; Travel | 1992 |
Sensitivity status of Plasmodium falciparum to chloroquine, amodiaquine, quinine, mefloquine and sulfadoxine/pyrimethamine in a tribal population of District Sundargarh, Orissa.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; India; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1992 |
Malaria therapy in 452 patients, with special reference to the use of quinine.
Topics: Adolescent; Adult; Aged; Antimalarials; Child; Drug Resistance; Drug Therapy, Combination; Female; Humans; Immunity; Malaria; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Quinine; Sulfadoxine; Travel; Treatment Outcome | 1992 |
Antimalarial drug sensitivity patterns in the western province of Zambia. Implications for the management of primary health care (PHC).
Topics: Adolescent; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Pyrimethamine; Sulfadoxine; Zambia | 1992 |
Efficacies of chloroquine, pyrimethamine/sulphadoxine and pyrimethamine/sulphalene against P. falciparum in northeastern Nigeria.
Topics: Animals; Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Humans; Incidence; Infant; Malaria, Falciparum; Nigeria; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfalene | 1992 |
Treatment of chloroquine-resistant malaria in African children: a cost-effectiveness analysis.
Topics: Africa; Amodiaquine; Animals; Antimalarials; Child, Preschool; Chloroquine; Cost-Benefit Analysis; Decision Trees; Drug Combinations; Drug Costs; Drug Resistance; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 1992 |
The disposition of oral and intramuscular pyrimethamine/sulphadoxine in Kenyan children with high parasitaemia but clinically non-severe falciparum malaria.
Topics: Administration, Oral; Child; Child, Preschool; Drug Combinations; Humans; Infant; Injections, Intramuscular; Kenya; Malaria, Falciparum; Pyrimethamine; Sulfadoxine | 1992 |
Mefloquine for multidrug-resistant malaria.
Topics: Animals; Antimalarials; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Psychoses, Substance-Induced; Pyrimethamine; Refugees; Sulfadoxine | 1991 |
In vivo response of multi-resistant Plasmodium falciparum infections to mefloquine and its combination with sulfadoxine/pyrimethamine in Cambodia.
Topics: Animals; Cambodia; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pyrimethamine; Recurrence; Sulfadoxine | 1991 |